
<html lang="en"     class="pb-page"  data-request-id="a2ab8636-383f-4dda-b3b8-d17e8deba39e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.0c00431;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies" /></meta><meta name="dc.Creator" content="Anna  Notaro" /></meta><meta name="dc.Creator" content="Angelo  Frei" /></meta><meta name="dc.Creator" content="Riccardo  Rubbiani" /></meta><meta name="dc.Creator" content="Marta  Jakubaszek" /></meta><meta name="dc.Creator" content="Uttara  Basu" /></meta><meta name="dc.Creator" content="Severin  Koch" /></meta><meta name="dc.Creator" content="Cristina  Mari" /></meta><meta name="dc.Creator" content="Mazzarine  Dotou" /></meta><meta name="dc.Creator" content="Olivier  Blacque" /></meta><meta name="dc.Creator" content="Jérémie  Gouyon" /></meta><meta name="dc.Creator" content="Fethi  Bedioui" /></meta><meta name="dc.Creator" content="Nils  Rotthowe" /></meta><meta name="dc.Creator" content="Rainer F.  Winter" /></meta><meta name="dc.Creator" content="Bruno  Goud" /></meta><meta name="dc.Creator" content="Stefano  Ferrari" /></meta><meta name="dc.Creator" content="Mickaël  Tharaud" /></meta><meta name="dc.Creator" content="Martina  Řezáčová" /></meta><meta name="dc.Creator" content="Jana  Humajová" /></meta><meta name="dc.Creator" content="Pavel  Tomšík" /></meta><meta name="dc.Creator" content="Gilles  Gasser" /></meta><meta name="dc.Description" content="Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have bee..." /></meta><meta name="Description" content="Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have bee..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 22, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00431" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00431" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00431" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00431" /></link>
        
    
    

<title>Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00431" /></meta><meta property="og:title" content="Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0013.jpeg" /></meta><meta property="og:description" content="Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have been investigated over the years to discover new targets and synergistic mechanisms of action including multicellular targets. In this work, we designed a new chemotherapeutic drug candidate against cancer, namely, [Ru(DIP)2(sq)](PF6) (Ru-sq) (DIP = 4,7-diphenyl-1,10-phenanthroline; sq = semiquinonate ligand). The aim was to combine the great potential expressed by Ru(II) polypyridyl complexes and the singular redox and biological properties associated with the catecholate moiety. Experimental evidence (e.g., X-ray crystallography, electron paramagnetic resonance, electrochemistry) demonstrates that the semiquinonate is the preferred oxidation state of the dioxo ligand in this complex. The biological activity of Ru-sq was then scrutinized in vitro and in vivo, and the results highlight the promising potential of this complex as a chemotherapeutic agent against cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00431"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00431">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00431&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00431&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00431&amp;href=/doi/10.1021/acs.jmedchem.0c00431" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5568-5584</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00424" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00628" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to <i>In Vivo</i> Studies</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Anna Notaro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna Notaro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Notaro">Anna Notaro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angelo Frei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angelo Frei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angelo++Frei">Angelo Frei</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6169-2491" title="Orcid link">http://orcid.org/0000-0001-6169-2491</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Riccardo Rubbiani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Riccardo Rubbiani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Riccardo++Rubbiani">Riccardo Rubbiani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Jakubaszek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Jakubaszek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</div><div class="loa-info-affiliations-info">Institut Curie, PSL University, CNRS UMR 144, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Jakubaszek">Marta Jakubaszek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Uttara Basu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Uttara Basu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Uttara++Basu">Uttara Basu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Severin Koch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Severin Koch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Severin++Koch">Severin Koch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cristina Mari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Mari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Mari">Cristina Mari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mazzarine Dotou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mazzarine Dotou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mazzarine++Dotou">Mazzarine Dotou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Olivier Blacque</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olivier Blacque</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Blacque">Olivier Blacque</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jérémie Gouyon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jérémie Gouyon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Team Synthèse, Electrochimie, Imagerie et Systèmes Analytiques pour le Diagnostic, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%A9r%C3%A9mie++Gouyon">Jérémie Gouyon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fethi Bedioui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fethi Bedioui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Team Synthèse, Electrochimie, Imagerie et Systèmes Analytiques pour le Diagnostic, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fethi++Bedioui">Fethi Bedioui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nils Rotthowe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nils Rotthowe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Konstanz, Universitätsstrasse 10, D-78457 Konstanz, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nils++Rotthowe">Nils Rotthowe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainer F. Winter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainer F. Winter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Konstanz, Universitätsstrasse 10, D-78457 Konstanz, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainer+F.++Winter">Rainer F. Winter</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8381-0647" title="Orcid link">http://orcid.org/0000-0001-8381-0647</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruno Goud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruno Goud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut Curie, PSL University, CNRS UMR 144, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruno++Goud">Bruno Goud</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefano Ferrari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefano Ferrari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Molecular Cancer Research, University of Zurich, CH-8057 Zurich, Switzerland</div><div class="loa-info-affiliations-info">Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 143 00 Prague, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Ferrari">Stefano Ferrari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mickaël Tharaud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mickaël Tharaud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université de Paris, Institut de physique du Globe de Paris, CNRS, F-75005 Paris, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Micka%C3%ABl++Tharaud">Mickaël Tharaud</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6131-655X" title="Orcid link">http://orcid.org/0000-0001-6131-655X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Řezáčová</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Řezáčová</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Šimkova 870, 500 03 Hradec Kralove, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++%C5%98ez%C3%A1%C4%8Dov%C3%A1">Martina Řezáčová</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jana Humajová</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jana Humajová</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, 150 06 Prague, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Humajov%C3%A1">Jana Humajová</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pavel Tomšík</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pavel Tomšík</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Šimkova 870, 500 03 Hradec Kralove, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pavel++Tom%C5%A1%C3%ADk">Pavel Tomšík</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Gilles Gasser</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gilles Gasser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#2047494c4c45530e474153534552604348494d455041524953544543480e50534c0e4555"><span class="__cf_email__" data-cfemail="1077797c7c75633e777163637562507378797d756071627963647573783e60637c3e7565">[email protected]</span></a>. Phone: +33 1 44 27 56 02. www.gassergroup.com.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gilles++Gasser">Gilles Gasser</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4244-5097" title="Orcid link">http://orcid.org/0000-0002-4244-5097</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00431&amp;href=/doi/10.1021%2Facs.jmedchem.0c00431" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5568–5584</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 22, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 March 2020</li><li><span class="item_label"><b>Published</b> online</span>22 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00431" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00431</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5568%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnna%2BNotaro%252C%2BAngelo%2BFrei%252C%2BRiccardo%2BRubbiani%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.0c00431%26title%3DRuthenium%2528II%2529%2BComplex%2BContaining%2Ba%2BRedox-Active%2BSemiquinonate%2BLigand%2Bas%2Ba%2BPotential%2BChemotherapeutic%2BAgent%253A%2BFrom%2BSynthesis%2Bto%2BIn%2BVivo%2BStudies%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5584%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00431"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">892</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00431" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Notaro&quot;},{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;Frei&quot;},{&quot;first_name&quot;:&quot;Riccardo&quot;,&quot;last_name&quot;:&quot;Rubbiani&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Jakubaszek&quot;},{&quot;first_name&quot;:&quot;Uttara&quot;,&quot;last_name&quot;:&quot;Basu&quot;},{&quot;first_name&quot;:&quot;Severin&quot;,&quot;last_name&quot;:&quot;Koch&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Mari&quot;},{&quot;first_name&quot;:&quot;Mazzarine&quot;,&quot;last_name&quot;:&quot;Dotou&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Blacque&quot;},{&quot;first_name&quot;:&quot;Jérémie&quot;,&quot;last_name&quot;:&quot;Gouyon&quot;},{&quot;first_name&quot;:&quot;Fethi&quot;,&quot;last_name&quot;:&quot;Bedioui&quot;},{&quot;first_name&quot;:&quot;Nils&quot;,&quot;last_name&quot;:&quot;Rotthowe&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;F. Winter&quot;},{&quot;first_name&quot;:&quot;Bruno&quot;,&quot;last_name&quot;:&quot;Goud&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Ferrari&quot;},{&quot;first_name&quot;:&quot;Mickaël&quot;,&quot;last_name&quot;:&quot;Tharaud&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Řezáčová&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Humajová&quot;},{&quot;first_name&quot;:&quot;Pavel&quot;,&quot;last_name&quot;:&quot;Tomšík&quot;},{&quot;first_name&quot;:&quot;Gilles&quot;,&quot;last_name&quot;:&quot;Gasser&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5568-5584&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00431&quot;},&quot;abstract&quot;:&quot;Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have been investigated over the years to discover new targets and synergistic mechanisms of action including multicellular targets. In this work, we designed a new chemotherapeutic drug candidate against cancer, namely, [Ru(DIP)2(sq)](PF6) (Ru-sq) (DIP = 4,7-diphenyl-1,10-phenanthroline; sq = semiquinonate ligand). The aim was to combine the great potential expressed by Ru(II) polypyridyl complexes and the singular redox and biological properties associated with the catecholate moiety. Experimental evidence (e.g., X-ray crystallography, electron paramagnetic resonance, electrochemistry) demonstrates that the semiquinonate is the preferred oxidation state of the dioxo ligand in this complex. The biological activity of Ru-sq was then scrutinized in vitro and in vivo, and the results highlight the promising potential of this c&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00431&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00431" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00431&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00431" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00431&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00431" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00431&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00431&amp;href=/doi/10.1021/acs.jmedchem.0c00431" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00431" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00431" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00431%26sid%3Dliteratum%253Aachs%26pmid%3D32319768%26genre%3Darticle%26aulast%3DNotaro%26date%3D2020%26atitle%3DRuthenium%2528II%2529%2BComplex%2BContaining%2Ba%2BRedox-Active%2BSemiquinonate%2BLigand%2Bas%2Ba%2BPotential%2BChemotherapeutic%2BAgent%253A%2BFrom%2BSynthesis%2Bto%2BIn%2BVivo%2BStudies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5568%26epage%3D5584%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290768" title="Antineoplastic agents">Antineoplastic agents</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have been investigated over the years to discover new targets and synergistic mechanisms of action including multicellular targets. In this work, we designed a new chemotherapeutic drug candidate against cancer, namely, <b>[Ru(DIP)</b><sub><b>2</b></sub><b>(sq)](PF</b><sub><b>6</b></sub><b>)</b> (<b>Ru-sq</b>) (DIP = 4,7-diphenyl-1,10-phenanthroline; sq = semiquinonate ligand). The aim was to combine the great potential expressed by Ru(II) polypyridyl complexes and the singular redox and biological properties associated with the catecholate moiety. Experimental evidence (<i>e.g</i>., X-ray crystallography, electron paramagnetic resonance, electrochemistry) demonstrates that the semiquinonate is the preferred oxidation state of the dioxo ligand in this complex. The biological activity of <b>Ru-sq</b> was then scrutinized <i>in vitro</i> and <i>in vivo</i>, and the results highlight the promising potential of this complex as a chemotherapeutic agent against cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the last decades, the search for new chemotherapeutic agents against cancer has challenged scientists worldwide. Chemotherapy, together with surgery, radiotherapy, and immunotherapy, is used in a combined modality therapy to treat cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The goal of this combination is to overcome the drawbacks of each singular treatment to afford the best chances of survival for the patients.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Cisplatin is one of the most common chemotherapeutic agents utilized against cancer. However, its severe side effects are limiting its clinical use.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2−6)</a> Therefore, many other platinum-based drug candidates have been investigated over the last 40 years, leading to the worldwide clinical approval of carboplatin and oxaliplatin.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> On the basis of these groundbreaking discoveries and the observed occurrence of resistance with platinum treatment, a large number of metal complexes based on metals other than platinum have been examined.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(9−18)</a> In this field, ruthenium complexes play a central role due to their inherent advantages (<i>e.g</i>., multiple stable oxidation states, well-established chemistry, <i>etc</i>.).<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23">(19−23)</a> Interestingly, Ru(III) and Ru(II) complexes usually have ligand exchange kinetics similar to those of Pt(II) complexes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In addition, ruthenium complexes have found applications in different fields of medicinal chemistry against cancer since they behave differently, depending on the biological settings, therefore displaying different biological targets.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29">(24−29)</a> KP-1019, IT-139 (formerly NKP-1339), and NAMI-A are, to date, the only three Ru complexes to have reached clinical trials as anticancer agents. Their mechanism of action involves ligand exchange, resembling therefore the one of cisplatin.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35">(30−35)</a> Of note, TLD-1433, a substitutionally inert Ru(II) polypyridyl complex, has recently entered a phase II clinical trial as a photosensitizer for photodynamic therapy (PDT).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Another very promising class of ruthenium complexes is the coordinatively saturated and substitutionally inert ruthenium polypyridyl complexes. These compounds have been intensely investigated over the last years, and several applications as potential chemotherapeutic agents have been unearthed.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> At first, most of the bioactivity of these compounds was associated to interactions with DNA.<a onclick="showRef(event, 'ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41">(38−41)</a> However, over the years, many other modes of action were identified, such as the triggering of mitochondrial dysfunction,<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> topoisomerases I and II inhibition,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> modification of cell membranes,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and others.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Due to the great opportunities offered by this class of Ru compounds, in this work, we designed a new Ru polypyridyl complex, namely, <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> (<b>Ru-sq</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a), where DIP is 4,7-diphenyl-1,10-phenanthroline and sq is a semiquinonate ligand, which was found to be a very interesting anticancer drug candidate. Semiquinonate is a so-called “noninnocent” ligand as its electrochemical properties strongly resemble that of the metal center.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Semiquinonate is the oxidized form of catechol, a well-known dioxo ligand, which can exist in three redox forms, namely, catecholate (cat), semiquinonate (sq), and quinone (q) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Catecholate and its oxidation products have already been intensively investigated as ligands.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> However, the focus of these studies has mostly been on the unique electronic/redox properties of metal complexes containing such “noninnocent” dioxo ligands.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55">(52−55)</a> Catechols are also known as pan-assay interference compounds (PAINS) due to their redox and chelating properties.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Nevertheless, catecholate and its derivatives have also shown potential in different fields of biological interest,<a onclick="showRef(event, 'ref57 ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59 ref60 ref61">(57−61)</a> such as cancer chemoprevention,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> antifungal activity,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and the inhibition of the spontaneous Aβ fibril formation,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> which is a key target for the treatment of Alzheimer’s disease. Worthy of note, vanadium compounds carrying catechol-like ligands have been investigated by Crans and co-workers.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> During these studies, particularly potent cytotoxic vanadium (V) catecholate complexes toward bone cancer cells were unveiled.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The cytotoxicity on glial cells of [Ru<sup>III</sup>(NH<sub>3</sub>)<sub>4</sub>(catecholate)]<sup>+</sup> was also investigated in 2007 by Almeida and co-workers.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In this case, the catechol was found to be more cytotoxic than the Ru(III) complex itself, with an EC<sub>50</sub> of 0.342 mM against rat astrocytes and 0.568 mM against the human glioblastoma GL-15 cell line, while the [Ru<sup>III</sup>(NH<sub>3</sub>)<sub>4</sub>(catecholate)]<sup>+</sup> complex had EC<sub>50</sub> = 1.380 and 2.6 mM against rat astrocytes and the human glioblastoma, respectively.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Further studies suggested that depletion of glutathione and induction of apoptosis were possible explanations for the cytotoxicity observed for catechol toward the mouse neuroblastoma N2a cell line.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> These preliminary studies rationalize our choice to integrate catechol and its oxidation products into a Ru(II) polypyridyl complex. To the best of our knowledge, <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> is the first Ru(II) polypyridyl complex containing a catechol moiety to be deeply investigated from both a physicochemical and  biological point of view. The complex was isolated as a racemic mixture of Δ and Λ enantiomers. No effort was made in this work to isolate pure enantiomers. As described below, <i>in vitro</i> and <i>in vivo</i> studies demonstrate a significant potential of this compound as a chemotherapeutic agent against cancer.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) Synthesis of <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b>;<sup>a</sup> (b) Catecholate (cat) and Its Oxidized Forms, Semiquinonate (sq) and Quinone (q)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(I) DIP, LiCl, dimethylformamide (DMF), reflux, 24 h, 78%; (II) (i) NaOH, catechol, 2-propanol, reflux, 24 h; (ii) air, 2 h; and (iii) NH<sub>4</sub>PF<sub>6</sub>, 2-propanol/H<sub>2</sub>O (1:8), 19%.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis and Characterization of <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b></h3><div class="NLM_p last">The synthesis of the target compound <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> was achieved in a two-step synthesis (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a). Briefly, the known Ru(DMSO)<sub>2</sub>Cl<sub>2</sub>,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> DIP, and LiCl were refluxed in DMF to afford <b>Ru(DIP)<sub>2</sub>Cl<sub>2</sub></b> in 72% yield after precipitation with acetone.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The compound was then refluxed in a nitrogen atmosphere overnight with catechol in the presence of NaOH in 2-propanol. The oxidation step of the catecholate to the semiquinonate was performed by exposing the solution of the Ru complex in 2-propanol to air for 2 h. <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> was obtained in 19% yield after precipitation with a large excess of NH<sub>4</sub>PF<sub>6</sub> and purification <i>via</i> silica gel chromatography. The identity of the product was confirmed by high-resolution mass spectrometry (HRMS) and NMR spectroscopy. <sup>1</sup>H NMR spectra showed a characteristic peak broadening in the aromatic region between 7 and 9 ppm due to the paramagnetism of the complex. In the <sup>13</sup>C NMR and two-dimensional (2D) <sup>1</sup>H–<sup>13</sup>C heteronuclear single quantum coherence (HSQC) spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S1</a>), 10 inequivalent <i>C</i>H carbons were observed. The purity of the product was confirmed by microanalysis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> X-ray Crystallography of [Ru(DIP)<sub>2</sub>(sq)](Cl)</h3><div class="NLM_p">The crystal structure of [Ru(DIP)<sub>2</sub>(sq)](Cl) was determined by a single-crystal X-ray diffraction study. Suitable single crystals were grown from slow diffusion of diethyl ether into a solution of the product prior to precipitation with NH<sub>4</sub>PF<sub>6</sub> in MeCN. The crystal structure revealed two independent Ru molecules (Ru-1 and Ru-2 in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S2</a>), two chloride counterions (from LiCl), and three water molecules in the asymmetric unit (monoclinic <i>P</i>2<sub>1</sub>/<i>c</i> space group). Both Cl atoms are disordered over two sets of sites with site-occupancy ratios of 0.299/0.701(3) and 0.244/0.756(5). The H atoms of the isolated water molecules could be introduced in the final refinements, but their positions were kept fixed to satisfy reliable hydrogen bonding. The molecular structure of one of the independent Ru molecules is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, and a selection of the most relevant bond lengths and angles is provided in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Tables S1 and S2</a> (additional crystallographic information can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Supporting Information</a>). The X-ray crystal structure determination also provided evidence for the nature of the dioxo ligand, as it can exist as catecholate, semiquinonate, and quinone.<a onclick="showRef(event, 'ref49 ref53 ref66'); return false;" href="javascript:void(0);" class="ref ref49 ref53 ref66">(49,53,66)</a> The typical range for the C–O bond length of such a ligand coordinated to a metal is 1.34–1.47 Å for the catecholate form, 1.27–1.31 Å for the semiquinonate form, and around 1.23 Å for the quinone.<a onclick="showRef(event, 'ref49 ref66'); return false;" href="javascript:void(0);" class="ref ref49 ref66">(49,66)</a> The C–O bond distances of the dioxo ligand in [Ru(DIP)<sub>2</sub>(sq)](Cl) are 1.309(4), 1.314(4), 1.315(4), and 1.319(4) Å, which suggest that it is present in its semiquinonate form.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structure of [Ru(DIP)<sub>2</sub>(sq)](Cl). The asymmetric unit contains two crystallographically independent Ru cations, only one of which is presented. The Cl<sup>–</sup> counterions, H atoms, and solvent molecules are omitted for clarity. The thermal ellipsoids are shown at the 30% probability level.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Electrochemistry</h3><div class="NLM_p last">The electrochemistry of <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> (abbreviated as <b>Ru-sq</b>) was investigated using cyclic voltammetry (CV) and rotating disc electrode (RDE) voltammetry in DMF containing 0.1 M tetrabutylammonium hexafluorophosphate (TBAPF<sub>6</sub>). The RDE voltammogram shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_002.csv" class="ext-link">Figure S3</a> exhibits four well-defined, reversible waves, in addition to that of decamethylferrocene, which was used as an internal reference with a half-wave potential of 0.030 V <i>vs</i> the saturated calomel electrode (SCE). The four features related to the <b>Ru-sq</b> have the same intensity, which attests that the related redox processes involve the same number of exchanged electrons. By comparison with the data reported in the literature for closely related complexes under similar conditions,<a onclick="showRef(event, 'ref52 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref52 ref67 ref68">(52,67,68)</a> the underlying redox processes were assigned as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Table S3</a>. The oxidation located at +0.647 V <i>vs</i> SCE can be attributed to the Ru(II)/Ru(III) redox couple, while the sq/cat redox couple can be associated with the first reduction process at −0.249 V <i>vs</i> SCE. The following two processes, at more negative potentials, can be assigned to the sequential reductions of the ancillary ligands (DIP<sup>0/–</sup>). Of note, the latter are separate couples with some quite substantial redox splitting.<a onclick="showRef(event, 'ref52 ref67'); return false;" href="javascript:void(0);" class="ref ref52 ref67">(52,67)</a> These data clearly show how the presence of the semiquinonate ligand influences the redox properties of the metal center, causing a shift to a lower potential. The couple of Ru (III)–quinone ligand is not observed in these conditions since they are possibly located outside the anodic limit of a DMF-based electrolyte. Moreover, the CV experiment (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S3</a>) indicates the reversibility of the redox processes, at least on the voltammetric time scale.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Electron Paramagnetic Resonance (EPR)</h3><div class="NLM_p"><b>Ru-sq</b> in its native state is electron paramagnetic resonance (EPR)-active in dichloromethane (DCM) due to the presence of an unpaired spin as already inferred by X-ray crystallography (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S4a</a>). At room temperature (rt), a rather broad isotropic signal was observed. Its <i>g</i>-value of 2.0244 is in line with a ligand-centered spin density and deviates only slightly form the Landé <i>g</i>-factor of the free electron of <i>g</i><sub>e</sub> = 2.0023. This behavior is in strong contrast to a metal-centered spin of a Ru(III) complex, which would only become observable at low temperatures due to rapid relaxation and display a broad, axial or rhombic signal with large anisotropy.<a onclick="showRef(event, 'ref53 ref69'); return false;" href="javascript:void(0);" class="ref ref53 ref69">(53,69)</a> The reduced form <b>Ru-cat</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was generated by the reaction of <b>Ru-sq</b> with equimolar amounts of cobaltocene (Cp<sub>2</sub>Co, <i>E</i><sub>1/2</sub> = −0.880 V <i>vs</i> SCE in DMF/0.1 M NBu<sub>4</sub>PF<sub>6</sub>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S4b</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Owing to the presence of a low-spin Ru(II) ion and a closed-shell catecholate ligand, this species is EPR-silent. The same holds true also for oxidized, dicationic <b>Ru</b><sup><b>+</b></sup><b>-sq</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), which was prepared by the treatment of <b>Ru-sq</b> with an excess of 1,1′-diacetylferrocenium hexafluoroantimonate (Ac<sub>2</sub>FcSbF<sub>6</sub>, <i>E</i><sub>1/2</sub> = 0.940 V <i>vs</i> SCE in DMF/0.1 M NBu<sub>4</sub>PF<sub>6</sub>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S4c</a>).<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> The absence of an EPR signal indicates that the unpaired spins at the Ru(III) ion (<b>Ru</b><sup><b>+</b></sup>) and the sq ligand are antiferromagnetically coupled.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Structures of <b>Ru-cat</b>, <b>Ru-sq</b>, and <b>Ru</b><sup><b>+</b></sup><b>-sq</b>, Carrying a Catecholate or a Semiquinonate Ligand and Ru in the Oxidation State +II (<b>Ru</b>) or +III (<b>Ru</b><sup><b>+</b></sup>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Stability in Dimethyl Sulfoxide (DMSO) and Human Plasma</h3><div class="NLM_p last">The stability of a compound plays an important role in its biological activity and viability. Therefore, the integrity of <b>Ru-sq</b> was first assessed in DMSO-<i>d</i><sub>6</sub> using <sup>1</sup>H NMR spectroscopy. <b>Ru-sq</b> was found to be stable in DMSO over 8 days. No change in the NMR spectra of the complex was observed over 8 days (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S5</a>). Next, to obtain preliminary insight into the behavior of <b>Ru-sq</b> under physiological conditions, the stability of <b>Ru-sq</b> in human plasma was investigated by ultraperformance liquid chromatography (UPLC), following a procedure already established by our group.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><b>Ru-sq</b> was incubated in human plasma at 37 °C for 0, 4, 6, 12, 20, and 24 h using diazepam as an internal standard. The UV traces of the UPLC analysis are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S6a</a>. The concentration of <b>Ru-sq</b> was normalized with respect to the internal standard and plotted against time. The linear trend shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S6b</a> clearly demonstrates that between 6 and 20 h, a decomposition of 50% of the compound was observed to reach a total degradation of the compound after 24 h.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cytotoxicity Studies</h3><div class="NLM_p">After a full characterization of <b>Ru-sq</b>, its potential activity as a chemotherapeutic agent was investigated, starting from the biological evaluation of its behavior against cancer cells in monolayer cell cultures. The cytotoxicity of <b>Ru-sq</b> toward human cervical adenocarcinoma (HeLa), human ovarian carcinoma (A2780), human cisplatin-resistant ovarian carcinoma (A2780 cis), human doxorubicin-resistant ovarian carcinoma (A2780 ADR), mouse colon adenocarcinoma (CT-26), mouse colon adenocarcinoma stably expressing luciferase (CT-26 LUC), human normal retinal pigment epithelial (RPE-1), and human normal lung fibroblast (MRC-5) cell lines was therefore investigated using a fluorometric cell viability assay (single graphs available in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S7</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The cytotoxicity of cisplatin and doxorubicin was determined in the same cell lines as positive controls and, as additional controls, <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> and catechol were also tested.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, where the half-maximal inhibitory concentration (IC<sub>50</sub>) values are reported, <b>Ru-sq</b> displayed IC<sub>50</sub> values between the high nanomolar and low micromolar range in the cell lines investigated in this study, while the <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> precursor and the catechol ligand itself showed much lower cytotoxicity. Very impressively, <b>Ru-sq</b> exerted an activity 40 times higher than that of cisplatin against a cisplatin-resistant cell line. On the other hand, the cytotoxicity of doxorubicin and <b>Ru-sq</b> against a doxorubicin-resistant cell line appeared to be on the same order of magnitude. Overall, complex <b>Ru-sq</b> displays a cytotoxicity that is comparable to that of doxorubicin and much higher than the one of cisplatin. However, no selectivity was observed between cancerous and noncancerous cell lines. This shortcoming is often faced in medicinal chemistry and could be improved by the introduction of a targeting moiety or by nanoformulation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values of <b>Ru-sq</b>, the <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> Precursor, and the Catechol Ligand in Tested Cell Lines<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">HeLa</th><th class="colsep0 rowsep0" align="center" char="±">A2780</th><th class="colsep0 rowsep0" align="center">A2780 ADR</th><th class="colsep0 rowsep0" align="center" char="±">A2780 cis</th><th class="colsep0 rowsep0" align="center" char="±">CT-26</th><th class="colsep0 rowsep0" align="center" char="±">CT-26 LUC</th><th class="colsep0 rowsep0" align="center">RPE-1</th><th class="colsep0 rowsep0" align="center">MRC-5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cisplatin</td><td class="colsep0 rowsep0" align="left">9.28 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">4.00 ± 0.76</td><td class="colsep0 rowsep0" align="left">8.32 ± 0.71</td><td class="colsep0 rowsep0" align="char" char="±">18.33 ± 2.92</td><td class="colsep0 rowsep0" align="char" char="±">2.60 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">2.42 ± 0.23</td><td class="colsep0 rowsep0" align="left">30.24 ± 5.11</td><td class="colsep0 rowsep0" align="left">11.20 ± 2.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doxorubicin</td><td class="colsep0 rowsep0" align="left">0.34 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.19 ± 0.03</td><td class="colsep0 rowsep0" align="left">5.94 ± 0.58</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.082 ± 0.003</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.006</td><td class="colsep0 rowsep0" align="left">0.89 ± 0.17</td><td class="colsep0 rowsep0" align="left">3.37 ± 1.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ru-sq</b></td><td class="colsep0 rowsep0" align="left">0.50 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.04</td><td class="colsep0 rowsep0" align="left">4.13 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">1.00 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">1.51 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.90 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ru(DIP)<sub>2</sub>Cl<sub>2</sub></b></td><td class="colsep0 rowsep0" align="left">15.03 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">4.69 ± 0.14</td><td class="colsep0 rowsep0" align="left">78.27 ± 4.9</td><td class="colsep0 rowsep0" align="char" char="±">6.36 ± 0.57</td><td class="colsep0 rowsep0" align="char" char="±">9.20 ± 1.22</td><td class="colsep0 rowsep0" align="char" char="±">6.65 ± 0.5</td><td class="colsep0 rowsep0" align="left">3.13 ± 0.07</td><td class="colsep0 rowsep0" align="left">5.54 ± 0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">catechol</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">22.80 ± 5.96</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">54.55 ± 11.30</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 4.14</td><td class="colsep0 rowsep0" align="char" char="±">11.56 ± 0.40</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Cisplatin and doxorubicin were used as positive controls.</p></div></div></div><div class="NLM_p">We then decided to pursue the investigation of <b>Ru-sq</b> behavior in a multicellular tumor spheroids (MCTS) model.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> It was previously shown that such a model mimics the <i>in vivo</i> microenvironment and tumor metabolism.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> Moreover, large MCTS develops a central necrosis core similar to that found in the inner core of tumors.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> These unique features give a better representation of a cancer model compared to a 2D model, lowering the disparity between <i>in vitro</i> and <i>in vivo</i> models.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a><a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> shows the IC<sub>50</sub> values obtained <i>via</i> a luminescent cell viability assay for compounds that were administered to HeLa MCTS for 48 h (single graphs are available in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S8</a>). The <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> precursor and the catechol ligand were tested as additional controls and exhibited lower cytotoxicity than that of <b>Ru-sq</b>. Catechol showed no toxicity toward the cell line tested (IC<sub>50</sub> > 100 μM), while the precursor displayed a cytotoxicity comparable to that of cisplatin. Cisplatin was used as positive control, and the results are in line with literature data.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The cytotoxicity of <b>Ru-sq</b> in HeLa MCTS was impressively high after 48 h treatment, with IC<sub>50</sub> ∼ 14 μM, which is 3 times lower than that of cisplatin or doxorubicin (IC<sub>50</sub> ∼ 47 or 39 μM, respectively). Noteworthily, the cytotoxicity of <b>Ru-sq</b> was comparable to the one of doxorubicin after 72 h treatment (IC<sub>50</sub> ∼ 11 μM).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> These studies clearly demonstrate the high potential of <b>Ru-sq</b> as an anticancer drug candidate. The impressive bioactivity, comparable to that of doxorubicin in monolayer cell culture, was also confirmed in the three-dimensional (3D) tumor model, HeLa MCTS.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values of <b>Ru-sq</b>, the <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> Precursor, and the Catechol Ligand in Multicellular HeLa Cancer Cell Spheroids (Approximately 400 μm in Diameter)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±">cisplatin</th><th class="colsep0 rowsep0" align="center" char="±">doxorubicin</th><th class="colsep0 rowsep0" align="center" char="±"><b>Ru-sq</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>Ru(DIP)<sub>2</sub>Cl<sub>2</sub></b></th><th class="colsep0 rowsep0" align="center">catechol</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HeLa MCTS</td><td class="colsep0 rowsep0" align="char" char="±">46.49 ± 4.18</td><td class="colsep0 rowsep0" align="char" char="±">38.59 ± 0.43</td><td class="colsep0 rowsep0" align="char" char="±">14.11 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">59.84 ± 3.05</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Cisplatin and doxorubicin were used as positive controls.</p></div></div></div><div class="NLM_p">Spheroid integrity and growth upon treatment are very useful tools to determine potential drug activity.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In this study, MCTS were monitored over 13 days after treatment with different concentrations of <b>Ru-sq</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Every 3 days, the spheroids were washed to remove dead cells and their diameters were measured (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). It is important to note that at each washing step, half of the media was removed and replaced with fresh one, diluting twice the quantity of the compound in each well. The effect of <b>Ru-sq</b> on growth inhibition is dose-dependent and already visible after 3 days. Low-concentration treatments (1 and 2.5 μM) led to regrowth of the spheroids after the first 72 h, while for 5 and 10 μM treatments, the regrowth is visible after 6 and 9 days, respectively. <b>Ru-sq</b> treatment with concentrations higher than IC<sub>50</sub> (20 and 25 μM) completely inhibits the spheroid growth after 13 days of treatment. Overall, we can conclude that <b>Ru-sq</b> treatment at 20 and 25 μM concentrations severely affects the size and integrity of the spheroids after 13 days of treatment.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Growth kinetics of HeLa MCTS upon treatment with different concentrations of <b>Ru-sq</b> (1, 2.5, 5, 10, and 20 μM). (a) Images collected at day 0 (before treatment) and at day 3, 6, 9, and 13. (b) MCTS diameter calculated at different time points. The dotted blue line indicates the day of seeding, the dashed red line indicates the day of the treatment, and the dotted green lines indicate the days of washing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cell Death Mechanism</h3><div class="NLM_p">The excellent activity displayed by <b>Ru-sq</b> in HeLa MCTS encouraged us to perform further experiments to obtain more insights into its <i>in vitro</i> behavior. The first step was the evaluation of the type of cell death occurring when cancer cells were treated with <b>Ru-sq</b>. For this experiment, HeLa cells were analyzed <i>via</i> flow cytometry using the Annexin V and propidium iodide (PI) staining method.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Staurosporine, a known inducer of apoptosis, was employed as a positive control.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">S9</a> (dot plots), <b>Ru-sq</b> induced significant apoptosis as early as 30 min treatment with progression from early to late apoptosis at 4 h. The level of apoptosis induction by the complex after 4 h was comparable to that caused by 24 h staurosporine treatment. These data clearly demonstrate that <b>Ru-sq</b> induces apoptosis as the only type of cell death in HeLa cells.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Induction of apoptosis/necrosis in HeLa cells upon treatment with <b>Ru-sq</b> (10 μM) and staurosporine (1 μM) at different time frames. The values are expressed as a mean ± standard deviation (SD) of three biological repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Uptake, Intracellular Distribution, and DNA Metalation Studies</h3><div class="NLM_p">Next, the cellular uptake of <b>Ru-sq</b> and cisplatin was investigated in HeLa cells. The amount of ruthenium accumulated was detected by inductively coupled plasma mass spectrometry (ICP-MS). Working concentrations and incubation times were chosen to avoid extended cell mass loss due to the high cytotoxicity of the complexes but considering a final amount of ruthenium that could afford the determination of the metal content. After 2 h treatment (5 μM), <b>Ru-sq</b> internalizes slightly better than the drug cisplatin (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). The low accumulation of cisplatin in these working conditions is in agreement with the literature data.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> To have more insights about uptake mechanisms of <b>Ru-sq</b> into HeLa cells, additional experiments were performed. Cells were pretreated with different inhibitors of uptake pathways or kept at different temperatures to assess the energy dependence of the uptake mechanism(s) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S10</a>). More specifically, low temperature (4 °C), pretreatment with metabolic inhibitors (which decreases adenosine 5′-triphosphate (ATP) production), pretreatment with chloroquine or ammonium chloride (which mostly impedes endocytic pathways), or pretreatment with tetraethylammonium chloride (mostly inhibiting cation transporters) decreased <b>Ru-sq</b> accumulation in cells by half when compared to the 37 °C condition (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S10</a>). This outcome indicates that <b>Ru-sq</b> might be transported into the HeLa cells by both energy-dependent (active) and energy-independent (passive) pathways. Further cellular fractionation experiments showed preferential accumulation of <b>Ru-sq</b> inside the nucleus (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). These findings suggest that the mode of action could be related to the damage caused to DNA and/or to the prevention of replication as well as transcription.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a> To identify DNA as a potential target for the complex, the genetic material was extracted from HeLa cells after 2 h treatment with <b>Ru-sq</b> or cisplatin and the amount of metal was analyzed by ICP-MS. The DNA of cells treated with <b>Ru-sq</b> displayed a metal content much higher than that of cisplatin-treated cells. Taken together, these findings strongly suggest direct interaction with DNA as a possible mechanism of the action exerted by <b>Ru-sq</b>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Cellular uptake, (b) cellular fractionation, and (c) DNA metalation of HeLa cells after treatment with tested compounds (5 μM, 2 h). Data are presented as the mean ± SD of at least three biological replicates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> JC-1 Mitochondrial Membrane Potential Test and Metabolic Studies</h3><div class="NLM_p">The search for additional mechanisms of action associated with the treatment of <b>Ru-sq</b> led us to the investigation of the mitochondrial metabolism impairment.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> First, the mitochondrial membrane potential was studied with the use of a largely used indicator, JC-1 (a membrane-permeant dye).<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> At high potentials, the dye forms red-emitting aggregates in the mitochondria membrane, whereas at low potentials, it stays as a green-emitting monomer.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> The membrane potential is directly connected to oxidative phosphorylation (the main mitochondrial function).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> HeLa cells were treated for 24 h with increasing concentrations of <b>Ru-sq</b> (from 0.2 to 0.6 μM). <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a shows a slight decrease in the red fluorescence signal with increasing concentrations of <b>Ru-sq</b> and a significant drop in the signal at around the IC<sub>50</sub> concentration (0.5 μM, marked in red). However, the dramatic collapse of mitochondrial membrane potential could also be caused by ongoing apoptosis.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), an uncoupling agent that impairs the membrane potential,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> was used as a positive control.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Comparison of the results obtained with <b>Ru-sq</b> (0.5 μM) and the FCCP treatment showed that the same loss in potential was detected. These findings strongly suggest a contribution of the membrane potential impairment to the cell death mechanism.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Fluorescence signal of the JC-1 dye detected in HeLa cells treated for 24 h with different concentrations of <b>Ru-sq</b> (from 0.2 to 0.6 μM). The bar marked in red indicates the IC<sub>50</sub> concentration (0.5 μM). FCCP is used as a positive control, and cisplatin and DMSO (1%) are used as negative controls. (b) Mito stress test profile in HeLa cells after 24 h treatment; the oxygen consumption rate (OCR) changes after treatment with specific electron transport chain inhibitors: oligomycin (inhibitor of ATP synthase (complex V)), FCCP (uncoupling agent), antimycin-A (complex III inhibitor), and rotenone (complex I inhibitor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Inspired by these findings, we performed further studies on the metabolic pathways that could be affected by the complex. For this purpose, a Seahorse XF analyzer was used to measure, in real time, the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of treated cells. First, the effect of <b>Ru-sq</b> on the oxidative phosphorylation in the HeLa cell line was investigated. Mitochondrial respiration was found to be severely impaired in cells treated with <b>Ru-sq</b> as opposed to the precursor <b>Ru(DIP)<sub>2</sub>Cl<sub>2</sub></b>. This was evident from the low basal respiration and the inhibition of ATP production compared to those of untreated cells. The mitochondrial membrane of the cells treated with <b>Ru-sq</b> lost the capacity to restore the proton balance when treated with an uncoupling agent (FCCP). The maximal respiration (the OCR value when the mitochondrial membrane is uncoupled) and spare respiratory capacity (difference in the OCR values between maximal respiration and basal respiration) of the cells were reduced compared to those of untreated cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">S11</a>). The combination of these effects suggests disrupted mitochondrial respiration in cervical cancer cells caused by <b>Ru-sq</b>. The effect on glycolysis and the possible metabolic modulation of the three primary fuel pathways (involving glucose, glutamine, or fatty acids as substrates) were then examined. In contrast to what was observed for the mitochondrial respiration, the cell glycolysis, which is a cytosolic process, was not affected by <b>Ru-sq</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S12</a>). Additionally, due to the very low oxygen consumption rate in cells treated with <b>Ru-sq</b>, a direct effect on the three primary fuel pathways could not be determined (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">Figure S13</a>). Overall, metabolic studies showed that the accumulation of <b>Ru-sq</b> in the mitochondria has a significant role in the impairment of oxidative phosphorylation. This effect, together with the results obtained by the JC-1 staining, strongly suggests mitochondrial dysfunction as one of the modes of action of <b>Ru-sq</b>. In contrast, the chemotherapeutic drug cisplatin showed no significant effect on the mitochondrial metabolism of HeLa cells. This data suggests fundamental differences between the mode of action of <b>Ru-sq</b> and cisplatin. The latter covalently binds to the nuclear DNA and inhibits the replication process. It is widely known that DNA cross-links can be repaired by different mechanisms such as the nucleotide excision repair (NER) that eventually leads to drug resistance in cancer cells. <b>Ru-sq</b>, with its multiple cellular targets, could potentially evade these repair pathways and circumvent such drawbacks associated with cisplatin.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>In Vivo</i> Efficacy Studies</h3><div class="NLM_p last">It is very difficult to evaluate the selectivity of the anticancer drugs <i>in vitro</i>, as the proliferation of nonmalignant cells is greatly affected by nonphysiological conditions of cell culture in 2D and 3D models. The promising results obtained in studies conducted <i>in vitro</i> justified the assessment of <b>Ru-sq</b> efficacy in the context of a whole organism. To this end, we performed <i>in vivo</i> studies to evaluate the effect on both tumor growth and survival of tumor-bearing mice. The doses were selected according to the dose-finding study, which had revealed a maximum tolerated dose (MTD) of 15 mg/kg of body weight. Two distinct models for testing the <i>in vivo</i> efficacy of antitumor drugs are possible: a syngeneic (mice) tumor growing in a naturally immunocompetent mouse or human tumor cells growing in immunodeficient animals. As both approaches have their advantages and pitfalls, we decided to use both models in this study.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Effect of <b>Ru-sq</b> on the Growth of Ehrlich Mammary Carcinoma in Immunocompetent NMRI Mice and the Survival of Tumor-Bearing Mice</h3><div class="NLM_p">Even though the use of syngeneic tumor allografts in naturally immunocompetent animals had been often considered inferior during the era of athymic mice models, this method made a comeback as the necessity of diversified, near-physiological experimental sets was recognized. In this model, we can observe the effect of the tested compound within the context of the genuine immune system that plays a key role in tumor resistance.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div><div class="NLM_p">During the study of the effect on the survival of immunocompetent NMRI mice bearing Ehrlich carcinoma (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), it was observed that the geometric mean of the overall survival of tumor-bearing mice without therapy was 20.6 days. Among the three doses of <b>Ru-sq</b> tested, only 5 mg/kg prolonged the survival time significantly when compared with untreated tumor-bearing control mice (geom. mean = 31.9 days, <i>P</i> = 0.033). <b>Ru-sq</b> (10 and 15 mg/kg) seemed to exceed the optimal dose, causing a nonsignificant prolongation of survival (<i>P</i> > 0.05), with the geometric means of 30.2 and 25.5 days, respectively. The explanation may be a subclinical toxic effect that negatively affects immune surveillance as well as other body functions necessary for the natural cancer defense. Although the optimal intracellular cancer-suppressing concentration may correspond to higher doses, subtle systemic toxicity does not allow the desired effect <i>in vivo</i> to be developed. The positive control cisplatin appeared to have a similar efficacy (geom. mean = 33.7 days, <i>P</i> = 0.014). An interesting and rare phenomenon was observed in all three groups of <b>Ru-sq</b>. Although the tumor was advanced in the later stage of the experiment, all mice treated with <b>Ru-sq</b> showed active behavior, little cachexia, and unsuppressed food consumption.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Kaplan–Meier analysis of the survival of immunocompetent NMRI mice bearing Ehrlich carcinoma. Only the administration of complex <b>Ru-sq</b> 5 mg/kg intraperitoneally (i.p.) and that of cisplatin (5 mg/kg) significantly prolonged the survival of tumor-bearing mice when compared with the mixture of the co-solvent and water. The compounds were administered i.p. on days 1 and 7 after tumor inoculation (<i>n</i> = 7 in each group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, the effect of <b>Ru-sq</b> on tumor growth was examined. <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> shows the weight of tumors at day 10 in mice treated with a mixture of the co-solvent and water, <b>Ru-sq</b> at 5, 10, or 15 mg/kg, or cisplatin at 5 mg/kg and documents differences in the effect of the used drugs. Although only cisplatin exhibited a significant inhibitory effect on tumor growth (<i>P</i> = 0.0011), there was a slight but insignificant suppression at 5 mg/kg <b>Ru-sq</b> (<i>P</i> = 0.108). As in the survival study, also, here, the optimum dose of <b>Ru-sq</b> seems to be in the lower part of the range tested.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Weight of the solid Ehrlich tumor (in grams) on day 10 of mice injected on days 1 and 7 i.p. with the pure vehicle, <b>Ru-sq</b>, or cisplatin. Values are the means ± standard error of the mean (SEM) (<i>n</i> = 7 in each group). Control: the tumor-bearing control treated with a mixture of the co-solvent and water; Pt: cisplatin 5 mg/kg i.p.; Ru 5: <b>Ru-sq</b> 5 mg/kg i.p.; Ru 10: <b>Ru-sq</b> 10 mg/kg i.p.; and Ru 15: <b>Ru-sq</b> 15 mg/kg i.p. Significantly different from the controls (**<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Effect of <b>Ru-sq</b> on the Growth of A2780 Human Ovarian Cancer in Immunodeficient Nude Mice and the Survival of Tumor-Bearing Mice</h3><div class="NLM_p">To compare the efficacy of the drug, the therapeutic and survival experiment was repeated with athymic nude mice and a human cancer cell line. The A2780 human ovarian cancer cell line was chosen because of the use of cisplatin as a comparative drug. Cisplatin is usually used for the therapy of ovarian cancer. Unfortunately, resistance often arises in treated patients. The use of human tumor xenografts in immunodeficient mice to examine the therapeutic effect of potential chemotherapeutics has several advantages. The major one is the use of actual human tumor tissue, featuring the complexity of genetic and epigenetic abnormalities that exist in the human tumor cell population.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> We evaluated the growth of A2780 human ovarian cancer cells in immunodeficient nude mice and their survival. <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> shows the survival of animals; the longest average day of death is surprisingly associated with the negative control (42.88 ± 16.97 days). However, there was one surviving mouse in the group treated with <b>Ru-sq</b> 10 mg/kg and in the group treated with cisplatin. Two surviving mice were found in the group treated with a higher dose of <b>Ru-sq</b> (15 mg/kg). Very interestingly, one of them was completely cured with no observable tumor.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Kaplan–Meier analysis of the survival of immunodeficient nude mice bearing A2780 human ovarian cancer. The treatment of Ru 15 mg/kg led to a completely cancer free mouse. The compounds were administered i.p. on days 1 and 7 after the tumor reached 5–8 mm in size (<i>n</i> = 8 in each group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Looking at the effect of <b>Ru-sq</b> on tumor growth (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), we observed that during the first days of therapy (day 4), there is a significant difference between groups treated with <b>Ru-sq</b> 15 mg/kg and cisplatin (<i>P</i> = 0.00675). Similar results between these two groups were observed at days 11 and 15 (<i>P</i> = 0.04246 for day 11 and <i>P</i> = 0.0262 for day 15). Comparison with the untreated control group showed significant differences at days 11 and 15 (<i>P</i> = 0.024 for day 11; <i>P</i> = 0.00931 for day 15). <b>Ru-sq</b> administered in the dose of 15 mg/kg also showed a decrease in the tumor size over 15 days. Very interestingly, one mouse of this group was completely cured; no tumor volume was observed on the day 36 until the end of the experiment (day 60, data not shown). The longer survival of untreated mice observed in the nude model could be rationalized by considering the higher sensitivity of immunocompromised animals to any kind of treatment. In addition, the intraperitoneal administration of the compound itself was found not ideal because of solubility reasons, which could have led to toxic peritonitis and eventually death.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Tumor growth of the A2780 cancer cell line in nude mice in the first 15 days of therapy. The tumor size is shown as the volume in cm<sup>3</sup>. Control: the tumor-bearing control treated with a mixture of the co-solvent and water; Pt: cisplatin 5 mg/kg i.p.; Ru 5: <b>Ru-sq</b> 5 mg/kg i.p.; Ru 10: <b>Ru-sq</b> 10 mg/kg i.p.; and Ru 15: <b>Ru-sq</b> 15 mg/kg i.p. The most significant slowing down of tumor growth is observable in the group with <b>Ru-sq</b> 15 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These data demonstrate that the group treated with <b>Ru-sq</b> 15 mg/kg experienced a healing effect (in some points better than cisplatin), warranting further research. <b>Ru-sq</b> in a dose of 15 mg/kg has shown great potential to be an alternative and better drug candidate than cisplatin.</div><div class="NLM_p last">Taken together, we might conclude that in both models used, <b>Ru-sq</b> reduces the growth of tumor cells and prolongs tumor-bearing mice survival in immunocompetent NMRI mice bearing Ehrlich carcinoma. Moreover, the optimal dose would be different, depending on the strain of the mice and tumor type.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Akt-1 Protein Levels in HeLa Cells</h3><div class="NLM_p">The interesting results obtained during the <i>in vivo</i> studies led us to further investigate the influence of <b>Ru-sq</b> on cell proliferation and/or migration. Akt is a serine/threonine kinase that promotes cellular survival.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Three isoforms of this protein exist in mammalian cells: Akt-1, Akt-2, and Akt-3.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Despite their high sequence similarity, they exhibit unique functions.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Akt-1 was found to be involved in the regulation of cell proliferation, transformation, and tumor metastasis.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In this study, we assessed the influence of different concentrations of <b>Ru-sq</b> on total Akt-1 protein levels in HeLa cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a,b, treatment with the complex at concentrations lower than the IC<sub>50</sub> does not change the total Akt-1 protein levels. A similar effect is observed upon treatment with cisplatin and doxorubicin at their IC<sub>50</sub> concentrations (IC<sub>50</sub> = 10 and 0.3 μM, respectively, for cisplatin and doxorubicin). On the other hand, Akt-1 protein levels significantly decreased when HeLa cells were treated with <b>Ru-sq</b> at IC<sub>50</sub> concentration (0.5 μM) and higher. It is important to note that GAPDH protein levels (loading control) are also changing at these concentrations, probably indicating ongoing cell death. Although the <b>Ru-sq</b> complex does not change the total amount of the Akt-1 protein levels, we cannot exclude its impact on the amount of active form of this protein. It is known that Akt-1 needs to be phosphorylated for its activity<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> and hyperactivation of this protein is frequently found in human cancers.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Further studies will be needed to fully understand the influence of our compound on cell proliferation and/or migration.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Western blot analysis of Akt-1 protein levels in the HeLa cell line after 24 h treatment with different concentrations of <b>Ru-sq</b>. Cisplatin, doxorubicin, and untreated cells were used as controls. The positions of the nearest molecular weight markers are indicated. (b) Akt-1 protein levels normalized to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) signal. Data is presented as the mean ± SD of at least three independent experiments. The IC<sub>50</sub> concentration of the complex is marked in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Ru-sq</b> was successfully synthesized and fully characterized. Crystal structure, electrochemical, and EPR studies confirmed the oxidation state of the dioxo ligand (semiquinonate), which led to an overall positive charge of the complex. <b>Ru-sq</b> was found to be stable at room temperature in a DMSO solution over 1 week and to have a half-life of 12 h upon incubation in human plasma at 37 °C. Cytotoxicity studies were performed in both cellular monolayer (2D) and multicellular tumor spheroids (MCTSs) (3D) models. The cytotoxicity in the 2D model was tested against different cell lines showing higher activity than that of cisplatin, with IC<sub>50</sub> values mostly in the nanomolar range. The cytotoxicity in HeLa MCTS confirmed the higher activity compared to that of cisplatin. Great tumor growth inhibition was observed after treatment with <b>Ru-sq</b> at 20 and 25 μM. Deeper investigation revealed apoptosis as the main cause of cell death. <b>Ru-sq</b> was found to be taken up by HeLa cells more efficiently than cisplatin and to accumulate preferentially in the nucleus. DNA ruthenation studies suggest that <b>Ru-sq</b> might damage the DNA and/or prevent replication as well as transcription processes. The mitochondrial function upon <b>Ru-sq</b> treatment was also studied using an indicator of the mitochondrial membrane potential (JC-1) and mito stress test (Seahorse Technology). From these studies, a severe impairment of the mitochondrial potential was observed, suggesting that mitochondrial dysfunction contributes to the mode of action of <b>Ru-sq</b>. <i>In vivo</i> studies were performed using two different models: a syngeneic tumor growing in a naturally immunocompetent mouse or human tumor cells growing in immunodeficient animals. <b>Ru-sq</b> reduces the growth of tumor cells and prolongs the survival of tumor-bearing mice. However, the optimal dose would be different, depending on the strain of the mouse and tumor type. In addition, during this study, especially in the case of the nude animals, the intraperitoneal administration was found to be not ideal because of solubility reasons, which probably lead to some toxicity and eventually death.</div><div class="NLM_p last">Overall, <b>Ru-sq</b> displayed better activity than cisplatin in 2D and 3D cell cultures as well as for some conditions used <i>in vivo</i>. In conclusion, in this work, combining the well-known anticancer activity of Ru(II) polypyridyl complexes and the unique properties of the noninnocent ligand, semiquinonate, we discovered a remarkable complex, <b>Ru-sq</b>, with promising potential as a chemotherapeutic agent against cancer. Further studies are currently ongoing in our group toward a different formulation of the compound prior to administration. We hope that these studies might lead our compound to advance toward preclinical trials.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Materials</h3><div class="NLM_p last">All chemicals were of either reagent or analytical grade and used as purchased from commercial sources without additional purification. Ruthenium trichloride hydrate was provided by I<sup>2</sup>CNS, 4,7-diphenyl-1,10-phenanthroline, lithium chloride (anhydrous, 99%), and catechol by Alfa Aesar, and tetrabutylammonium hexafluorophosphate by Sigma-Aldrich. All solvents purchased were of analytical or high-performance liquid chromatography (HPLC) grade. When necessary, solvents were degassed by purging with dry, oxygen-free nitrogen for at least 30 min before use.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Instrumentation and Methods</h3><div class="NLM_p">Amber glass or clear glassware wrapped in a tin foil was used when protection from the light was necessary. Schlenk glassware and a vacuum line were employed when reactions sensitive to moisture/oxygen had to be performed under a nitrogen atmosphere. Thin-layer chromatography (TLC) was performed using silica gel 60 F-254 (Merck) plates, with the detection of spots being achieved by exposure to UV light. Column chromatography was done using silica gel 60–200 μm (VWR). Eluent mixtures are expressed as volume-to-volume (v/v) ratios. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Bruker Avance III HD 400 MHz or Bruker Avance Neo 500 MHz spectrometers using the signal of the deuterated solvent as an internal standard.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The chemical shifts δ are reported in parts per million (ppm) relative to tetramethylsilane (TMS) or signals from the residual protons of deuterated solvents. Coupling constants <i>J</i> are given in hertz (Hz). The abbreviation for the peak multiplicity is broad (br). electrospray ionization (ESI)-HRMS experiments were carried out using an LTQ-Orbitrap XL from Thermo Scientific (Thermo Fisher Scientific, Courtaboeuf, France) and operated in the positive ionization mode, with a spray voltage of 3.6 kV. Sheath and auxiliary gases were set at a flow rate of 5 and 0 au, respectively. Applied voltages were 40 and 100 V for the ion transfer capillary and the tube lens, respectively. The ion transfer capillary was held at 275 °C. Detection was achieved in the Orbitrap with a resolution set to 100 000 (at <i>m</i>/<i>z</i> 400) and an <i>m</i>/<i>z</i> range between 200 and 2000 in the profile mode. The spectrum was analyzed using the acquisition software XCalibur 2.1 (Thermo Fisher Scientific, Courtaboeuf, France). The automatic gain control (AGC) allowed the accumulation of up to 2.105 ions for Fourier transform mass spectrometry (FTMS) scans. Maximum injection time was set to 300 ms, and 1 μscan was acquired. A total of 5 μL was injected using a Thermo Finnigan Surveyor HPLC system (Thermo Fisher Scientific, Courtaboeuf, France), with a continuous infusion of methanol at 100 μL/min. The purity of the compounds was determined by elemental analysis performed at the Science Centre, London Metropolitan University using Thermo Fisher (Carlo Erba) Flash 2000 Elemental Analyzer, configured for %CHN, confirming ≥95% purity. IR spectra were recorded with a SpectrumTwo Fourier transform infrared (FTIR) spectrometer (PerkinElmer) equipped with a Specac Golden Gate attenuated total reflection (ATR) accessory; 1/λ in cm<sup>–1</sup>. Analytical HPLC measurements were performed using the following system: 2× Agilent G1361 1260 Prep Pump system with an Agilent G7115A 1260 DAD WR detector equipped with an Agilent Pursuit XRs 5C18 (100 Å, C18, 5 μm, 250 × 4.6 mm<sup>2</sup>) column and an Agilent G1364B 1260-FC fraction collector. The solvents (HPLC grade) were Millipore water (0.1% trifluoroacetic acid (TFA), solvent A) and acetonitrile (0.1% TFA, solvent B). The HPLC gradient used is the following: 0–3 min: isocratic 90% A (5% B); 3–25 min: linear gradient from 90% A (5% B) to 0% A (100% B); 25–30 min: isocratic 0% A (100% B); 30–35 min: linear gradient from 0% A (100% B) to 95% A (5% B). The flow rate was 1 mL/min. Detection was performed at 215, 250, 350, 450, 550, and 650 nm with a slit of 4 nm. Stability in human plasma was assessed by HPLC (Acquity Ultra Performance LC, Waters) and a mass spectrometer (Bruker Esquire 6000) operated in the ESI mode. The ACQUITY UPLC BEH C18 Gravity 1.7 μm (2.1 × 50 mm<sup>2</sup>) reverse-phase column was used with a flow rate of 0.6 mL/min, and UV absorption was measured at 275 nm. The runs were performed with a linear gradient of A (acetonitrile (Sigma-Aldrich HPLC grade)) and B (distilled water containing 0.1% formic acid): <i>t</i> = 0–0.25 min, 95% A; <i>t</i> = 1.5 min, 100% A; <i>t</i> = 2.5 min, 100% A. Fractionation ICP-MS measurements were performed on an Agilent QQQ 8800 Triple quad ICP-MS spectrometer (Agilent Technologies) with an ASX200 autosampler (Agilent Technologies), equipped with standard nickel cones and a “micromist” quartz nebulizer fed with 0.3 mL/min analytic flow (as a 2% HNO<sub>3</sub> aqueous (aq) solution). Cellular uptake, the mechanism of uptake, and ruthenation of the DNA were assessed using a high-resolution ICP-MS Element II from Thermo Scientific by the Environmental Biogeochemistry team of the Institut de Physique du Globe de Paris. This ICP-MS enables working in different resolution modes (LR = 400, MR = 4000, and HR = 10 000) for better discrimination between elements of interest and interferences.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p last">For the metabolic studies, a Seahorse XFe96 analyzer by Agilent Technologies was used.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis and Characterization</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Ru(DMSO)<sub>2</sub>Cl<sub>2</sub></h4><div class="NLM_p last">Ru(DMSO)<sub>2</sub>Cl<sub>2</sub> was synthesized following an adapted literature procedure.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Spectroscopic data (<sup>1</sup>H NMR) was in agreement with the literature.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Ru(DIP)<sub>2</sub>Cl<sub>2</sub></h4><div class="NLM_p last">The complex was synthesized following an adapted literature procedure.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> A mixture of Ru(DMSO)<sub>2</sub>Cl<sub>2</sub> (3.0 g, 6.19 mmol), 4,7-diphenyl-1,10-phenanthroline (4.11 g, 12.38 mmol), and LiCl (2.0 g, 47.18 mmol) dissolved in DMF (100 mL) was refluxed for 24 h. After cooling the mixture to rt, the solvent was reduced in vacuo to 8 and 350 mL of acetone was added. The mixture was then stored at −20 °C overnight before filtration with a Buchner funnel and washed with acetone and Et<sub>2</sub>O to afford <b>Ru(DIP)<sub>2</sub>Cl<sub>2</sub></b> as a deep-purple solid (3.76 g, 4.49 mmol, 72%). Spectroscopic data (<sup>1</sup>H NMR) were in agreement with the literature.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> (<b>Ru-sq</b>)</h4><div class="NLM_p last"><b>Ru(DIP)<sub>2</sub>Cl<sub>2</sub></b> (0.739 g, 0.88 mmol) and aq NaOH (0.5 mL, 1 M) were dissolved in 2-propanol (40 mL). The solution was degassed for 15 min, and catechol (0.155 g, 1.41 mmol) was added. The mixture was heated to reflux for 24 h under a N<sub>2</sub> atmosphere and protected from light. After being cooled to rt, the mixture was stirred and opened to air while still protected from light, and the solvent was removed under vacuum. The residual solid was dissolved in 2-propanol (7 mL), and H<sub>2</sub>O (56 mL) and NH<sub>4</sub>PF<sub>6</sub> (0.700 g, 4.3 mmol) were added. The mixture was stored in the fridge (4 °C) overnight. The precipitate was filtered with a Buchner funnel and washed with H<sub>2</sub>O (3× 50 mL) and Et<sub>2</sub>O (3× 50 mL). The solid was collected with DCM and dried under vacuum to deliver a crude product as the PF<sub>6</sub> salt (0.70 g), which was chromatographed on silica (DCM/MeCN 20:1 <i>R</i><sub><i>f</i></sub>: 0.3). Evaporation of the solvent under vacuum provided <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b> as a deep-red solid. Further washing with Et<sub>2</sub>O and heptane were necessary to obtain a clean product. The solid with the washing solvent (10 mL) was sonicated for 10 min and then centrifuged. This procedure was repeated three times for each solvent. Finally, the red solid was collected with DCM and dried under vacuum to afford a clean product (0.17 g, 0.167 mmol, 19%). IR (Golden Gate, cm<sup>–1</sup>): 3345 (w), 1710 (m), 1600 (w), 1520 (s), 1455 (s), 1335 (s), 1270 (s), 1125 (s), 820 (s), 760 (m). <sup>1</sup>H NMR (400 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ/ppm = 8.79–8.20 (br, 5H, arom.), 8.09–7.88 (br, 5H, arom.), 7.73–7.42 (br, 14H, arom.), 7.26–6.92 (br, 10H, arom.), 6.92–6.63 (br, 2H, arom.). <sup>13</sup>C NMR (125 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ/ppm = 149.84, 144.68, 136.10, 133.56, 130.36, 129.89, 129.53, 128.41, 126.21, 125.36, 121.47, 116.35. For the quaternary carbons, only two signals were observed in the <sup>13</sup>C NMR spectrum, whereas five were expected. This could be explained by the peak overlap or the signal being too weak to be detected within the acquisition time of the experiment, which is common for quaternary carbons. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> 874.1887 [M – PF<sub>6</sub>]<sup>+</sup>. Elemental analysis: calcd for C<sub>54</sub>H<sub>36</sub>F<sub>6</sub>N<sub>4</sub>O<sub>2</sub>PRu═C, 63.65; H, 3.56; N, 5.50. Found = C, 63.62; H, 3.52; N, 5.45. HPLC: <i>T</i><sub>R</sub> = 31.304 min.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> X-ray Crystallography</h3><div class="NLM_p">Single-crystal X-ray diffraction data were collected at 183(1) K on a Rigaku OD XtaLAB Synergy, Dualflex, Pilatus 200 K diffractometer using a single-wavelength X-ray source (Mo Kα radiation: λ = 0.71073 Å)<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> from a microfocus sealed X-ray tube and an Oxford liquid-nitrogen Cryostream cooler. The selected suitable single crystal was mounted using polybutene oil on a flexible loop fixed on a goniometer head and transferred to the diffractometer. Pre-experiment, data collection, data reduction, and analytical absorption correction<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> were performed with the program suite CrysAlisPro.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Using Olex2,<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> the structure was solved with the SHELXT<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> small-molecule structure solution program and refined with the SHELXL program package<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> (version 2018/3) by full-matrix least-squares minimization on F<sup>2</sup>. PLATON<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> was used to check the result of the X-ray analysis.</div><div class="NLM_p last">CCDC 1950873 contains the supporting crystallographic data for this compound and can be obtained free of charge from the Cambridge Crystallographic Data Centre <i>via</i><a href="http://www.ccdc.cam.ac.uk/data_request/cif" class="extLink">www.ccdc.cam.ac.uk/data_request/cif</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Electrochemical Measurements</h3><div class="NLM_p last">The electrochemical experiments were carried out with a conventional three-electrode cell (solution volume of 15 mL) and a personal computer (PC)-controlled potentiostat/galvanostat (Princeton Applied Research Inc., model 263A). The working electrode was a vitreous carbon electrode from Origalys (France), exposing a geometrical area of 0.071 cm<sup>2</sup> and mounted in Teflon. The electrode was polished before each experiment with 3 and 0.3 μm alumina pastes, followed by extensive rinsing with ultrapure Milli-Q water. A platinum wire was used as the counter electrode and a saturated calomel electrode, SCE, as the reference electrode. Electrolytic solutions, DMF containing 0.1 M tetrabutylammonium hexafluorophosphate (TBAPF<sub>6</sub>, Aldrich, +99%) as supporting electrolyte, were routinely deoxygenated by argon bubbling. All of the potential values are given <i>vs</i> the calomel saturated electrode (SCE) and recalculated <i>vs</i> the Me<sub>10</sub>Fc<sup>0/+</sup> potential value.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> EPR</h3><div class="NLM_p last">Electron paramagnetic resonance (EPR) experiments were performed on a MiniScope MS400 table-top X-band spectrometer from Magnettech. The simulation of the experimental EPR spectra was performed with the MATLAB EasySpin program.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> All samples were dissolved in dry and N<sub>2</sub>-saturated DCM at a concentration of ca. 1 mM. Oxidized forms were generated using 1,1′-diacetylferrocenium hexafluoroantimonate (Ac<sub>2</sub>FcSbF<sub>6</sub>, <i>E</i><sub>1/2</sub> = 0.940 V <i>vs</i> SCE in DMF/0.1 M NBu<sub>4</sub>PF<sub>6</sub>).<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> Chemical reduction was achieved using cobaltocene (Cp<sub>2</sub>Co, <i>E</i><sub>1/2</sub> = −0.880 V <i>vs</i> SCE in DMF/0.1 M NBu<sub>4</sub>PF<sub>6</sub>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Stability Studies</h3><div class="NLM_p">The stability in DMSO-<i>d</i><sub>6</sub> at room temperature was assessed by <sup>1</sup>H NMR over 8 days.</div><div class="NLM_p last">The stability of <b>Ru-sq</b> in human plasma at 37 °C was evaluated following a slightly modified procedure already reported by our group.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The human plasma was provided by the Blutspendezentrum, Zurich, Switzerland. Diazepam (internal standard) was obtained from Sigma-Aldrich. Stock solutions of the complexes (20 mM) and diazepam (3.2 mM) were prepared in DMSO. For a typical experiment, an aliquot of the respective stock solutions and DMSO were then added to the plasma solution (975 μL) to a total volume of 1000 μL and final concentrations of 40 μM for the complexes and diazepam. The resulting plasma solution was incubated for either 0, 4, 6, 12, 20, 24, or 48 h at 37 °C with continuous and gentle shaking (ca. 600 rpm). The reaction was stopped by the addition of 2 mL of methanol, and the mixture was centrifuged for 45 min at 650<i>g</i> at room temperature. The methanolic solution was evaporated, and the residue was suspended in 500 μL of a 1:1 (v/v) acetonitrile/H<sub>2</sub>O solution. The suspension was filtered and analyzed using UPLC–MS with a total injection volume of 2 μL.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Cell Culture</h3><div class="NLM_p last">HeLa and CT-26 cell lines were cultured in Dulbecco’s modified Eagle’s media (DMEM) (Gibco). The CT-26 LUC cell line was cultured in DMEM media (Gibco) supplemented with 1.6 mg/mL Genticin. The RPE-1 cell line was cultured in DMEM/F-12 media (Gibco). The MRC-5 cell line was cultured in DMEM/F-10 media (Gibco). A2780, A2780 cis, and A2780 ADR cell lines were cultured in Roswell Park Memorial Institute (RPMI) 1640 media (Gibco). The resistance of A2780 cis was maintained by cisplatin treatment (1 μM) for 1 week every month. The cells were used in the assays after 1 week from the end of the treatment to avoid interfered results. The resistance of A2780 ADR was maintained by doxorubicin treatment (0.1 μM) once a week. Cells were used in the assays after 3 days post doxorubicin treatment to avoid interfered results. All cell lines were complemented with 10% of fetal calf serum (Gibco) and 100 U/mL penicillin–streptomycin mixture (Gibco) and maintained in a humidified atmosphere at 37 °C and 5% of CO<sub>2</sub>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Cytotoxicity Assay Using a 2D Cellular Model</h3><div class="NLM_p last">The cytotoxicity of the tested <b>Ru-sq</b> and <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> complexes was assessed by a fluorometric cell viability assay using resazurin (Acros Organics). Briefly, cells were seeded in triplicates in 96-well plates at a density of 4 × 10<sup>3</sup> cells/well in 100 μL. After 24 h, cells were treated with increasing concentrations of the ruthenium complexes. Dilutions for <b>Ru-sq</b> were prepared as follows: 2.0 mM stock in DMSO was diluted to 25 μM with media and then filtrated (0.22 μm filter VWR). For <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub>, 2.5 mM stock in DMF was prepared, which was further diluted to 100 μM and filtrated (0.22 μm filter VWR). After 48 h incubation, the medium was removed, and 100 μL of the complete medium containing resazurin (0.2 mg/mL final concentration) was added. After 4 h of incubation at 37 °C, the fluorescence signal of the resorufin product was read (ex: 540 nm; em: 590 nm) in a SpectraMax M5 microplate reader. IC<sub>50</sub> values were then calculated using the GraphPad Prism software.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Generation of 3D HeLa MCTS</h3><div class="NLM_p last">MCTSs were cultured using ultralow attachment 96-well plates from Corning (Fisher Scientific 15329740). HeLa cells were seeded at a density of 5000 cells/well in 200 μL. The single cells would generate MCTS approximately 400 μm in diameter at day 4 with 37 °C and 5% CO<sub>2</sub>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Treatment of 3D HeLa MCTS</h3><div class="NLM_p last">HeLa MCTSs after 4 days of growing at 37 °C and 5% CO<sub>2</sub> were treated by replacing half of the medium in the well with the increasing concentration of compounds for 48 h in the dark. For untreated reference MCTS, half of the medium was replaced by fresh medium only. The cytotoxicity was measured by ATP concentration with a CellTiter-Glo cell viability kit (Promega).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> CellTiter-Glo Viability Test</h3><div class="NLM_p last">The cell viability test for MCTS was performed <i>via</i> an ATP assay using luciferase. A CellTiter-Glo kit from Promega was used. The spheroids were incubated for 1 h after replacing half of the media with the CellTiter-Glo reagent, and the luminescence of the plate was read by a SpectraMax M5 microplate reader. IC<sub>50</sub> values were calculated using the GraphPad Prism software.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> HeLa MCTS Growth Inhibition</h3><div class="NLM_p last">MCTSs were grown and treated as previously described (see above). MCTS sizes were observed under a light microscope, and pictures were taken with a Samsung Galaxy A5 2017 SM-A520FZKAXEF, thanks to a phone microscope adaptor. Before imaging, the plate was shaken and half of the media was exchanged to remove dead cells. Images were recorded before treatment (day 0) and at day 3, 6, 9, and 13 after the treatment. Pictures were first processed using GIMP, a cross-platform image editor with a batch automation plug-in. The MCTS sizes were then calculated with SpheroidSizer, a MATLAB-based and open-source software application to measure the size of tumor spheroids automatically and accurately. Data analysis was done using the GraphPad Prism software.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Annexin V/PI Assay</h3><div class="NLM_p last">Apoptosis and necrosis induction in HeLa cells treated with <b>Ru-sq</b> was evaluated <i>via</i> an Annexin V/PI staining assay using flow cytometry. Briefly, cells were seeded at a density of 2 × 10<sup>6</sup> cells in a 10 cm cell culture dish 24 h prior to cell treatments. The medium was removed and replaced with a 10 μM solution of <b>Ru-sq</b> or 1 μm staurosporine (positive control, Abcam Cat. no. 120056) and further incubated for 30 min, 4 h, or 24 h. Cells were collected, washed twice with ice-cold phosphate-buffered saline (PBS), and resuspended in 1× Annexin V binding buffer (10× buffer composition: 0.1 M <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES) (pH 7.4), 1.4 M NaCl, and 25 mM CaCl<sub>2</sub>). Samples were processed according to the manufacturer instructions (BD Scientific, Cat. nos. 556463 and 556419) and analyzed using a ZE5 Bio-Rad instrument at the Cytometry Platform at Institut Curie. Data were analyzed using the FlowJo software.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Sample Preparation for Cellular Uptake</h3><div class="NLM_p last">Cells were seeded at a density of 2 × 10<sup>6</sup>. The next day, cells were treated with 5 μM concentration of <b>Ru-sq</b> or cisplatin. After 2 h, cells were collected, counted, and snap-frozen in liquid nitrogen and stored at −20 °C. ICP-MS samples were prepared as follows: samples were digested using 70% nitric acid (1 mL, 60 °C, overnight). Samples were then further diluted 1:100 (1% HCl solution in Milli-Q water) and analyzed using ICP-MS.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Sample Preparation for Cellular Fractionation</h3><div class="NLM_p">HeLa cells were seeded in three 15 cm<sup>2</sup> cell culture dishes so that on the day of treatment cells were 90% confluent. On the day of treatment, cells were incubated with the target complex at a concentration of 5 μM for 2 h. After that time, the medium was removed; cells were washed, collected, and counted. After resuspension in cold PBS, the organelles were isolated <i>via</i> different protocols (one cell culture dish per isolation was used).</div><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Mitochondria Isolation</h4><div class="NLM_p last">To isolate the mitochondria, a mitochondria isolation kit (Cat. no. MITOISO2, Sigma-Aldrich) was used according to the manufacturer procedure for the isolation of the mitochondria <i>via</i> the homogenization method.</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Lysosome Isolation</h4><div class="NLM_p last">To isolate lysosomes, a lysosome isolation kit (Cat. no. LYSISO1, Sigma-Aldrich) was used, according to the manufacturer procedure for the isolation of lysosomes <i>via</i> option C.</div></div><div id="sec4_16_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Nuclear and Cytoplasm Isolation</h4><div class="NLM_p">To isolate nuclear and cytoplasmic fractions, the ROCKLAND nuclear extract protocol was used.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Briefly, cells were collected by centrifugation, resuspended in a cytoplasmic extraction buffer, and incubated on ice. The tubes were centrifuged, and the supernatant (CE) was removed. Pellets were washed with a cytoplasmic extraction buffer without a detergent and centrifuged. The pellet (NE) was resuspended in a nuclear extraction buffer and incubated on ice. Both CE and NE were centrifuged. The supernatant from CE samples was indicated as the cytoplasmic extract, whereas the pellet obtained from NE samples was indicated as the nuclear extract.</div><div class="NLM_p last">ICP-MS samples were prepared as follows: isolated cellular fractions were lyophilized and digested using 5 mL of 70% nitric acid (60 °C, overnight). Samples were then further diluted (1:1000 for nuclear pellet samples and 1:100 for all of the other samples) in Milli-Q water (containing 1% HCl solution) and analyzed using ICP-MS.</div></div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Sample Preparation for Studies on the Mechanism of Cellular Uptake</h3><div class="NLM_p last">HeLa cells were seeded at a density of 2 × 10<sup>6</sup> and the next day were pretreated with corresponding inhibitors or kept at a specific temperature for 1 h. Next, cells were washed with PBS and incubated with 5 μM <b>Ru-sq</b> for 2 h (the low-temperature sample was still kept at 4 °C). Afterward, cells were washed with PBS, collected, counted, and snap-frozen in liquid nitrogen. Pellets were stored at −20 °C. ICP-MS samples were prepared as follows: samples were digested using 70% nitric acid (1 mL, 60 °C, overnight), further diluted 1:100 (1% HCl solution in Milli-Q water), and analyzed using ICP-MS.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> DNA Metalation of HeLa Cells</h3><div class="NLM_p last">Cells were seeded at a density of 2 × 10<sup>6</sup>. The following day, cells were treated with 5 μM concentration of <b>Ru-sq</b> or cisplatin. After 2 h, cells were collected, snap-frozen in liquid nitrogen, and stored at −20 °C. The following day, DNA was extracted using a PureLink Genomic DNA Mini Kit (Invitrogen). DNA purity was checked by absorbance measurements at 260 and 280 nm. Concentrations of genomic DNA were calculated, assuming that one absorbance unit equals 50 μg/mL. ICP-MS samples were prepared as follows: samples were digested using 70% nitric acid (60 °C, overnight) in 1:1.6 DNA-to-acid volume ratio. Samples were then further diluted 1:10 or 1:100 (1% HCl solution in Milli-Q water) and analyzed using ICP-MS.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> ICP-MS Studies</h3><div class="NLM_p last">All ICP-MS measurements were performed on a high-resolution ICP-MS (Element II, Thermo Scientific) located at the Institut de Physique du Globe de Paris (France). The monitored isotopes are <sup>101</sup>Ru and <sup>195</sup>Pt. Daily, prior to the analytical sequence, the instrument was first tuned to produce maximum sensitivity and stability while also maintaining low uranium oxide formation (UO/U ≤ 5%). The data were treated as follows: intensities were converted into concentrations using user-FRiendly Elemental dAta proceSsIng (uFREASI).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> This software, made for the high-resolution (HR)-ICP-MS user community, is free and available on <a href="http://www.ipgp.fr/~tharaud/uFREASI" class="extLink">http://www.ipgp.fr/~tharaud/uFREASI</a>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> ICP-MS Data Analysis</h3><div id="sec4_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Cellular Uptake Studies</h4><div class="NLM_p last">The amount of metal detected in the cell samples was transformed from ppb into μg of metal. Data were subsequently normalized to the number of cells and expressed as μmol of metal/amount of cells.</div></div><div id="sec4_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Cellular Fractionation</h4><div class="NLM_p last">The amount of detected ruthenium in the cell samples was transformed from ppb into μg of ruthenium. Values were then normalized to the number of cells used for specific extraction. Due to low yield of lysosome extraction (only 25%), the values obtained were multiplied by a factor of 4. Because of a low yield of mitochondria extraction (50% of the cells were homogenized), the values obtained for that organelle were multiplied by a factor of 2. Extraction protocols allow for the isolation of pure subcellular fractions. Therefore, the total amount of metal found in the cells was calculated, summing the values obtained for the pure organelles.</div></div><div id="sec4_20_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Mechanism of Uptake</h4><div class="NLM_p last">The amount of ruthenium detected in cell samples was transformed from ppb into μg of ruthenium, and values obtained were normalized to the number of cells used for specific treatment. The value for the ruthenium found in the 37 °C sample was used as a 100%.</div></div><div id="sec4_20_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Cellular Metalation</h4><div class="NLM_p last">The amount of ruthenium detected in cell samples was transformed from ppb into μg of ruthenium, and the value obtained was normalized to the amount of DNA.</div></div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> JC-1 Mitochondrial Membrane Potential Test</h3><div class="NLM_p last">HeLa cells were seeded at a density of 6000 cells/well in a black 96-well plate (costar 3916). The next day, the cells were treated with different concentrations of <b>Ru-sq</b> and <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub>. After further 24 h, the cells were treated according to the JC-1 mitochondrial membrane potential assay kit (Abcam, ab113850). The data were analyzed using the GraphPad Prism software.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Mito Stress Test</h3><div class="NLM_p last">HeLa cells were seeded in Seahorse XFe96 well plates at a density of 30 000 cells/well in 80 μL. After 24 h, the medium was replaced with fresh medium and cisplatin (10 μM), catechol (10 μM), DIP (1 μM), and complex <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> (10 μM) or complex <b>Ru-sq</b> (1 μM) were added. After 24 h of incubation, the regular medium was removed and the cells were washed thrice using bicarbonate- and serum-free DMEM, supplemented with 1.8 mg/mL glucose, 1% glutamine, and 1% sodium pyruvate, and incubated in a non-CO<sub>2</sub> incubator at 37 °C for 1 h. The mito stress assay was run using 1 μM oligomycin, 1 μM FCCP, and a mixture of antimycin-A/rotenone 1 μM each in ports A, B, and C, respectively, using a Seahorse XFe96 extracellular flux analyzer.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Glycolysis Stress Test</h3><div class="NLM_p last">HeLa cells were seeded in Seahorse XFe96 well plates at a density of 30 000 cells/well in 80 μL. After 24 h, the medium was replaced with fresh medium and cisplatin (10 μM), catechol (10 μM), DIP (1 μM), and complex <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> (10 μM) or complex <b>Ru-sq</b> (1 μM) were added. After 24 h of incubation, the regular medium was removed and the cells were washed thrice using bicarbonate-, glucose-, and serum-free DMEM, supplemented with 1% glutamine and 1% sodium pyruvate, and incubated in a non-CO<sub>2</sub> incubator at 37 °C for an hour. The glycolytic stress test was run using 10 mM glucose, 1 μM oligomycin, and 50 mM 2-deoxyglucose in ports A, B, and C, respectively, using a Seahorse XFe96 extracellular flux analyzer.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Mito Fuel Flex Test</h3><div class="NLM_p last">HeLa cells were seeded in Seahorse XFe96 well plates at a density of 30 000 cells/well in 80 μL. After 24 h, the medium was replaced with fresh medium and cisplatin (10 μM), catechol (10 μM), DIP (1 μM), and complex <b>Ru(DIP)</b><sub><b>2</b></sub><b>Cl</b><sub><b>2</b></sub> (10 μM) or complex <b>Ru-sq</b> (1 μM) were added. After 24 h of incubation, the regular medium was removed and the cells were washed thrice using bicarbonate- and serum-free DMEM, supplemented with 1.8 mg/mL glucose, 1% glutamine, and 1% sodium pyruvate, and incubated in a non-CO<sub>2</sub> incubator at 37 °C for an hour. The fuel flex assay for the different fuel pathways, viz. glucose, glutamine, and fatty acids, was performed by measuring the basal oxygen consumption rates and those after the addition of the inhibitor of the target pathway in port A and a mixture of the inhibitors of the other two pathways in port B. This gave a measure of the dependency of the cells on a fuel pathway. To study the capacity of a certain fuel pathway, the sequence of the addition of the inhibitors was reversed. In port A was added the mixture of inhibitors for the other pathways, and in port B was added the inhibitor for the target pathway. UK-5099 (pyruvate dehydrogenase inhibitor, 20 μM) was used as an inhibitor for the glucose pathway. Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) (a selective inhibitor of glutaminase GLS1, 30 μM) was used as an inhibitor for the glutamine pathway. Etomoxir (<i>O</i>-carnitine palmitoyltransferase-1 (CPT-1) inhibitor, 40 μM) was used as an inhibitor for the fatty acid pathway.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Animals and the Tumor Model for Ehrlich Mammary Carcinoma in Immunocompetent NMRI Mice</h3><div class="NLM_p last">Due to the poor solubility of <b>Ru-sq</b> in water, dimethyl sulfoxide (DMSO), 1.81 mL/kg body weight, had to be added to water for injections, for which reason the i.p. route of administration rather than intravenous (i.v.) was chosen. Female outbred mice (NMRI) were used for this study, and they were obtained from Masaryk University (Brno, Czech Republic). Animal care was conformed to EU recommendations and in accordance with the European Convention for the Protection of Vertebrate Animals used for experimental and other scientific purposes; it was approved by the Ethical Commission of the Medical Faculty in Hradec Králové (no. MSMT-56249/2012-310). For the MTD assessment, two or three healthy mice per group were observed for weight loss (the limit was 10%) over 14 days after injection of the solution. For the <i>in vivo</i> activity study, 70 NMRI female mice, 7 weeks old and weighing on an average 31.8 g (SD = 1.27), were fed a standard diet and water ad libitum. A solid Ehrlich tumor was purchased from the Research Institute for Pharmacy and Biochemistry (VUFB) in Prague and then maintained in NMRI mice by periodical transplantations. The homogenized tumor tissue was inoculated subcutaneously into all mice on day 0, using 0.2 mL of 1/1 (v/v) homogenate freshly prepared in an isotonic glucose solution. The tumor-bearing mice were then divided into five groups of 14 animals as follows: a control group treated with the pure solvent (DMSO and water), three groups of animals treated with <b>Ru-sq</b> in doses of 5, 10, and 15 mg/kg i.p., and a positive control receiving 5 mg/kg cisplatin i.p. (cisplatin 50 mL/25 mg, EBEWE Pharma, Austria). The solutions were administered on days 1 and 7 in volumes of 0.2 mL per 20 g of the body weight. On the 10th day, half of the mice were sacrificed, and their tumors were weighed. The remaining animals were left to observe their survival.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Statistical Analysis for Ehrlich Mammary Carcinoma in Immunocompetent NMRI Mice</h3><div class="NLM_p last">One-way analysis of variance with post hoc Dunnett’s multiple comparison test was used to detect differences in tumor weight. Kaplan–Meier curves and log rank tests were used to compare survival times in groups. Here, the level of significance was α = 0.05. MS Excel 2003 and NCSS software were used for the calculations and statistical evaluations.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Animals and Tumor Model for A2780 Human Ovarian Cancer in Immunodeficient Nude Mice</h3><div class="NLM_p last">The animal experiments depicted hereafter were performed in accordance with the Act on Experimental Work with Animals (Public Notice of the Ministry of Agriculture of the Czech Republic nos. 246/1992, 311/1997, 207/2004; Decree of the Ministry of the Environment of the Czech Republic no. 117/1987; and Act of the Czech National Assembly no. 149/2004), which is fully compatible with the corresponding European Union directives. Athymic nude mice were used for the experiment (obtained from AnLab Ltd., Prague, Czech Republic, females, 8 weeks old, <i>n</i> = 40). After acclimatization, the A2780 human ovarian cancer cell line was implanted subcutaneously in the shaved right flank of mice (obtained from Sigma-Aldrich, Missouri, used medium RPMI with 10% fetal bovine serum, 2 × 10<sup>6</sup> cells per mouse applied with a cell-to-Matrigel ratio of 2:1). The animals were randomly divided into five groups (<i>n</i> = 8) when the tumor reached the size of 5–8 mm in diameter. A 5% dimethyl sulfoxide (DMSO) solution containing <b>Ru-sq</b> 5, 10, or 15 mg/kg (in volume 200 μL per 20 g of the mouse weight) was administered intraperitoneally to the first three groups (day 1). Another group received cisplatin (5 mg/kg) in the same manner as that of the positive control. The last group (as negative untreated control) received intraperitoneally a 5% solution of DMSO with a physiological solution. The application of all substances was repeated on day 7 of therapy. The animals were observed 60 days from the first application, and tumor growth, the weight of mice, and survival were monitored at regular intervals. The mice had free access to water and food ad libitum throughout the experiment. At the end of the experiment (after 60 days), all surviving mice were sacrificed using an overdose of intramuscular anesthetic.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Statistical Analysis for A2780 Human Ovarian Cancer in Immunodeficient Nude Mice</h3><div class="NLM_p last">One-way analysis of variance with post hoc Dunnett’s multiple comparison test was used to detect differences in tumor weight. Kaplan–Meier curves and log rank tests were used to compare survival times in groups. Here, the level of significance was α = 0.05. MS Excel 2016 and OriginPro 8 software were used for the calculations and statistical evaluations.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Western Blot Analysis of Akt-1 Protein Levels in HeLa Cells</h3><div class="NLM_p last">HeLa cells were seeded on a 10 cm dish so that, at the time of the treatment, cells were confluent. The next day, the cells were treated for 24 h with the compounds. After that time, the cells were collected, counted, snap-frozen in liquid nitrogen, and then stored at −20 °C. Samples were then lysed in 4× sodium borate (SB) buffer in reducing conditions so that 10 μL of the sample contained 100 000 cells. Samples were passaged 10 times through a 5 mL syringe with a narrow needle and then boiled for 10 min. Samples were then loaded on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (10 μL). Proteins were then blotted on a nitrocellulose membrane (Amersham Protran 0.2). Detection of Akt-1 and GAPDH proteins was conducted using the following primary antibodies: anti-GAPDH (1:10 000, Sigma-Aldrich, G9545) and anti-Akt-1 (B-1) (1:50, Santa Cruz Biotechnology, sc-5298). Images were taken using a ChemiDoc Touch Imaging System by Bio-rad. Images with nonsaturated bands allowed for normalization in the Fiji software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00431" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00431?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00431</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">NMR spectra and HPLC chromatogram, CV and RDE spectra, and electrochemical data of <b>Ru-sq</b>; crystallographic data of <b>[Ru(DIP)2(sq)](Cl)</b>; selected bond lengths and angles of <b>Ru-1</b> and <b>Ru-2</b> molecules; EPR spectra of <b>Ru-sq</b>, its reduced form <b>Ru-sq<sup>–</sup></b>, and its oxidized form <b>Ru-sq<sup>+</sup></b>; overlap of <sup>1</sup>H spectra of <b>Ru-sq</b> in DMSO over 8 days; UV traces of UPLC analysis of <b>Ru-sq</b> and percentage concentration of <b>Ru-sq</b> over time; fluorometric cell viability assay; CellTiter-Glo viability test; dot plots of cell death mechanism; cellular uptake mechanism; oxygen consumption rates and different respiration parameters in HeLa cells; extracellular acidification rate and different parameters of glycolytic respiration in HeLa cells; fuel flex assay in HeLa cells; and Akt-1 protein levels in HeLa cells treated with different concentrations of <b>Ru-sq</b>, doxorubicin, and cisplatin (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf">jm0c00431_si_001.pdf (2.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_002.csv">jm0c00431_si_002.csv (0.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00431" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilles Gasser</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4244-5097" title="Orcid link">http://orcid.org/0000-0002-4244-5097</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#482f2124242d3b662f293b3b2d3a082b2021252d38293a213b3c2d2b2066383b24662d3d"><span class="__cf_email__" data-cfemail="d9beb0b5b5bcaaf7beb8aaaabcab99bab1b0b4bca9b8abb0aaadbcbab1f7a9aab5f7bcac">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Notaro</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo Frei</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6169-2491" title="Orcid link">http://orcid.org/0000-0001-6169-2491</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Riccardo Rubbiani</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Jakubaszek</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
Curie, PSL University, CNRS UMR 144, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uttara Basu</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Severin Koch</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Mari</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mazzarine Dotou</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Blacque</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jérémie Gouyon</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Team Synthèse, Electrochimie, Imagerie et
Systèmes Analytiques pour le Diagnostic, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fethi Bedioui</span> - <span class="hlFld-Affiliation affiliation">Chimie
ParisTech, PSL University, CNRS, Institute of Chemistry for Life and
Health Sciences, Team Synthèse, Electrochimie, Imagerie et
Systèmes Analytiques pour le Diagnostic, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nils Rotthowe</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Konstanz, Universitätsstrasse 10, D-78457 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer F. Winter</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Konstanz, Universitätsstrasse 10, D-78457 Konstanz, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8381-0647" title="Orcid link">http://orcid.org/0000-0001-8381-0647</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruno Goud</span> - <span class="hlFld-Affiliation affiliation">Institut
Curie, PSL University, CNRS UMR 144, F-75005 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Ferrari</span> - <span class="hlFld-Affiliation affiliation">Institute
of Molecular Cancer Research, University
of Zurich, CH-8057 Zurich, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 143 00 Prague, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mickaël Tharaud</span> - <span class="hlFld-Affiliation affiliation">Université
de Paris, Institut de physique du Globe de Paris, CNRS, F-75005 Paris, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6131-655X" title="Orcid link">http://orcid.org/0000-0001-6131-655X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Řezáčová</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Šimkova 870, 500 03 Hradec Kralove, Czech
Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Humajová</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, 150 06 Prague, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pavel Tomšík</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Šimkova 870, 500 03 Hradec Kralove, Czech
Republic</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.N., A.F., and R.R. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2915-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was financially supported by an ERC Consolidator Grant PhotoMedMet to G.G. (GA 681679) and has received support under the program Investissements d’Avenir launched by the French Government and implemented by the ANR with the reference ANR-10-IDEX-0001-02 PSL (G.G.). This work was financed by the Swiss National Science Foundation (Professorship nos. PP00P2_133568 and PP00P2_157545 to G.G.), the University of Zurich (G.G.), the Novartis Jubilee Foundation (G.G. and R.R.), the Forschungskredit of the University of Zurich (R.R.), the UBS Promedica Stiftung (G.G. and R.R.), and the Charles University program Progres Q40/01. Ile de France Region is gratefully acknowledged for financial support of the 500 MHz NMR spectrometer of Chimie ParisTech in the framework of the SESAME equipment project. We acknowledge the loan of Agilent’s equipment to Chimie ParisTech. Part of this work was supported by IPGP multidisciplinary program PARI and by Region Île-de-France SESAME Grant no. 12015908. S.F. is supported by a grant of the Czech Science Foundation (17-02080S).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">A2780</td><td class="NLM_def"><p class="first last">human ovarian carcinoma</p></td></tr><tr><td class="NLM_term">A2780 ADR</td><td class="NLM_def"><p class="first last">human doxorubicin-resistant ovarian carcinoma</p></td></tr><tr><td class="NLM_term">A2780 cis</td><td class="NLM_def"><p class="first last">human cisplatin-resistant ovarian carcinoma</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">serine/threonine kinase</p></td></tr><tr><td class="NLM_term">cat</td><td class="NLM_def"><p class="first last">catecholate</p></td></tr><tr><td class="NLM_term">CT-26</td><td class="NLM_def"><p class="first last">mouse colon adenocarcinoma</p></td></tr><tr><td class="NLM_term">CT-26 LUC</td><td class="NLM_def"><p class="first last">mouse colon adenocarcinoma stably expressing luciferase</p></td></tr><tr><td class="NLM_term">CV</td><td class="NLM_def"><p class="first last">cyclic voltammetry</p></td></tr><tr><td class="NLM_term">DIP</td><td class="NLM_def"><p class="first last">4,7-diphenyl-1,10-phenanthroline</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-wave potential</p></td></tr><tr><td class="NLM_term">ECAR</td><td class="NLM_def"><p class="first last">extracellular acidification rate</p></td></tr><tr><td class="NLM_term">FCCP</td><td class="NLM_def"><p class="first last">carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GL-15</td><td class="NLM_def"><p class="first last">human glioblastoma</p></td></tr><tr><td class="NLM_term">HeLa</td><td class="NLM_def"><p class="first last">human cervical adenocarcinoma</p></td></tr><tr><td class="NLM_term">ICP-MS</td><td class="NLM_def"><p class="first last">inductively coupled plasma mass spectrometry</p></td></tr><tr><td class="NLM_term">JC-1</td><td class="NLM_def"><p class="first last">5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide</p></td></tr><tr><td class="NLM_term">MCTSs</td><td class="NLM_def"><p class="first last">multicellular tumor spheroids</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MRC-5</td><td class="NLM_def"><p class="first last">human normal lung fibroblast</p></td></tr><tr><td class="NLM_term">N2a</td><td class="NLM_def"><p class="first last">mouse neuroblastoma</p></td></tr><tr><td class="NLM_term">NER</td><td class="NLM_def"><p class="first last">nucleotide excision repair</p></td></tr><tr><td class="NLM_term">OCR</td><td class="NLM_def"><p class="first last">oxygen consumption rate</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan-assay interference compounds</p></td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quinone</p></td></tr><tr><td class="NLM_term">RDE</td><td class="NLM_def"><p class="first last">rotating disc electrode</p></td></tr><tr><td class="NLM_term">RPE-1</td><td class="NLM_def"><p class="first last">human normal retinal pigment epithelial</p></td></tr><tr><td class="NLM_term">SCE</td><td class="NLM_def"><p class="first last">saturated calomel electrode</p></td></tr><tr><td class="NLM_term">sq</td><td class="NLM_def"><p class="first last">semiquinonate</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultrahigh-pressure liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 112 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urruticoechea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemany, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viñals, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capellá, G.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Cancer Therapy: An Overview</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.2174/138161210789941847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2174%2F138161210789941847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=20214614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3-10&author=A.+Urruticoecheaauthor=R.+Alemanyauthor=J.+Balartauthor=A.+Villanuevaauthor=F.+Vi%C3%B1alsauthor=G.+Capell%C3%A1&title=Recent+Advances+in+Cancer+Therapy%3A+An+Overview&doi=10.2174%2F138161210789941847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in cancer therapy: an overview</span></div><div class="casAuthors">Urruticoechea, A.; Alemany, R.; Balart, J.; Villanueva, A.; Vinals, F.; Capella, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The landscape of cancer treatment has dramatically changed over the last four decades.  The age when surgery and radiotherapy were the only effective way to fight tumor growth has ended.  A complex scenario where the mol. features of tumors seem to be the cornerstone of any therapy is now emerging.  Here we provide an overview on the different approaches to cancer treatment.  This review will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanims underpinning their efficacy.  Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small mols., antiangiogenics and viral therapy.  We briefly elaborate, finally, on new biomarkers development and how it should rule and det. the future of therapeutic research in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFhYFS1gpWjrVg90H21EOLACvtfcHk0liR2gm6RJ1D5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKmu7c%253D&md5=b81c202cb6bc38fedaeaea1e139858f5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161210789941847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210789941847%26sid%3Dliteratum%253Aachs%26aulast%3DUrruticoechea%26aufirst%3DA.%26aulast%3DAlemany%26aufirst%3DR.%26aulast%3DBalart%26aufirst%3DJ.%26aulast%3DVillanueva%26aufirst%3DA.%26aulast%3DVi%25C3%25B1als%26aufirst%3DF.%26aulast%3DCapell%25C3%25A1%26aufirst%3DG.%26atitle%3DRecent%2520Advances%2520in%2520Cancer%2520Therapy%253A%2520An%2520Overview%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3%26epage%3D10%26doi%3D10.2174%2F138161210789941847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Camp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krigas, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cell Division in <i>Escherichia coli</i> by Electrolysis Products from a Platinum Electrode</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">699</span>, <span class="refDoi"> DOI: 10.1038/205698a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2F205698a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=14287410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaF2MXns1aruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1965&pages=698-699&author=B.+Rosenbergauthor=L.+Van+Campauthor=T.+Krigas&title=Inhibition+of+Cell+Division+in+Escherichia+coli+by+Electrolysis+Products+from+a+Platinum+Electrode&doi=10.1038%2F205698a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode</span></div><div class="casAuthors">Rosenberg, Barnett; Van Camp, Loretta; Krigas, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">4972</span>),
    <span class="NLM_cas:pages">698-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">E. coli cells grown in a continuous culture app. with an esp. designed chamber contg. 2 Pt electrodes were subjected to an elec. field in an O atm.  With an applied voltage of 500 to 6000 cycles/sec., cell division ceased and filamentous growth occurred.  A similar effect was shown with a soln. of 10 ppm. (NH4)2PtCl6.  Pt(IV) was found in the electrolyzed medium in concns. of 8 ppm.  Other transition metal ions, including Rh, in concns. of 1-10 ppm. inhibited cell division in E. coli while not interfering with growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDyKBEDeGaCrVg90H21EOLACvtfcHk0liR2gm6RJ1D5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXns1aruw%253D%253D&md5=2d2e79bfe93d202de21a43b131ea95b2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F205698a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F205698a0%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%26aulast%3DVan%2BCamp%26aufirst%3DL.%26aulast%3DKrigas%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Cell%2520Division%2520in%2520Escherichia%2520coli%2520by%2520Electrolysis%2520Products%2520from%2520a%2520Platinum%2520Electrode%26jtitle%3DNature%26date%3D1965%26volume%3D205%26spage%3D698%26epage%3D699%26doi%3D10.1038%2F205698a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Camp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimley, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, A. J.</span></span> <span> </span><span class="NLM_article-title">The Inhibition of Growth or Cell Division in <i>Escherichia coli</i> by Different Ionic Species of Platinum (IV) Complexes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>242</i></span>,  <span class="NLM_fpage">1347</span>– <span class="NLM_lpage">1352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=5337590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaF2sXntlGjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=1967&pages=1347-1352&author=B.+Rosenbergauthor=L.+van+Campauthor=E.+B.+Grimleyauthor=A.+J.+Thomson&title=The+Inhibition+of+Growth+or+Cell+Division+in+Escherichia+coli+by+Different+Ionic+Species+of+Platinum+%28IV%29+Complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes</span></div><div class="casAuthors">Rosenberg, Barnett; Van Camp, Loretta; Grimley, Eugene B.; Thomson, Andrew James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">242</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1347-52</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">When a soln. contg. the complex ion, [PtCl6]=, and NH4+ ions is irradiated, a photochem. change occurs in which the chloride ions of the ligand are sequentially replaced by 1, 2, or 3 ammonia mols.  The total charge on the complex ion decreases by 1 neg. charge for each replacement.  These changes can be followed by changes occurring in absorption spectra or in ionophoretic patterns.  Each charged species of the complex has a unique effect on the growth of E. coli.  The doubly neg. species is a bactericide.  The singly neg. species appears to have little effect on either growth or cell division processes.  The neutral species has little effect on growth, but markedly inhibits cell division processes, forcing filamentous growth.  The cis and trans forms of the diamino complex, [PtCl4(NH3)2]0, have been synthesized.  The absorption spectra of both have a λmax. at 207 mμ.  The electrophoretic patterns indicate predominantly neutral species in both cases.  The trans form is relatively inefficient in inhibiting cell division, whereas the cis form is fully as efficient as the neutral species in inhibiting cell division, identifying the neutral species as the cis form of the complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTlqzE2htyHbVg90H21EOLACvtfcHk0liR2gm6RJ1D5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXntlGjtA%253D%253D&md5=0dba955e8327fc9b31455fe342311640</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%26aulast%3Dvan%2BCamp%26aufirst%3DL.%26aulast%3DGrimley%26aufirst%3DE.%2BB.%26aulast%3DThomson%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520Inhibition%2520of%2520Growth%2520or%2520Cell%2520Division%2520in%2520Escherichia%2520coli%2520by%2520Different%2520Ionic%2520Species%2520of%2520Platinum%2520%2528IV%2529%2520Complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1967%26volume%3D242%26spage%3D1347%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Camp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trosko, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, V. H.</span></span> <span> </span><span class="NLM_article-title">Platinum Compounds: A New Class of Potent Antitumour Agents</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>222</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1038/222385a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2F222385a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=5782119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaF1MXktVWquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=1969&pages=385-386&author=B.+Rosenbergauthor=L.+Van+Campauthor=J.+E.+Troskoauthor=V.+H.+Mansour&title=Platinum+Compounds%3A+A+New+Class+of+Potent+Antitumour+Agents&doi=10.1038%2F222385a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum compounds:  a new class of potent antitumor agents</span></div><div class="casAuthors">Rosenberg, Barnett; VanCamp, Loretta; Trosko, James E.; Mansour, Virginia H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">5191</span>),
    <span class="NLM_cas:pages">385-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The platinum compds., cis-Pt(NH3)2Cl4, cis-Pt(NH3)2Cl2, Pt(en)Cl2, and Pt(en)Cl4, when injected i.p. at 0.5-10.0 mg./kg., daily, inhibited sarcoma 180 in mice.  cis-Pt(NH3)2Cl2 injected i.p. at 5-10 mg./kg. was a potent antileukemic agent against leukemia L-1210 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2aCa0V0sT0bVg90H21EOLACvtfcHk0lj4BAr5wzvEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXktVWquro%253D&md5=dc39b2856a15013e111128b36ec22855</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F222385a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F222385a0%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%26aulast%3DVan%2BCamp%26aufirst%3DL.%26aulast%3DTrosko%26aufirst%3DJ.%2BE.%26aulast%3DMansour%26aufirst%3DV.%2BH.%26atitle%3DPlatinum%2520Compounds%253A%2520A%2520New%2520Class%2520of%2520Potent%2520Antitumour%2520Agents%26jtitle%3DNature%26date%3D1969%26volume%3D222%26spage%3D385%26epage%3D386%26doi%3D10.1038%2F222385a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B. B.</span></span> <span> </span><span class="NLM_article-title">Some Biological Effects of Platinum Compounds</span>. <i>Platinum Met. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaE3MXksVOjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1971&pages=42-51&author=B.+B.+Rosenberg&title=Some+Biological+Effects+of+Platinum+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Biological effects of platinum compounds.  New agents for the control of tumors</span></div><div class="casAuthors">Rosenberg, Barnett</div><div class="citationInfo"><span class="NLM_cas:title">Platinum Metals Review</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">PTMRA3</span>;
        ISSN:<span class="NLM_cas:issn">0032-1400</span>.
    </div><div class="casAbstract">A review is given of the properties and effects of Pt compds.  Topics mentioned include antitumor activity, toxicol. effects of Pt complexes, mol. biol. of Pt complexes, and speculation on the mode of action of the antitumor effects.  Possible antitumor activity is mentioned for cis-dichlorodiamineplatinum and other inorg. compds.  20 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyyVK5yDzUubVg90H21EOLACvtfcHk0lj4BAr5wzvEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXksVOjsb4%253D&md5=58c5434d36355c00ba6956e071f673c4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%2BB.%26atitle%3DSome%2520Biological%2520Effects%2520of%2520Platinum%2520Compounds%26jtitle%3DPlatinum%2520Met.%2520Rev.%26date%3D1971%26volume%3D15%26spage%3D42%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pil, P.</span>; <span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Cisplatin and Related Drugs</span>. In  <i>Encyclopedia of Cancer</i>;<span class="NLM_contrib-group"><span class="NLM_string-name">Bertino, J. R.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">1</span>, p  <span class="NLM_fpage">392</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=392&author=P.+Pil&author=S.+J.+Lippardauthor=J.+R.+Bertino&title=Encyclopedia+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPil%26aufirst%3DP.%26atitle%3DCisplatin%2520and%2520Related%2520Drugs%26btitle%3DEncyclopedia%2520of%2520Cancer%26aulast%3DBertino%26aufirst%3DJ.%2BR.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D1%26spage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giandomenico, C. M.</span></span> <span> </span><span class="NLM_article-title">Current Status of Platinum-Based Antitumor Drugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">2451</span>– <span class="NLM_lpage">2466</span>, <span class="refDoi"> DOI: 10.1021/cr980420v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr980420v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK1MXltFSrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2451-2466&author=E.+Wongauthor=C.+M.+Giandomenico&title=Current+Status+of+Platinum-Based+Antitumor+Drugs&doi=10.1021%2Fcr980420v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Current Status of Platinum-Based Antitumor Drugs</span></div><div class="casAuthors">Wong, Ernest; Giandomenico, Christen M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2451-2466</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 239 refs.  The primary purpose of this review is to give an update of the Pt drugs currently in human clin. trials and to give an overview of the design of new compds. within the last 10 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4bnyP6NJWybVg90H21EOLACvtfcHk0lj4BAr5wzvEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFSrsrc%253D&md5=85f7f4c185096f8b3bb1676629ccb3ae</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcr980420v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980420v%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26aulast%3DGiandomenico%26aufirst%3DC.%2BM.%26atitle%3DCurrent%2520Status%2520of%2520Platinum-Based%2520Antitumor%2520Drugs%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2451%26epage%3D2466%26doi%3D10.1021%2Fcr980420v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebwohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canetta, R.</span></span> <span> </span><span class="NLM_article-title">Clinical Development of Platinum Complexes in Cancer Therapy: An Historical Perspective and an Update</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1522</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(98)00224-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2FS0959-8049%2898%2900224-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=9893623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVSku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=1522-1534&author=D.+Lebwohlauthor=R.+Canetta&title=Clinical+Development+of+Platinum+Complexes+in+Cancer+Therapy%3A+An+Historical+Perspective+and+an+Update&doi=10.1016%2FS0959-8049%2898%2900224-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical development of platinum complexes in cancer therapy: an historical perspective and an update</span></div><div class="casAuthors">Lebwohl, D.; Canetta, R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1522-1534</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 132 refs.  The vast amt. of basic research on platinum coordination complexes has produced, over the past 25 yr, several thousand new mols. for preclin. screening and 28 compds. which have entered clin. development.  The goals of these research activities have been to identify compds. with superior efficacy, reduced toxicity, lack of cross-resistance or improved pharmacol. characteristics as compared with the parent compd., cisplatin.  After the remarkable therapeutic effects of cisplatin had been established, only a few other platinum compds. succeeded in reaching general availability.  Whereas carboplatin is an analog with an improved therapeutic index (mostly driven by reduced organ toxicity) over that of cisplatin, new compds. clearly more active than or non-cross-resistant with cisplatin have not yet been identified.  The platinum analogs that remain under investigation are focusing on expanding the utilisation of platinum therapy to tumor types not usually treated with, or responsive to, cisplatin or carboplatin.  In addn., novel routes of administration constitute another avenue of research.  The clin. development of platinum coordination complexes, with emphasis on those compds. still under active development, is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4jtprGEjGjbVg90H21EOLACvtfcHk0lhEckKquXn4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVSku7Y%253D&md5=5c440a98eae520a9c5f61bdebb01b84e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2898%2900224-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252898%252900224-X%26sid%3Dliteratum%253Aachs%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DCanetta%26aufirst%3DR.%26atitle%3DClinical%2520Development%2520of%2520Platinum%2520Complexes%2520in%2520Cancer%2520Therapy%253A%2520An%2520Historical%2520Perspective%2520and%2520an%2520Update%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1998%26volume%3D34%26spage%3D1522%26epage%3D1534%26doi%3D10.1016%2FS0959-8049%2898%2900224-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fricker, S. P.</span></span> <span> </span><span class="NLM_article-title">Metal Based Drugs: From Serendipity to Design</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">4903</span>– <span class="NLM_lpage">4917</span>, <span class="refDoi"> DOI: 10.1039/b705551j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb705551j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17992275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=4903-4917&author=S.+P.+Fricker&title=Metal+Based+Drugs%3A+From+Serendipity+to+Design&doi=10.1039%2Fb705551j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Metal based drugs: from serendipity to design</span></div><div class="casAuthors">Fricker, Simon Paul</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4903-4917</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The platinum anticancer drug cisplatin has made a major contribution to the treatment of testicular and ovarian cancer.  This chance discovery has been the stimulus for research into other metal-based drugs.  Inorg. chem. offers many opportunities for medicinal chem., and the discovery of metal-based drugs has moved on from chance discovery to rational drug design.  There are however, many challenges assocd. with the drug discovery and development process.  The aim of this review is to provide case histories exemplifying the role of rational drug design in modern inorg. medicinal chem. in the context of these challenges.  The evolution of platinum drugs from cisplatin to third generation drugs is described.  The mol. target for the platinum agents is DNA.  Alternative mol. targets such as thiol-contg. proteins and redox processes are proposed.  The example of a simple, safe, efficacious metal-based drug, Fosrenol, is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnD2NhKPWN7Vg90H21EOLACvtfcHk0lhEckKquXn4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rJ&md5=6467524515fc593832760ea0dc511a81</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1039%2Fb705551j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705551j%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DMetal%2520Based%2520Drugs%253A%2520From%2520Serendipity%2520to%2520Design%26jtitle%3DDalton%2520Trans.%26date%3D2007%26spage%3D4903%26epage%3D4917%26doi%3D10.1039%2Fb705551j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azad, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomar, R. S.</span></span> <span> </span><span class="NLM_article-title">Anti-Cancer Drug KP1019 Induces Hog1 Phosphorylation and Protein Ubiquitylation in <i>Saccharomyces cerevisiae</i></span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>736</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.ejphar.2014.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24797784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=736&publication_year=2014&pages=77-85&author=V.+Singhauthor=G.+K.+Azadauthor=M.+A.+Reddyauthor=S.+Baranwalauthor=R.+S.+Tomar&title=Anti-Cancer+Drug+KP1019+Induces+Hog1+Phosphorylation+and+Protein+Ubiquitylation+in+Saccharomyces+cerevisiae&doi=10.1016%2Fj.ejphar.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer drug KP1019 induces Hog1 phosphorylation and protein ubiquitylation in Saccharomyces cerevisiae</span></div><div class="casAuthors">Singh, Vikash; Azad, Gajendra Kumar; Reddy M., Amarendar; Baranwal, Shivani; Tomar, Raghuvir S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">736</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-85</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ruthenium-based anti-cancer drugs have attracted increasing interest in the last 20 years.  KP1019 is one of the ruthenium-contg. compds. that has demonstrated anti-tumor activity against various cancers, and has been tested in several clin. trials.  Despite its success, the mode of action of KP1019 is not well described.  In the present study, we have used budding yeast Saccharomyces cerevisiae to elucidate the action of KP1019.  We have found that KP1019 causes dose-dependent cell arrest in the S-phase of cell cycle.  Furthermore, we have demonstrated for the first time that the yeast mitogen-activated protein (MAP) kinase Hog1 is essential for the cells in response to KP1019.  Hog1 is rapidly phosphorylated upon treatment with KP1019, and the deletion of the HOG1 gene potentiates the growth inhibition effect of KP1019.  Moreover, we also obsd. the up-regulation of glycerol-3-phosphate dehydrogenase 1 (GPD1) mRNA in response to KP1019 treatment, a factor that is essential for the hyperosmotic stress response.  Our results also reveal that membrane-bound sensor proteins of high osmolarity glycerol (HOG) pathway are crucial for Hog1 phosphorylation in response to KP1019-induced stress.  Furthermore, KP1019 has also been found to increase the accumulation of ubiquitinated proteins and deletion of several members of ubiquitination pathways conferred sensitivity for KP1019.  The findings presented here strongly suggest the ability of KP1019 to activate Hog1 MAP kinase and induce protein ubiquitination, which may underlie the therapeutic potential of this compd.  In summary, we have disclosed a novel mechanism of KP1019 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9WSyFcOp0rVg90H21EOLACvtfcHk0lhEckKquXn4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFSqt7g%253D&md5=286539ac54e6845c498ce4331426c883</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DAzad%26aufirst%3DG.%2BK.%26aulast%3DReddy%26aufirst%3DM.%2BA.%26aulast%3DBaranwal%26aufirst%3DS.%26aulast%3DTomar%26aufirst%3DR.%2BS.%26atitle%3DAnti-Cancer%2520Drug%2520KP1019%2520Induces%2520Hog1%2520Phosphorylation%2520and%2520Protein%2520Ubiquitylation%2520in%2520Saccharomyces%2520cerevisiae%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D736%26spage%3D77%26epage%3D85%26doi%3D10.1016%2Fj.ejphar.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Classification of Metal-Based Drugs According to Their Mechanisms of Action</span>. <i>Chem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.chempr.2019.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.chempr.2019.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=32864503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslGmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=41-60&author=E.+Borosauthor=P.+J.+Dysonauthor=G.+Gasser&title=Classification+of+Metal-Based+Drugs+According+to+Their+Mechanisms+of+Action&doi=10.1016%2Fj.chempr.2019.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of Metal-Based Drugs according to Their Mechanisms of Action</span></div><div class="casAuthors">Boros, Eszter; Dyson, Paul J.; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-60</span>CODEN:
                <span class="NLM_cas:coden">CHEMVE</span>;
        ISSN:<span class="NLM_cas:issn">2451-9294</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metal-based drugs and imaging agents are extensively used in the clinic for the treatment and diagnosis of cancers and a wide range of other diseases.  The current clin. arsenal of compds. operate via a limited no. of mechanisms, whereas new putative compds. explore alternative mechanisms of action, which could potentially bring new chemotherapeutic approaches into the clinic.  In this review, metal-based drugs and imaging agents are characterized according to their primary mode of action, and the key properties and features of each class of compds. are defined wherever possible.  A better understanding of the roles played by metal compds. at a mechanistic level will help to deliver new metal-based therapies to the clinic by providing an alternative, targeted, and rational approach to supplement non-targeted screening of novel chem. entities for biol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wpw2si5_UrVg90H21EOLACvtfcHk0lhEckKquXn4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslGmsrg%253D&md5=38ac3bc496a57accfa26907ad8f73412</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chempr.2019.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chempr.2019.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DClassification%2520of%2520Metal-Based%2520Drugs%2520According%2520to%2520Their%2520Mechanisms%2520of%2520Action%26jtitle%3DChem%26date%3D2020%26volume%3D6%26spage%3D41%26epage%3D60%26doi%3D10.1016%2Fj.chempr.2019.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S. W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B. Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, V. K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. H.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">13091</span>– <span class="NLM_lpage">13095</span>, <span class="refDoi"> DOI: 10.1002/anie.201807305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fanie.201807305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCls7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=13091-13095&author=G.+J.+Yangauthor=W.+Wangauthor=S.+W.+F.+Mokauthor=C.+Wuauthor=B.+Y.+K.+Lawauthor=X.+M.+Miaoauthor=K.+J.+Wuauthor=H.+J.+Zhongauthor=C.+Y.+Wongauthor=V.+K.+W.+Wongauthor=D.+L.+Maauthor=C.+H.+Leung&title=Selective+Inhibition+of+Lysine-Specific+Demethylase+5A+%28KDM5A%29+Using+a+Rhodium%28III%29+Complex+for+Triple-Negative+Breast+Cancer+Therapy&doi=10.1002%2Fanie.201807305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy</span></div><div class="casAuthors">Yang, Guan-Jun; Wang, Wanhe; Mok, Simon Wing Fai; Wu, Chun; Law, Betty Yuen Kwan; Miao, Xiang-Min; Wu, Ke-Jia; Zhong, Hai-Jing; Wong, Chun-Yuen; Wong, Vincent Kam Wai; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">13091-13095</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 5A (KDM5A) has recently become a promising target for epigenetic therapy.  In this study, the authors designed and synthesized metal complexes bearing ligands with reported demethylase and p27 modulating activities.  The Rh(III) complex 1 (I) was identified as a direct, selective and potent inhibitor of KDM5A that directly abrogate KDM5A demethylase activity via antagonizing the KDM5A-tri-/di-methylated histone 3 protein-protein interaction (PPI) in vitro and in cellulo.  Complex 1 induced accumulation of H3K4me3 and H3K4me2 levels in cells, causing growth arrest at G1 phase in the triple-neg. breast cancer (TNBC) cell lines, MDA-MB-231 and 4T1.  Finally, 1 exhibited potent anti-tumor activity against TNBC xenografts in an in vivo mouse model, presumably via targeting of KDM5A and hence upregulating p27.  Moreover, complex 1 was less toxic compared with two clin. drugs, cisplatin and doxorubicin.  To the authors' knowledge, complex 1 is the first metal-based KDM5A inhibitor reported in the literature.  The authors anticipate that complex 1 may be used as a novel scaffold for the further development of more potent epigenetic agents against cancers, including TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriUnhpINRuOrVg90H21EOLACvtfcHk0lgLV6vo9fyNHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCls7vM&md5=9a8f6097e7401592667690c255f1c9e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fanie.201807305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201807305%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMok%26aufirst%3DS.%2BW.%2BF.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DLaw%26aufirst%3DB.%2BY.%2BK.%26aulast%3DMiao%26aufirst%3DX.%2BM.%26aulast%3DWu%26aufirst%3DK.%2BJ.%26aulast%3DZhong%26aufirst%3DH.%2BJ.%26aulast%3DWong%26aufirst%3DC.%2BY.%26aulast%3DWong%26aufirst%3DV.%2BK.%2BW.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DSelective%2520Inhibition%2520of%2520Lysine-Specific%2520Demethylase%25205A%2520%2528KDM5A%2529%2520Using%2520a%2520Rhodium%2528III%2529%2520Complex%2520for%2520Triple-Negative%2520Breast%2520Cancer%2520Therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D13091%26epage%3D13095%26doi%3D10.1002%2Fanie.201807305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndagi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mhlongo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, M. E.</span></span> <span> </span><span class="NLM_article-title">Metal Complexes in Cancer Therapy – An Update from Drug Design Perspective</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S119488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2147%2FDDDT.S119488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28424538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOgs7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=599-616&author=U.+Ndagiauthor=N.+Mhlongoauthor=M.+E.+Soliman&title=Metal+Complexes+in+Cancer+Therapy+%E2%80%93+An+Update+from+Drug+Design+Perspective&doi=10.2147%2FDDDT.S119488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Metal complexes in cancer therapy - an update from drug design perspective</span></div><div class="casAuthors">Ndagi, Umar; Mhlongo, Ndumiso; Soliman, Mahmoud E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">599-616</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">In the past, metal-based compds. were widely used in the treatment of disease conditions, but the lack of clear distinction between the therapeutic and toxic doses was a major challenge.  With the discovery of cisplatin by Barnett Rosenberg in 1960, a milestone in the history of metal-based compds. used in the treatment of cancers was witnessed.  This forms the foundation for the modern era of the metal-based anticancer drugs.  Platinum drugs, such as cisplatin, carboplatin and oxaliplatin, are the mainstay of the metal-based compds. in the treatment of cancer, but the delay in the therapeutic accomplishment of other metal-based compds. hampered the progress of research in this field.  Recently, however, there has been an upsurge of activities relying on the structural information, aimed at improving and developing other forms of metal-based compds. and nonclassical platinum complexes whose mechanism of action is distinct from known drugs such as cisplatin.  In line with this, many more metal-based compds. have been synthesized by redesigning the existing chem. structure through ligand substitution or building the entire new compd. with enhanced safety and cytotoxic profile.  However, because of increased emphasis on the clin. relevance of metal-based complexes, a few of these drugs are currently on clin. trial and many more are awaiting ethical approval to join the trial.  In this review, we seek to give an overview of previous reviews on the cytotoxic effect of metal-based complexes while focusing more on newly designed metal-based complexes and their cytotoxic effect on the cancer cell lines, as well as on new approach to metal-based drug design and mol. target in cancer therapy.  We are optimistic that the concept of selective targeting remains the hope of the future in developing therapeutics that would selectively target cancer cells and leave healthy cells unharmed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltxUp021QdrVg90H21EOLACvtfcHk0lgLV6vo9fyNHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOgs7bI&md5=3ef5ff6ea1338c3c47fb10901a18c4c8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S119488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S119488%26sid%3Dliteratum%253Aachs%26aulast%3DNdagi%26aufirst%3DU.%26aulast%3DMhlongo%26aufirst%3DN.%26aulast%3DSoliman%26aufirst%3DM.%2BE.%26atitle%3DMetal%2520Complexes%2520in%2520Cancer%2520Therapy%2520%25E2%2580%2593%2520An%2520Update%2520from%2520Drug%2520Design%2520Perspective%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2017%26volume%3D11%26spage%3D599%26epage%3D616%26doi%3D10.2147%2FDDDT.S119488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vellaisamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span> <span> </span><span class="NLM_article-title">A Long-Lived Peptide-Conjugated Iridium(III) Complex as a Luminescent Probe and Inhibitor of the Cell Migration Mediator, Formyl Peptide Receptor 2</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">8171</span>– <span class="NLM_lpage">8177</span>, <span class="refDoi"> DOI: 10.1039/C8SC02733A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC8SC02733A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30568767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVamt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=8171-8177&author=K.+Vellaisamyauthor=G.+Liauthor=W.+Wangauthor=C.+H.+Leungauthor=D.+L.+Ma&title=A+Long-Lived+Peptide-Conjugated+Iridium%28III%29+Complex+as+a+Luminescent+Probe+and+Inhibitor+of+the+Cell+Migration+Mediator%2C+Formyl+Peptide+Receptor+2&doi=10.1039%2FC8SC02733A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A long-lived peptide-conjugated iridium(III) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2</span></div><div class="casAuthors">Vellaisamy, Kasipandi; Li, Guodong; Wang, Wanhe; Leung, Chung-Hang; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">8171-8177</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Formyl peptide receptors play important biol. and therapeutic roles in wound repair and inflammatory diseases.  In this work, we present a luminescent iridium(III) complex (6) conjugated with the peptide agonist WKYMVm as a luminescent formyl peptide receptor 2 (FPR2) imaging probe in living cells.  Complex 6 displayed ideal cell imaging characteristics, high photostability and low cytotoxicity.  Competition assays with a known FPR2 antagonist, WRW4, and siRNA knockdown expts. both revealed that complex 6 selectively targeted FPR2 in living HUVEC cells.  Moreover, complex 6 regulated FPR2 signalling in HUVEC cells as shown using a mech. scratch assay.  Finally, complex 6 reduced epithelial cell migration capacity and inhibited lipoxin A4 (LXA4)-triggered cell migration in HUVEC cells, demonstrating the ability of this complex to inhibit FPR2 in living cells.  To our knowledge, this is the first long-lived probe for imaging FPR2 in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZynoDN9lu7Vg90H21EOLACvtfcHk0lgLV6vo9fyNHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVamt7zN&md5=d8615d4bb3be18434b1ff5c22eeb8658</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC8SC02733A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC02733A%26sid%3Dliteratum%253Aachs%26aulast%3DVellaisamy%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26aulast%3DMa%26aufirst%3DD.%2BL.%26atitle%3DA%2520Long-Lived%2520Peptide-Conjugated%2520Iridium%2528III%2529%2520Complex%2520as%2520a%2520Luminescent%2520Probe%2520and%2520Inhibitor%2520of%2520the%2520Cell%2520Migration%2520Mediator%252C%2520Formyl%2520Peptide%2520Receptor%25202%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D8171%26epage%3D8177%26doi%3D10.1039%2FC8SC02733A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Rhodamine-Modified Fluorescent Half-Sandwich Iridium and Ruthenium Complexes: Potential Application as Bioimaging and Anticancer Agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4788</span>– <span class="NLM_lpage">4793</span>, <span class="refDoi"> DOI: 10.1039/C9DT00999J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC9DT00999J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30892340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks12mtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=4788-4793&author=W.+Maauthor=L.+Guoauthor=Z.+Tianauthor=S.+Zhangauthor=X.+Heauthor=J.+Liauthor=Y.+Yangauthor=Z.+Liu&title=Rhodamine-Modified+Fluorescent+Half-Sandwich+Iridium+and+Ruthenium+Complexes%3A+Potential+Application+as+Bioimaging+and+Anticancer+Agents&doi=10.1039%2FC9DT00999J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents</span></div><div class="casAuthors">Ma, Wenli; Guo, Lihua; Tian, Zhenzhen; Zhang, Shumiao; He, Xiangdong; Li, JuanJuan; Yang, Yuliang; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4788-4793</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Most half-sandwich metal anticancer complexes are non-fluorescent, which results in an uncertain mechanism of action (MoA).  The authors designed and synthesized eight fluorescent half-sandwich iridium(Ir) and ruthenium (Ru) complexes by introducing rhodamine derivs. into the N-N-chelating ligand.  These complexes have features of bio-imaging and anticancer agents and may merit future development as novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMUUWoGJtWLVg90H21EOLACvtfcHk0lhjhi3xiIOrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks12mtbk%253D&md5=615a128072c2c4170d08fc347d19a251</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2FC9DT00999J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9DT00999J%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DRhodamine-Modified%2520Fluorescent%2520Half-Sandwich%2520Iridium%2520and%2520Ruthenium%2520Complexes%253A%2520Potential%2520Application%2520as%2520Bioimaging%2520and%2520Anticancer%2520Agents%26jtitle%3DDalton%2520Trans.%26date%3D2019%26volume%3D48%26spage%3D4788%26epage%3D4793%26doi%3D10.1039%2FC9DT00999J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Bichromophoric Anticancer Drug: Targeting Lysosome with Rhodamine Modified Cyclometalated Iridium(III) Complexes</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2018.10.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.dyepig.2018.10.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyit7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=385-393&author=W.+Maauthor=X.+Geauthor=L.+Guoauthor=S.+Zhangauthor=J.+J.+Liauthor=X.+Heauthor=Z.+Liu&title=Bichromophoric+Anticancer+Drug%3A+Targeting+Lysosome+with+Rhodamine+Modified+Cyclometalated+Iridium%28III%29+Complexes&doi=10.1016%2Fj.dyepig.2018.10.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bichromophoric anticancer drug: Targeting lysosome with rhodamine modified cyclometalated Iridium(III) complexes</span></div><div class="casAuthors">Ma, Wenli; Ge, Xingxing; Guo, Lihua; Zhang, Shumiao; Li, JuanJuan; He, Xiangdong; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-393</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Four bichromophoric cyclometalated iridium complexes were synthesized and fully characterized.  Their antiproliferative capacity against A549, HepG2 cells and HeLa cells as well as two human normal cells was studied by MTT assay.  Rhodamine B modified complexes 2 and 4 were not cytotoxic to A549 cells while both rhodamine 6 g modified complexes 1 and 3 showed greater cytotoxicity than cisplatin.  In particular, the antiproliferative activity of complex 3 was about 4.6 times than that of cisplatin.  Thus, complex 3 was used for stability and pH sensitivity studies.  The results indicated that the complex not only had rich fluorescence properties under acidic conditions, but also showed good stability.  Further, interaction of complex with bovine serum albumin (BSA) has been investigated by UV-vis, fluorescence, synchronous fluorescence spectroscopy.  The complexes have a certain ability to bind the BSA.  Interestingly, these complexes can catalyze the reaction of the coenzyme NADH to NAD+, which is consistent with the apparent growth of ROS in cells.  In addn., complex 3 can cause S phase arrest in the cell cycle, induce apoptosis, and affect mitochondrial membrane potential changes.  Localization expts. of intracellular complexes by confocal microscopy suggested that these complexes enter cancer cells through energy dependence and specifically target the lysosomes, thus resulting in the damage of lysosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybDB7VJ5HS7Vg90H21EOLACvtfcHk0lhjhi3xiIOrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyit7%252FL&md5=0b4eb62fda5e25e8f39cac71e81e8dc3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2018.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2018.10.019%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DBichromophoric%2520Anticancer%2520Drug%253A%2520Targeting%2520Lysosome%2520with%2520Rhodamine%2520Modified%2520Cyclometalated%2520Iridium%2528III%2529%2520Complexes%26jtitle%3DDyes%2520Pigm.%26date%3D2019%26volume%3D162%26spage%3D385%26epage%3D393%26doi%3D10.1016%2Fj.dyepig.2018.10.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">13552</span>– <span class="NLM_lpage">13563</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b02161</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b02161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGju7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=13552-13563&author=J.+Liauthor=L.+Guoauthor=Z.+Tianauthor=S.+Zhangauthor=Z.+Xuauthor=Y.+Hanauthor=R.+Liauthor=Y.+Liauthor=Z.+Liu&title=Half-Sandwich+Iridium+and+Ruthenium+Complexes%3A+Effective+Tracking+in+Cells+and+Anticancer+Studies&doi=10.1021%2Facs.inorgchem.8b02161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies</span></div><div class="casAuthors">Li, JuanJuan; Guo, Lihua; Tian, Zhenzhen; Zhang, Shumiao; Xu, Zhishan; Han, Yali; Li, Ruixia; Li, Yan; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13552-13563</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Half-sandwich metal-based 2-pyridinecarbaldimine anticancer complexes [Cp'Ir(L2)Cl] and [(arene)Ru(L2)Cl] [1-6; Cp' = C5Me5, C5Me4, 4-PhC6H4; arene = C6H6, p-cymene, Ph(CH2)3OH, Ph(CH2)4OH; L2 = 2-pyCH:NCPh3] suffer from uncertain targets and mechanisms of action.  Herein we report the observation of the images of half-sandwich iridium and ruthenium complexes in cells detected by confocal microscopy.  The confocal microscopy images showed that the cyclopentadienyl iridium complex 1 mainly accumulated in nuclei in A549 lung cancer cells, whereas the arene ruthenium complex 3 is located in mitochondria and lysosomes, mostly in mitochondria, although both complexes entered A549 cells mainly through energy-dependent active transport.  The nuclear morphol. changes caused by Ir complex 1 were also detected by confocal microscopy.  Ir complex 1 is more potent than cisplatin toward A549 and HeLa cells.  DNA binding studies involved interaction with the nucleobases 9-ethylguanine, 9-methyladenine, ctDNA, and plasmid DNA.  The detn. of bovine serum albumin binding was also performed.  Hydrolysis, stability, nucleobase binding, and catalytic NAD+/NADH hydride transfer tests for complexes 1 and 3 were also carried out.  Both complexes activated depolarization of mitochondrial membrane potential and intracellular ROS overprodn. and induced cell apoptosis.  Complex 3 arrested the cell cycle at the G0/G1 phase by inactivation of CDK 4/cyclin D1.  This work paves the way to track and monitor half-sandwich metal complexes in cells, shines a light on understanding their mechanism of action, and indicates their potential application as theranostic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruWrOZczbNY7Vg90H21EOLACvtfcHk0lhjhi3xiIOrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGju7nI&md5=7afbfa5bef2a4aebdda9e16438ce30f6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b02161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b02161%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DHalf-Sandwich%2520Iridium%2520and%2520Ruthenium%2520Complexes%253A%2520Effective%2520Tracking%2520in%2520Cells%2520and%2520Anticancer%2520Studies%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26spage%3D13552%26epage%3D13563%26doi%3D10.1021%2Facs.inorgchem.8b02161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Theranostic Iridium(III) Complexes as One- and Two-Photon Phosphorescent Trackers to Monitor Autophagic Lysosomes</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">12137</span>– <span class="NLM_lpage">12141</span>, <span class="refDoi"> DOI: 10.1002/anie.201407468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fanie.201407468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVenu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=12137-12141&author=L.+Heauthor=C.+P.+Tanauthor=R.+R.+Yeauthor=Y.+Z.+Zhaoauthor=Y.+H.+Liuauthor=Q.+Zhaoauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Theranostic+Iridium%28III%29+Complexes+as+One-+and+Two-Photon+Phosphorescent+Trackers+to+Monitor+Autophagic+Lysosomes&doi=10.1002%2Fanie.201407468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Iridium(III) Complexes as One- and Two-Photon Phosphorescent Trackers to Monitor Autophagic Lysosomes</span></div><div class="casAuthors">He, Liang; Tan, Cai-Ping; Ye, Rui-Rong; Zhao, Yi-Zhi; Liu, Ya-Hong; Zhao, Qiang; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">12137-12141</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">During autophagy, the intracellular components are captured in autophagosomes and delivered to lysosomes for degrdn. and recycling.  Changes in lysosomal trafficking and contents are key events in the regulation of autophagy, which has been implicated in many physiol. and pathol. processes.  In this work, two iridium(III) complexes (LysoIr1 and LysoIr2) are developed as theranostic agents to monitor autophagic lysosomes.  These complexes display lysosome-activated phosphorescence and can specifically label lysosomes with high photostability.  Simultaneously, they can induce autophagy potently without initiating an apoptosis response.  We demonstrate that LysoIr2 can effectively implement two functions, namely autophagy induction and lysosomal tracking, in the visualization of autophagosomal-lysosomal fusion.  More importantly, they display strong two-photon excited fluorescence (TPEF), which is favorable for live cell imaging and in vivo applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUHVPaqhDpPrVg90H21EOLACvtfcHk0ljp06Tc5IjrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVenu73M&md5=22f87ed3ce76f90623a68d7810d6040e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407468%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DYe%26aufirst%3DR.%2BR.%26aulast%3DZhao%26aufirst%3DY.%2BZ.%26aulast%3DLiu%26aufirst%3DY.%2BH.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DTheranostic%2520Iridium%2528III%2529%2520Complexes%2520as%2520One-%2520and%2520Two-Photon%2520Phosphorescent%2520Trackers%2520to%2520Monitor%2520Autophagic%2520Lysosomes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D12137%26epage%3D12141%26doi%3D10.1002%2Fanie.201407468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allardyce, B. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium in Medicine: Current Clinical Uses and Future Prospects</span>. <i>Platinum Met. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=62-69&author=B.+C.+S.+Allardyceauthor=P.+J.+Dyson&title=Ruthenium+in+Medicine%3A+Current+Clinical+Uses+and+Future+Prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium in medicine: Current clinical uses and future prospects</span></div><div class="casAuthors">Allardyce, Claire S.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Platinum Metals Review</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">62-69</span>CODEN:
                <span class="NLM_cas:coden">PTMRA3</span>;
        ISSN:<span class="NLM_cas:issn">0032-1400</span>.
    
            (<span class="NLM_cas:orgname">Johnson Matthey Public Ltd. Co.</span>)
        </div><div class="casAbstract">A review.  There is no doubt about the success of precious metals in the clinic, with, for example, platinum compds. being widely used in the treatment of cancer, silver compds. being useful antimicrobial agents and gold compds. used routinely in the treatment of rheumatoid arthritis.  The medicinal properties of the other platinum group metals are now being recognized and of these a ruthenium anticancer agent has recently entered the clinic, showing promising activity on otherwise resistant tumors.  Like all metal drugs, the activity of the ruthenium compds. depends on both the oxidn. state and the ligands.  By manipulating these features ruthenium-centered antimalarial, antibiotic and immunosuppressive drugs have been made.  In addn., ruthenium has unique properties which make it particularly useful in drug design.  In this review we discuss ruthenium from a clin. stance and outline the medicinal uses of ruthenium-based compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppc8V-Mj8EArVg90H21EOLACvtfcHk0ljp06Tc5IjrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D&md5=778378be61f6e9a4629abe1c585cf87a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllardyce%26aufirst%3DB.%2BC.%2BS.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DRuthenium%2520in%2520Medicine%253A%2520Current%2520Clinical%2520Uses%2520and%2520Future%2520Prospects%26jtitle%3DPlatinum%2520Met.%2520Rev.%26date%3D2001%26volume%3D45%26spage%3D62%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonarakis, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emadi, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-Based Chemotherapeutics: Are They Ready for Prime Time?</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s00280-010-1293-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1007%2Fs00280-010-1293-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=20213076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1-9&author=E.+S.+Antonarakisauthor=A.+Emadi&title=Ruthenium-Based+Chemotherapeutics%3A+Are+They+Ready+for+Prime+Time%3F&doi=10.1007%2Fs00280-010-1293-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-based chemotherapeutics: are they ready for prime time?</span></div><div class="casAuthors">Antonarakis, Emmanuel S.; Emadi, Ashkan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Since the discovery of cis-platinum, many transition metal complexes have been synthesized and assayed for antineoplastic activity.  In recent years, ruthenium-based mols. have emerged as promising antitumor and antimetastatic agents with potential uses in platinum-resistant tumors or as alternatives to platinum.  Ruthenium compds. theor. possess unique biochem. features allowing them to accumulate preferentially in neoplastic tissues and to convert to their active state only after entering tumor cells.  Intriguingly, some ruthenium agents show significant activity against cancer metastases but have minimal effects on primary tumors.  Two ruthenium-based drugs, NAMI-A and KP1019, have reached human clin. testing.  This review will highlight the chem. properties, mechanism of action, preclin. data, and early phase clin. results of these two lead ruthenium compds.  Other promising ruthenium agents will also be reviewed with emphasis on the novel ruthenium compd. ONCO4417, and DW1/2 that has demonstrated Pim-1 kinase inhibition in preclin. systems.  Further development of these and other ruthenium agents may rely on novel approaches including rational combination strategies as well as identification of potential pharmacodynamic biomarkers of drug activity aiding early phase clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAaeL0zbqnFLVg90H21EOLACvtfcHk0ljp06Tc5IjrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D&md5=cb705a7e874eeb25d755a8096e6b2a4e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1293-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1293-1%26sid%3Dliteratum%253Aachs%26aulast%3DAntonarakis%26aufirst%3DE.%2BS.%26aulast%3DEmadi%26aufirst%3DA.%26atitle%3DRuthenium-Based%2520Chemotherapeutics%253A%2520Are%2520They%2520Ready%2520for%2520Prime%2520Time%253F%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D1%26epage%3D9%26doi%3D10.1007%2Fs00280-010-1293-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pongratz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schluga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arion, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allmaier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">Transferrin Binding and Transferrin-Mediated Cellular Uptake of the Ruthenium Coordination Compound KP1019, Studied by Means of AAS, ESI-MS and CD Spectroscopy</span>. <i>J. Anal. At. Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1039/b309160k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb309160k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=46-51&author=M.+Pongratzauthor=P.+Schlugaauthor=M.+A.+Jakupecauthor=V.+B.+Arionauthor=C.+G.+Hartingerauthor=G.+Allmaierauthor=B.+K.+Keppler&title=Transferrin+Binding+and+Transferrin-Mediated+Cellular+Uptake+of+the+Ruthenium+Coordination+Compound+KP1019%2C+Studied+by+Means+of+AAS%2C+ESI-MS+and+CD+Spectroscopy&doi=10.1039%2Fb309160k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy</span></div><div class="casAuthors">Pongratz, Martina; Schluga, Petra; Jakupec, Michael A.; Arion, Vladimir B.; Hartinger, Christian G.; Allmaier, Guenter; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Analytical Atomic Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-51</span>CODEN:
                <span class="NLM_cas:coden">JASPE2</span>;
        ISSN:<span class="NLM_cas:issn">0267-9477</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(iii)] (KP1019) shows particular promise as an antitumor agent against colorectal cancer.  It is known that KP1019 reacts with human serum proteins, whereby the major amt. binds to albumin (present in large excess) and a smaller amt. to transferrin.  It has been hypothesised that transferrin-mediated uptake by transferrin receptor expressing tumor cells may in part explain the apparent tumor selectivity of this compd.  CD spectroscopy and electrospray ionization mass spectrometry studies demonstrate that two equiv.  Of KP1019 bind specifically to human apotransferrin, while addnl. amts. of the ruthenium complex bind unspecifically.  Uptake studies in the transferrin receptor-expressing human colon carcinoma cell line SW480 revealed a higher cellular accumulation of KP1019 in comparison to a KP1019-transferrin adduct (2:1), while the uptake of a KP1019-Fe(iii)-transferrin conjugate (1:0.3:1) significantly exceeded that of KP1019, suggesting that iron binding is necessary to obtain a protein conformation which favors recognition by the transferrin receptors on the cell surface.  Our study showed that KP1019 is transported into the cell by both transferrin-independent and transferrin-dependent mechanisms.  Transferrin-mediated uptake is more efficient when transferrin is satd. with iron to a physiol. degree (∼30%).  Cell fractionation expts. demonstrated that after a 2 h treatment of human colon cancer cells with 10 μM KP1019 on av. 55% of the intracellular ruthenium is located in the cellular nucleus, while 45% remain in the cytosol and other cellular components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Ias6Es1jfbVg90H21EOLACvtfcHk0lhcKCTEc3GGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslehtA%253D%253D&md5=640227f005871cd1ca1d827389a18487</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2Fb309160k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb309160k%26sid%3Dliteratum%253Aachs%26aulast%3DPongratz%26aufirst%3DM.%26aulast%3DSchluga%26aufirst%3DP.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DArion%26aufirst%3DV.%2BB.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DAllmaier%26aufirst%3DG.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DTransferrin%2520Binding%2520and%2520Transferrin-Mediated%2520Cellular%2520Uptake%2520of%2520the%2520Ruthenium%2520Coordination%2520Compound%2520KP1019%252C%2520Studied%2520by%2520Means%2520of%2520AAS%252C%2520ESI-MS%2520and%2520CD%2520Spectroscopy%26jtitle%3DJ.%2520Anal.%2520At.%2520Spectrom.%26date%3D2004%26volume%3D19%26spage%3D46%26epage%3D51%26doi%3D10.1039%2Fb309160k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span> <span> </span><span class="NLM_article-title">Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1560</span>, <span class="refDoi"> DOI: 10.1002/ejic.201600986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fejic.201600986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1549-1560&author=E.+Alessio&title=Thirty+Years+of+the+Drug+Candidate+NAMI-A+and+the+Myths+in+the+Field+of+Ruthenium+Anticancer+Compounds%3A+A+Personal+Perspective&doi=10.1002%2Fejic.201600986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective</span></div><div class="casAuthors">Alessio, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1549-1560</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">As anticipated in the title, this contribution is basically divided into two, strictly connected, parts.  The first is a personal overview of the ruthenium drug candidate NAMI-A, almost 30 years after its synthesis and the discovery of its unprecedented antimetastatic properties in animal models at nontoxic dosages.  The sections relating to the chem. and biol. behavior of the complex, and the hypotheses on its mechanism(s) of action, are kept to a min., whereas more space is devoted to discussion of the results of the clin. investigations.  The second part deals in detail with a no. of undemonstrated misconceptions (or myths) that, over the years, have thrived around NAMI-A and other ruthenium drug candidates, thus neg. affecting the whole field of Ru anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjex9sRUkCbVg90H21EOLACvtfcHk0lhcKCTEc3GGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK&md5=ca48413b7dd02a63edf5049a9a5c7377</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fejic.201600986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201600986%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26atitle%3DThirty%2520Years%2520of%2520the%2520Drug%2520Candidate%2520NAMI-A%2520and%2520the%2520Myths%2520in%2520the%2520Field%2520of%2520Ruthenium%2520Anticancer%2520Compounds%253A%2520A%2520Personal%2520Perspective%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1549%26epage%3D1560%26doi%3D10.1002%2Fejic.201600986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E. J.</span></span> <span> </span><span class="NLM_article-title">Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5805</span>– <span class="NLM_lpage">5821</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5805-5821&author=S.+Thotaauthor=D.+A.+Rodriguesauthor=D.+C.+Cransauthor=E.+J.+Barreiro&title=Ru%28II%29+Compounds%3A+Next-Generation+Anticancer+Metallotherapeutics%3F&doi=10.1021%2Facs.jmedchem.7b01689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?</span></div><div class="casAuthors">Thota, Sreekanth; Rodrigues, Daniel A.; Crans, Debbie C.; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5805-5821</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metal based therapeutics are a precious class of drugs in oncol. research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics applications.  Ruthenium compds. have shown selective bioactivity and the ability to overcome the resistance that platinum-based therapeutics face, making them effective oncotherapeutic competitors in rational drug invention approaches.  The development of antineoplastic ruthenium therapeutics is of particular interest because ruthenium contg. complexes NAMI-A, KP1019, and KP1339 entered clin. trials and DW1/2 is in preclin. levels.  The very robust, conformationally rigid organometallic Ru(II) compd. DW1/2 is a protein kinase inhibitor and presents new Ru(II) compd. designs as anticancer agents.  Over the recent years, numerous strategies have been used to encapsulate Ru(II) derived compds. in a nanomaterial system, improving their targeting and delivery into neoplastic cells.  A new photodynamic therapy based Ru(II) therapeutic, TLD-1433, has also entered clin. trials.  Ru(II)-based compds. can also be photosensitizers for photodynamic therapy, which has proven to be an effective new, alternative, and noninvasive oncotherapy modality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpCNrozZw4y7Vg90H21EOLACvtfcHk0lhcKCTEc3GGFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCgsbc%253D&md5=2b539999f1e68e2ea1369b8f8ff9c719</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01689%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DRu%2528II%2529%2520Compounds%253A%2520Next-Generation%2520Anticancer%2520Metallotherapeutics%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5805%26epage%3D5821%26doi%3D10.1021%2Facs.jmedchem.7b01689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Notaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Monomeric and Dimeric Coordinatively Saturated and Substitutionally Inert Ru(II) Polypyridyl Complexes as Anticancer Drug Candidates</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7317</span>– <span class="NLM_lpage">7337</span>, <span class="refDoi"> DOI: 10.1039/C7CS00356K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC7CS00356K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=29027562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7317-7337&author=A.+Notaroauthor=G.+Gasser&title=Monomeric+and+Dimeric+Coordinatively+Saturated+and+Substitutionally+Inert+Ru%28II%29+Polypyridyl+Complexes+as+Anticancer+Drug+Candidates&doi=10.1039%2FC7CS00356K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(II) polypyridyl complexes as anticancer drug candidates</span></div><div class="casAuthors">Notaro, Anna; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7317-7337</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Due to the increasing impact of cancer on worldwide mortality, more and more attention is being devoted to the investigation of novel anticancer strategies.  Among these, chemotherapy plays a key role in fighting cancer.  This explains the increasing engagement of both the pharmaceutical industry and academia towards the discovery of new chemotherapeutic agents.  In recent years, metal-based drugs have attracted much attention due to their atypical physico-chem. properties compared to org. mols.  After the approval of cisplatin as a chemotherapeutic agent in 1978, several types of metal-based drugs have been explored.  Among them, Ru-based anticancer drug candidates have become a central subject in this research field.  However, most of the Ru-based compds. investigated over the last two decades express their cytotoxicity with a mechanism of action involving, among others, a ligand-exchange mechanism.  In this Review, we give a complete overview of a specific class of antiproliferative ruthenium complexes, namely coordinatively satd. and substitutionally inert Ru(II) polypyridyl complexes.  This implies that the cytotoxicity obsd. comes from the entire complex and not from ligand-exchange.  In this Review, we present monomeric and dimeric Ru(II) polypyridyl complexes, which have been found to be toxic to cancer cells.  More specifically, monomeric Ru(II) polypyridyl complexes are analyzed considering their direct interaction or not with DNA as the cause of cell death, while dimeric Ru(II) polypyridyl complexes are classified according to their biol. targets.  Very importantly, the cellular targets of these complexes are discussed in detail.  Indeed, several targets were identified and different mechanisms of action were suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC29dn6JqWwLVg90H21EOLACvtfcHk0lhgu3gyL4htKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI&md5=7e75dd00ef156901717f18db3f67d304</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7CS00356K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00356K%26sid%3Dliteratum%253Aachs%26aulast%3DNotaro%26aufirst%3DA.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMonomeric%2520and%2520Dimeric%2520Coordinatively%2520Saturated%2520and%2520Substitutionally%2520Inert%2520Ru%2528II%2529%2520Polypyridyl%2520Complexes%2520as%2520Anticancer%2520Drug%2520Candidates%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D7317%26epage%3D7337%26doi%3D10.1039%2FC7CS00356K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">KP1019, a New Redox-Active Anticancer Agent--Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2155</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200890195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcbdv.200890195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=18972504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWktLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=2140-2155&author=C.+G.+Hartingerauthor=M.+A.+Jakupecauthor=S.+Zorbas-Seifriedauthor=M.+Groesslauthor=A.+Eggerauthor=W.+Bergerauthor=H.+Zorbasauthor=P.+J.+Dysonauthor=B.+K.+Keppler&title=KP1019%2C+a+New+Redox-Active+Anticancer+Agent%2D%2DPreclinical+Development+and+Results+of+a+Clinical+Phase+I+Study+in+Tumor+Patients&doi=10.1002%2Fcbdv.200890195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients</span></div><div class="casAuthors">Hartinger, Christian G.; Jakupec, Michael A.; Zorbas-Seifried, Stefanie; Groessl, Michael; Egger, Alexander; Berger, Walter; Zorbas, Haralabos; Dyson, Paul J.; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2140-2155</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">A review.  The promising drug candidate indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) is the second Ru-based anticancer agent to enter clin. trials.  In this review, which is an update of a paper from 2006, the exptl. evidence for the proposed mode of action of this coordination compd. is discussed, including transport into the cell via the transferrin cycle and activation by redn.  The results of the early clin. development of KP1019 are summarized in which 5 out of 6 evaluated patients experienced disease stabilization with no severe side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFbfjYPQ2wKrVg90H21EOLACvtfcHk0lhgu3gyL4htKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWktLvO&md5=2d209d437e1c5fefb72827d3eade21d7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200890195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200890195%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DGroessl%26aufirst%3DM.%26aulast%3DEgger%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DKP1019%252C%2520a%2520New%2520Redox-Active%2520Anticancer%2520Agent--Preclinical%2520Development%2520and%2520Results%2520of%2520a%2520Clinical%2520Phase%2520I%2520Study%2520in%2520Tumor%2520Patients%26jtitle%3DChem.%2520Biodiversity%26date%3D2008%26volume%3D5%26spage%3D2140%26epage%3D2155%26doi%3D10.1002%2Fcbdv.200890195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, K. K.</span></span> <span> </span><span class="NLM_article-title">Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2231</span>– <span class="NLM_lpage">2247</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b02979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b02979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=2231-2247&author=J.+Shumauthor=P.+K.+Leungauthor=K.+K.+Lo&title=Luminescent+Ruthenium%28II%29+Polypyridine+Complexes+for+a+Wide+Variety+of+Biomolecular+and+Cellular+Applications&doi=10.1021%2Facs.inorgchem.8b02979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications</span></div><div class="casAuthors">Shum, Justin; Leung, Peter Kam-Keung; Lo, Kenneth Kam-Wing</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2231-2247</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with refs.  Ruthenium(II) polypyridine complexes are one of the most extensively studied and developed systems in the family of luminescent transition-metal complexes.  Notably, there has been a large amt. of interest in the biol. applications of these luminescent ruthenium(II) complexes because of their rich photophys. and photochem. properties.  In this Viewpoint, we explore past and recent works on the possible biol. and cellular applications of these promising complexes, with a focus on their use as bioimaging reagents, biomol. probes, and phototherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq19TDxfAlWLVg90H21EOLACvtfcHk0lhgu3gyL4htKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWmt70%253D&md5=3c63870a2c07c7a0a8d9f44eb4cdb69c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b02979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b02979%26sid%3Dliteratum%253Aachs%26aulast%3DShum%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DP.%2BK.%26aulast%3DLo%26aufirst%3DK.%2BK.%26atitle%3DLuminescent%2520Ruthenium%2528II%2529%2520Polypyridine%2520Complexes%2520for%2520a%2520Wide%2520Variety%2520of%2520Biomolecular%2520and%2520Cellular%2520Applications%26jtitle%3DInorg.%2520Chem.%26date%3D2019%26volume%3D58%26spage%3D2231%26epage%3D2247%26doi%3D10.1021%2Facs.inorgchem.8b02979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Organometallic Compounds: An Opportunity for Chemical Biology?</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1252</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcbic.201200159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=22619182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1232-1252&author=M.+Patraauthor=G.+Gasser&title=Organometallic+Compounds%3A+An+Opportunity+for+Chemical+Biology%3F&doi=10.1002%2Fcbic.201200159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Compounds: An Opportunity for Chemical Biology?</span></div><div class="casAuthors">Patra, Malay; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1232-1252</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Organometallic compds. are renowned for their remarkable applications in the field of catalysis, but much less is known about their potential in chem. biol.  Indeed, such compds. have long been considered to be either unstable under physiol. conditions or cytotoxic.  As a consequence, little attention has been paid to their possible utilization for biol. purposes.  Because of their outstanding physicochem. properties, which include chem. stability, structural diversity and unique photo- and electrochem. properties, however, organometallic compds. have the ability to play a leading role in the field of chem. biol.  Indeed, remarkable examples of the use of such compds.-notably as enzyme inhibitors and as luminescent agents-have recently been reported.  Here we summarise recent advances in the use of organometallic compds. for chem. biol. purposes, an area that we define as "organometallic chem. biol.".  We also demonstrate that these recent discoveries are only a beginning and that many other organometallic complexes are likely to be found useful in this field of research in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNf0UB7MS87Vg90H21EOLACvtfcHk0li6JBhTf7WfKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D&md5=45260dcd1168ae3b7311dad351669eda</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200159%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DOrganometallic%2520Compounds%253A%2520An%2520Opportunity%2520for%2520Chemical%2520Biology%253F%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26spage%3D1232%26epage%3D1252%26doi%3D10.1002%2Fcbic.201200159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dörr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Metal Complexes as Structural Templates for Targeting Proteins</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2014.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.cbpa.2014.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24561508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A280%3ADC%252BC2cvnt1ClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=76-81&author=M.+D%C3%B6rrauthor=E.+Meggers&title=Metal+Complexes+as+Structural+Templates+for+Targeting+Proteins&doi=10.1016%2Fj.cbpa.2014.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Metal complexes as structural templates for targeting proteins</span></div><div class="casAuthors">Dorr Markus; Meggers Eric</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in chemical biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article reviews recent advances in the design and discovery of inert metal complexes as protein binders.  In these metal-based probes or drug candidates, the metal is supposed to exert a purely structural role by organizing the coordinating ligands in the three dimensional space to achieve a shape and functional group complementarity with the targeted protein pockets.  Presented examples of sandwich, half-sandwich and octahedral d(6)-metal complexes reinforce previous perceptions that metal complexes are highly promising scaffolds for the design of small-molecule protein binders and complement the molecular diversity of organic chemistry by opening untapped chemical space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsX3lyk_77rjnyZkbE8yXfW6udTcc2eYBtfwjhPiyN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvnt1ClsA%253D%253D&md5=b27797c33ed4ef96ee3185c8ed3fecda</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2014.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2014.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25B6rr%26aufirst%3DM.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DMetal%2520Complexes%2520as%2520Structural%2520Templates%2520for%2520Targeting%2520Proteins%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D19%26spage%3D76%26epage%3D81%26doi%3D10.1016%2Fj.cbpa.2014.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakubaszek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goud, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Action of Ru (II) Polypyridyl Complexes in Living Cells upon Light Irradiation</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">13040</span>– <span class="NLM_lpage">13059</span>, <span class="refDoi"> DOI: 10.1039/C8CC05928D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC8CC05928D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30398487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFynsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=13040-13059&author=M.+Jakubaszekauthor=B.+Goudauthor=S.+Ferrariauthor=G.+Gasser&title=Mechanisms+of+Action+of+Ru+%28II%29+Polypyridyl+Complexes+in+Living+Cells+upon+Light+Irradiation&doi=10.1039%2FC8CC05928D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of Ru(II) polypyridyl complexes in living cells upon light irradiation</span></div><div class="casAuthors">Jakubaszek, Marta; Goud, Bruno; Ferrari, Stefano; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">93</span>),
    <span class="NLM_cas:pages">13040-13059</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The unique photophys. properties of Ru(II) polypyridyl complexes make them very attractive candidates as photosensitizers in Photodynamic Therapy (PDT).  However, to date, there are not many studies exploring in detail the mechanism(s) of action of such compds. in living systems upon light irradn.  This feature article provides an overview of the most in-depth biol. studies on such compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru9cgu7gof7LVg90H21EOLACvtfcHk0li6JBhTf7WfKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFynsrfF&md5=5a2720aac8223eb35c5560865b88efef</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC8CC05928D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC05928D%26sid%3Dliteratum%253Aachs%26aulast%3DJakubaszek%26aufirst%3DM.%26aulast%3DGoud%26aufirst%3DB.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMechanisms%2520of%2520Action%2520of%2520Ru%2520%2528II%2529%2520Polypyridyl%2520Complexes%2520in%2520Living%2520Cells%2520upon%2520Light%2520Irradiation%26jtitle%3DChem.%2520Commun.%26date%3D2018%26volume%3D54%26spage%3D13040%26epage%3D13059%26doi%3D10.1039%2FC8CC05928D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capozzi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clerici, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Control of Lung Metastases of Solid Tumours by a Novel Ruthenium Complex</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1023/A:1006521715400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1023%2FA%3A1006521715400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=9626816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK1cXktVCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=371-379&author=G.+Savaauthor=I.+Capozziauthor=K.+Clericiauthor=G.+Gagliardiauthor=E.+Alessioauthor=G.+Mestroni&title=Pharmacological+Control+of+Lung+Metastases+of+Solid+Tumours+by+a+Novel+Ruthenium+Complex&doi=10.1023%2FA%3A1006521715400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological control of lung metastases of solid tumors by a novel ruthenium complex</span></div><div class="casAuthors">Sava, G.; Capozzi, I.; Clerici, K.; Gagliardi, G.; Alessio, E.; Mestroni, G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-379</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Imidazolium trans-imidazoledimethylsulfoxidetetrachlororuthenate ImH[trans-RuCl4(DMSO)Im] (NAMI-A), a ruthenium compd. that replaces Na+ with ImH+ in the mol. of Na[trans-RuCl4(DMSO)Im] (NAMI), was studied for the anti-metastasis effects in models of solid metastasizing tumors of the mouse.  NAMI-A, given i.p. at 35 mg/kg/day for six consecutive days, a dose equimolar to that of NAMI, to mice bearing Lewis lung carcinoma and MCa mammary carcinoma, markedly reduces lung metastasis wt. by 80-90%, with an effect equal or even superior to that of NAMI, depending on the exptl. system adopted.  Correspondingly, NAMI-A increases the content of connective tissue in the tumor matrix, around blood vessels, and in the tumor capsule, augments the percentage of tumor cells in G2/M phase and reduces the amt. of CD45+ cells infiltrating the tumor parenchyma.  The effects of the same doses on spleen lymphocytes correspond to an increase of CD8+ subset without any change of the distribution of cells in G0/G1, S and G2/M phases.  The study shows that NAMI-A behaves similarly to NAMI on the several parameters examd. in comparison expts. and therefore we suggest to credit NAMI-A with all the biol. actions already described for NAMI during the last 3 yr.  The replacement of Na+ with ImH+ therefore, besides the better chem. stability of the mol., confers to [trans-RuCl4(DMSO)Im]- a closer similarity with a true drug to be used in humans, and suggests this mol. for future studies of preclin. toxicol. and phase I and II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroao_W_m8lCbVg90H21EOLACvtfcHk0li6JBhTf7WfKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVCls74%253D&md5=90d2e969623e74ae0c788017193ce0b2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006521715400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006521715400%26sid%3Dliteratum%253Aachs%26aulast%3DSava%26aufirst%3DG.%26aulast%3DCapozzi%26aufirst%3DI.%26aulast%3DClerici%26aufirst%3DK.%26aulast%3DGagliardi%26aufirst%3DG.%26aulast%3DAlessio%26aufirst%3DE.%26aulast%3DMestroni%26aufirst%3DG.%26atitle%3DPharmacological%2520Control%2520of%2520Lung%2520Metastases%2520of%2520Solid%2520Tumours%2520by%2520a%2520Novel%2520Ruthenium%2520Complex%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D1998%26volume%3D16%26spage%3D371%26epage%3D379%26doi%3D10.1023%2FA%3A1006521715400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lentz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drescher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheulen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaehde, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of a Novel Anticancer Ruthenium Complex (KP1019, FFC14A) in a Phase I Dose-Escalation Study</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1097/CAD.0b013e328322fbc5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1097%2FCAD.0b013e328322fbc5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=19209025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVSitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=97-103&author=F.+Lentzauthor=A.+Drescherauthor=A.+Lindauerauthor=M.+Henkeauthor=R.+A.+Hilgerauthor=C.+G.+Hartingerauthor=M.+E.+Scheulenauthor=C.+Dittrichauthor=B.+K.+Kepplerauthor=U.+Jaehde&title=Pharmacokinetics+of+a+Novel+Anticancer+Ruthenium+Complex+%28KP1019%2C+FFC14A%29+in+a+Phase+I+Dose-Escalation+Study&doi=10.1097%2FCAD.0b013e328322fbc5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study</span></div><div class="casAuthors">Lentz, Frederike; Drescher, Anne; Lindauer, Andreas; Henke, Magdalena; Hilger, Ralf A.; Hartinger, Christian G.; Scheulen, Max E.; Dittrich, Christian; Keppler, Bernhard K.; Jaehde, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A phase I and pharmacokinetic study was carried out with the new ruthenium complex indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019, FFC14A).  Seven patients with various types of solid tumors refractory to std. therapy were treated with escalating doses of KP1019 (25-600 mg) twice weekly for 3 wk.  No dose-limiting toxicity occurred.  Ruthenium plasma concn.-time profiles after the first dose and under multiple-dose conditions were analyzed using a compartmental approach.  The pharmacokinetic disposition was characterized by a small vol. of distribution, low clearance and long half-life.  Only a small fraction of ruthenium was excreted renally.  The area under the curve values increased proportionally with dose indicating linear pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoISQUGWLMSRLVg90H21EOLACvtfcHk0lhhEyyakwBjzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVSitLk%253D&md5=d9932340c33d687d18de202db61cb853</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1097%2FCAD.0b013e328322fbc5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0b013e328322fbc5%26sid%3Dliteratum%253Aachs%26aulast%3DLentz%26aufirst%3DF.%26aulast%3DDrescher%26aufirst%3DA.%26aulast%3DLindauer%26aufirst%3DA.%26aulast%3DHenke%26aufirst%3DM.%26aulast%3DHilger%26aufirst%3DR.%2BA.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DScheulen%26aufirst%3DM.%2BE.%26aulast%3DDittrich%26aufirst%3DC.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DJaehde%26aufirst%3DU.%26atitle%3DPharmacokinetics%2520of%2520a%2520Novel%2520Anticancer%2520Ruthenium%2520Complex%2520%2528KP1019%252C%2520FFC14A%2529%2520in%2520a%2520Phase%2520I%2520Dose-Escalation%2520Study%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D97%26epage%3D103%26doi%3D10.1097%2FCAD.0b013e328322fbc5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trondl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">NKP-1339, the First Ruthenium-Based Anticancer Drug on the Edge to Clinical Application</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2925</span>– <span class="NLM_lpage">2932</span>, <span class="refDoi"> DOI: 10.1039/C3SC53243G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC3SC53243G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2925-2932&author=R.+Trondlauthor=P.+Heffeterauthor=C.+R.+Kowolauthor=M.+A.+Jakupecauthor=W.+Bergerauthor=B.+K.+Keppler&title=NKP-1339%2C+the+First+Ruthenium-Based+Anticancer+Drug+on+the+Edge+to+Clinical+Application&doi=10.1039%2FC3SC53243G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application</span></div><div class="casAuthors">Trondl, Robert; Heffeter, Petra; Kowol, Christian R.; Jakupec, Michael A.; Berger, Walter; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2925-2932</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">NKP-1339 is the first-in-class ruthenium-based anticancer drug in clin. development against solid cancer and has recently been studied successfully in a phase I clin. trial.  Ruthenium compds. such as KP1019 (indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) and NKP-1339 (the sodium salt analog of KP1019, sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) have a high tumor targeting potential based (1) on their strong binding to serum proteins such as albumin and transferrin as well as (2) on their activation in the reductive tumor milieu.  The redox activity of ruthenium compds. is believed to represent one major mode of action leading to disturbance of the cellular redox balance and, consequently, induction of G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway.  Moreover, potent synergistic activities of NKP-1339 with the clin. approved tyrosine kinase inhibitor sorafenib were recently reported in vitro and in vivo.  Taken together, KP1019 and NKP-1339 are promising drug candidates, and esp. the very limited side effects obsd. so far in clin. phase I trials seem to be a major advantage of this class of ruthenium drugs as compared to other chemotherapeutics and targeted anticancer compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEg6EqdpG67rVg90H21EOLACvtfcHk0lhhEyyakwBjzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM&md5=6f64a036fee96d03f0f0803b80ff1da7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC3SC53243G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3SC53243G%26sid%3Dliteratum%253Aachs%26aulast%3DTrondl%26aufirst%3DR.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DKowol%26aufirst%3DC.%2BR.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DNKP-1339%252C%2520the%2520First%2520Ruthenium-Based%2520Anticancer%2520Drug%2520on%2520the%2520Edge%2520to%2520Clinical%2520Application%26jtitle%3DChem.%2520Sci.%26date%3D2014%26volume%3D5%26spage%3D2925%26epage%3D2932%26doi%3D10.1039%2FC3SC53243G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kynast, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">From Bench to Bedside - Preclinical and Early Clinical Development of the Anticancer Agent Indazolium Trans-[Tetrachlorobis(1H-Indazole)Ruthenate(III)] (KP1019 or FFC14A)</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2006.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jinorgbio.2006.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=16603249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=891-904&author=C.+G.+Hartingerauthor=S.+Zorbas-Seifriedauthor=M.+A.+Jakupecauthor=B.+Kynastauthor=H.+Zorbasauthor=B.+K.+Keppler&title=From+Bench+to+Bedside+-+Preclinical+and+Early+Clinical+Development+of+the+Anticancer+Agent+Indazolium+Trans-%5BTetrachlorobis%281H-Indazole%29Ruthenate%28III%29%5D+%28KP1019+or+FFC14A%29&doi=10.1016%2Fj.jinorgbio.2006.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)</span></div><div class="casAuthors">Hartinger, Christian G.; Zorbas-Seifried, Stefanie; Jakupec, Michael A.; Kynast, Bernd; Zorbas, Haralabos; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">891-904</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A) is just the second ruthenium-based anticancer agent after NAMI-A which was developed to the stage of clin. trials.  Important steps in the mode of action of KP1019 are thought to be the binding to the serum protein transferrin and the transport into the cell via the transferrin pathway.  Addnl., the selective activation by redn. in the tumor might contribute to the low side effects obsd. in in vivo studies.  Apoptosis is induced at non-toxic levels via the mitochondrial pathway.  These features distinguish it from the established platinum anticancer drugs and suggest that different types of cancer might be treatable with this drug.  Indeed, promising activity against certain types of tumors, which are not successfully treatable with cisplatin, and only a very low incidence of acquired resistance has been obsd. in in vitro and in vivo studies.  Recently, a clin. phase I trial was finished in which none of the treated patients experienced serious side effects, while disease stabilization in five of six evaluable patients was achieved.  In this review, the preclin. and early clin. development of KP1019 - from bench to bedside - is recapitulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQXGOcIpo0P7Vg90H21EOLACvtfcHk0lhhEyyakwBjzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D&md5=8fe177baac72fa807e2eb96ecce7e07a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2006.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2006.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DKynast%26aufirst%3DB.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DFrom%2520Bench%2520to%2520Bedside%2520-%2520Preclinical%2520and%2520Early%2520Clinical%2520Development%2520of%2520the%2520Anticancer%2520Agent%2520Indazolium%2520Trans-%255BTetrachlorobis%25281H-Indazole%2529Ruthenate%2528III%2529%255D%2520%2528KP1019%2520or%2520FFC14A%2529%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2006%26volume%3D100%26spage%3D891%26epage%3D904%26doi%3D10.1016%2Fj.jinorgbio.2006.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakewell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigel, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D.</span></span> <span> </span><span class="NLM_article-title">Safety and Activity of IT-139, a Ruthenium-Based Compound, in Patients with Advanced Solid Tumours: A First- Phase I Study with Expansion Cohort</span>. <i>ESMO Open</i> <span class="NLM_year" style="font-weight: bold;">2016</span>, <span class="NLM_elocation-id">e000154</span> <span class="refDoi"> DOI: 10.1136/esmoopen-2016-000154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1136%2Fesmoopen-2016-000154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28848672" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+A.+Burrisauthor=S.+Bakewellauthor=J.+C.+Bendellauthor=J.+Infanteauthor=S.+F.+Jonesauthor=D.+R.+Spigelauthor=G.+J.+Weissauthor=R.+K.+Ramanathanauthor=A.+Ogdenauthor=D.+Von+Hoff&title=Safety+and+Activity+of+IT-139%2C+a+Ruthenium-Based+Compound%2C+in+Patients+with+Advanced+Solid+Tumours%3A+A+First-+Phase+I+Study+with+Expansion+Cohort&doi=10.1136%2Fesmoopen-2016-000154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1136%2Fesmoopen-2016-000154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fesmoopen-2016-000154%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DBakewell%26aufirst%3DS.%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DOgden%26aufirst%3DA.%26aulast%3DVon%2BHoff%26aufirst%3DD.%26atitle%3DSafety%2520and%2520Activity%2520of%2520IT-139%252C%2520a%2520Ruthenium-Based%2520Compound%252C%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumours%253A%2520A%2520First-%2520Phase%2520I%2520Study%2520with%2520Expansion%2520Cohort%26jtitle%3DESMO%2520Open%26date%3D2016%26doi%3D10.1136%2Fesmoopen-2016-000154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumoulin-White, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Metal-Based Photosensitizers for Photodynamic Therapy: The Future of Multimodal Oncology?</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2019.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.cbpa.2019.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=31759225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1arsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2020&pages=23-27&author=S.+A.+McFarlandauthor=A.+Mandelauthor=R.+Dumoulin-Whiteauthor=G.+Gasser&title=Metal-Based+Photosensitizers+for+Photodynamic+Therapy%3A+The+Future+of+Multimodal+Oncology%3F&doi=10.1016%2Fj.cbpa.2019.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?</span></div><div class="casAuthors">McFarland, Sherri A.; Mandel, Arkady; Dumoulin-White, Roger; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an approved medical technique to treat certain forms of cancer.  It has been used to complement traditional anticancer modalities such as surgery, chemotherapy or radiotherapy, and in certain cases, to replace these treatments.  One crit. parameter of PDT is the photosensitizer (PS); historically, a purely org. macrocyclic tetrapyrrole-based structure.  This short review surveys two recent clin. examples of metal complexes, namely TOOKAD-Sol. and TLD-1433, which have ideal photophys. properties to act as PDT PSs.  We highlight the important role played by the metal ions in the PS for PDT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1FSY6muUTurVg90H21EOLACvtfcHk0liE_xNbciNVlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1arsrzE&md5=2d29a57575c5fd9d67a210683fbcab0d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26aulast%3DMandel%26aufirst%3DA.%26aulast%3DDumoulin-White%26aufirst%3DR.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMetal-Based%2520Photosensitizers%2520for%2520Photodynamic%2520Therapy%253A%2520The%2520Future%2520of%2520Multimodal%2520Oncology%253F%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2020%26volume%3D56%26spage%3D23%26epage%3D27%26doi%3D10.1016%2Fj.cbpa.2019.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colo, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcfarland, S. A.</span></span> <span> </span><span class="NLM_article-title">Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=797-828&author=H.+Yinauthor=J.+Roqueauthor=P.+Kondaauthor=S.+Monroauthor=K.+L.+Coloauthor=S.+Gujarauthor=R.+P.+Thummelauthor=L.+Lilgeauthor=C.+G.+Cameronauthor=S.+A.+Mcfarland&title=Transition+Metal+Complexes+and+Photodynamic+Therapy+from+a+Tumor-Centered+Approach%3A+Challenges%2C+Opportunities%2C+and+Highlights+from+the+Development+of+TLD1433&doi=10.1021%2Facs.chemrev.8b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433</span></div><div class="casAuthors">Monro, Susan; Colon, Katsuya L.; Yin, Huimin; Roque, John; Konda, Prathyusha; Gujar, Shashi; Thummel, Randolph P.; Lilge, Lothar; Cameron, Colin G.; McFarland, Sherri A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-828</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition metal complexes are of increasing interest as photosensitizers in photodynamic therapy (PDT) and, more recently, for photochemotherapy (PCT).  In recent years, Ru(II) polypyridyl complexes have emerged as promising systems for both PDT and PCT.  Their rich photochem. and photophys. properties derive from a variety of excited-state electronic configurations accessible with visible and near-IR light, and these properties can be exploited for both energy- and electron-transfer processes that can yield highly potent oxygen-dependent and/or oxygen-independent photobiol. activity.  Selected examples highlight the use of rational design in coordination chem. to control the lowest-energy triplet excited-state configurations for eliciting a particular type of photoreactivity for PDT and/or PCT effects.  These principles are also discussed in the context of the development of TLD1433, the first Ru(II)-based photosensitizer for PDT to enter a human clin. trial.  The design of TLD1433 arose from a tumor-centered approach, as part of a complete PDT package that includes the light component and the protocol for treating non-muscle invasive bladder cancer.  Briefly, this review summarizes the challenges to bringing PDT into mainstream cancer therapy.  It considers the chem. and photophys. solns. that transition metal complexes offer, and it puts into context the multidisciplinary effort needed to bring a new drug to clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvMiOuSE20lbVg90H21EOLACvtfcHk0liE_xNbciNVlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK&md5=73b333b327b1f83a6146b321dfe80ba9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00211%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DRoque%26aufirst%3DJ.%26aulast%3DKonda%26aufirst%3DP.%26aulast%3DMonro%26aufirst%3DS.%26aulast%3DColo%26aufirst%3DK.%2BL.%26aulast%3DGujar%26aufirst%3DS.%26aulast%3DThummel%26aufirst%3DR.%2BP.%26aulast%3DLilge%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DC.%2BG.%26aulast%3DMcfarland%26aufirst%3DS.%2BA.%26atitle%3DTransition%2520Metal%2520Complexes%2520and%2520Photodynamic%2520Therapy%2520from%2520a%2520Tumor-Centered%2520Approach%253A%2520Challenges%252C%2520Opportunities%252C%2520and%2520Highlights%2520from%2520the%2520Development%2520of%2520TLD1433%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D797%26epage%3D828%26doi%3D10.1021%2Facs.chemrev.8b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><a href="http://Https://clinicaltrials.gov/ct2/show/NCT03945162?term=TLD-1433&amp;rank=1" class="extLink">Https://clinicaltrials.gov/ct2/show/NCT03945162?term=TLD-1433&rank=1</a> (accessed Sept 27, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03945162%3Fterm%3DTLD-1433%26rank%3D1+%28accessed+Sept+27%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smythe, C. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) Metallo-Intercalators: DNA Imaging and Cytotoxicity</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1002/cbic.201000782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcbic.201000782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=21433240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12huro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=877-880&author=M.+R.+Gillauthor=H.+Derratauthor=C.+G.+W.+Smytheauthor=G.+Battagliaauthor=J.+A.+Thomas&title=Ruthenium%28II%29+Metallo-Intercalators%3A+DNA+Imaging+and+Cytotoxicity&doi=10.1002%2Fcbic.201000782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) Metallo-intercalators: DNA Imaging and Cytotoxicity</span></div><div class="casAuthors">Gill, Martin R.; Derrat, Hanan; Smythe, Carl G. W.; Battaglia, Giuseppe; Thomas, Jim A.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">877-880</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ruthenium(II) metallo-intercalator imaging of tumors and cytotoxicity were studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0UAUiJit37LVg90H21EOLACvtfcHk0li-UrtxxaQm7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12huro%253D&md5=8211ef3f1e015e9061a3f1b7f8679b91</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201000782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201000782%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DM.%2BR.%26aulast%3DDerrat%26aufirst%3DH.%26aulast%3DSmythe%26aufirst%3DC.%2BG.%2BW.%26aulast%3DBattaglia%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26atitle%3DRuthenium%2528II%2529%2520Metallo-Intercalators%253A%2520DNA%2520Imaging%2520and%2520Cytotoxicity%26jtitle%3DChemBioChem%26date%3D2011%26volume%3D12%26spage%3D877%26epage%3D880%26doi%3D10.1002%2Fcbic.201000782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deepika, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shobha Devi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praveen Kumar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laxma Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkat Reddy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anil Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satyanarayana, S.</span></span> <span> </span><span class="NLM_article-title">DNA-Binding, Cytotoxicity, Cellular Uptake, Apoptosis and Photocleavage Studies of Ru(II) Complexes</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2016.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jphotobiol.2016.03.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=27107334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVGmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=142-153&author=N.+Deepikaauthor=C.+Shobha+Deviauthor=Y.+Praveen+Kumarauthor=K.+Laxma+Reddyauthor=P.+Venkat+Reddyauthor=D.+Anil+Kumarauthor=S.+S.+Singhauthor=S.+Satyanarayana&title=DNA-Binding%2C+Cytotoxicity%2C+Cellular+Uptake%2C+Apoptosis+and+Photocleavage+Studies+of+Ru%28II%29+Complexes&doi=10.1016%2Fj.jphotobiol.2016.03.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-binding, cytotoxicity, cellular uptake, apoptosis and photocleavage studies of Ru(II) complexes</span></div><div class="casAuthors">Deepika, N.; Shobha Devi, C.; Praveen Kumar, Y.; Laxma Reddy, K.; Venkat Reddy, P.; Anil Kumar, D.; Singh, Surya S.; Satyanarayana, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">142-153</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two Ru(II) complexes [Ru(phen)2bppp](ClO4)2 (1) and [Ru(phen)27-Br-dppz](ClO4)2 (2) [phen = 1,10 phenanthroline, 7-Br-dppz = 7-fluorodipyrido[3,2-a:2',3'-c]phenazine, bppp = 11-bromo-pyrido[2',3':5,6]pyrazino[2,3-f] [1,10]phenanthroline] have been synthesized and characterized by elemental anal., ES-MS, 1H-NMR, 13C-NMR and IR.  The in vitro cytotoxicity of the complexes examd. against a panel of cancer cell lines (HeLa, Du145 and A549) by MTT method, both complexes show prominent anticancer activity against various cancer cells.  Live cell imaging study and flow cytometric anal. demonstrate that both the complexes 1 and 2 could cross the cell membrane accumulating in the nucleus.  Further, flow cytometry expts. showed that the cytotoxic Ru(II) complexes 1 and 2 induced apoptosis of HeLa tumor cell lines.  Photo induced DNA cleavage studies have been performed and results indicate that both the complexes efficiently photo cleave pBR322 DNA.  The binding properties of two complexes toward CT-DNA were investigated by various optical methods and viscosity measurements.  The exptl. results suggested that both Ru(II) complexes can intercalate into DNA base pairs.  The complexes were docked into DNA-base pairs using the GOLD docking program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMQmCqtnGu87Vg90H21EOLACvtfcHk0li-UrtxxaQm7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVGmt7o%253D&md5=1069e390ce8531b90bc6bfa39faa8d6b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2016.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2016.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DDeepika%26aufirst%3DN.%26aulast%3DShobha%2BDevi%26aufirst%3DC.%26aulast%3DPraveen%2BKumar%26aufirst%3DY.%26aulast%3DLaxma%2BReddy%26aufirst%3DK.%26aulast%3DVenkat%2BReddy%26aufirst%3DP.%26aulast%3DAnil%2BKumar%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DS.%2BS.%26aulast%3DSatyanarayana%26aufirst%3DS.%26atitle%3DDNA-Binding%252C%2520Cytotoxicity%252C%2520Cellular%2520Uptake%252C%2520Apoptosis%2520and%2520Photocleavage%2520Studies%2520of%2520Ru%2528II%2529%2520Complexes%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2016%26volume%3D160%26spage%3D142%26epage%3D153%26doi%3D10.1016%2Fj.jphotobiol.2016.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.-N.</span></span> <span> </span><span class="NLM_article-title">Targeting Telomeric G-Quadruplexes with the Ruthenium(II) Complexes [Ru(Bpy)<sub>2</sub>(Ptpn)]<sup>2+</sup> and [Ru(Phen)<sub>2</sub>(Ptpn)]<sup>2+</sup></span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4397</span>, <span class="refDoi"> DOI: 10.1039/c3dt32921f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fc3dt32921f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23400220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFegtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=4386-4397&author=X.+Chenauthor=J.-H.+Wuauthor=Y.-W.+Laiauthor=R.+Zhaoauthor=H.+Chaoauthor=L.-N.+Ji&title=Targeting+Telomeric+G-Quadruplexes+with+the+Ruthenium%28II%29+Complexes+%5BRu%28Bpy%292%28Ptpn%29%5D2%2B+and+%5BRu%28Phen%292%28Ptpn%29%5D2%2B&doi=10.1039%2Fc3dt32921f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting telomeric G-quadruplexes with the ruthenium(II) complexes [Ru(bpy)2(ptpn)]2+ and [Ru(phen)2(ptpn)]2+</span></div><div class="casAuthors">Chen, Xiang; Wu, Jing-Heng; Lai, Ying-Wei; Zhao, Rong; Chao, Hui; Ji, Liang-Nian</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4386-4397</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two ruthenium(II) polypyridyl complexes, [Ru(bpy)2(ptpn)]2+ (1) (bpy = 2,2'-bipyridine, ptpn = 3-(1,10-phenanthroline-2-yl)-as-triazino[5,6-f]1,10-phenanthroline) and [Ru(phen)2(ptpn)]2+ (2) (phen = 1,10-phenanthroline), were synthesized and characterized.  Crystal structure anal. shows that complex 1 has a large planar arom. area and possesses the potential to fit the geometric structure of G-quadruplex.  The interaction of the G-quadruplex DNA with Ru(II) complexes was explored by means of CD (CD), fluorescence resonance energy transfer (FRET) melting assay, competitive FRET assay and polymerase chain reaction (PCR) stop assay.  The results indicated that complexes 1 and 2 both have the ability to promote the formation and stabilization of the human telomeric d[(TTAGGG)n] (HTG22) quadruplex and exhibit high G-quadruplex DNA selectivity over duplex DNA.  The telomere repeat amplification protocol (TRAP) assay and long-term proliferation expts. further demonstrate that the Ru(II) complexes are potent telomerase inhibitors and HeLa cell proliferation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquU8BlqaHxPbVg90H21EOLACvtfcHk0li-UrtxxaQm7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFegtLw%253D&md5=decbc4138712e57318eaf2d7a138063b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2Fc3dt32921f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3dt32921f%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DLai%26aufirst%3DY.-W.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DL.-N.%26atitle%3DTargeting%2520Telomeric%2520G-Quadruplexes%2520with%2520the%2520Ruthenium%2528II%2529%2520Complexes%2520%255BRu%2528Bpy%25292%2528Ptpn%2529%255D2%252B%2520and%2520%255BRu%2528Phen%25292%2528Ptpn%2529%255D2%252B%26jtitle%3DDalton%2520Trans.%26date%3D2013%26volume%3D42%26spage%3D4386%26epage%3D4397%26doi%3D10.1039%2Fc3dt32921f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srishailam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkat Reddy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambigari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuruputuri, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satyanarayana, S.</span></span> <span> </span><span class="NLM_article-title">Cellular Uptake, Cytotoxicity, Apoptosis, DNA-Binding, Photocleavage and Molecular Docking Studies of Ruthenium(II) Polypyridyl Complexes</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jphotobiol.2014.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24607611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2014&pages=111-123&author=A.+Srishailamauthor=Y.+P.+Kumarauthor=P.+Venkat+Reddyauthor=N.+Nambigariauthor=U.+Vuruputuriauthor=S.+S.+Singhauthor=S.+Satyanarayana&title=Cellular+Uptake%2C+Cytotoxicity%2C+Apoptosis%2C+DNA-Binding%2C+Photocleavage+and+Molecular+Docking+Studies+of+Ruthenium%28II%29+Polypyridyl+Complexes&doi=10.1016%2Fj.jphotobiol.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium(II) polypyridyl complexes</span></div><div class="casAuthors">Srishailam, A.; Kumar, Yata Praveen; Venkat Reddy, P.; Nambigari, Navaneetha; Vuruputuri, Uma; Singh, Surya S.; Satyanarayana, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111-123</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three new mononuclear [Ru (phen)2 ptip]2+ (1), [Ru (bpy)2 ptip]2+ (2) and [Ru (dmb)2 ptip]2+ (3) [ptip = (2-(5-phenylthiophen-2-yl)-1H-imidazo[4, 5-f][1,10 phenanthroline, phen = 1, 10 phenanthroline, bpy = 2, 2' bipyridine, dmb = 4, 4'-dimethyl 2, 2' bipyridine] complexes were synthesized and characterized by elemental anal., IR, NMR and Mass spectra.  The DNA-binding behaviors were investigated by electronic absorption titrn., luminescence spectra, viscosity measurements and photo-activated cleavage.  The DNA-binding consts. Kb of complexes 1, 2 and 3 were detd. to be 7.0 (±0.06) × 105, 3.87 (±0.04) × 105, 2.79 (±0.07) × 105 resp.  The results showed that these complexes interact with CT-DNA by intercalative mode.  Cell viability expts. indicated that the Ru(II) complex showed significant dose-dependent cytotoxicity to HeLa tumor cell lines.  Further flow cytometry expts. showed that the cytotoxic Ru(II) complex induced apoptosis of HeLa tumor cell lines.  Our data demonstrated that the Ru(II) polypyridyl complex binds to DNA and thereby induces apoptosis in tumor cells, suggesting that anti-tumor activity of the Ru(II) complex could be related to its interaction with DNA.  The mol. dynamic simulations and docking methods were used to predict the DNA binding affinity of ruthenium complexes and with good visualisation images supporting with exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNyXMTBkNDp7Vg90H21EOLACvtfcHk0lhPMYxD9wJ5jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGnsbw%253D&md5=45a212bc41a9b9f8ad4e7c055d5ce9bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DSrishailam%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DY.%2BP.%26aulast%3DVenkat%2BReddy%26aufirst%3DP.%26aulast%3DNambigari%26aufirst%3DN.%26aulast%3DVuruputuri%26aufirst%3DU.%26aulast%3DSingh%26aufirst%3DS.%2BS.%26aulast%3DSatyanarayana%26aufirst%3DS.%26atitle%3DCellular%2520Uptake%252C%2520Cytotoxicity%252C%2520Apoptosis%252C%2520DNA-Binding%252C%2520Photocleavage%2520and%2520Molecular%2520Docking%2520Studies%2520of%2520Ruthenium%2528II%2529%2520Polypyridyl%2520Complexes%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2014%26volume%3D132%26spage%3D111%26epage%3D123%26doi%3D10.1016%2Fj.jphotobiol.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear Permeable Ruthenium(II) β-Carboline Complexes Induce Autophagy to Antagonize Mitochondrial-Mediated Apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7613</span>– <span class="NLM_lpage">7624</span>, <span class="refDoi"> DOI: 10.1021/jm1009296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7613-7624&author=C.+Tanauthor=S.+Laiauthor=S.+Wuauthor=S.+Huauthor=L.+Zhouauthor=Y.+Chenauthor=M.+Wangauthor=Y.+Zhuauthor=W.+Lianauthor=W.+Pengauthor=L.+Jiauthor=A.+Xu&title=Nuclear+Permeable+Ruthenium%28II%29+%CE%B2-Carboline+Complexes+Induce+Autophagy+to+Antagonize+Mitochondrial-Mediated+Apoptosis&doi=10.1021%2Fjm1009296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Permeable Ruthenium(II) β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis</span></div><div class="casAuthors">Tan, Caiping; Lai, Sensen; Wu, Shouhai; Hu, Sheng; Zhou, Lingjun; Chen, Yu; Wang, Minxu; Zhu, Yiping; Lian, Wu; Peng, Wenlie; Ji, Liangnian; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7613-7624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The role of autophagy in cancer development and response to cancer therapy has been a subject of debate.  Here we demonstrate that a series of ruthenium(II) complexes contg. a β-carboline alkaloid as ligand can simultaneously induce autophagy and apoptosis in tumor cells.  These Ru(II) complexes are nuclear permeable and highly active against a panel of human cancer cell lines, with complex 3 displaying activities greater than those of cisplatin.  The antiproliferative potentialities of 1-3 are in accordance with their relative lipophilicities, cell membrane penetration abilities, and in vitro DNA binding affinities.  Complexes 1-3 trigger release of reactive oxygen species (ROS) and attenuation of ROS by scavengers reduced the sub-G1 population, suggesting ROS-dependent apoptosis.  Inhibition of ROS generation also reduces autophagy, indicating that ROS triggers autophagy.  Further studies show that suppression of autophagy using pharmacol. inhibitors (3-methyladenine and chloroquine) enhances apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfI94bSBZCQLVg90H21EOLACvtfcHk0lhPMYxD9wJ5jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN&md5=8c2e1e1037d4a28e485e4776ddef930c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm1009296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009296%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DNuclear%2520Permeable%2520Ruthenium%2528II%2529%2520%25CE%25B2-Carboline%2520Complexes%2520Induce%2520Autophagy%2520to%2520Antagonize%2520Mitochondrial-Mediated%2520Apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7613%26epage%3D7624%26doi%3D10.1021%2Fjm1009296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonidova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiccia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-Pyrimidine-4-Carboxylic Acid</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">20376</span>– <span class="NLM_lpage">20387</span>, <span class="refDoi"> DOI: 10.1021/ja307288s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja307288s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=20376-20387&author=V.+Pierrozauthor=T.+Joshiauthor=A.+Leonidovaauthor=C.+Mariauthor=J.+Schurauthor=I.+Ottauthor=L.+Spicciaauthor=S.+Ferrariauthor=G.+Gasser&title=Molecular+and+Cellular+Characterization+of+the+Biological+Effects+of+Ruthenium%28II%29+Complexes+Incorporating+2-Pyridyl-2-Pyrimidine-4-Carboxylic+Acid&doi=10.1021%2Fja307288s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid</span></div><div class="casAuthors">Pierroz, Vanessa; Joshi, Tanmaya; Leonidova, Anna; Mari, Cristina; Schur, Julia; Ott, Ingo; Spiccia, Leone; Ferrari, Stefano; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20376-20387</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A great majority of the Ru complexes currently studied in anticancer research exert their antiproliferative activity, at least partially, through ligand exchange.  In recent years, however, coordinatively satd. and substitutionally inert polypyridyl Ru(II) compds. have emerged as potential anticancer drug candidates.  In this work, we present the synthesis and detailed characterization of two novel inert Ru(II) complexes, namely, [Ru(bipy)2(Cpp-NH-Hex-COOH)]2+ (2) and [Ru(dppz)2(CppH)]2+ (3) (bipy = 2,2'-bipyridine; CppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid; Cpp-NH-Hex-COOH = 6-(2-(pyridin-2-yl)pyrimidine-4-carboxamido)hexanoic acid; dppz = dipyrido[3,2-a:2',3'-c]phenazine).  3 Is of particular interest as it was found to have IC50 values comparable to cisplatin, a benchmark std. in the field, on three cancer cell lines and a better activity on one cisplatin-resistant cell line than cisplatin itself.  The mechanism of action of 3 was then investigated in detail and it could be demonstrated that, although 3 binds to calf-thymus DNA by intercalation, the biol. effects that it induces did not involve a nuclear DNA related mode of action.  On the contrary, confocal microscopy colocalization studies in HeLa cells showed that 3 specifically targeted mitochondria.  This was further correlated by ruthenium quantification using High-resoln. at. absorption spectrometry.  Furthermore, as detd. by two independent assays, 3 induced apoptosis at a relatively late stage of treatment.  The generation of reactive oxygen species could be excluded as the cause of the obsd. cytotoxicity.  It was demonstrated that the mitochondrial membrane potential in HeLa was impaired by 3 as early as 2 h after its introduction and even more with increasing time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJRlZwbuToLVg90H21EOLACvtfcHk0lhPMYxD9wJ5jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgsLjJ&md5=d83dbd762eca12ef0daf75aa060d3853</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja307288s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja307288s%26sid%3Dliteratum%253Aachs%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DJoshi%26aufirst%3DT.%26aulast%3DLeonidova%26aufirst%3DA.%26aulast%3DMari%26aufirst%3DC.%26aulast%3DSchur%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DI.%26aulast%3DSpiccia%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMolecular%2520and%2520Cellular%2520Characterization%2520of%2520the%2520Biological%2520Effects%2520of%2520Ruthenium%2528II%2529%2520Complexes%2520Incorporating%25202-Pyridyl-2-Pyrimidine-4-Carboxylic%2520Acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D20376%26epage%3D20387%26doi%3D10.1021%2Fja307288s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) Polypyridyl Complexes Induce BEL-7402 Cell Apoptosis by ROS-Mediated Mitochondrial Pathway</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2014.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jinorgbio.2014.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25268891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOqsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=170-179&author=G.-B.+Jiangauthor=X.+Zhengauthor=J.-H.+Yaoauthor=B.-J.+Hanauthor=W.+Liauthor=J.+Wangauthor=H.-L.+Huangauthor=Y.-J.+Liu&title=Ruthenium%28II%29+Polypyridyl+Complexes+Induce+BEL-7402+Cell+Apoptosis+by+ROS-Mediated+Mitochondrial+Pathway&doi=10.1016%2Fj.jinorgbio.2014.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway</span></div><div class="casAuthors">Jiang, Guang-Bin; Zheng, Xiang; Yao, Jun-Hua; Han, Bing-Jie; Li, Wei; Wang, Ji; Huang, Hong-Liang; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">170-179</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A new ligand dmdppz and its four ruthenium(II) polypyridyl complexes [Ru(dmb)2(dmdppz)](ClO4)2 (1), [Ru(bpy)2(dmdppz)](ClO4)2 (2), [Ru(phen)2(dmdppz)](ClO4)2 (3) and [Ru(dmp)2(dmdppz)](ClO4)2 (4) (where dmb, bpy, phen, dmp and dmdppz stand for 4,4'-dimethyl-2,2'-bipyridine, 2,2'-bipyridine, 1,10-phenanthroline, 2,9-dimethyl-1,10-phenanthroline and 5,8-dimethoxylpyrido[3,2-a:2',3'-c]phenazine, resp.) have been synthesized and characterized.  Their DNA binding behaviors show that the complexes bind to calf thymus DNA by intercalation.  The complexes exhibit efficient photocleavage of pBR322 DNA on irradn.  The cytotoxicity of the ligand and the complexes toward HepG-2, HeLa, MG-63, A549 and BEL-7402 were assayed by MTT ((3-(4,5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide)) method.  The IC50 values of the complexes 1, 2, 3 and 4 toward BEL-7402 cells are 14.6, 16.8, 18.0 and 16.7 μM, resp.  Dmdppz shows no cytotoxic activity against selected cell lines.  The cellular uptake, apoptosis, comet assay, reactive oxygen species (ROS), mitochondrial membrane potential and western blot anal. were investigated.  These results indicate that complexes 1-4 exert their toxicity through the intrinsic ROS-mediated mitochondrial pathway, which is accompanied by the regulation of Bcl-2 family proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOidPqyTc7eLVg90H21EOLACvtfcHk0lgz7-Mtfm6cDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOqsL3N&md5=cf025ba89250d70c28809f92dd04d0c3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DG.-B.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DJ.-H.%26aulast%3DHan%26aufirst%3DB.-J.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.-L.%26aulast%3DLiu%26aufirst%3DY.-J.%26atitle%3DRuthenium%2528II%2529%2520Polypyridyl%2520Complexes%2520Induce%2520BEL-7402%2520Cell%2520Apoptosis%2520by%2520ROS-Mediated%2520Mitochondrial%2520Pathway%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D141%26spage%3D170%26epage%3D179%26doi%3D10.1016%2Fj.jinorgbio.2014.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span> <span> </span><span class="NLM_article-title">Dual Topoisomerase i and II Poisoning by Chiral Ru(II) Complexes Containing 2-Thiophenylimidazo[4,5-f][1,10]Phenanthroline Derivatives</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2013.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jinorgbio.2013.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24145066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=15-27&author=Y.+C.+Wangauthor=C.+Qianauthor=Z.+L.+Pengauthor=X.+J.+Houauthor=L.+L.+Wangauthor=H.+Chaoauthor=L.+N.+Ji&title=Dual+Topoisomerase+i+and+II+Poisoning+by+Chiral+Ru%28II%29+Complexes+Containing+2-Thiophenylimidazo%5B4%2C5-f%5D%5B1%2C10%5DPhenanthroline+Derivatives&doi=10.1016%2Fj.jinorgbio.2013.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f|[1,10|phenanthroline derivatives</span></div><div class="casAuthors">Wang, Yu-Chuan; Qian, Chen; Peng, Zai-Li; Hou, Xiao-Juan; Wang, Li-Li; Chao, Hui; Ji, Liang-Nian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A series of chiral RuII complexes bearing thiophene ligands were synthesized and characterized.  Both RuII complexes Δ/Λ-Rubpy2pscl|2+ Δ/Λ-1 and Δ/Λ-Rubpy2psbr|2+ Δ/Λ-2 bpy = 2,2'-bipyridine, pscl = 2-5-chlorothiophen-2-ylimidazo4,5-f|1,10|phenanthroline, psbr = 2-5-bromothiophen-2-ylimidazo4,5-f|1,10|phenanthroline showed antitumor activities against A549, HepG2 and BEL-7402 tumor cell lines, esp. HeLa tumor cell line.  Moreover, Δ enantiomers were more active than Λ enantiomers, accounting for the different cellular uptake.  In addn., with the extension of time, these enantiomers could finally accumulate in the nucleus, suggesting that nucleic acids were the cellular target of these enantiomers.  The DNA-binding behaviors of complexes were studied using spectroscopic and viscosity measurements.  Results suggested that four complexes could bind to DNA in an intercalative mode but no obvious DNA-binding selectivity between the enantiomers was obsd.  Topoisomerase inhibition and DNA religation assay confirmed that four complexes acted as efficient dual topoisomerase I and II poisons, DNA strand breaks had also been obsd. from alk. single cell gel electrophoresis comet assay. Δ-1 and Δ-2 inhibited the growth of HeLa cells through the induction of apoptotic cell death, as evidenced by the Alexa Fluor 488 annexin V staining assays and flow cytometry anal.  The results demonstrated that Δ/Λ-1 and Δ/Λ-2 acted as dual topoisomerase I and II poisons and caused DNA damage that could lead to cell cycle arrest by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JeacrSJiWrVg90H21EOLACvtfcHk0lgz7-Mtfm6cDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vN&md5=6401d758e09548ffdb3ed7aebb6889e8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2013.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2013.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DZ.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BL.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DL.%2BN.%26atitle%3DDual%2520Topoisomerase%2520i%2520and%2520II%2520Poisoning%2520by%2520Chiral%2520Ru%2528II%2529%2520Complexes%2520Containing%25202-Thiophenylimidazo%255B4%252C5-f%255D%255B1%252C10%255DPhenanthroline%2520Derivatives%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D130%26spage%3D15%26epage%3D27%26doi%3D10.1016%2Fj.jinorgbio.2013.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span> <span> </span><span class="NLM_article-title">Chiral Ruthenium(II) Anthraquinone Complexes as Dual Inhibitors of Topoisomerases I and II</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1007/s00775-011-0831-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1007%2Fs00775-011-0831-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=21858685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVCqt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=81-96&author=J.+F.+Kouauthor=C.+Qianauthor=J.+Q.+Wangauthor=X.+Chenauthor=L.+L.+Wangauthor=H.+Chaoauthor=L.+N.+Ji&title=Chiral+Ruthenium%28II%29+Anthraquinone+Complexes+as+Dual+Inhibitors+of+Topoisomerases+I+and+II&doi=10.1007%2Fs00775-011-0831-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II</span></div><div class="casAuthors">Kou, Jun-Feng; Qian, Chen; Wang, Jin-Quan; Chen, Xiang; Wang, Li-Li; Chao, Hui; Ji, Liang-Nian</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-96</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: DNA topoisomerases (I and II) have been one of the excellent targets in anticancer drug development.  Here two chiral ruthenium(II) anthraquinone complexes, Δ- and Λ-[Ru(bpy)2(ipad)]2+, where bpy is 2,2'-bipyridine and ipad is 2-(anthracene-9,10-dione-2-yl)imidazo[4,5-f][1,10]phenanthroline, were synthesized and characterized.  As expected, both of the Ru(II) complexes intercalate into DNA base pairs and possess an obviously greater affinity with DNA.  Topoisomerase inhibition and DNA strand passage assay confirmed that the two complexes are efficient dual inhibitors of topoisomerases I and II by interference with the DNA religation.  In MTT cytotoxicity studies, two Ru(II) complexes exhibited antitumor activity against HeLa, MCF-7, HepG2 and BEL-7402 tumor cell lines.  Flow cytometry anal. shows an increase in the percentage of cells with apoptotic morphol. features in the sub-G1 phase for Ru(II) complexes.  Nuclear chromatin cleavage has also been obsd. from AO/EB staining assay and alk. single-cell gel electrophoresis (comet assay).  The results demonstrated that Δ- and Λ-[Ru(bpy)2(ipad)]2+ act as dual inhibitors of topoisomerases I and II, and cause DNA damage that can lead to cell cycle arrest and/or cell death by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJQ1mIWegYO7Vg90H21EOLACvtfcHk0lgz7-Mtfm6cDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVCqt7vF&md5=de4b490f9df023d8502d371855ab5ba9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00775-011-0831-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-011-0831-6%26sid%3Dliteratum%253Aachs%26aulast%3DKou%26aufirst%3DJ.%2BF.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%2BQ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%2BL.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DL.%2BN.%26atitle%3DChiral%2520Ruthenium%2528II%2529%2520Anthraquinone%2520Complexes%2520as%2520Dual%2520Inhibitors%2520of%2520Topoisomerases%2520I%2520and%2520II%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2012%26volume%3D17%26spage%3D81%26epage%3D96%26doi%3D10.1007%2Fs00775-011-0831-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schatzschneider, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niesel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alborzinia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wölfl, S.</span></span> <span> </span><span class="NLM_article-title">Cellular Uptake, Cytotoxicity, and Metabolic Profiling of Human Cancer Cells Treated with Ruthenium(II) Polypyridyl Complexes [Ru(Bpy) 2(N-N)]Cl2 with N-N = bpy, Phen, Dpq, Dppz, and Dppn</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1104</span>– <span class="NLM_lpage">1109</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcmdc.200800039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=18425738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1104-1109&author=U.+Schatzschneiderauthor=J.+Nieselauthor=I.+Ottauthor=R.+Gustauthor=H.+Alborziniaauthor=S.+W%C3%B6lfl&title=Cellular+Uptake%2C+Cytotoxicity%2C+and+Metabolic+Profiling+of+Human+Cancer+Cells+Treated+with+Ruthenium%28II%29+Polypyridyl+Complexes+%5BRu%28Bpy%29+2%28N-N%29%5DCl2+with+N-N+%3D+bpy%2C+Phen%2C+Dpq%2C+Dppz%2C+and+Dppn&doi=10.1002%2Fcmdc.200800039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N-N)]Cl2 with N-N = bpy, phen, dpq, dppz, and dppn</span></div><div class="casAuthors">Schatzschneider, Ulrich; Niesel, Johanna; Ott, Ingo; Gust, Ronald; Alborzinia, Hamed; Woelfl, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1104-1109</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of five ruthenium(II) polypyridyl complexes [Ru(bpy)2(N-N)]Cl2 was tested against human HT-29 and MCF-7 cancer cell lines.  Cellular uptake efficiency and cytotoxicity were found to increase with the size of the arom. surface area of the N-N ligand.  The most active compd. carrying the dppn ligand exhibits a low micromolar IC50 value against both cell lines comparable to that of cisplatin under similar conditions.  Continuous measurement of oxygen consumption, extracellular acidification rate, and impedance of the cell layer with a chip-based sensor system upon exposure to the complexes showed only small changes for the first two parameters throughout the series.  A significant and irreversible decrease in impedance was, however, found for the dppn compd.  This suggests that its biol. activity is related to modifications in cell morphol. or cell-cell and cell-matrix contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ5JwIvtSnN7Vg90H21EOLACvtfcHk0lhSVusQU8Zp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWgsbY%253D&md5=2cb0f9be5c2808d478dbd7f9efd08cde</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800039%26sid%3Dliteratum%253Aachs%26aulast%3DSchatzschneider%26aufirst%3DU.%26aulast%3DNiesel%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DI.%26aulast%3DGust%26aufirst%3DR.%26aulast%3DAlborzinia%26aufirst%3DH.%26aulast%3DW%25C3%25B6lfl%26aufirst%3DS.%26atitle%3DCellular%2520Uptake%252C%2520Cytotoxicity%252C%2520and%2520Metabolic%2520Profiling%2520of%2520Human%2520Cancer%2520Cells%2520Treated%2520with%2520Ruthenium%2528II%2529%2520Polypyridyl%2520Complexes%2520%255BRu%2528Bpy%2529%25202%2528N-N%2529%255DCl2%2520with%2520N-N%2520%253D%2520bpy%252C%2520Phen%252C%2520Dpq%252C%2520Dppz%252C%2520and%2520Dppn%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1104%26epage%3D1109%26doi%3D10.1002%2Fcmdc.200800039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mccleverty, J. A.</span></span> <span> </span><span class="NLM_article-title">Non-Innocent Behaviour in Mononuclear and Polynuclear Complexes: Consequences for Redox and Electronic Spectroscopic Properties</span>. <i>J. Chem. Soc., Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1039/b110131p</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb110131p" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=275-288&author=M.+D.+Wardauthor=J.+A.+Mccleverty&title=Non-Innocent+Behaviour+in+Mononuclear+and+Polynuclear+Complexes%3A+Consequences+for+Redox+and+Electronic+Spectroscopic+Properties&doi=10.1039%2Fb110131p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Non-innocent behavior in mononuclear and polynuclear complexes: consequences for redox and electronic spectroscopic properties</span></div><div class="casAuthors">Ward, Michael D.; McCleverty, Jon A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Dalton Transactions</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-288</span>CODEN:
                <span class="NLM_cas:coden">JCSDAA</span>;
        ISSN:<span class="NLM_cas:issn">1472-7773</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This article reviews recent work in the area of non-innocent behavior in polynuclear metal complexes.  Non-innocence, which occurs when metal-based and ligand-based redox orbitals are similar in energy, was known since the 1st dithiolene complexes of the Ni triad.  The authors' recent work in this field is with complexes of two distinct types: polynuclear complexes of Ru(ii) with dioxolene-type bridging ligands; and dinuclear complexes based on tris(pyrazolyl)borato-Mo(v) or -Mo(i) units linked by bis-phenolate or bis-pyridyl bridging ligands.  Detailed redox and UV/visible/NIR spectroelectrochem. studies on these complexes were carried out.  An important point which emerges is that non-innocent behavior in dinuclear complexes is an essential prerequisite for strong metal-metal electronic coupling across extended bridging ligands.  Many of the complexes studied show intense charge-transfer transitions in the near-IR region of the spectrum, and the use of these in prototypical optical devices is briefly discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhY5G4HCnmW7Vg90H21EOLACvtfcHk0lhSVusQU8Zp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gnt7k%253D&md5=0c24a8f5e1b178e09200c695127a4083</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2Fb110131p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb110131p%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DM.%2BD.%26aulast%3DMccleverty%26aufirst%3DJ.%2BA.%26atitle%3DNon-Innocent%2520Behaviour%2520in%2520Mononuclear%2520and%2520Polynuclear%2520Complexes%253A%2520Consequences%2520for%2520Redox%2520and%2520Electronic%2520Spectroscopic%2520Properties%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Dalton%2520Trans.%26date%3D2002%26spage%3D275%26epage%3D288%26doi%3D10.1039%2Fb110131p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlček, A.</span></span> <span> </span><span class="NLM_article-title">Metal and Ligand Oxidation States in Dioxolene Complexes: Meaning, Assignment and Control</span>. <i>Comments Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1080/02603599408035860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1080%2F02603599408035860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK28Xms1ahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1994&pages=207-228&author=A.+Vl%C4%8Dek&title=Metal+and+Ligand+Oxidation+States+in+Dioxolene+Complexes%3A+Meaning%2C+Assignment+and+Control&doi=10.1080%2F02603599408035860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Metal and ligand oxidation states in dioxolene complexes: meaning, assignment and control</span></div><div class="casAuthors">Vlcek, Antonin, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Comments on Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-228</span>CODEN:
                <span class="NLM_cas:coden">COICDZ</span>;
        ISSN:<span class="NLM_cas:issn">0260-3594</span>.
    
            (<span class="NLM_cas:orgname">Gordon & Breach</span>)
        </div><div class="casAbstract">A review, with ∼72 refs.  Many features of the structural, magnetochem., spectral, electrochem., and chem. behavior of transition metal complexes with redox-active dioxolene ligands indicate that most of them are valence-localized species with well defined and exptl. distinguishable metal- and dioxolene-oxidn. states.  The valence localization results mainly from large structural differences between individual oxidn. states of the dioxolene ligands.  Dioxolene complexes may be treated like weakly coupled mixed-valence compds., and a qual. localized-valence model is developed to interpret phys. and chem. properties of dioxolene complexes, including their bistability, in a unifying way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmheOlkp4b47Vg90H21EOLACvtfcHk0lhSVusQU8Zp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xms1ahu7g%253D&md5=581773247f4867f47674fd33b237ba86</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F02603599408035860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02603599408035860%26sid%3Dliteratum%253Aachs%26aulast%3DVl%25C4%258Dek%26aufirst%3DA.%26atitle%3DMetal%2520and%2520Ligand%2520Oxidation%2520States%2520in%2520Dioxolene%2520Complexes%253A%2520Meaning%252C%2520Assignment%2520and%2520Control%26jtitle%3DComments%2520Inorg.%2520Chem.%26date%3D1994%26volume%3D16%26spage%3D207%26epage%3D228%26doi%3D10.1080%2F02603599408035860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierpont, C. G.</span></span> <span> </span><span class="NLM_article-title">Studies on Charge Distribution and Valence Tautomerism in Transition Metal Complexes of Catecholate and Semiquinonate Ligands</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>216–217</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/S0010-8545(01)00309-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2FS0010-8545%2801%2900309-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlCgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216%E2%80%93217&publication_year=2001&pages=99-125&author=C.+G.+Pierpont&title=Studies+on+Charge+Distribution+and+Valence+Tautomerism+in+Transition+Metal+Complexes+of+Catecholate+and+Semiquinonate+Ligands&doi=10.1016%2FS0010-8545%2801%2900309-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on charge distribution and valence tautomerism in transition metal complexes of catecholate and semiquinonate ligands</span></div><div class="casAuthors">Pierpont, C. G.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">216-217</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99-125</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review with 42 refs. presents an overview of recent research on complexes of quinone ligands that exhibit reversible shifts in charge distribution under equil. conditions.  Transition metal complexes contg. 1st row metal ions chelated by catecholate (Cat) and semiquinonate (SQ) ligands have localized electronic structures with quinone ligands bonded in both SQ and Cat electronic forms.  In exceptional cases the balance of metal and quinone orbital energies is sufficiently close as to permit magnetic and spectroscopic observations on isomers differing in charge distribution together under equil. conditions.  Equil. occurring between Mn(SQ√-) and Mn+1(Cat2-) redox isomers were obsd. in soln. and in the solid state for complexes of Co, Mn, and Cu.  The temp. range over which equil. may be obsd., is defined by enthalpy and entropy changes assocd., mainly, with changes in charge and spin-state of the metal ion.  This effect was considered as an example of valence tautomerism (VT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9Amu8_u6GsrVg90H21EOLACvtfcHk0lhSVusQU8Zp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlCgu7w%253D&md5=0d14cffeda2095ca24ab8f1c063627d3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2801%2900309-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252801%252900309-5%26sid%3Dliteratum%253Aachs%26aulast%3DPierpont%26aufirst%3DC.%2BG.%26atitle%3DStudies%2520on%2520Charge%2520Distribution%2520and%2520Valence%2520Tautomerism%2520in%2520Transition%2520Metal%2520Complexes%2520of%2520Catecholate%2520and%2520Semiquinonate%2520Ligands%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2001%26volume%3D216%25E2%2580%2593217%26spage%3D99%26epage%3D125%26doi%3D10.1016%2FS0010-8545%2801%2900309-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creutz, C.</span></span> In  <i>Progress in Inorganic Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, K. D.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>, <span class="NLM_year">1994</span>; Vol.  <span class="NLM_volume">41</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=C.+Creutzauthor=K.+D.+Karlin&title=Progress+in+Inorganic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCreutz%26aufirst%3DC.%26btitle%3DProgress%2520in%2520Inorganic%2520Chemistry%26aulast%3DKarlin%26aufirst%3DK.%2BD.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D1994%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodsworth, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, A. B. P.</span></span> <span> </span><span class="NLM_article-title">Catechol-Quinone Redox Series Involving Bis (Bipyridine) Ruthenium (II) and Tetrakis (Pyridine) Ruthenium (II)</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1021/ic00224a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00224a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL28Xht1Wrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=447-453&author=M.+Hagaauthor=E.+S.+Dodsworthauthor=A.+B.+P.+Lever&title=Catechol-Quinone+Redox+Series+Involving+Bis+%28Bipyridine%29+Ruthenium+%28II%29+and+Tetrakis+%28Pyridine%29+Ruthenium+%28II%29&doi=10.1021%2Fic00224a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-quinone redox series involving bis(bipyridine)ruthenium(II) and tetrakis(pyridine)ruthenium(II)</span></div><div class="casAuthors">Haga, Masaaki; Dodsworth, Elaine S.; Lever, A. B. P.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-53</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">A series of species belonging to the redox chain RuL4(cat), [RuL4(sq)]+, and [RuL4(q)]2+ were prepd. and characterized by electronic, IR, and ESR spectroscopy and electrochem. (L2 = 2,2'-bipyridine, L = py; H2cat = catechol, 3,5-di-tert-butylcatechol, and tetrachlorocatechol and their 1- and 2-electron-oxidn. products sq and q, resp.).  Evidence is presented that oxidn. of the dioxolene ligand to quinone occurs before oxidn. of Ru(II) to Ru(III).  Rich electronic spectra and electrochem. are reported and assigned.  The positions of the charge-transfer bands (metal to ligand, and ligand to ligand) are discussed in terms of the electrochem. potentials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowncrPLO4IwLVg90H21EOLACvtfcHk0lgc_fA9AYwvAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1Wrtbc%253D&md5=bee22ecd5b3b446db1004fc4811b6e08</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fic00224a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00224a013%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DM.%26aulast%3DDodsworth%26aufirst%3DE.%2BS.%26aulast%3DLever%26aufirst%3DA.%2BB.%2BP.%26atitle%3DCatechol-Quinone%2520Redox%2520Series%2520Involving%2520Bis%2520%2528Bipyridine%2529%2520Ruthenium%2520%2528II%2529%2520and%2520Tetrakis%2520%2528Pyridine%2529%2520Ruthenium%2520%2528II%2529%26jtitle%3DInorg.%2520Chem.%26date%3D1986%26volume%3D25%26spage%3D447%26epage%3D453%26doi%3D10.1021%2Fic00224a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Experimental and Theoretical Evaluation of the Charge Distribution over the Ruthenium and Dioxolene Framework of [Ru(OAc)(Dioxolene)(Terpy)] (Terpy = 2,2′:6′,2″-Terpyridine) Depending on the Substituents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">8887</span>– <span class="NLM_lpage">8894</span>, <span class="refDoi"> DOI: 10.1021/ic060696i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic060696i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVChtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=8887-8894&author=T.+Wadaauthor=M.+Yamanakaauthor=T.+Fujiharaauthor=Y.+Miyazatoauthor=K.+Tanaka&title=Experimental+and+Theoretical+Evaluation+of+the+Charge+Distribution+over+the+Ruthenium+and+Dioxolene+Framework+of+%5BRu%28OAc%29%28Dioxolene%29%28Terpy%29%5D+%28Terpy+%3D+2%2C2%E2%80%B2%3A6%E2%80%B2%2C2%E2%80%B3-Terpyridine%29+Depending+on+the+Substituents&doi=10.1021%2Fic060696i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Theoretical Evaluation of the Charge Distribution over the Ruthenium and Dioxolene Framework of [Ru(OAc)(dioxolene)(terpy)] (terpy = 2,2':6',2''-terpyridine) Depending on the Substituents</span></div><div class="casAuthors">Wada, Tohru; Yamanaka, Masahiro; Fujihara, Tetsuaki; Miyazato, Yuji; Tanaka, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8887-8894</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ru complexes [Ru(OAc)(dioxolene)(terpy)] having various substituents on the dioxolene ligand (dioxolene = 3,5-t-Bu2C6H2O2 (1), 4-t-BuC6H3O2 (2), 4-ClC6H3O2 (3), 3,5-Cl2C6H2O2 (4), Cl4C6O2 (5); terpy = 2,2':6'2''-terpyridine) were prepd.  EPR spectra of these complexes in glassy frozen solns. (CH2Cl2:MeOH = 95:5, vol./vol.) at 20 K showed anisotropic signals with g tensor components 2.242 > g1 > 2.104, 2.097 > g2 > 2.042, and 1.951 > g3 > 1.846.  An anisotropic value, Δg = g1-g3, and an isotropic g value, 〈g〉 = [(g12 + g22 + g32)/3]1/2, increase in the order 1 < 2 < 3 < 4 < 5.  The resonance between the RuII(sq) (sq = semiquinone) and RuIII(cat) (cat = catecholato) frameworks shifts to the latter with an increase of the no. of electron-withdrawing substituents on the dioxolene ligand.  DFT calcns. of 1, 2, 3, and 5 also support the increase of the Ru spin d. (RuIII character) with an increase of the no. of Cl atoms on the dioxolene ligand.  The singly occupied MOs (SOMOs) of 1 and 5 are very similar to each other and stretch out the Ru-dioxolene frameworks, whereas the LUMO of 5 is localized on Ru and two O atoms of dioxolene in comparison with that of 1.  Electron-withdrawing groups decrease the energy levels of both the SOMO and LUMO.  An increase in the no. of Cl atoms in the dioxolene ligand results in an increase of the pos. charge on Ru.  Successive shifts in the electronic structure between the RuII(sq) and RuIII(cat) frameworks caused by the variation of the substituents are compatible with the exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzusMh4cRpWrVg90H21EOLACvtfcHk0lgc_fA9AYwvAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVChtrjK&md5=623adeaedd6f88429c27c757cc7b3edc</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fic060696i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic060696i%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DM.%26aulast%3DFujihara%26aufirst%3DT.%26aulast%3DMiyazato%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DExperimental%2520and%2520Theoretical%2520Evaluation%2520of%2520the%2520Charge%2520Distribution%2520over%2520the%2520Ruthenium%2520and%2520Dioxolene%2520Framework%2520of%2520%255BRu%2528OAc%2529%2528Dioxolene%2529%2528Terpy%2529%255D%2520%2528Terpy%2520%253D%25202%252C2%25E2%2580%25B2%253A6%25E2%2580%25B2%252C2%25E2%2580%25B3-Terpyridine%2529%2520Depending%2520on%2520the%2520Substituents%26jtitle%3DInorg.%2520Chem.%26date%3D2006%26volume%3D45%26spage%3D8887%26epage%3D8894%26doi%3D10.1021%2Fic060696i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muckerman, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyansky, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, E.</span></span> <span> </span><span class="NLM_article-title">Water Oxidation by a Ruthenium Complex with Noninnocent Quinone Ligands: Possible Formation of an O-O Bond at a Low Oxidation State of the Metal</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1021/ic701892v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic701892v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFChsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1787-1802&author=J.+T.+Muckermanauthor=D.+E.+Polyanskyauthor=T.+Wadaauthor=K.+Tanakaauthor=E.+Fujita&title=Water+Oxidation+by+a+Ruthenium+Complex+with+Noninnocent+Quinone+Ligands%3A+Possible+Formation+of+an+O-O+Bond+at+a+Low+Oxidation+State+of+the+Metal&doi=10.1021%2Fic701892v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Water Oxidation by a Ruthenium Complex with Noninnocent Quinone Ligands: Possible Formation of an O-O Bond at a Low Oxidation State of the Metal</span></div><div class="casAuthors">Muckerman, James T.; Polyansky, Dmitry E.; Wada, Tohru; Tanaka, Koji; Fujita, Etsuko</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1787-1802</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tanaka and co-workers reported a novel dinuclear Ru complex, [Ru2(OH)2(3,6-Bu2Q)2(btpyan)](SbF6)2 (3,6-Bu2Q = 3,6-ditert-butyl-1,2-benzoquinone, btpyan = 1,8-bis(2,2':6',2''-terpyrid-4'-yl)anthracene), that contains redox active quinone ligands and has an excellent electrocatalytic activity for H2O oxidn. when immobilized on an In-Sn-oxide electrode (Inorg. Chem., 2001, 40, 329-337).  The novel features of the dinuclear and related mononuclear Ru species with quinone ligands, and comparison of their properties to those of the Ru analogs with the bpy ligand (bpy = 2,2'-bipyridine) replacing quinone, are summarized here together with new theor. and exptl. results that show striking features for both the dinuclear and mononuclear species.  The identity and oxidn. state of key mononuclear species, including the previously reported oxyl radical, were reassigned.  The gas-phase theor. calcns. indicate that the Tanaka Ru-dinuclear catalyst seems to maintain predominantly Ru(II) centers while the quinone ligands and H2O moiety are involved in redox reactions throughout the entire catalytic cycle for H2O oxidn.  The theor. study identifies [Ru2(O2-)(Q-1.5)2(btpyan)] as a key intermediate and the most reduced catalyst species that is formed by removal of all 4 protons before 4-electron oxidn. takes place.  While the study toward understanding the complicated electronic and geometric structures of possible intermediates in the catalytic cycle is still in progress, the current status and new directions for kinetic and mechanistic studies, and key issues and challenges in H2O oxidn. with the Tanaka catalyst (and its analogs with Cl- or NO2-substituted quinones and a species with a xanthene bridge instead an anthracene) are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBjjw_tm4NCbVg90H21EOLACvtfcHk0lgc_fA9AYwvAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFChsr0%253D&md5=4d0e0f2f5ba0dfd8cd5f4bf1dedbc199</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fic701892v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic701892v%26sid%3Dliteratum%253Aachs%26aulast%3DMuckerman%26aufirst%3DJ.%2BT.%26aulast%3DPolyansky%26aufirst%3DD.%2BE.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DE.%26atitle%3DWater%2520Oxidation%2520by%2520a%2520Ruthenium%2520Complex%2520with%2520Noninnocent%2520Quinone%2520Ligands%253A%2520Possible%2520Formation%2520of%2520an%2520O-O%2520Bond%2520at%2520a%2520Low%2520Oxidation%2520State%2520of%2520the%2520Metal%26jtitle%3DInorg.%2520Chem.%26date%3D2008%26volume%3D47%26spage%3D1787%26epage%3D1802%26doi%3D10.1021%2Fic701892v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, D. T.</span></span> <span> </span><span class="NLM_article-title">Redox Chemistry of Metal-Catechol Complexes in Aprotic Media. 2. 3,5-Di-Fert-Butylcatecholato Complexes of Manganese(IV) and Manganese(III)</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4257</span>– <span class="NLM_lpage">4262</span>, <span class="refDoi"> DOI: 10.1021/ic50226a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic50226a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL3MXmtFWrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1981&pages=4257-4262&author=S.+E.+Jonesauthor=D.+Chinauthor=D.+T.+Sawyer&title=Redox+Chemistry+of+Metal-Catechol+Complexes+in+Aprotic+Media.+2.+3%2C5-Di-Fert-Butylcatecholato+Complexes+of+Manganese%28IV%29+and+Manganese%28III%29&doi=10.1021%2Fic50226a045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Redox chemistry of metal-catechol complexes in aprotic media.  2.  3,5-Di-tert-butylcatecholato complexes of manganese(IV) and manganese(III)</span></div><div class="casAuthors">Jones, Stephen E.; Chin, Der Hang; Sawyer, Donald T.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4257-62</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">When mixts. of Mn(II) and 3,5-di-tert-butyl-o-quinone (DTBQ) with 1:3 and 1:2 molar ratios are reduced in aprotic solvents, stable [Mn(DTBC)3]2- and [Mn(DTBC)2]- (where H2DTBC is di-tert-butylcatechol) complexes are formed, resp.  These complexes and their oxidn.-redn. products were characterized by cyclic voltammetry, controlled-potential electrolysis, optical spectroscopy, ESR spectroscopy, and magnetic susceptibility measurements in DMF, Me2SO and MeCN.  Based on these results, a self-consistent redox mechanism is presented for the interconversion of the various species of Mn(II)-DTBQ system with 1:1, 1:2, and 1:3 molar ratios.  The catechol complexes of Mn(II), -(III), and -(IV) are versatile electron-transfer agents and should be effective redox catalysts and O activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldIs4DM2ItLVg90H21EOLACvtfcHk0liVFrjB9PdbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmtFWrurk%253D&md5=0d8e021b6fc3078236aa44789d944d47</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fic50226a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic50226a045%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DSawyer%26aufirst%3DD.%2BT.%26atitle%3DRedox%2520Chemistry%2520of%2520Metal-Catechol%2520Complexes%2520in%2520Aprotic%2520Media.%25202.%25203%252C5-Di-Fert-Butylcatecholato%2520Complexes%2520of%2520Manganese%2528IV%2529%2520and%2520Manganese%2528III%2529%26jtitle%3DInorg.%2520Chem.%26date%3D1981%26volume%3D20%26spage%3D4257%26epage%3D4262%26doi%3D10.1021%2Fic50226a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+Nature%E2%80%99s+PAINS%3A+Natural+Products%2C+Natural+Product+Drugs%2C+and+Pan+Assay+Interference+Compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0liVFrjB9PdbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520Nature%25E2%2580%2599s%2520PAINS%253A%2520Natural%2520Products%252C%2520Natural%2520Product%2520Drugs%252C%2520and%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lima, R. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, L. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarêncio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bachá, R. S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic Effects of Catechol to Neuroblastoma N2a Cells</span>. <i>Gen. Physiol. Biophys</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=19202205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=306-314&author=R.+M.+F.+Limaauthor=L.+D.+G.+Alvarezauthor=M.+F.+D.+Costaauthor=S.+Costaauthor=J.+Clar%C3%AAncioauthor=R.+S.+El-Bach%C3%A1&title=Cytotoxic+Effects+of+Catechol+to+Neuroblastoma+N2a+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of catechol to neuroblastoma N2a cells</span></div><div class="casAuthors">Lima, Rute M. F.; Alvarez, Lisandro D. G.; Costa, Maria F. D.; Costa, Silvia L.; Clarencio, Jorge; El-Bacha, Ramon S.</div><div class="citationInfo"><span class="NLM_cas:title">General Physiology and Biophysics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">306-314</span>CODEN:
                <span class="NLM_cas:coden">GPBIE2</span>;
        ISSN:<span class="NLM_cas:issn">0231-5882</span>.
    
            (<span class="NLM_cas:orgname">Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences</span>)
        </div><div class="casAbstract">The mechanisms of catechol-induced cytotoxicity were studied in cultures of neuroblastoma N2a cells.  The minimal cytotoxic concn. after 72 h was 20 μmol/l-1.  The EC50 after 72 h was 38 μmol/l-1.  There was not a correlation between the cytotoxicity and the formation of quinones in the medium.  Catechol-induced cytotoxicity was increased significantly when superoxide dismutase (SOD) was added.  The addn. of catalase did not protect cells, but this enzyme reverted the deleterious effect of SOD.  The exptl. studies showed a detrimental effect of deferoxamine on catechol-induced cytotoxicity suggesting that cells need iron to maintain its metab.  NF-κB inhibitors increased the cytotoxicity, suggesting that this factor is also important for cell viability.  L-cysteine and N-acetyl-L-cysteine protected cells significantly in a dose-dependent manner.  The use of monochlorobimane showed that catechol induced reduced glutathione (GSH) depletion after 24 h, prior to cell death.  The mode of cell death was studied by flow cytometry after double staining with annexin V and propidium iodide.  Catechol induced apoptosis after 72 h.  Furthermore, catechol also induced nuclear fragmentation.  These data showed that catechol-induced cytotoxicity to N2a cell was not directly a consequence of reactive oxygen species prodn.  Rather, it was due to GSH depletion followed by the induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqm4qQxCC7X7Vg90H21EOLACvtfcHk0liVFrjB9PdbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCit78%253D&md5=27a9a156fab210c77f5c2054c0bdcb8c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DR.%2BM.%2BF.%26aulast%3DAlvarez%26aufirst%3DL.%2BD.%2BG.%26aulast%3DCosta%26aufirst%3DM.%2BF.%2BD.%26aulast%3DCosta%26aufirst%3DS.%26aulast%3DClar%25C3%25AAncio%26aufirst%3DJ.%26aulast%3DEl-Bach%25C3%25A1%26aufirst%3DR.%2BS.%26atitle%3DCytotoxic%2520Effects%2520of%2520Catechol%2520to%2520Neuroblastoma%2520N2a%2520Cells%26jtitle%3DGen.%2520Physiol.%2520Biophys%26date%3D2008%26volume%3D27%26spage%3D306%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, W. L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vítor, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, M. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desá, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, L. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Rocha, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bachá, R. S.</span></span> <span> </span><span class="NLM_article-title">Redox Properties of Ruthenium Complex with Catechol Are Involved in Toxicity to Glial Cells</span>. <i>J. Chil. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1240</span>– <span class="NLM_lpage">1243</span>, <span class="refDoi"> DOI: 10.4067/S0717-97072007000300010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.4067%2FS0717-97072007000300010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSqtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1240-1243&author=W.+L.+C.+Almeidaauthor=D.+N.+V%C3%ADtorauthor=M.+R.+G.+Pereiraauthor=D.+S.+Des%C3%A1author=L.+D.+G.+Alvarezauthor=A.+M.+Pinheiroauthor=S.+L.+Costaauthor=M.+F.+D.+Costaauthor=Z.+N.+Da+Rochaauthor=R.+S.+El-Bach%C3%A1&title=Redox+Properties+of+Ruthenium+Complex+with+Catechol+Are+Involved+in+Toxicity+to+Glial+Cells&doi=10.4067%2FS0717-97072007000300010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Redox properties of ruthenium complex with catechol are involved in toxicity to glial cells</span></div><div class="casAuthors">Almeida, Wagner L. C.; Vitor, Daniela N.; Pereira, Marco R. G.; De Sa, Denise S.; Alvarez, Lisandro D. G.; Pinheiro, Alexandre M.; Costa, Silvia L.; Costa, Maria F. D.; Da Rocha, Zenis N.; El-Bacha, Ramon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chilean Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1240-1243</span>CODEN:
                <span class="NLM_cas:coden">JCCSCB</span>;
        ISSN:<span class="NLM_cas:issn">0717-9324</span>.
    
            (<span class="NLM_cas:orgname">Journal of the Chilean Chemical Society</span>)
        </div><div class="casAbstract">Since the biol. activity of [RuIII(NH3)4(catechol)]+ has never been tested, its cytotoxicity to glial cells was assayed and correlated with its redox properties.  Coordinated catechol oxidizes faster than catechol in the presence of oxygen, but controlled potential electrolysis showed that its oxidn. involves only one-electron.  However, the oxidn. of the free ligand by oxygen involves two electrons, which could generate more reactive oxygen species.  Indeed, catechol was more cytotoxic than [RuIII(NH3)4(catechol)]+ complex to human glioblastoma GL-15 cells and also to rat astrocytes.  [RuIII(NH3)4(catechol)]+-induced cytotoxicity was related to the generation of reactive oxygen species and [RuII(NH3)4(quinone)]2+.  However, other mechanisms should be involved since antioxidant enzymes and deferoxamine only partially protected GL-15 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_76dkR2goQrVg90H21EOLACvtfcHk0lguIxtvwiYDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSqtLbN&md5=eb0487a4a1a59941ca85f33b681a3164</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4067%2FS0717-97072007000300010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4067%252FS0717-97072007000300010%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DW.%2BL.%2BC.%26aulast%3DV%25C3%25ADtor%26aufirst%3DD.%2BN.%26aulast%3DPereira%26aufirst%3DM.%2BR.%2BG.%26aulast%3DDes%25C3%25A1%26aufirst%3DD.%2BS.%26aulast%3DAlvarez%26aufirst%3DL.%2BD.%2BG.%26aulast%3DPinheiro%26aufirst%3DA.%2BM.%26aulast%3DCosta%26aufirst%3DS.%2BL.%26aulast%3DCosta%26aufirst%3DM.%2BF.%2BD.%26aulast%3DDa%2BRocha%26aufirst%3DZ.%2BN.%26aulast%3DEl-Bach%25C3%25A1%26aufirst%3DR.%2BS.%26atitle%3DRedox%2520Properties%2520of%2520Ruthenium%2520Complex%2520with%2520Catechol%2520Are%2520Involved%2520in%2520Toxicity%2520to%2520Glial%2520Cells%26jtitle%3DJ.%2520Chil.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D52%26spage%3D1240%26epage%3D1243%26doi%3D10.4067%2FS0717-97072007000300010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span> <span> </span><span class="NLM_article-title">Toward an Understanding of the Role of a Catechol Moiety in Cancer Chemoprevention: The Case of Copper- and o-Quinone-Dependent Nrf2 Activation by a Catechol-Type Resveratrol Analog</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2395</span>– <span class="NLM_lpage">2406</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201500297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fmnfr.201500297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=26314862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=2395-2406&author=D.+Linauthor=F.+Daiauthor=L.-D.+Sunauthor=B.+Zhou&title=Toward+an+Understanding+of+the+Role+of+a+Catechol+Moiety+in+Cancer+Chemoprevention%3A+The+Case+of+Copper-+and+o-Quinone-Dependent+Nrf2+Activation+by+a+Catechol-Type+Resveratrol+Analog&doi=10.1002%2Fmnfr.201500297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog</span></div><div class="casAuthors">Lin, Dong; Dai, Fang; Sun, Lan-Di; Zhou, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2395-2406</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Scope : Catechol moieties are commonly present in dietary natural products that exert cancer chemopreventive activity.  While the oxidative conversion of catechols into their corresponding o-quinones is generally considered to contribute to their cancer chemopreventive effects, the mechanism of the intracellular conversion has not been fully elucidated.  Methods and results : Among resveratrol and its hydroxylated analogs examd., only 3,4-dihydroxy-trans-stilbene exerted cytoprotective effects against t-butylhydroperoxide-induced death of HepG2 cells.  This resveratrol analog activated the nuclear factor erythroid-2-related factor 2 (Nrf2) pathway through stimulating phosphorylation of Akt and inducing keap1 modification, thereby resulting in its nuclear translocation and subsequent transcriptional induction of phase II detoxifying enzymes.  Its cytoprotective effect through Nrf2 activation was largely abrogated by pretreatment of cells with DTT, a sulfhydryl-contg. nucleophile, and neocuproine, a specific chelating agent for copper ions.  Conclusion : We identified 3,4-dihydroxy-trans-stilbene as a novel Nrf2 activator that is converted intracellularly into its corresponding o-quinone electrophile by copper ions.  The copper-mediated oxidn. was required for the Nrf2 activation, subsequent transcriptional induction of phase II detoxifying enzymes and ultimately for cytoprotection.  The findings demonstrate a previously underrecognized role for intracellular copper ions in the cancer chemopreventive effects of catechol-contg. dietary natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD5oMLcomlnbVg90H21EOLACvtfcHk0lguIxtvwiYDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb%252FL&md5=f95d11ec79e6f4c3bb883bd1503e3b3b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201500297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201500297%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DD.%26aulast%3DDai%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DL.-D.%26aulast%3DZhou%26aufirst%3DB.%26atitle%3DToward%2520an%2520Understanding%2520of%2520the%2520Role%2520of%2520a%2520Catechol%2520Moiety%2520in%2520Cancer%2520Chemoprevention%253A%2520The%2520Case%2520of%2520Copper-%2520and%2520o-Quinone-Dependent%2520Nrf2%2520Activation%2520by%2520a%2520Catechol-Type%2520Resveratrol%2520Analog%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2015%26volume%3D59%26spage%3D2395%26epage%3D2406%26doi%3D10.1002%2Fmnfr.201500297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lima, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, A. B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana
da Silva, R.</span></span> <span> </span><span class="NLM_article-title">Antifungal Activity of Novel Catecholamine Ruthenium (III) Complexes</span>. <i>Transition Met. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1023/A:1022967403627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1023%2FA%3A1022967403627" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=272-275&author=R.+G.+de%0ALimaauthor=A.+B.+P.+Leverauthor=I.+Y.+Itoauthor=R.+Santana%0Ada+Silva&title=Antifungal+Activity+of+Novel+Catecholamine+Ruthenium+%28III%29+Complexes&doi=10.1023%2FA%3A1022967403627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022967403627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022967403627%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLima%26aufirst%3DR.%2BG.%26aulast%3DLever%26aufirst%3DA.%2BB.%2BP.%26aulast%3DIto%26aufirst%3DI.%2BY.%26aulast%3DSantana%2Bda%2BSilva%26aufirst%3DR.%26atitle%3DAntifungal%2520Activity%2520of%2520Novel%2520Catecholamine%2520Ruthenium%2520%2528III%2529%2520Complexes%26jtitle%3DTransition%2520Met.%2520Chem.%26date%3D2003%26volume%3D28%26spage%3D272%26epage%3D275%26doi%3D10.1023%2FA%3A1022967403627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huong, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanouchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimauchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umakoshi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuboi, R.</span></span> <span> </span><span class="NLM_article-title">Catechol Derivatives Inhibit the Fibril Formation of Amyloid-β Peptides</span>. <i>J. Biosci. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/j.jbiosc.2009.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jbiosc.2009.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=20471605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCktbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2010&pages=629-634&author=V.+T.+Huongauthor=T.+Shimanouchiauthor=N.+Shimauchiauthor=H.+Yagiauthor=H.+Umakoshiauthor=Y.+Gotoauthor=R.+Kuboi&title=Catechol+Derivatives+Inhibit+the+Fibril+Formation+of+Amyloid-%CE%B2+Peptides&doi=10.1016%2Fj.jbiosc.2009.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol derivatives inhibit the fibril formation of amyloid-β peptides</span></div><div class="casAuthors">Huong, Vu Thi; Shimanouchi, Toshinori; Shimauchi, Naoya; Yagi, Hisashi; Umakoshi, Hiroshi; Goto, Yuji; Kuboi, Ryoichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioscience and Bioengineering</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">629-634</span>CODEN:
                <span class="NLM_cas:coden">JBBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1389-1723</span>.
    
            (<span class="NLM_cas:orgname">Society for Biotechnology, Japan</span>)
        </div><div class="casAbstract">The inhibition of fibril formation of amyloid β proteins (Aβ) would be attractive therapeutic targets for the treatment of Alzheimer's disease (AD).  Dopamine (DA) and other catechol derivs. were used as inhibitory factors for Aβ fibril formation.  The fibril formation of Aβ was monitored by Thioflavin T fluorescence, a transmission electron microscopy (TEM) and a total internal reflection fluorescence microscopy (TIRFM).  Catechol and its derivs. showed the dose-dependent inhibitory effects on the spontaneous Aβ fibril formation.  The inhibitory activity depended on the chem. structure of catechol derivs. both in the presence and absence of the liposome a model of biomembrane.  Formation of catechol quinone-conjugated-Aβ adduct by a Schiff-base is a key step for the inhibition effect of Aβ fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu1GULN78jEbVg90H21EOLACvtfcHk0lguIxtvwiYDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCktbrO&md5=9a7ca59c2a561d580c6bef63316fb0aa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiosc.2009.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiosc.2009.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DHuong%26aufirst%3DV.%2BT.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DShimauchi%26aufirst%3DN.%26aulast%3DYagi%26aufirst%3DH.%26aulast%3DUmakoshi%26aufirst%3DH.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DKuboi%26aufirst%3DR.%26atitle%3DCatechol%2520Derivatives%2520Inhibit%2520the%2520Fibril%2520Formation%2520of%2520Amyloid-%25CE%25B2%2520Peptides%26jtitle%3DJ.%2520Biosci.%2520Bioeng.%26date%3D2010%26volume%3D109%26spage%3D629%26epage%3D634%26doi%3D10.1016%2Fj.jbiosc.2009.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehn, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petry, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glover, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijetunga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lay, P. A.</span></span> <span> </span><span class="NLM_article-title">Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(v) catecholate complexes</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6383</span>– <span class="NLM_lpage">6395</span>, <span class="refDoi"> DOI: 10.1039/C9DT00601J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC9DT00601J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30941380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvV2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=6383-6395&author=D.+C.+Cransauthor=J.+T.+Koehnauthor=S.+M.+Petryauthor=C.+M.+Gloverauthor=A.+Wijetungaauthor=R.+Kaurauthor=A.+Levinaauthor=P.+A.+Lay&title=Hydrophobicity+may+enhance+membrane+affinity+and+anti-cancer+effects+of+Schiff+base+vanadium%28v%29+catecholate+complexes&doi=10.1039%2FC9DT00601J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(V) catecholate complexes</span></div><div class="casAuthors">Crans, Debbie C.; Koehn, Jordan T.; Petry, Stephanie M.; Glover, Caleb M.; Wijetunga, Asanka; Kaur, Ravinder; Levina, Aviva; Lay, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6383-6395</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Anti-cancer activities of vanadium compds. have generated recent interest because of a combination of desirable properties for chemotherapy, i.e., strong cytotoxicities, anti-metastatic activities and relatively low systemic toxicities.  Certain hydrophobic vanadium(V) Schiff base/catecholate compds., which as shown herein, have increased stability in aq. media and affinity for membrane interfaces.  Depending on their hydrophobicity, they may be able to enter cells intact.  In this manuscript, two hydrophobic V(V) catecholate substituted analogs, [VO(Hshed)(cat)] and [VO(Hshed)(dtb)], (Hshed = N-(salicylideneaminato)-N'-(2-hydroxyethyl)-1,2-ethanediamine, cat = pyrocatechol, and dtb = 3,5-di(tert-butyl)catechol and the vanadium(V) precursor [V(O)2(Hshed)]) were synthesized for their ability to interact with membranes and their anti-cancer effects.  Using 51V and 1H NMR spectroscopy, the presence and location of the free ligand, H2shed, and the three V(V) complexes were examd. in a model membrane microemulsion system.  The stability of the three complexes was measured in aq. soln., cell media and an inhomogeneous microemulsion system.  The results demonstrated here that free ligand H2shed and the intact V(V) complexes assocd. with the interface but that the V-complexes hydrolyzed to some extent because oxovanadates were obsd. by 51V NMR spectroscopy and decreasing complex by absorption spectroscopy in cell media.  When detg. the effects of V(V) catecholate complexes on bone cancer cells, the strongest effects were obsd. with the more stable hydrophobic complex [VO(Hshed)(dtb)] that was able to best assoc. and penetrate the model membrane system intact.  These studies are consistent with the membrane permeability studies being a good predictor for in vitro cytotoxicity assays because [VO(Hshed)(dtb)] can pass through the cellular membrane intact, which may enhance its anti-cancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZU4YFJIVhBrVg90H21EOLACvtfcHk0lj3Mgb_InJ4-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvV2ht7g%253D&md5=3e8cd564f35ccbc769fcabae7c5d0a2c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1039%2FC9DT00601J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9DT00601J%26sid%3Dliteratum%253Aachs%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DKoehn%26aufirst%3DJ.%2BT.%26aulast%3DPetry%26aufirst%3DS.%2BM.%26aulast%3DGlover%26aufirst%3DC.%2BM.%26aulast%3DWijetunga%26aufirst%3DA.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DLevina%26aufirst%3DA.%26aulast%3DLay%26aufirst%3DP.%2BA.%26atitle%3DHydrophobicity%2520may%2520enhance%2520membrane%2520affinity%2520and%2520anti-cancer%2520effects%2520of%2520Schiff%2520base%2520vanadium%2528v%2529%2520catecholate%2520complexes%26jtitle%3DDalton%2520Trans.%26date%3D2019%26volume%3D48%26spage%3D6383%26epage%3D6395%26doi%3D10.1039%2FC9DT00601J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemons, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richens, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedgwick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. D.</span></span> <span> </span><span class="NLM_article-title">Stabilization of a Vanadium(V)–Catechol Complex by Compartmentalization and Reduced Solvation inside Reverse Micelles</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1039/C2NJ40524E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC2NJ40524E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVertL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2013&pages=75-91&author=B.+G.+Lemonsauthor=D.+T.+Richensauthor=A.+Andersonauthor=M.+Sedgwickauthor=D.+C.+Cransauthor=M.+D.+Johnson&title=Stabilization+of+a+Vanadium%28V%29%E2%80%93Catechol+Complex+by+Compartmentalization+and+Reduced+Solvation+inside+Reverse+Micelles&doi=10.1039%2FC2NJ40524E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of a vanadium(V)-catechol complex by compartmentalization and reduced solvation inside reverse micelles</span></div><div class="casAuthors">Lemons, Brant G.; Richens, David T.; Anderson, Ashley; Sedgwick, Myles; Crans, Debbie C.; Johnson, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">New Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">NJCHE5</span>;
        ISSN:<span class="NLM_cas:issn">1144-0546</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The kinetics of 1 : 1 complex formation and hydrolysis between catechol and 3-substituted catechols with aq. vanadium(V) at pH ∼ 1 have been investigated in NaAOT (sodium bis(2-ethylhexyl)sulfosuccinate) derived aq. reverse micelle microemulsions in isooctane.  Compared with the reaction in bulk water, the forward rate const. of catechol complexation was modestly accelerated (2 fold) in the reverse micelle microemulsions for even the smallest nanosized water pools (wo = 2).  In contrast, the first order reverse (aquation) reaction was significantly suppressed in the water pools below wo = 10.  The modest rate acceleration of complex formation within the microemulsions is attributed to changes in water solvation, reaction properties and compartmentalization of the reactants.  The dramatic fall off in the rate of catechol dissocn. from [VO2(cat)(OH2)2]- is attributed to the redn. in water content as the size of the nanopools is decreased below 200 water mols.  The result is a 10 fold increase in the kinetic formation const. for [VO2(cat)(OH2)2]- under confinement in the RM microemulsion environment.  This increase predicts that vanadium catechol complexes will be more stable in vivo and may suggest a general principle for fine-tuning efficacy of metal-based drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0fLj9WvafCrVg90H21EOLACvtfcHk0lj3Mgb_InJ4-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVertL7J&md5=652aaba8e042c4e76269c93e063c5b0a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1039%2FC2NJ40524E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2NJ40524E%26sid%3Dliteratum%253Aachs%26aulast%3DLemons%26aufirst%3DB.%2BG.%26aulast%3DRichens%26aufirst%3DD.%2BT.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DSedgwick%26aufirst%3DM.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26atitle%3DStabilization%2520of%2520a%2520Vanadium%2528V%2529%25E2%2580%2593Catechol%2520Complex%2520by%2520Compartmentalization%2520and%2520Reduced%2520Solvation%2520inside%2520Reverse%2520Micelles%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2013%26volume%3D37%26spage%3D75%26epage%3D91%26doi%3D10.1039%2FC2NJ40524E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brastos, I.</span>; <span class="NLM_string-name">Alessio, E.</span>; <span class="NLM_string-name">Ringenberg, M. E.</span>; <span class="NLM_string-name">Rauchfuss, T. B.</span></span> <span> </span><span class="NLM_article-title">Ruthenium Complexes</span>. In  <i>Inorganic Syntheses</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauchfuss, T. B.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Chichester</span>, <span class="NLM_year">2010</span>; Vol.  <span class="NLM_volume">35</span>, pp  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">163</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=148-163&author=I.+Brastos&author=E.+Alessio&author=M.+E.+Ringenberg&author=T.+B.+Rauchfussauthor=T.+B.+Rauchfuss&title=Inorganic+Syntheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrastos%26aufirst%3DI.%26atitle%3DRuthenium%2520Complexes%26btitle%3DInorganic%2520Syntheses%26aulast%3DRauchfuss%26aufirst%3DT.%2BB.%26pub%3DWiley%26date%3D2010%26volume%3D35%26spage%3D148%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caspar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waern, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyard-Duhayon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruselle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Floch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amouri, H.</span></span> <span> </span><span class="NLM_article-title">A New Family of Mono- and Dicarboxylic Ruthenium Complexes [Ru(DIP)<sub>2</sub>(L2)]<sup>2+</sup> (DIP = 4,7-Diphenyl-1,10-Phenanthroline): Synthesis, Solution Behavior, and X-Ray Molecular Structure of Trans -[Ru(DIP)<sub>2</sub>(MeOH)<sub>2</sub>][OTf]<sub>2</sub></span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4071</span>– <span class="NLM_lpage">4078</span>, <span class="refDoi"> DOI: 10.1021/ic0601236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic0601236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFWnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=4071-4078&author=R.+Casparauthor=C.+Cordierauthor=J.+B.+Waernauthor=C.+Guyard-Duhayonauthor=M.+Gruselleauthor=P.+Le+Flochauthor=H.+Amouri&title=A+New+Family+of+Mono-+and+Dicarboxylic+Ruthenium+Complexes+%5BRu%28DIP%292%28L2%29%5D2%2B+%28DIP+%3D+4%2C7-Diphenyl-1%2C10-Phenanthroline%29%3A+Synthesis%2C+Solution+Behavior%2C+and+X-Ray+Molecular+Structure+of+Trans+-%5BRu%28DIP%292%28MeOH%292%5D%5BOTf%5D2&doi=10.1021%2Fic0601236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A New Family of Mono- and Dicarboxylic Ruthenium Complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): Synthesis, Solution Behavior, and X-ray Molecular Structure of trans-[Ru(DIP)2(MeOH)2][OTf]2</span></div><div class="casAuthors">Caspar, Regis; Cordier, Christine; Waern, Jenny B.; Guyard-Duhayon, Carine; Gruselle, Michel; Le Floch, Pascal; Amouri, Hani</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4071-4078</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new family of Ru complexes [Ru(DIP)2(L2)]2+, where DIP = 4,7-diphenyl-1,10-phenanthroline, a bidentate ligand with an extended arom. system, was prepd. and fully characterized.  When L is a monodentate ligand, the following complexes were obtained: L = CF3SO3-1 (2), MeCN (3), and MeOH (4).  When L2 is a bidentate ligand, [Ru(DIP)2(Hcmbpy)][Cl]2 (5) and [Ru(DIP)2(H2dcbpy)][Cl]2 (6) were prepd. (Hcmbpy = 4-carboxy-4'-methyl-2,2-bipyridine, H2dcbpy = 4,4'-dicarboxy-2,2'-bipyridine).  [Ru(DIP)2(MeOH)2][OTf]2 (4) displayed a trans configuration of the DIP ligands, which is rare for octahedral complexes featuring DIP bidentate ligands.  DFT calcns. carried out on 4 showed that the cis isomer is more stable by 12.2 kcal/mol relative to the trans species.  The soln. behaviors of monocarboxylic complex [Ru(DIP)2(Hcmbpy)][Cl]2 (5) and dicarboxylic complex [Ru(DIP)2(H2dcbpy)][Cl]2 (6) were studied by 1H NMR spectroscopy.  VT-NMR, concn. dependence, and reaction with NaOD allowed the authors to suggest that aggregation of the cationic species in soln., esp. for 6, originates mainly from H bonding interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5q49bOX8ksrVg90H21EOLACvtfcHk0liZA6wKQjoMQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFWnt7c%253D&md5=cf9491f29e38d68d94e259f988488216</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fic0601236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic0601236%26sid%3Dliteratum%253Aachs%26aulast%3DCaspar%26aufirst%3DR.%26aulast%3DCordier%26aufirst%3DC.%26aulast%3DWaern%26aufirst%3DJ.%2BB.%26aulast%3DGuyard-Duhayon%26aufirst%3DC.%26aulast%3DGruselle%26aufirst%3DM.%26aulast%3DLe%2BFloch%26aufirst%3DP.%26aulast%3DAmouri%26aufirst%3DH.%26atitle%3DA%2520New%2520Family%2520of%2520Mono-%2520and%2520Dicarboxylic%2520Ruthenium%2520Complexes%2520%255BRu%2528DIP%25292%2528L2%2529%255D2%252B%2520%2528DIP%2520%253D%25204%252C7-Diphenyl-1%252C10-Phenanthroline%2529%253A%2520Synthesis%252C%2520Solution%2520Behavior%252C%2520and%2520X-Ray%2520Molecular%2520Structure%2520of%2520Trans%2520-%255BRu%2528DIP%25292%2528MeOH%25292%255D%255BOTf%255D2%26jtitle%3DInorg.%2520Chem.%26date%3D2006%26volume%3D45%26spage%3D4071%26epage%3D4078%26doi%3D10.1021%2Fic0601236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carugo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellani, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djinovicb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span> <span> </span><span class="NLM_article-title">Ligands Derived from O-Benzoquinone: Statistical Correlation between Oxidation State and Structural Features</span>. <i>J. Chem. Soc., Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">837</span>, <span class="refDoi"> DOI: 10.1039/dt9920000837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fdt9920000837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1992&pages=837&author=O.+Carugoauthor=C.+B.+Castellaniauthor=K.+Djinovicbauthor=M.+Rizzi&title=Ligands+Derived+from+O-Benzoquinone%3A+Statistical+Correlation+between+Oxidation+State+and+Structural+Features&doi=10.1039%2Fdt9920000837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2Fdt9920000837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fdt9920000837%26sid%3Dliteratum%253Aachs%26aulast%3DCarugo%26aufirst%3DO.%26aulast%3DCastellani%26aufirst%3DC.%2BB.%26aulast%3DDjinovicb%26aufirst%3DK.%26aulast%3DRizzi%26aufirst%3DM.%26atitle%3DLigands%2520Derived%2520from%2520O-Benzoquinone%253A%2520Statistical%2520Correlation%2520between%2520Oxidation%2520State%2520and%2520Structural%2520Features%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Dalton%2520Trans.%26date%3D1992%26volume%3D10%26spage%3D837%26doi%3D10.1039%2Fdt9920000837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, S. L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. J.</span></span> <span> </span><span class="NLM_article-title">Redox, Spectroscopic, and Photophysical Properties of Ru-Pt Mixed-Metal Complexes Incorporating 4,7-Diphenyl-1,10-Phenanthroline as Efficient DNA Binding and Photocleaving Agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1021/ic100958r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic100958r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=463-470&author=S.+L.+H.+Higginsauthor=T.+A.+Whiteauthor=B.+S.+J.+Winkelauthor=K.+J.+Brewer&title=Redox%2C+Spectroscopic%2C+and+Photophysical+Properties+of+Ru-Pt+Mixed-Metal+Complexes+Incorporating+4%2C7-Diphenyl-1%2C10-Phenanthroline+as+Efficient+DNA+Binding+and+Photocleaving+Agents&doi=10.1021%2Fic100958r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Redox, Spectroscopic, and Photophysical Properties of Ru-Pt Mixed-Metal Complexes Incorporating 4,7-Diphenyl-1,10-phenanthroline as Efficient DNA Binding and Photocleaving Agents</span></div><div class="casAuthors">Higgins, Samantha L. H.; White, Travis A.; Winkel, Brenda S. J.; Brewer, Karen J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The redox, spectroscopic, and photophys. properties as well as DNA interactions of the new bimetallic complexes [(Ph2phen)2Ru(BL)PtCl2]2+ (Ph2phen = 4,7-diphenyl-1,10-phenanthroline, and BL (bridging ligand) dpp = 2,3-bis(2-pyridyl)pyrazine, or dpq = 2,3-bis(2-pyridyl)quinoxaline) were investigated.  These Ru-polyazine chromophores with Ph2phen TLs (terminal ligands) and polyazine BLs are efficient light absorbers.  The [(Ph2phen)2Ru(BL)PtCl2]2+ complexes display reversible RuII/III oxidns. at 1.57 (dpp) and 1.58 (dpq) V vs. SCE with an irreversible PtII/IV oxidn. occurring prior at 1.47 V vs. SCE.  Four, reversible ligand redns. occur at -0.50 dpp0/-, -1.06 dpp-/2-, -1.37 Ph2phen0/-, and -1.56 V vs. SCE Ph2phen0/-.  For the [(Ph2phen)2Ru(dpq)PtCl2]2+ complex, the first two redns. shift to more pos. potentials at -0.23 and -0.96 V vs. SCE.  The electronic absorption spectroscopy is dominated in the UV region by π→π* ligand transitions and in the visible region by metal-to-ligand charge transfer (MLCT) transitions at 517 nm for [(Ph2phen)2Ru(dpp)PtCl2]2+ and 600 nm for [(Ph2phen)2Ru(dpq)PtCl2]2+.  Emission spectroscopy shows that upon attaching Pt to the Ru monometallic precursor the λmaxem shifts from 664 nm for [(Ph2phen)2Ru(dpp)]2+ to 740 nm for [(Ph2phen)2Ru(dpp)PtCl2]2+.  The cis-PtIICl2 bioactive site offers the potential of targeting DNA by covalently binding the mixed-metal complex to DNA bases.  The multifunctional interactions with DNA were assayed using both linear and circular plasmid pUC18 DNA gel shift assays.  Both title complexes can bind to and photocleave DNA with dramatically enhanced efficiency relative to previously reported systems.  The impact of the Ph2phen TL on photophysics and bioreactivity is somewhat surprising given the Ru→BL charge transfer (CT) nature of the photoreactive state in the complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3qKniILId7Vg90H21EOLACvtfcHk0liZA6wKQjoMQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt77F&md5=5a2cd38d01d9df412faf06eb2568bd36</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fic100958r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic100958r%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DS.%2BL.%2BH.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DWinkel%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DBrewer%26aufirst%3DK.%2BJ.%26atitle%3DRedox%252C%2520Spectroscopic%252C%2520and%2520Photophysical%2520Properties%2520of%2520Ru-Pt%2520Mixed-Metal%2520Complexes%2520Incorporating%25204%252C7-Diphenyl-1%252C10-Phenanthroline%2520as%2520Efficient%2520DNA%2520Binding%2520and%2520Photocleaving%2520Agents%26jtitle%3DInorg.%2520Chem.%26date%3D2011%26volume%3D50%26spage%3D463%26epage%3D470%26doi%3D10.1021%2Fic100958r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mongelli, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Study of the Light Absorbing, Redox and Photophysical Properties of Ru(II) and Os(II) Complexes of 4,7-Diphenyl-1,10-Phenanthroline Containing the Polyazine Bridging Ligand 2,3-Bis(2-Pyridyl)Pyrazine</span>. <i>Inorg. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1016/j.inoche.2006.04.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.inoche.2006.04.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=877-881&author=M.+T.+Mongelliauthor=K.+J.+Brewer&title=Synthesis+and+Study+of+the+Light+Absorbing%2C+Redox+and+Photophysical+Properties+of+Ru%28II%29+and+Os%28II%29+Complexes+of+4%2C7-Diphenyl-1%2C10-Phenanthroline+Containing+the+Polyazine+Bridging+Ligand+2%2C3-Bis%282-Pyridyl%29Pyrazine&doi=10.1016%2Fj.inoche.2006.04.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and study of the light absorbing, redox and photophysical properties of Ru(II) and Os(II) complexes of 4,7-diphenyl-1,10-phenanthroline containing the polyazine bridging ligand 2,3-bis(2-pyridyl)pyrazine</span></div><div class="casAuthors">Mongelli, Matthew T.; Brewer, Karen J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">877-881</span>CODEN:
                <span class="NLM_cas:coden">ICCOFP</span>;
        ISSN:<span class="NLM_cas:issn">1387-7003</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monometallic light absorbing complexes [(Ph2phen)2M(dpp)]2+ (M = Os(II) or Ru(II), Ph2phen = 4,7-diphenyl-1,10-phenanthroline, dpp = 2,3-bis(2-pyridyl)pyrazine) were synthesized.  The coupling of Ph2phen to Ru and Os complexes with polyazine bridging ligands will allow for the incorporation of these chromophores into supramol. assemblies.  The spectroscopic, redox and photochem. properties were studied.  The complexes exhibit overlapping 1MLCT (metal-to-ligand charge transfer) transitions in their electronic absorbance spectroscopy with lowest energy peaks at 444 nm and 494 nm for [(Ph2phen)2Ru(dpp)]2+ and [(Ph2phen)2Os(dpp)]2+, resp.  An intense 3MLCT absorption for the Os complex centered at ∼650 nm is also obsd.  The redox properties show significantly different reversible one electron metal oxidns., E0x1/2 = 1.39 V and 1.02 V vs. Ag/AgCl for the Ru and Os complexes, resp.  Each complex displays three reversible redns. based on each polyazine ligand.  The photophys. properties show strong 3MLCT emissions centered at 697 and 800 nm for the Ru and Os complexes, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonJl_DVCrPBbVg90H21EOLACvtfcHk0liZA6wKQjoMQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrtrc%253D&md5=1f58312ff9178e73260b2459bd9ce6c7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.inoche.2006.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.inoche.2006.04.022%26sid%3Dliteratum%253Aachs%26aulast%3DMongelli%26aufirst%3DM.%2BT.%26aulast%3DBrewer%26aufirst%3DK.%2BJ.%26atitle%3DSynthesis%2520and%2520Study%2520of%2520the%2520Light%2520Absorbing%252C%2520Redox%2520and%2520Photophysical%2520Properties%2520of%2520Ru%2528II%2529%2520and%2520Os%2528II%2529%2520Complexes%2520of%25204%252C7-Diphenyl-1%252C10-Phenanthroline%2520Containing%2520the%2520Polyazine%2520Bridging%2520Ligand%25202%252C3-Bis%25282-Pyridyl%2529Pyrazine%26jtitle%3DInorg.%2520Chem.%2520Commun.%26date%3D2006%26volume%3D9%26spage%3D877%26epage%3D881%26doi%3D10.1016%2Fj.inoche.2006.04.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medhi, O. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwala, U.</span></span> <span> </span><span class="NLM_article-title">Electron Spin Resonance Studies of Some Ruthenium(III) Complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1384</span>, <span class="refDoi"> DOI: 10.1021/ic50207a055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic50207a055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL3cXitVKmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=1381-1384&author=O.+K.+Medhiauthor=U.+Agarwala&title=Electron+Spin+Resonance+Studies+of+Some+Ruthenium%28III%29+Complexes&doi=10.1021%2Fic50207a055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Electron spin resonance studies of some ruthenium(III) complexes</span></div><div class="casAuthors">Medhi, O. K.; Agarwala, U.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1381-4</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">An ESR study was carried out on a no. of low-spin Ru(III) complexes contg. Ph3As, Ph3P, and β-diketonate ligands.  Their geometries, ground states, and other spectral parameters were obtained by using the ligand field theory for low-spin d5 systems.  The results show a large axial distortion and a 2B(or 2A) ground term for these complexes.  The low-symmetry ligand field component is larger than the spin-orbit coupling const.  There may be 2 contributing factors for the large axial distortion: (1) a geometric factor; and (2) anisotropy in the covalent bonding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9FVHFvxZBr7Vg90H21EOLACvtfcHk0ljHRG-ypKuyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXitVKmtbg%253D&md5=c8c5b53623a8ffc8a3e657017439a8fe</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fic50207a055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic50207a055%26sid%3Dliteratum%253Aachs%26aulast%3DMedhi%26aufirst%3DO.%2BK.%26aulast%3DAgarwala%26aufirst%3DU.%26atitle%3DElectron%2520Spin%2520Resonance%2520Studies%2520of%2520Some%2520Ruthenium%2528III%2529%2520Complexes%26jtitle%3DInorg.%2520Chem.%26date%3D1980%26volume%3D19%26spage%3D1381%26epage%3D1384%26doi%3D10.1021%2Fic50207a055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, W. E.</span></span> <span> </span><span class="NLM_article-title">Chemical Redox Agents for Organometallic Chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">910</span>, <span class="refDoi"> DOI: 10.1021/cr940053x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr940053x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK28XhsVGhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=877-910&author=N.+G.+Connellyauthor=W.+E.+Geiger&title=Chemical+Redox+Agents+for+Organometallic+Chemistry&doi=10.1021%2Fcr940053x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Redox Agents for Organometallic Chemistry</span></div><div class="casAuthors">Connelly, Neil G.; Geiger, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-910</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with >461 refs., showing how one-electron oxidants and reductants have been used in preparative chem. (incorporating both synthetic applications and generation of species for in situ characterization) in nonaq. solns., the usual media for organometallic ET reactions.  The authors do not treat photochem.-generated reducing agents which, although generally transient species, may have advantages in some applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgEDXkQMqzxLVg90H21EOLACvtfcHk0ljHRG-ypKuyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVGhu7Y%253D&md5=205b204d99818aded3c41067d4bf85e3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcr940053x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr940053x%26sid%3Dliteratum%253Aachs%26aulast%3DConnelly%26aufirst%3DN.%2BG.%26aulast%3DGeiger%26aufirst%3DW.%2BE.%26atitle%3DChemical%2520Redox%2520Agents%2520for%2520Organometallic%2520Chemistry%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D877%26epage%3D910%26doi%3D10.1021%2Fcr940053x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyer, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerasimenko, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullev, V. I.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Oxidation of Ferrocene: A Strong Dependence on the Concentration of the Supporting Electrolyte for Nonpolar Solvents</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1021/jp809105f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp809105f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1259-1267&author=D.+Baoauthor=B.+Millareauthor=W.+Xiaauthor=B.+G.+Steyerauthor=A.+A.+Gerasimenkoauthor=A.+Ferreiraauthor=A.+Contrerasauthor=V.+I.+Vullev&title=Electrochemical+Oxidation+of+Ferrocene%3A+A+Strong+Dependence+on+the+Concentration+of+the+Supporting+Electrolyte+for+Nonpolar+Solvents&doi=10.1021%2Fjp809105f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical Oxidation of Ferrocene: A Strong Dependence on the Concentration of the Supporting Electrolyte for Nonpolar Solvents</span></div><div class="casAuthors">Bao, Duoduo; Millare, Brent; Xia, Wei; Steyer, Benjamin G.; Gerasimenko, Alexander A.; Ferreira, Amy; Contreras, Antonio; Vullev, Valentine I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1259-1267</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The estn. of the driving force for photoinduced charge-transfer processes, using the Rehm-Weller equation, requires the employment of redox and spectroscopic quantities describing the participating electron donor and acceptor.  Although the spectroscopic data are usually obtained from dild. solns., the redox potentials are most frequently obtained from electrochem. measurements conducted in concd. electrolyte solns.  To correct for the differences in the media, in which the various types of measurements are conducted, a term, based on the Born equation for solvation energy of ions, is introduced in the Rehm-Weller equation.  The Born correction term, however, requires a prior knowledge of the dielec. consts. of the electrolyte solns. used for the redox measurements.  Because of limited information for such dielecs., the values for the dielec. consts. of electrolyte solns. are approximated to the values of the dielec. consts. of the corresponding neat solvents.  The authors examd. the validity of this approxn.  Using cyclic voltammetry, the authors recorded the 1st 1-electron oxidn. potential of ferrocene for 3 different solvents in the presence of 1-500 mM supporting electrolyte.  The dielec. consts. for some of the electrolyte solns. were extd. from fluorescence measurements of a dimethylaminonaphthalimide chromophore that exhibits pronounced solvatochromism.  The dielec. consts. of the concd. electrolyte solns. correlated well with the corresponding oxidn. potentials.  The dependence of the oxidn. potential of ferrocene on the electrolyte concn. for different solvents revealed that the abovementioned approxn. in the Born correction term indeed introduces a significant error in the estn. of the charge-transfer driving force from redox data collected using relatively nonpolar solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTEUH9F5-rs7Vg90H21EOLACvtfcHk0ljHRG-ypKuyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlOgtw%253D%253D&md5=45127d9df45b0419f247fa541f9ab6b4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjp809105f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp809105f%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DD.%26aulast%3DMillare%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DSteyer%26aufirst%3DB.%2BG.%26aulast%3DGerasimenko%26aufirst%3DA.%2BA.%26aulast%3DFerreira%26aufirst%3DA.%26aulast%3DContreras%26aufirst%3DA.%26aulast%3DVullev%26aufirst%3DV.%2BI.%26atitle%3DElectrochemical%2520Oxidation%2520of%2520Ferrocene%253A%2520A%2520Strong%2520Dependence%2520on%2520the%2520Concentration%2520of%2520the%2520Supporting%2520Electrolyte%2520for%2520Nonpolar%2520Solvents%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2009%26volume%3D113%26spage%3D1259%26epage%3D1267%26doi%3D10.1021%2Fjp809105f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbiani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubafard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstaett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felgenträger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiccia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Characterization, and Biological Evaluation of New Ru(II) Polypyridyl Photosensitizers for Photodynamic Therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7280</span>– <span class="NLM_lpage">7292</span>, <span class="refDoi"> DOI: 10.1021/jm500566f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500566f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7280-7292&author=A.+Freiauthor=R.+Rubbianiauthor=S.+Tubafardauthor=O.+Blacqueauthor=P.+Anstaettauthor=A.+Felgentr%C3%A4gerauthor=T.+Maischauthor=L.+Spicciaauthor=G.+Gasser&title=Synthesis%2C+Characterization%2C+and+Biological+Evaluation+of+New+Ru%28II%29+Polypyridyl+Photosensitizers+for+Photodynamic+Therapy&doi=10.1021%2Fjm500566f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Biological Evaluation of New Ru(II) Polypyridyl Photosensitizers for Photodynamic Therapy</span></div><div class="casAuthors">Frei, Angelo; Rubbiani, Riccardo; Tubafard, Solmaz; Blacque, Olivier; Anstaett, Philipp; Felgentrager, Ariane; Maisch, Tim; Spiccia, Leone; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7280-7292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two Ru(II) polypyridyl complexes, Ru(DIP)2(bdt) (1) and [Ru(dqpCO2Me)(ptpy)]2+ (2) (DIP = 4,7-diphenyl-1,10-phenanthroline, bdt = 1,2-benzenedithiolate, dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2''-terpyridine) have been investigated as photosensitizers (PSs) for photodynamic therapy (PDT).  In our exptl. settings, the phototoxicity and phototoxic index (PI) of 2 (IC50(light): 25.3 μM, 420 nm, 6.95 J/cm2; PI >4) and particularly of 1 (IC50(light): 0.62 μM, 420 nm, 6.95 J/cm2; PI: 80) are considerably superior compared to the two clin. approved PSs porfimer sodium and 5-aminolevulinic acid.  Cellular uptake and distribution of these complexes was investigated by confocal microscopy (1) and by inductively coupled plasma mass spectrometry (1 and 2).  Their phototoxicity was also detd. against the Gram-(+) Staphylococcus aureus and Gram-(-) Escherichia coli for potential antimicrobial PDT (aPDT) applications.  Both complexes showed significant aPDT activity (420 nm, 8 J/cm2) against Gram-(+) (S. aureus; >6 log10 CFU redn.) and, for 2, also against Gram-(-) E. coli (>4 log10 CFU redn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QENinj0EILVg90H21EOLACvtfcHk0liMLX7Mrme69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M&md5=95f232e052cf5ad756557e861e9086e5</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm500566f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500566f%26sid%3Dliteratum%253Aachs%26aulast%3DFrei%26aufirst%3DA.%26aulast%3DRubbiani%26aufirst%3DR.%26aulast%3DTubafard%26aufirst%3DS.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DAnstaett%26aufirst%3DP.%26aulast%3DFelgentr%25C3%25A4ger%26aufirst%3DA.%26aulast%3DMaisch%26aufirst%3DT.%26aulast%3DSpiccia%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520Characterization%252C%2520and%2520Biological%2520Evaluation%2520of%2520New%2520Ru%2528II%2529%2520Polypyridyl%2520Photosensitizers%2520for%2520Photodynamic%2520Therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7280%26epage%3D7292%26doi%3D10.1021%2Fjm500566f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cepeda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuertes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castilla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J.</span></span> <span> </span><span class="NLM_article-title">Biochemical Mechanisms of Cisplatin Cytotoxicity</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.2174/187152007779314044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2174%2F187152007779314044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17266502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlyktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=3-18&author=V.+Cepedaauthor=M.+Fuertesauthor=J.+Castillaauthor=C.+Alonsoauthor=C.+Quevedoauthor=J.+Perez&title=Biochemical+Mechanisms+of+Cisplatin+Cytotoxicity&doi=10.2174%2F187152007779314044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical mechanisms of cisplatin cytotoxicity</span></div><div class="casAuthors">Cepeda, Victoria; Fuertes, Miguel A.; Castilla, Josefina; Alonso, Carlos; Quevedo, Celia; Perez, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-18</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery by Rosenberg and collaborators of the antitumor activity of cisplatin 35 years ago, 3 platinum antitumor drugs (cisplatin, carboplatin, and oxaliplatin) have enjoyed a huge clin. and com. hit.  Ever since the initial discovery of the anticancer activity of cisplatin, major efforts were devoted to elucidate the biochem. mechanisms of antitumor activity of cisplatin to be able to rationally design novel Pt based drugs with superior pharmacol. profiles.  In this report we attempt to provide a current picture of the known facts pertaining to the mechanism of action of the drug, including those involved in drug uptake, DNA damage signals transduction, and cell death through apoptosis or necrosis.  A deep knowledge of the biochem. mechanisms, which are triggered in the tumor cell in response to cisplatin injury not only may lead to the design of more efficient Pt antitumor drugs but also may provide new therapeutic strategies based on the biochem. modulation of cisplatin activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP_AAU2HTQbbVg90H21EOLACvtfcHk0liMLX7Mrme69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlyktL8%253D&md5=af25f14b9970e88e255c14b03028f294</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2174%2F187152007779314044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152007779314044%26sid%3Dliteratum%253Aachs%26aulast%3DCepeda%26aufirst%3DV.%26aulast%3DFuertes%26aufirst%3DM.%26aulast%3DCastilla%26aufirst%3DJ.%26aulast%3DAlonso%26aufirst%3DC.%26aulast%3DQuevedo%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DJ.%26atitle%3DBiochemical%2520Mechanisms%2520of%2520Cisplatin%2520Cytotoxicity%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D3%26epage%3D18%26doi%3D10.2174%2F187152007779314044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keizer, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinedo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuurhuis, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joenje, H.</span></span> <span> </span><span class="NLM_article-title">Doxorubicin (Adriamycin): A Critical Review of Free Radical-Dependent Mechanisms of Cyototoxicity</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(90)90088-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2F0163-7258%2890%2990088-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=2203071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=219-231&author=H.+G.+Keizerauthor=H.+M.+Pinedoauthor=G.+J.+Schuurhuisauthor=H.+Joenje&title=Doxorubicin+%28Adriamycin%29%3A+A+Critical+Review+of+Free+Radical-Dependent+Mechanisms+of+Cyototoxicity&doi=10.1016%2F0163-7258%2890%2990088-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin (adriamycin):  a critical review of free radical-dependent mechanisms of cytotoxicity</span></div><div class="casAuthors">Keizer, H. G.; Pinedo, H. M.; Schuurhuis, G. J.; Joenje, H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-31</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼130 refs.  The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered crit. for its antitumor action.  However, for most tumor cell lines, this mechanism of cytotoxicity does not appear to play a major role.  Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh7SgS1hAtL7Vg90H21EOLACvtfcHk0liMLX7Mrme69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D&md5=4dd568ea3172c73030b58b6822f9477f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2890%2990088-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252890%252990088-J%26sid%3Dliteratum%253Aachs%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DSchuurhuis%26aufirst%3DG.%2BJ.%26aulast%3DJoenje%26aufirst%3DH.%26atitle%3DDoxorubicin%2520%2528Adriamycin%2529%253A%2520A%2520Critical%2520Review%2520of%2520Free%2520Radical-Dependent%2520Mechanisms%2520of%2520Cyototoxicity%26jtitle%3DPharmacol.%2520Ther.%26date%3D1990%26volume%3D47%26spage%3D219%26epage%3D231%26doi%3D10.1016%2F0163-7258%2890%2990088-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelm, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fussenegger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L. K.</span></span> <span> </span><span class="NLM_article-title">Multicellular Tumor Spheroids Applicable to a Wide Variety of Cell Types</span>. <i>Biotechnol. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1002/bit.10655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fbit.10655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=12768623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslaitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2003&pages=173-180&author=J.+M.+Kelmauthor=N.+E.+Timminsauthor=C.+J.+Brownauthor=M.+Fusseneggerauthor=L.+K.+Nielsen&title=Multicellular+Tumor+Spheroids+Applicable+to+a+Wide+Variety+of+Cell+Types&doi=10.1002%2Fbit.10655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types</span></div><div class="casAuthors">Kelm, Jens M.; Timmins, Nicholas E.; Brown, Catherine J.; Fussenegger, Martin; Nielsen, Lars K.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology and Bioengineering</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-180</span>CODEN:
                <span class="NLM_cas:coden">BIBIAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3592</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Multicellular tumor spheroids (MCTS) are used as organotypic models of normal and solid tumor tissue.  Traditional techniques for generating MCTS, such as growth on nonadherent surfaces, in suspension, or on scaffolds, have a no. of drawbacks, including the need for manual selection to achieve a homogeneous population and the use of nonphysiol. matrix compds.  In this study the authors describe a mild method for the generation of MCTS, in which individual spheroids form in hanging drops suspended from a microtiter plate.  The method was successfully applied to a broad range of cell lines and shows nearly 100% efficiency (i.e., one spheroid per drop).  Using the hepatoma cell line, HepG2, the hanging drop method generated well-rounded MCTS with a narrow size distribution (coeff. of variation [CV] 10% to 15%, compared with 40% to 60% for growth on nonadherent surfaces).  Structural anal. of HepG2 and a mammary gland adenocarcinoma cell line, MCF-7, composed spheroids, revealed highly organized, 3-dimensional, tissue-like structures with an extensive extracellular matrix.  The hanging drop method represents an attractive for MCTS prodn., because it is mild, can be applied to a wide variety of cell lines, and can produce spheroids of a homogeneous size without the need for sieving or manual selection.  The method has applications for basic studies of physiol. and metab., tumor biol., toxicol., cellular organization, and the development of bioartificial tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfiddBoeMx_bVg90H21EOLACvtfcHk0liMLX7Mrme69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslaitbk%253D&md5=1277f55c4fcec36c0fe94ee1f8245cac</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fbit.10655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbit.10655%26sid%3Dliteratum%253Aachs%26aulast%3DKelm%26aufirst%3DJ.%2BM.%26aulast%3DTimmins%26aufirst%3DN.%2BE.%26aulast%3DBrown%26aufirst%3DC.%2BJ.%26aulast%3DFussenegger%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DL.%2BK.%26atitle%3DMulticellular%2520Tumor%2520Spheroids%2520Applicable%2520to%2520a%2520Wide%2520Variety%2520of%2520Cell%2520Types%26jtitle%3DBiotechnol.%2520Bioeng.%26date%3D2003%26volume%3D83%26spage%3D173%26epage%3D180%26doi%3D10.1002%2Fbit.10655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomshine, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.-J.</span></span> <span> </span><span class="NLM_article-title">Multicellular Tumor Spheroids as an In Vivo-Like Tumor Model for Three-Dimensional Imaging of Chemotherapeutic and Nano Material Cellular Penetration</span>. <i>Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.2310/7290.2012.00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2310%2F7290.2012.00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23084249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVel" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=487-498&author=H.-l.+Maauthor=Q.+Jiangauthor=S.+Hanauthor=Y.+Wuauthor=J.+C.+Tomshineauthor=D.+Wangauthor=Y.+Ganauthor=G.+Zouauthor=X.-J.+Liang&title=Multicellular+Tumor+Spheroids+as+an+In+Vivo-Like+Tumor+Model+for+Three-Dimensional+Imaging+of+Chemotherapeutic+and+Nano+Material+Cellular+Penetration&doi=10.2310%2F7290.2012.00012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration</span></div><div class="casAuthors">Ma, Hui-li; Jiang, Qiao; Han, Siyuan; Wu, Yan; Tomshine, Jin Cui; Wang, Dongliang; Gan, Yaling; Zou, Guozhang; Liang, Xing-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">487-498</span>CODEN:
                <span class="NLM_cas:coden">MIOMBP</span>;
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    
            (<span class="NLM_cas:orgname">Decker Publishing</span>)
        </div><div class="casAbstract">A flexible and highly reproducible method was developed using three-dimensional (3D) multicellular tumor spheroids to quantify chemotherapeutic and nanoparticle penetration properties in vitro.  Generated was HeLa cell-derived spheroids using the liq. overlay method.  To properly characterize HeLa spheroids, SEM, transmission electron microscopy, and multiphoton microscopy were used to obtain high-resoln. 3D images of HeLa spheroids.  Next, pairing high-resoln. optical characterization techniques with flow cytometry, we quant. compared the penetration of doxorubicin, quantum dots, and synthetic micelles into 3D HeLa spheroid vs. HeLa cells grown in a traditional two-dimensional culturing system.  The 3D cultured HeLa cells acquired several clin. relevant morpol. and cellular characteristics (such as resistance to chemotherapeutics) often found in human solid tumors.  These characteristic, however, could not be captured using conventional two-dimensional cell culture techniques.  This study demonstrated the remarkable versatility of HeLa spheroid 3D imaging.  In addn., the results revealed the capability of HeLa spheroids to function as a screening tool for nanoparticles or synthetic micelles that, due to their inherent size, charge, and hydrophobicity, can penetrate into solid tumors and act as delivery vehicles for chemotherapeutics.  The development of this image-based, reproducible, and quantifiable in vitro HeLa spheroid screening tool will greatly aid future exploration of chemotherapeutics and nanoparticle delivery into solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8UaDBbDeBLVg90H21EOLACvtfcHk0lhwZWRPL6HnMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVel&md5=fca14f9809f9f403cad39c1440e0afee</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.2310%2F7290.2012.00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2310%252F7290.2012.00012%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.-l.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DTomshine%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DGan%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DX.-J.%26atitle%3DMulticellular%2520Tumor%2520Spheroids%2520as%2520an%2520In%2520Vivo-Like%2520Tumor%2520Model%2520for%2520Three-Dimensional%2520Imaging%2520of%2520Chemotherapeutic%2520and%2520Nano%2520Material%2520Cellular%2520Penetration%26jtitle%3DMol.%2520Imaging%26date%3D2012%26volume%3D11%26spage%3D487%26epage%3D498%26doi%3D10.2310%2F7290.2012.00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapałczyńska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolenda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybyła, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zajączkowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teresiak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliźniak, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">State of the Art Paper 2D and 3D Cell Cultures – a Comparison of Different Types of Cancer Cell Cultures</span>. <i>Arch. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">910</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.5114/aoms.2016.63743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.5114%2Faoms.2016.63743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30002710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fns1GnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=910-919&author=M.+Kapa%C5%82czy%C5%84skaauthor=T.+Kolendaauthor=W.+Przyby%C5%82aauthor=M.+Zaj%C4%85czkowskaauthor=A.+Teresiakauthor=V.+Filasauthor=M.+Ibbsauthor=R.+Bli%C5%BAniak&title=State+of+the+Art+Paper+2D+and+3D+Cell+Cultures+%E2%80%93+a+Comparison+of+Different+Types+of+Cancer+Cell+Cultures&doi=10.5114%2Faoms.2016.63743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">2D and 3D cell cultures - a comparison of different types of cancer cell cultures</span></div><div class="casAuthors">Kapalczynska Marta; Kolenda Tomasz; Przybyla Weronika; ZajAczkowska Maria; Teresiak Anna; Blizniak Renata; Lamperska Katarzyna; Kolenda Tomasz; Filas Violetta; Ibbs Matthew; Luczewski Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Archives of medical science : AMS</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">910-919</span>
        ISSN:<span class="NLM_cas:issn">1734-1922</span>.
    </div><div class="casAbstract">Cell culture is a widely used in vitro tool for improving our understanding of cell biology, tissue morphology, and mechanisms of diseases, drug action, protein production and the development of tissue engineering.  Most research regarding cancer biology is based on experiments using two-dimensional (2D) cell cultures in vitro.  However, 2D cultures have many limitations, such as the disturbance of interactions between the cellular and extracellular environments, changes in cell morphology, polarity, and method of division.  These disadvantages led to the creation of models which are more closely able to mimic conditions in vivo.  One such method is three-dimensional culture (3D).  Optimisation of the culture conditions may allow for a better understanding of cancer biology and facilitate the study of biomarkers and targeting therapies.  In this review, we compare 2D and 3D cultures in vitro as well as different versions of 3D cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgPZJo90OQZ9bHMBt0mMIXfW6udTcc2eZ1tBPrnSdGsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fns1GnsQ%253D%253D&md5=b8314bcbb043ebe5b611bb12107584ed</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.5114%2Faoms.2016.63743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5114%252Faoms.2016.63743%26sid%3Dliteratum%253Aachs%26aulast%3DKapa%25C5%2582czy%25C5%2584ska%26aufirst%3DM.%26aulast%3DKolenda%26aufirst%3DT.%26aulast%3DPrzyby%25C5%2582a%26aufirst%3DW.%26aulast%3DZaj%25C4%2585czkowska%26aufirst%3DM.%26aulast%3DTeresiak%26aufirst%3DA.%26aulast%3DFilas%26aufirst%3DV.%26aulast%3DIbbs%26aufirst%3DM.%26aulast%3DBli%25C5%25BAniak%26aufirst%3DR.%26atitle%3DState%2520of%2520the%2520Art%2520Paper%25202D%2520and%25203D%2520Cell%2520Cultures%2520%25E2%2580%2593%2520a%2520Comparison%2520of%2520Different%2520Types%2520of%2520Cancer%2520Cell%2520Cultures%26jtitle%3DArch.%2520Med.%2520Sci.%26date%3D2018%26volume%3D14%26spage%3D910%26epage%3D919%26doi%3D10.5114%2Faoms.2016.63743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz-Schughart, L. A.</span></span> <span> </span><span class="NLM_article-title">Spheroid-Based Drug Screen: Considerations and Practical Approach</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2Fnprot.2008.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=19214182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslymtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=309-324&author=J.+Friedrichauthor=C.+Seidelauthor=R.+Ebnerauthor=L.+A.+Kunz-Schughart&title=Spheroid-Based+Drug+Screen%3A+Considerations+and+Practical+Approach&doi=10.1038%2Fnprot.2008.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Spheroid-based drug screen: considerations and practical approach</span></div><div class="casAuthors">Friedrich, Juergen; Seidel, Claudia; Ebner, Reinhard; Kunz-Schughart, Leoni A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-324</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although used in academic research for several decades, 3D culture models have long been regarded expensive, cumbersome and unnecessary in drug development processes.  Tech. advances, coupled with recent observations showing that gene expression in 3D is much closer to clin. expression profiles than those seen in 2D, have renewed attention and generated hope in the feasibility of maturing organotypic 3D systems to therapy test platforms with greater power to predict clin. efficacies.  Here we describe a standardized setup for reproducible, easy-handling culture, treatment and routine anal. of multicellular spheroids, the classical 3D culture system resembling many aspects of the pathophysiol. situation in human tumor tissue.  We discuss essential conceptual and practical considerations for an adequate establishment and use of spheroid-based drug screening platforms and also provide a list of human carcinoma cell lines, partly on the basis of the NCI-DTP 60-cell line screen, that produce treatable spheroids under identical culture conditions.  In contrast to many other settings with which to achieve similar results, the protocol is particularly useful to be integrated into standardized large-scale drug test routines as it requires a min. no. of defined spheroids and a limited amt. of drug.  The estd. time to run the complete screening protocol described herein, including spheroid initiation, drug treatment and detn. of the anal. end points (spheroid integrity, and cell survival through the acid phosphatase assay), is about 170 h.  Monitoring of spheroid growth kinetics to det. growth delay and regrowth, resp., after drug treatment requires long-term culturing (≥ 14 d).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvr2BggrU09LVg90H21EOLACvtfcHk0lgfRXuXEC1oqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslymtL8%253D&md5=9da11d166be494083e674206cbb4ee05</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.226%26sid%3Dliteratum%253Aachs%26aulast%3DFriedrich%26aufirst%3DJ.%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DEbner%26aufirst%3DR.%26aulast%3DKunz-Schughart%26aufirst%3DL.%2BA.%26atitle%3DSpheroid-Based%2520Drug%2520Screen%253A%2520Considerations%2520and%2520Practical%2520Approach%26jtitle%3DNat.%2520Protoc.%26date%3D2009%26volume%3D4%26spage%3D309%26epage%3D324%26doi%3D10.1038%2Fnprot.2008.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Evaluation of the Medicinal Potential of Two Ruthenium (II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">9888</span>– <span class="NLM_lpage">9896</span>, <span class="refDoi"> DOI: 10.1002/chem.201701392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fchem.201701392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28509422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=9888-9896&author=J.+Hessauthor=H.+Huangauthor=A.+Kaiserauthor=V.+Pierrozauthor=O.+Blacque&title=Evaluation+of+the+Medicinal+Potential+of+Two+Ruthenium+%28II%29+Polypyridine+Complexes+as+One-+and+Two-Photon+Photodynamic+Therapy+Photosensitizers&doi=10.1002%2Fchem.201701392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers</span></div><div class="casAuthors">Hess, Jeannine; Huang, Huaiyi; Kaiser, Adrian; Pierroz, Vanessa; Blacque, Olivier; Chao, Hui; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">9888-9896</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two [Ru(phen)2dppz]2+ derivs. (phen=1,10-phenantroline, dppz=dipyrido[3,2-a:2',3'-c]phenazine) with different functional groups on the dppz ligand [dppz-7,8-(OMe)2 (1), dppz-7,8-(OH)2 (2)] have been synthesized, characterized and investigated as photosensitizers (PSs) for photodynamic therapy (PDT) against cancer.  Both complexes showed intense red phosphorescence and promising singlet oxygen (1O2) quantum yields of 75 % (1) and 54 % (2) in acetonitrile.  Complex 1 (logPo/w=-0.52, 2.4 nmol Ru per mg protein) was found to be more lipophilic, having also a higher cellular uptake efficiency compared to 2 (logPo/w=-0.20, 0.9 nmol Ru per mg protein).  Complex 1 localized evenly in HeLa cells whereas 2, was mainly visualized in the cell membrane by confocal microscopy.  In the dark, complex 1 (IC50=36.5 μm) was found to be more toxic than complex 2 (IC50 >100 μm) on a HeLa cells monolayer.  Importantly, in view of PDT applications, both complexes were found to be non-toxic in the dark towards multicellular HeLa spheroids (IC50>100 μM).  Upon one-photon irradn. (420 nm, 9.27 J cm-2), 1 exhibited higher phototoxicity (IC50=3.1 μm) than 2 (IC50=16.7 μm) on HeLa cell monolayers.  When two-photon irradn. (800 nm, 9.90 J cm-2) was applied, only 1 (IC50=9.5 μm) was found to be active toward HeLa spheroids.  This study demonstrates that the functional group on the intercalative ligand has a strong influence on the cellular localization and anticancer activity of RuII polypyridyl complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALsMHxl67W7Vg90H21EOLACvtfcHk0lgfRXuXEC1oqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K&md5=5f4b0fb8ecd4d2cd980344015aaec947</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701392%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DBlacque%26aufirst%3DO.%26atitle%3DEvaluation%2520of%2520the%2520Medicinal%2520Potential%2520of%2520Two%2520Ruthenium%2520%2528II%2529%2520Polypyridine%2520Complexes%2520as%2520One-%2520and%2520Two-Photon%2520Photodynamic%2520Therapy%2520Photosensitizers%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D9888%26epage%3D9896%26doi%3D10.1002%2Fchem.201701392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seo, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S. S. A.</span></span> <span> </span><span class="NLM_article-title">Monitoring the Effects of Doxorubicin on 3D-Spheroid Tumor Cells in Real-Time</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">7207</span>– <span class="NLM_lpage">7218</span>, <span class="refDoi"> DOI: 10.2147/OTT.S112566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2147%2FOTT.S112566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=27920558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFais73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=7207-7218&author=O.+W.+Seoauthor=M.+Kimauthor=J.+Hulmeauthor=S.+S.+A.+An&title=Monitoring+the+Effects+of+Doxorubicin+on+3D-Spheroid+Tumor+Cells+in+Real-Time&doi=10.2147%2FOTT.S112566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time</span></div><div class="casAuthors">Baek, NamHuk; Seo, Ok Won; Kim, MinSung; Hulme, John; An, Seong Soo A.</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7207-7218</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Recently, increasing nos. of cell culture expts. with 3D spheroids presented better correlating results in vivo than traditional 2D cell culture systems. 3D spheroids could offer a simple and highly reproducible model that would exhibit many characteristics of natural tissue, such as the prodn. of extracellular matrix.  In this paper numerous cell lines were screened and selected depending on their ability to form and maintain a spherical shape.  The effects of increasing concns. of doxorubicin (DXR) on the integrity and viability of the selected spheroids were then measured at regular intervals and in real-time.  In total 12 cell lines, adenocarcinomic alveolar basal epithelial (A549), muscle (C2C12), prostate (DU145), testis (F9), pituitary epithelial-like (GH3), cervical cancer (HeLa), HeLa contaminant (HEp2), embryo (NIH3T3), embryo (PA317), neuroblastoma (SH-SY5Y), osteosarcoma U2OS, and embryonic kidney cells (293T), were screened.  Out of the 12, 8 cell lines, NIH3T3, C2C12, 293T, SH-SY5Y, A549, HeLa, PA317, and U2OS formed regular spheroids and the effects of DXR on these structures were measured at regular intervals.  Finally, 5 cell lines, A549, HeLa, SH-SY5Y, U2OS, and 293T, were selected for real-time monitoring and the effects of DXR treatment on their behavior were continuously recorded for 5 days.  A potential correlation regarding the effects of DXR on spheroid viability and ATP prodn. was measured on days 1, 3, and 5.  Cytotoxicity of DXR seemed to occur after endocytosis, since the cellular activities and ATP productions were still viable after 1 day of the treatment in all spheroids, except SH-SY5Y.  Both cellular activity and ATP prodn. were halted 3 and 5 days from the start of the treatment in all spheroids.  All cell lines maintained their spheroid shape, except SHSY-5, which behaved in an unpredictable manner when exposed to toxic concns. of DXR.  Cytotoxic effects of DXR towards SH-SY5Y seemed to cause degrdn. of the extracellular matrix, since all cells were dismantled from the spheroid upon cell death.  On the other hand, 293T spheroids revealed retarded cellular activity and ATP productions upon DXR treatment throughout the expt.  Since 293T was the embryonic kidney cells, the fast clearance or neutralizations could have made them resistant towards DXR.  In conclusion, the same degree of sensitivity from the 2D system did not translate to a 3D culture system, resulting in higher IC50 values than the 2D system.  The varying sensitivities and tolerances to drugs could be better understood with a 3D cell culture system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRUzfRKssbd7Vg90H21EOLACvtfcHk0lgfRXuXEC1oqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFais73P&md5=478cb185cc57506c530a5035f802e441</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.2147%2FOTT.S112566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S112566%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DO.%2BW.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHulme%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DS.%2BS.%2BA.%26atitle%3DMonitoring%2520the%2520Effects%2520of%2520Doxorubicin%2520on%25203D-Spheroid%2520Tumor%2520Cells%2520in%2520Real-Time%26jtitle%3DOncoTargets%2520Ther.%26date%3D2016%26volume%3D9%26spage%3D7207%26epage%3D7218%26doi%3D10.2147%2FOTT.S112566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konowalchuk, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreda, D. R.</span></span> <span> </span><span class="NLM_article-title">Modified Annexin V/Propidium Iodide Apoptosis Assay For Accurate Assessment of Cell Death</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.3791/2597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.3791%2F2597" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=2-5&author=A.+M.+Riegerauthor=K.+L.+Nelsonauthor=J.+D.+Konowalchukauthor=D.+R.+Barreda&title=Modified+Annexin+V%2FPropidium+Iodide+Apoptosis+Assay+For+Accurate+Assessment+of+Cell+Death&doi=10.3791%2F2597"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3791%2F2597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F2597%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DA.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DKonowalchuk%26aufirst%3DJ.%2BD.%26aulast%3DBarreda%26aufirst%3DD.%2BR.%26atitle%3DModified%2520Annexin%2520V%252FPropidium%2520Iodide%2520Apoptosis%2520Assay%2520For%2520Accurate%2520Assessment%2520of%2520Cell%2520Death%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2011%26volume%3D50%26spage%3D2%26epage%3D5%26doi%3D10.3791%2F2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belmokhtar, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillion, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ségal-Bendirdjian, E.</span></span> <span> </span><span class="NLM_article-title">Staurosporine Induces Apoptosis through Both Caspase-Dependent and Caspase-Independent Mechanisms</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3354</span>– <span class="NLM_lpage">3362</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1204436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2Fsj.onc.1204436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=11423986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=3354-3362&author=A.+C.+Belmokhtarauthor=J.+Hillionauthor=E.+S%C3%A9gal-Bendirdjian&title=Staurosporine+Induces+Apoptosis+through+Both+Caspase-Dependent+and+Caspase-Independent+Mechanisms&doi=10.1038%2Fsj.onc.1204436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms</span></div><div class="casAuthors">Belmokhtar, Chafke Ahmed; Hillion, Josette; Segal-Bendirdjian, Evelyne</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3354-3362</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sensitivity of tumor cells to anticancer therapy depends on the ability of the drug to induce apoptosis.  However, multiple signaling pathways control this induction and thus det. this sensitivity.  We report here that staurosporine, a well known inducer of apoptosis in a wide range of cell lines, displays distinct ability to trigger apoptosis in two different L1210 sublines (termed L1210/S and L1210/0).  Staurosporine treatment resulted in an early cell death (within 3 h) in L1210/S cells, while in L1210/0 cells, death occurred only after 12 h.  In both instances, death occurred by apoptosis.  A broad spectrum caspase inhibitor, z-VAD-fmk, blocked early apoptosis in L1210/S cells but did not confer any protection on late apoptosis in L1210/0 cells.  Protection by z-VAD-fmk obsd. in L1210/S cells was not lasting and unmasked a secondary process of cell death that also exhibited characteristics of apoptosis.  Thus, staurosporine induces apoptotic cell death through at least two redundant parallel pathways.  These two pathways normally coexist in L1210/S cells.  However, the early cell death mechanism depending on caspase activation disguises the late caspase-independent apoptotic process.  Staurosporine-induced apoptosis in L1210/0 cells develops only by the caspase-independent mechanism due to a general defect in caspase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9z7y7ORZWrVg90H21EOLACvtfcHk0liwGcXz3xh_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVSqsbc%253D&md5=370eb9557924e10b1167c304f91dde05</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1204436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1204436%26sid%3Dliteratum%253Aachs%26aulast%3DBelmokhtar%26aufirst%3DA.%2BC.%26aulast%3DHillion%26aufirst%3DJ.%26aulast%3DS%25C3%25A9gal-Bendirdjian%26aufirst%3DE.%26atitle%3DStaurosporine%2520Induces%2520Apoptosis%2520through%2520Both%2520Caspase-Dependent%2520and%2520Caspase-Independent%2520Mechanisms%26jtitle%3DOncogene%26date%3D2001%26volume%3D20%26spage%3D3354%26epage%3D3362%26doi%3D10.1038%2Fsj.onc.1204436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">15308</span>– <span class="NLM_lpage">15319</span>, <span class="refDoi"> DOI: 10.1002/chem.201502154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fchem.201502154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=26338207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOms73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=15308-15319&author=L.+Zengauthor=Y.+Chenauthor=H.+Huangauthor=J.+Wangauthor=D.+Zhaoauthor=L.+Jiauthor=H.+Chao&title=Cyclometalated+Ruthenium%28II%29+Anthraquinone+Complexes+Exhibit+Strong+Anticancer+Activity+in+Hypoxic+Tumor+Cells&doi=10.1002%2Fchem.201502154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells</span></div><div class="casAuthors">Zeng, Leli; Chen, Yu; Huang, Huaiyi; Wang, Jinquan; Zhao, Donglei; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15308-15319</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Hypoxia is the crit. feature of the tumor microenvironment that is known to lead to resistance to many chemotherapeutic drugs.  Six novel ruthenium(II) anthraquinone complexes were designed and synthesized; they exhibit similar or superior cytotoxicity compared to cisplatin in hypoxic HeLa, A549, and multidrug-resistant (A549R) tumor cell lines.  Their anticancer activities are related to their lipophilicity and cellular uptake; therefore, these physicochem. properties of the complexes can be changed by modifying the ligands to obtain better anticancer candidates.  Complex 1, the most potent member of the series, is highly active against hypoxic HeLa cancer cells (IC50=0.53 μΜ).  This complex likely has 46-fold better activity than cisplatin (IC50=24.62 μΜ) in HeLa cells.  This complex tends to accumulate in the mitochondria and the nucleus of hypoxic HeLa cells.  Further mechanistic studies show that complex 1 induced cell apoptosis during hypoxia through multiple pathways, including those of DNA damage, mitochondrial dysfunction, and the inhibition of DNA replication and HIF-1α expression, making it an outstanding candidate for further in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHe1ooDZtJLVg90H21EOLACvtfcHk0liwGcXz3xh_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOms73L&md5=26bba75899e5c715072ae71df1d82b6c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502154%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DCyclometalated%2520Ruthenium%2528II%2529%2520Anthraquinone%2520Complexes%2520Exhibit%2520Strong%2520Anticancer%2520Activity%2520in%2520Hypoxic%2520Tumor%2520Cells%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D15308%26epage%3D15319%26doi%3D10.1002%2Fchem.201502154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zisowsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarakonda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaehde, U.</span></span> <span> </span><span class="NLM_article-title">Relevance of Drug Uptake and Efflux for Cisplatin Sensitivity of Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2006.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.bcp.2006.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17097621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12rsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=298-307&author=J.+Zisowskyauthor=S.+Koegelauthor=S.+Leyersauthor=K.+Devarakondaauthor=M.+U.+Kassackauthor=M.+Osmakauthor=U.+Jaehde&title=Relevance+of+Drug+Uptake+and+Efflux+for+Cisplatin+Sensitivity+of+Tumor+Cells&doi=10.1016%2Fj.bcp.2006.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells</span></div><div class="casAuthors">Zisowsky, Jochen; Koegel, Susanne; Leyers, Stefan; Devarakonda, Krishna; Kassack, Matthias U.; Osmak, Maja; Jaehde, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-307</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Platinum sensitivity and platinum resistance may involve altered activity of transport proteins.  In order to assess the role of drug uptake and efflux in this phenomenon, we compared the expression of three copper transporters, intracellular platinum accumulation, DNA platination and cytotoxicity of cisplatin in two cisplatin-sensitive and -resistant tumor cell line pairs (ovarian A2780/A2780cis and cervical HeLa/HeLaCK cells).  Gene expression of importer CTR1, and ATP7A and ATP7B efflux transporters (with and without cisplatin treatment) was investigated using quant. real-time PCR and platinum concns. were detd. by flameless at. absorption spectrometry.  After incubation with cisplatin, DNA platination was significantly lower in the resistant variants compared to the resp. sensitive cell lines, whereas no obvious difference in DNA repair was found.  Accordingly, the resistant variants exhibited lower intracellular platinum concns. than their resp. parental cells (2.5- and 2.9-fold lower in A2780cis and HeLaCK cells, resp.).  No differences in efflux were obsd.  Resistant cells expressed lower levels of CTR1 (1.5-1.8-fold) than their sensitive counterparts.  Expression differences of ATP7A and ATP7B between resistant and sensitive cells were cell type-specific.  The results highlight the relevance of CTR1 for cisplatin sensitivity as there is a clear relationship between lower CTR1 expression, intracellular concn., DNA platination and cytotoxicity of cisplatin in both resistant cell lines.  Our data provide the basis for a quant. understanding of alterations in uptake and efflux processes leading to cisplatin resistance and might hence facilitate the development of ex vivo assays that can predict cisplatin sensitivity in tumor specimens of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqh6hqnZBhrrVg90H21EOLACvtfcHk0liwGcXz3xh_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12rsbbM&md5=41a415da97aa804a1bbd91f76ff2682d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DZisowsky%26aufirst%3DJ.%26aulast%3DKoegel%26aufirst%3DS.%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DDevarakonda%26aufirst%3DK.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DOsmak%26aufirst%3DM.%26aulast%3DJaehde%26aufirst%3DU.%26atitle%3DRelevance%2520of%2520Drug%2520Uptake%2520and%2520Efflux%2520for%2520Cisplatin%2520Sensitivity%2520of%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D298%26epage%3D307%26doi%3D10.1016%2Fj.bcp.2006.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Fluorescein Redirects a Ruthenium - Octaarginine Conjugate to the Nucleus</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">8738</span>– <span class="NLM_lpage">8739</span>, <span class="refDoi"> DOI: 10.1021/ja9025165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9025165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFCks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=8738-8739&author=C.+A.+Puckettauthor=J.+K.+Barton&title=Fluorescein+Redirects+a+Ruthenium+-+Octaarginine+Conjugate+to+the+Nucleus&doi=10.1021%2Fja9025165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescein Redirects a Ruthenium-Octaarginine Conjugate to the Nucleus</span></div><div class="casAuthors">Puckett, Cindy A.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8738-8739</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cellular uptake and localization of a Ru-octaarginine conjugate with and without an appended fluorescein are compared.  The inherent luminescence of the Ru(II) dipyridophenazine complex allows observation of its uptake without the addn. of a fluorophore.  Ru-octaarginine-fluorescein stains the cytosol, nuclei, and nucleoli of HeLa cells under conditions where the Ru-octaarginine conjugate without fluorescein shows only punctate cytoplasmic labeling.  At higher concns., however, Ru-octaarginine without the fluorescein tag does exhibit cytoplasmic, nuclear, and nucleolar staining.  Attaching fluorescein to Ru-octaarginine lowers the threshold concn. required for diffuse cytoplasmic labeling and nuclear entry.  Hence, the localization of the fluorophore-bound peptide cannot serve as a proxy for that of the free peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1rpVDe7aJHrVg90H21EOLACvtfcHk0lgNWVsXexB7iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFCks7g%253D&md5=3ddba2b8aaed5063679feb966145ae0a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fja9025165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9025165%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DFluorescein%2520Redirects%2520a%2520Ruthenium%2520-%2520Octaarginine%2520Conjugate%2520to%2520the%2520Nucleus%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D8738%26epage%3D8739%26doi%3D10.1021%2Fja9025165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, H. M.</span></span> <span> </span><span class="NLM_article-title">Crystal and Molecular Structure of a Chiral-Specific DNA-Binding Agent: Tris(4,7-Diphenyl-1,10-Phenanthroline)Ruthenium(II)</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1021/ic00226a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00226a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL28Xht1SgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=842-847&author=B.+M.+Goldsteinauthor=J.+K.+Bartonauthor=H.+M.+Berman&title=Crystal+and+Molecular+Structure+of+a+Chiral-Specific+DNA-Binding+Agent%3A+Tris%284%2C7-Diphenyl-1%2C10-Phenanthroline%29Ruthenium%28II%29&doi=10.1021%2Fic00226a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal and molecular structure of a chiral-specific DNA-binding agent:  tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II)</span></div><div class="casAuthors">Goldstein, Barry M.; Barton, Jacqueline K.; Berman, Helen M.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">842-7</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">The title complex is monoclinic, space group P21/c, with a 13.085(2), b 24.173(1), c 22.773(4) Å, and β = 110.91 (1)°; Z = 4.  The final R value is 0.082.  At. coordinates, bond lengths, and bond angles are given.  All the Ph groups are skew to the phenanthroline ligands.  There are no stacking interactions in the crystal.  A plausible model for the Δ enantiomer binding to right-handed DNA is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7GkBAbTTtDLVg90H21EOLACvtfcHk0lgNWVsXexB7iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1SgtbY%253D&md5=6d066dd27cea34298b9c46d3dc5c3f60</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fic00226a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00226a024%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DB.%2BM.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26aulast%3DBerman%26aufirst%3DH.%2BM.%26atitle%3DCrystal%2520and%2520Molecular%2520Structure%2520of%2520a%2520Chiral-Specific%2520DNA-Binding%2520Agent%253A%2520Tris%25284%252C7-Diphenyl-1%252C10-Phenanthroline%2529Ruthenium%2528II%2529%26jtitle%3DInorg.%2520Chem.%26date%3D1986%26volume%3D25%26spage%3D842%26epage%3D847%26doi%3D10.1021%2Fic00226a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Mitochondria and Cell Death</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4400645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2Fsj.cdd.4400645" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=134-135&author=Y.+Tsujimoto&title=Mitochondria+and+Cell+Death&doi=10.1038%2Fsj.cdd.4400645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4400645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4400645%26sid%3Dliteratum%253Aachs%26aulast%3DTsujimoto%26aufirst%3DY.%26atitle%3DMitochondria%2520and%2520Cell%2520Death%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2000%26volume%3D7%26spage%3D134%26epage%3D135%26doi%3D10.1038%2Fsj.cdd.4400645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dedov, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roufogalis, B. D.</span></span> <span> </span><span class="NLM_article-title">Visualisation of Mitochondria in Living Neurons with Single- and Two-Photon Fluorescence Laser Microscopy</span>. <i>Micron</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1016/S0968-4328(00)00065-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2FS0968-4328%2800%2900065-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=11334734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1Gnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=653-660&author=V.+N.+Dedovauthor=G.+C.+Coxauthor=B.+D.+Roufogalis&title=Visualisation+of+Mitochondria+in+Living+Neurons+with+Single-+and+Two-Photon+Fluorescence+Laser+Microscopy&doi=10.1016%2FS0968-4328%2800%2900065-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Visualization of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy</span></div><div class="casAuthors">Dedov, V. N.; Cox, G. C.; Roufogalis, B. D.</div><div class="citationInfo"><span class="NLM_cas:title">Micron</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">MCONEN</span>;
        ISSN:<span class="NLM_cas:issn">0968-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In this work we investigated the relative merits of conventional single-photon confocal laser scanning fluorescence microscopy (CLSM) and two-photon laser scanning fluorescence microscopy (2p-LSM) for the study of mitochondria in living neurons.  Dorsal root ganglion neurons were loaded with the mitochondrion-specific fluorescent dye JC-1, the ratio between red (J-aggregates) and green (monomer) fluorescence of which reflects mitochondrial membrane potential.  Cells were illuminated at 488 nm for single-photon excitation or at 870 nm for two-photon excitation.  In both modalities we found that mitochondria showed: (i) similar appearance; (ii) similar fluorescence ratio values over both whole cell bodies and individual mitochondria; and (iii) similar responses to mitochondrial uncoupler, which dropped the ratio values by 50%.  However, 2p-LSM exhibited several advantages over CLSM: (i) better signal/noise ratio in the green emission channel; (ii) less phototoxicity upon repetitive scanning in the focal plane; and (iii) no significant loss of image quality upon repetitive scans in the z direction.  We conclude that, while both techniques enable visualization of individual mitochondria in living cells, 2p-LSM has significant advantages for physiol. work requiring time-lapse expts. or four-dimensional reconstructs of mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtIC5q_a96bVg90H21EOLACvtfcHk0lgNWVsXexB7iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1Gnt70%253D&md5=b9c840959373ab79c7cbd9e7e9f8049b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0968-4328%2800%2900065-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-4328%252800%252900065-2%26sid%3Dliteratum%253Aachs%26aulast%3DDedov%26aufirst%3DV.%2BN.%26aulast%3DCox%26aufirst%3DG.%2BC.%26aulast%3DRoufogalis%26aufirst%3DB.%2BD.%26atitle%3DVisualisation%2520of%2520Mitochondria%2520in%2520Living%2520Neurons%2520with%2520Single-%2520and%2520Two-Photon%2520Fluorescence%2520Laser%2520Microscopy%26jtitle%3DMicron%26date%3D2001%26volume%3D32%26spage%3D653%26epage%3D660%26doi%3D10.1016%2FS0968-4328%2800%2900065-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">Achieving Efficient Photodynamic Therapy under Both Normoxia and Hypoxia Using Cyclometalated Ru(II) Photosensitizer through Type</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1039/C7SC03765A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC7SC03765A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=29619206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslChtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=502-512&author=Z.+Lvauthor=H.+Weiauthor=Q.+Liauthor=X.+Suauthor=S.+Liuauthor=K.+Y.+Zhangauthor=W.+Lvauthor=Q.+Zhaoauthor=X.+Liauthor=W.+Huang&title=Achieving+Efficient+Photodynamic+Therapy+under+Both+Normoxia+and+Hypoxia+Using+Cyclometalated+Ru%28II%29+Photosensitizer+through+Type&doi=10.1039%2FC7SC03765A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(II) photosensitizer through type I photochemical process</span></div><div class="casAuthors">Lv, Zhuang; Wei, Huanjie; Li, Qing; Su, Xianlong; Liu, Shujuan; Zhang, Kenneth Yin; Lv, Wen; Zhao, Qiang; Li, Xianghong; Huang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">502-512</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) through the generation of singlet oxygen utilizing photosensitizers (PSs) is significantly limited under hypoxic conditions in solid tumors.  So it is meaningful to develop effective PSs which can maintain excellent therapeutic effects under hypoxia.  Here we reported a coumarin-modified cyclometalated Ru(II) photosensitizer (Ru2), which exhibits lower oxidn. potential and stronger absorption in the visible region than the coumarin-free counterpart.  The evaluation of the PDT effect was performed under both normoxia and hypoxia.  The results showed that Ru2 has a better therapeutic effect than the coumarin-free counterpart in in vitro expts.  Esp. under hypoxia, Ru2 still retained an excellent PDT effect, which can be attributed to the direct charge transfer between the excited PS and an adjacent substrate through a type I photochem. process, forming highly-oxidative hydroxyl radicals to damage tumor cells.  The anti-tumor activity of Ru2 was further proven to be effective in tumor-bearing mice, and tumor growth was inhibited remarkably under PDT treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHsNotT-Qq7Vg90H21EOLACvtfcHk0ljWGYR9NzNMRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslChtrbM&md5=0513e9691b155940e6321180e118e238</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1039%2FC7SC03765A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC03765A%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DAchieving%2520Efficient%2520Photodynamic%2520Therapy%2520under%2520Both%2520Normoxia%2520and%2520Hypoxia%2520Using%2520Cyclometalated%2520Ru%2528II%2529%2520Photosensitizer%2520through%2520Type%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D502%26epage%3D512%26doi%3D10.1039%2FC7SC03765A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorova, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popkov, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikov, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silachev, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pevzner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankauskas, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babenko, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorov, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakireva, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhaszova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollott, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorov, D. B.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Membrane Potential</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.ab.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28711444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1entbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2018&pages=50-59&author=L.+D.+Zorovaauthor=V.+A.+Popkovauthor=E.+Y.+Plotnikovauthor=D.+N.+Silachevauthor=B.+Pevznerauthor=S.+S.+Jankauskasauthor=V.+A.+Babenkoauthor=S.+D.+Zorovauthor=A.+V.+Balakirevaauthor=M.+Juhaszovaauthor=S.+J.+Sollottauthor=D.+B.+Zorov&title=Mitochondrial+Membrane+Potential&doi=10.1016%2Fj.ab.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial membrane potential</span></div><div class="casAuthors">Zorova, Ljubava D.; Popkov, Vasily A.; Plotnikov, Egor Y.; Silachev, Denis N.; Pevzner, Irina B.; Jankauskas, Stanislovas S.; Babenko, Valentina A.; Zorov, Savva D.; Balakireva, Anastasia V.; Juhaszova, Magdalena; Sollott, Steven J.; Zorov, Dmitry B.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-59</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mitochondrial membrane potential (ΔΨm) generated by proton pumps (Complexes I, III and IV) is an essential component in the process of energy storage during oxidative phosphorylation.  Together with the proton gradient (ΔpH), ΔΨm forms the transmembrane potential of hydrogen ions which is harnessed to make ATP.  The levels of ΔΨm and ATP in the cell are kept relatively stable although there are limited fluctuations of both these factors that can occur reflecting normal physiol. activity.  However, sustained changes in both factors may be deleterious.  A long-lasting drop or rise of ΔΨm vs. normal levels may induce unwanted loss of cell viability and be a cause of various pathologies.  Among other factors, ΔΨm plays a key role in mitochondrial homeostasis through selective elimination of dysfunctional mitochondria.  It is also a driving force for transport of ions (other than H+) and proteins which are necessary for healthy mitochondrial functioning.  The authors propose addnl. potential mechanisms for which ΔΨm is essential for maintenance of cellular health and viability and provide recommendations how to accurately measure ΔΨm in a cell and discuss potential sources of artifacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr64t9rQy__dLVg90H21EOLACvtfcHk0ljWGYR9NzNMRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1entbnE&md5=93008a20d59f326e9e5ce21fc859708b</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DZorova%26aufirst%3DL.%2BD.%26aulast%3DPopkov%26aufirst%3DV.%2BA.%26aulast%3DPlotnikov%26aufirst%3DE.%2BY.%26aulast%3DSilachev%26aufirst%3DD.%2BN.%26aulast%3DPevzner%26aufirst%3DB.%26aulast%3DJankauskas%26aufirst%3DS.%2BS.%26aulast%3DBabenko%26aufirst%3DV.%2BA.%26aulast%3DZorov%26aufirst%3DS.%2BD.%26aulast%3DBalakireva%26aufirst%3DA.%2BV.%26aulast%3DJuhaszova%26aufirst%3DM.%26aulast%3DSollott%26aufirst%3DS.%2BJ.%26aulast%3DZorov%26aufirst%3DD.%2BB.%26atitle%3DMitochondrial%2520Membrane%2520Potential%26jtitle%3DAnal.%2520Biochem.%26date%3D2018%26volume%3D552%26spage%3D50%26epage%3D59%26doi%3D10.1016%2Fj.ab.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">The Mitochondrial Membrane Potential (Δ ψ m) in Apoptosis; an Update</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1023/A:1022945107762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1023%2FA%3A1022945107762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=12766472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=115-128&author=J.+D.+Lyauthor=D.+R.+Grubbauthor=A.+Lawen&title=The+Mitochondrial+Membrane+Potential+%28%CE%94+%CF%88+m%29+in+Apoptosis%3B+an+Update&doi=10.1023%2FA%3A1022945107762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The mitochondrial membrane potential (Δψm) in apoptosis; an update</span></div><div class="casAuthors">Ly, J. D.; Grubb, D. R.; Lawen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-128</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Mitochondrial dysfunction has been shown to participate in the induction of apoptosis and has even been suggested to be central to the apoptotic pathway.  Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to induce depolarization of the transmembrane potential (Δψm), release of apoptogenic factors, and loss of oxidative phosphorylation.  In some apoptotic systems, loss of Δψm may be an early event in the apoptotic process.  However, there are emerging data suggesting that, depending on the model of apoptosis, the loss of Δψm may not be an early requirement for apoptosis, but on the contrary may be a consequence of the apoptotic-signaling pathway.  Furthermore, to add to these conflicting data, loss of Δψm has been demonstrated to not be required for cytochrome c release, whereas release of apoptosis-inducing factor AIF is dependent upon disruption of Δψm early in the apoptotic pathway.  Together, the existing literature suggests that depending on the cell system under investigation and the apoptotic stimuli used, dissipation of Δψm may or may not be an early event in the apoptotic pathway.  Discrepancies in this area of apoptosis research may be attributed to the fluorochromes used to detect Δψm.  Differential degrees of sensitivity of these fluorochromes exist, and there are also important factors that contribute to their ability to accurately discriminate changes in Δψm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOzp4dhnT9xLVg90H21EOLACvtfcHk0ljWGYR9NzNMRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D&md5=f1369780028cb13a045faf2a3db73c87</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022945107762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022945107762%26sid%3Dliteratum%253Aachs%26aulast%3DLy%26aufirst%3DJ.%2BD.%26aulast%3DGrubb%26aufirst%3DD.%2BR.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3DThe%2520Mitochondrial%2520Membrane%2520Potential%2520%2528%25CE%2594%2520%25CF%2588%2520m%2529%2520in%2520Apoptosis%253B%2520an%2520Update%26jtitle%3DApoptosis%26date%3D2003%26volume%3D8%26spage%3D115%26epage%3D128%26doi%3D10.1023%2FA%3A1022945107762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamuru, S.</span>; <span class="NLM_string-name">Attene-Ramos, M. S.</span>; <span class="NLM_string-name">Xia, M.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Membrane Potential Assay</span>. In  <i>High-Throughput Screening Assays in Toxicology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span>; <span class="NLM_string-name">Xia, M.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>, <span class="NLM_year">2016</span>; Vol.  <span class="NLM_volume">1473</span>, pp  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">22</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1007%2F978-1-4939-6346-1_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=17-22&author=S.+Sakamuru&author=M.+S.+Attene-Ramos&author=M.+Xiaauthor=H.+Zhu&author=M.+Xia&title=High-Throughput+Screening+Assays+in+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-6346-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4939-6346-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DSakamuru%26aufirst%3DS.%26atitle%3DMitochondrial%2520Membrane%2520Potential%2520Assay%26btitle%3DHigh-Throughput%2520Screening%2520Assays%2520in%2520Toxicology%26aulast%3DZhu%26aufirst%3DH.%26pub%3DHumana%2520Press%26date%3D2016%26volume%3D1473%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Z.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.-l.</span></span> <span> </span><span class="NLM_article-title">Immunocompromised and Immunocompetent Mouse Models for Head and Neck Squamous Cell Carcinoma</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.2147/OTT.S95633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2147%2FOTT.S95633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=26869799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvFyrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=545-555&author=Z.-g.+Leiauthor=X.-h.+Renauthor=S.-s.+Wangauthor=X.-h.+Liangauthor=Y.-l.+Tang&title=Immunocompromised+and+Immunocompetent+Mouse+Models+for+Head+and+Neck+Squamous+Cell+Carcinoma&doi=10.2147%2FOTT.S95633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma</span></div><div class="casAuthors">Lei, Zhen-ge; Ren, Xiao-hua; Wang, Sha-sha; Liang, Xin-hua; Tang, Ya-ling</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Mouse models can closely mimic human oral squamous epithelial carcinogenesis, greatly expand the in vivo research possibilities, and play a crit. role in the development of diagnosis, monitoring, and treatment of head and neck squamous cell carcinoma.  With the development of the recent research on the contribution of immunity/inflammation to cancer initiation and progression, mouse models have been divided into two categories, namely, immunocompromised and immunocompetent mouse models.  And thus, this paper will review these two kinds of models applied in head and neck squamous cell carcinoma to provide a platform to understand the complicated histol., mol., and genetic changes of oral squamous epithelial tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgqfKwIwFr_LVg90H21EOLACvtfcHk0ljXnBzqar6fXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvFyrtbY%253D&md5=3631ac8c1e8f305f4fc54835debf815b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.2147%2FOTT.S95633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S95633%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DZ.-g.%26aulast%3DRen%26aufirst%3DX.-h.%26aulast%3DWang%26aufirst%3DS.-s.%26aulast%3DLiang%26aufirst%3DX.-h.%26aulast%3DTang%26aufirst%3DY.-l.%26atitle%3DImmunocompromised%2520and%2520Immunocompetent%2520Mouse%2520Models%2520for%2520Head%2520and%2520Neck%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DOncoTargets%2520Ther.%26date%3D2016%26volume%3D9%26spage%3D545%26epage%3D555%26doi%3D10.2147%2FOTT.S95633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span> <span> </span><span class="NLM_article-title">Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development</span>. <i>Toxicol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.5487/TR.2014.30.1.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.5487%2FTR.2014.30.1.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24795792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A280%3ADC%252BC2cnps12ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=1-5&author=J.+Jung&title=Human+Tumor+Xenograft+Models+for+Preclinical+Assessment+of+Anticancer+Drug+Development&doi=10.5487%2FTR.2014.30.1.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Human tumor xenograft models for preclinical assessment of anticancer drug development</span></div><div class="casAuthors">Jung Joohee</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-5</span>
        ISSN:<span class="NLM_cas:issn">1976-8257</span>.
    </div><div class="casAbstract">Xenograft models of human cancer play an important role in the screening and evaluation of candidates for new anticancer agents.  The models, which are derived from human tumor cell lines and are classified according to the transplant site, such as ectopic xenograft and orthotopic xenograft, are still utilized to evaluate therapeutic efficacy and toxicity.  The metastasis model is modified for the evaluation and prediction of cancer progression.  Recently, animal models are made from patient-derived tumor tissue.  The patient-derived tumor xenograft models with physiological characters similar to those of patients have been established for personalized medicine.  In the discovery of anticancer drugs, standard animal models save time and money and provide evidence to support clinical trials.  The current strategy for using xenograft models as an informative tool is introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpIORyaoe3FJ6KlWarZTAzfW6udTcc2eap3MtYbvJc-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnps12ktQ%253D%253D&md5=d674c1a53649f8b9c78837908af34731</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.5487%2FTR.2014.30.1.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5487%252FTR.2014.30.1.001%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.%26atitle%3DHuman%2520Tumor%2520Xenograft%2520Models%2520for%2520Preclinical%2520Assessment%2520of%2520Anticancer%2520Drug%2520Development%26jtitle%3DToxicol.%2520Res.%26date%3D2014%26volume%3D30%26spage%3D1%26epage%3D5%26doi%3D10.5487%2FTR.2014.30.1.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span> <span> </span><span class="NLM_article-title">Patient - Derived Xenograft Mouse Models: A High Fidelity Tool for Individualized Medicine (Review)</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.9583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.3892%2Fol.2018.9583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30655732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFejtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=3-10&author=C.+Xuauthor=X.+Liauthor=P.+Liuauthor=M.+A.+N.+Liauthor=F.+Luo&title=Patient+-+Derived+Xenograft+Mouse+Models%3A+A+High+Fidelity+Tool+for+Individualized+Medicine+%28Review%29&doi=10.3892%2Fol.2018.9583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Patient-derived xenograft mouse models: a high fidelity tool for individualized medicine (Review)</span></div><div class="casAuthors">Xu, Cong; Li, Xuelu; Liu, Pixu; Li, Man; Luo, Fuwen</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1082</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Patient-derived xenograft (PDX) mouse models involve the direct transfer of fresh human tumor samples into immunodeficient mice following surgical resection or other medical operations.  Gene expression in tumors may be maintained by serial passages of tumors from mouse to mouse.  These models aid research into tumor biol. and pharmacol. without manual manipulation of cell cultures in vitro. and are widely used in individualized cancer therapy/translational medicine, drug development and coclin. trials.  PDX models exhibit higher predictive values for clin. outcomes than cell line-derived xenograft models and genetically engineered mouse models.  However, PDX models are assocd. with certain challenges in clin. application.  The present study reviewed current collections of PDX models and assessed the challenges and future directions of this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3qg1QBflNO7Vg90H21EOLACvtfcHk0lhXaE95E_iGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFejtbbE&md5=a1ecbd184fc1cbd8b90a5aef7c23a6a1</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.9583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.9583%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DM.%2BA.%2BN.%26aulast%3DLuo%26aufirst%3DF.%26atitle%3DPatient%2520-%2520Derived%2520Xenograft%2520Mouse%2520Models%253A%2520A%2520High%2520Fidelity%2520Tool%2520for%2520Individualized%2520Medicine%2520%2528Review%2529%26jtitle%3DOncol.%2520Lett.%26date%3D2019%26volume%3D17%26spage%3D3%26epage%3D10%26doi%3D10.3892%2Fol.2018.9583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, P. A.</span></span> <span> </span><span class="NLM_article-title">Constitutive and Inducible Akt Activity Promotes Resistance to Chemotherapy, Trastuzumab, or Tamoxifen in Breast Cancer Cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=12479367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=707-717&author=A.+S.+Clarkauthor=K.+Westauthor=S.+Streicherauthor=P.+A.+Dennis&title=Constitutive+and+Inducible+Akt+Activity+Promotes+Resistance+to+Chemotherapy%2C+Trastuzumab%2C+or+Tamoxifen+in+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells</span></div><div class="casAuthors">Clark, Amy S.; West, Kip; Streicher, Samantha; Dennis, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">707-717</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To evaluate the role of the phosphatidylinositol 3-kinase (Pl3K)/Akt pathway in breast cancer cell survival and therapeutic resistance, we analyzed a panel of six breast cancer cell lines that varied in erbB2 and estrogen receptor status.  Akt activity was constitutive in four cell lines and was assocd. with either PTEN mutations or erbB2 overexpression.  Akt promoted breast cancer cell survival because a Pl3K inhibitor, LY294002, or transient transfection of a dominant-neg. Akt mutant inhibited Akt activity and increased apoptosis.  When combined with therapies commonly used in breast cancer treatment, LY294002 potentiated apoptosis caused by doxorubicin, trastuzumab, paclitaxel, or etoposide.  Potentiation of apoptosis by LY294002 correlated with induction of Akt by doxorubicin or trastuzumab alone that occurred before the onset of apoptosis.  Similar results were obsd. with tamoxifen.  Combining LY294002 with tamoxifen in estrogen receptor-pos. cells greatly potentiated apoptosis, which was correlated with tamoxifen-induced Akt phosphorylation that preceded apoptosis.  To confirm that the effects of LY294002 on chemotherapy-induced apoptosis were attributable to inhibition of Akt, we transiently transfected breast cancer cells with dominant-neg. Akt and obsd. increased doxorubicin-induced apoptosis.  Conversely, stably transfecting cells with constitutively active Akt increased Akt activity and attenuated doxorubicin-induced apoptosis.  These studies show that endogenous Akt activity promotes breast cancer cell survival and therapeutic resistance, and that induction of Akt by chemotherapy, trastuzumab, or tamoxifen might be an early compensatory mechanism that could be exploited to increase the efficacy of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFulbrsRhrLVg90H21EOLACvtfcHk0lhXaE95E_iGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D&md5=8524c66f332d0596592e72f57275a14b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BS.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DStreicher%26aufirst%3DS.%26aulast%3DDennis%26aufirst%3DP.%2BA.%26atitle%3DConstitutive%2520and%2520Inducible%2520Akt%2520Activity%2520Promotes%2520Resistance%2520to%2520Chemotherapy%252C%2520Trastuzumab%252C%2520or%2520Tamoxifen%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D707%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.-G.</span></span> <span> </span><span class="NLM_article-title">Regulation of AKT Gene Expression by Cisplatin</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.3892/ol.2013.1132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.3892%2Fol.2013.1132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23426872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1WnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=756-760&author=J.+Zhangauthor=L.-L.+Zhangauthor=L.+Shenauthor=X.-M.+Xuauthor=H.-G.+Yu&title=Regulation+of+AKT+Gene+Expression+by+Cisplatin&doi=10.3892%2Fol.2013.1132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of AKT gene expression by cisplatin</span></div><div class="casAuthors">Zhang, Jun; Zhang, Ling-Li; Shen, Lei; Xu, Xi-Ming; Yu, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">756-760</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The use of chemotherapy drugs for the treatment of cancer is an effective therapeutic measure.  However, chemoresistance affects the effectiveness of the treatment.  AKT overexpression has been obsd. in chemoresistance.  AKT expression in colon cells induced cisplatin resistance.  The present study demonstrated the role of reactive oxygen species (ROS) in the induction of AKT regulation by cisplatin through the activation of JAK2/STAT3 at the transcriptional level in colon cancer cells.  HCT-116 cells treated with cisplatin exhibited increased JAK2 and STAT3 activities.  Reducing the expression of JAK2 in colon cancer cells using small interfering RNA (siRNA) decreased AKT expression.  The present study demonstrated that AKT activation is closely assocd. with chemoresistance in human tumors.  The inhibition of ROS decreased the levels of AKT in colon cancer cell lines.  The JAK2/STAT3 pathway was also shown to mediate AKT expression and represents a potential target for overcoming cisplatin resistance in human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTNRVdDRrv7Vg90H21EOLACvtfcHk0lhXaE95E_iGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1WnsLg%253D&md5=bdb145cb87de53647848562079e61fc4</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.3892%2Fol.2013.1132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2013.1132%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.-M.%26aulast%3DYu%26aufirst%3DH.-G.%26atitle%3DRegulation%2520of%2520AKT%2520Gene%2520Expression%2520by%2520Cisplatin%26jtitle%3DOncol.%2520Lett.%26date%3D2013%26volume%3D5%26spage%3D756%26epage%3D760%26doi%3D10.3892%2Fol.2013.1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, A. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee</span></span> <span> </span><span class="NLM_article-title">The Akt Isoforms, Their Unique Functions and Potential as Anticancer Therapeutic Targets</span>. <i>BioMol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1515/bmc.2010.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1515%2Fbmc.2010.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25962012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=389-401&author=S.+A.+Santiauthor=A.+C.+H.+Douglasauthor=+Lee&title=The+Akt+Isoforms%2C+Their+Unique+Functions+and+Potential+as+Anticancer+Therapeutic+Targets&doi=10.1515%2Fbmc.2010.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt isoforms, their unique functions and potential as anticancer therapeutic targets</span></div><div class="casAuthors">Santi, Stacey A.; Douglas, Alison C.; Lee, Hoyun</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">389-401</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Akt (also known as protein kinase B or PKB) is the major downstream nodal point of the PI3K signaling pathway.  This pathway is a promising anticancer therapeutic target, because constitutive activation of the PI3K-Akt pathway is correlated with tumor development, progression, poor prognosis, and resistance to cancer therapies.  The Akt serine/threonine kinase regulates diverse cellular functions including cell growth, proliferation, glucose metab., and survival.  Although all three known Akt isoforms (Akt1-3) are encoded by sep. genes, their amino acid sequences show a high degree of similarity.  For this and other reasons, it has long been assumed that all three Akt isoforms are activated in the same way, and their functions largely overlap.  However, accumulating lines of evidence now suggest that the three Akt isoforms might have unique modes of activation and many distinct functions.  In particular, it has recently been found that the Akt isoforms are localized at different subcellular compartments in both adipocytes and cancer cells.  In this review, we highlight the unique roles of each Akt isoform by introducing published data obtained from both in vitro and in vivo studies.  We also discuss the significant potential of the Akt isoforms as effective anticancer therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBb0klElcohLVg90H21EOLACvtfcHk0lhXaE95E_iGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejtrvP&md5=246869bd1e0c0f60c2d4a4873a12d5f9</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1515%2Fbmc.2010.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc.2010.035%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DS.%2BA.%26aulast%3DDouglas%26aufirst%3DA.%2BC.%2BH.%26aulast%3DLee%26atitle%3DThe%2520Akt%2520Isoforms%252C%2520Their%2520Unique%2520Functions%2520and%2520Potential%2520as%2520Anticancer%2520Therapeutic%2520Targets%26jtitle%3DBioMol.%2520Concepts%26date%3D2010%26volume%3D1%26spage%3D389%26epage%3D401%26doi%3D10.1515%2Fbmc.2010.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, A.</span></span> <span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating the Network</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.cell.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28431241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=381-405&author=B.+D.+Manningauthor=A.+Toker&title=AKT%2FPKB+Signaling%3A+Navigating+the+Network&doi=10.1016%2Fj.cell.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">AKT/PKB signaling: Navigating the network</span></div><div class="casAuthors">Manning, Brendan D.; Toker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-405</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The Ser and Thr kinase AKT, also known as protein kinase B (PKB), was discovered 25 years ago and has been the focus of tens of thousands of studies in diverse fields of biol. and medicine.  There have been many advances in our knowledge of the upstream regulatory inputs into AKT, key multifunctional downstream signaling nodes (GSK3, FoxO, mTORC1), which greatly expand the functional repertoire of AKT, and the complex circuitry of this dynamically branching and looping signaling network that is ubiquitous to nearly every cell in our body.  Mouse and human genetic studies have also revealed physiol. roles for the AKT network in nearly every organ system.  Our comprehension of AKT regulation and functions is particularly important given the consequences of AKT dysfunction in diverse pathol. settings, including developmental and overgrowth syndromes, cancer, cardiovascular disease, insulin resistance and type 2 diabetes, inflammatory and autoimmune disorders, and neurol. disorders.  There has also been much progress in developing AKT-selective small mol. inhibitors.  Improved understanding of the mol. wiring of the AKT signaling network continues to make an impact that cuts across most disciplines of the biomedical sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kLW6vEG_DrVg90H21EOLACvtfcHk0li4s8V6DizDRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D&md5=46302014c33b00c447f187eeaf0162c4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DToker%26aufirst%3DA.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520the%2520Network%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D381%26epage%3D405%26doi%3D10.1016%2Fj.cell.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, J. R.</span></span> <span> </span><span class="NLM_article-title">Diverse Mechanisms of AKT Pathway Activation in Human Malignancy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.2174/1568009611313030002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2174%2F1568009611313030002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23297823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVOjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=234-244&author=M.+Cheungauthor=J.+R.+Testa&title=Diverse+Mechanisms+of+AKT+Pathway+Activation+in+Human+Malignancy&doi=10.2174%2F1568009611313030002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse mechanisms of AKT pathway activation in human malignancy</span></div><div class="casAuthors">Cheung, Mitchell; Testa, Joseph R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  AKT/PKB (Protein Kinase B) are central proteins mediating signals from receptor tyrosine kinases and phosphatidylinositol 3-kinase.  AKT kinases are involved in a no. of important cellular processes including cell proliferation and survival, cell size in response to nutrient availability, tumor invasion/metastasis, and angiogenesis.  Various components of the AKT signaling pathway are encoded by tumor suppressor genes and oncogenes whose loss or activation, resp., plays an important role in tumorigenesis.  The growing body of evidence connecting deregulated AKT signaling with sporadic human cancers and inherited cancer predisposition syndromes is discussed.  The authors also highlight new findings regarding the involvement of activating mutations of AKT1, AKT2, and AKT3 in somatic overgrowth disorders: Proteus syndrome, hypoglycemia with hypertrophy, and hemimegalencephaly, resp.  In addn., the authors review recent literature documenting the various ways the AKT signaling pathway is activated in human cancers and consequences for molecularly targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEi7WX9g3ssLVg90H21EOLACvtfcHk0li4s8V6DizDRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVOjsb4%253D&md5=d4367e31345ebe32edfe9da2e1367611</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.2174%2F1568009611313030002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009611313030002%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DDiverse%2520Mechanisms%2520of%2520AKT%2520Pathway%2520Activation%2520in%2520Human%2520Malignancy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2013%26volume%3D13%26spage%3D234%26epage%3D244%26doi%3D10.2174%2F1568009611313030002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulmer, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherden, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercaw, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K. I.</span></span> <span> </span><span class="NLM_article-title">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2176</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1021/om100106e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om100106e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=2176-2179&author=G.+R.+Fulmerauthor=A.+J.+M.+Millerauthor=N.+H.+Sherdenauthor=H.+E.+Gottliebauthor=A.+Nudelmanauthor=B.+M.+Stoltzauthor=J.+E.+Bercawauthor=K.+I.+Goldberg&title=NMR+Chemical+Shifts+of+Trace+Impurities%3A+Common+Laboratory+Solvents%2C+Organics%2C+and+Gases+in+Deuterated+Solvents+Relevant+to+the+Organometallic+Chemist&doi=10.1021%2Fom100106e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span></div><div class="casAuthors">Fulmer, Gregory R.; Miller, Alexander J. M.; Sherden, Nathaniel H.; Gottlieb, Hugo E.; Nudelman, Abraham; Stoltz, Brian M.; Bercaw, John E.; Goldberg, Karen I.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2176-2179</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tables of 1H and 13C NMR chem. shifts have been compiled for common org. compds. often used as reagents or found as products or contaminants in deuterated org. solvents.  Building upon the work of Gottlieb, Kotlyar, and Nudelman in the Journal of Org. Chem., signals for common impurities are now reported in addnl. NMR solvents (tetrahydrofuran-d8, toluene-d8, dichloromethane-d2, chlorobenzene-d5, and 2,2,2-trifluoroethanol-d3) which are frequently used in organometallic labs.  Chem. shifts for other orgs. which are often used as reagents or internal stds. or are found as products in organometallic chem. are also reported for all the listed solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3GGHumCq_P7Vg90H21EOLACvtfcHk0li4s8V6DizDRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D&md5=53317e05fe3be77fe7de48d8fe1fb8b7</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fom100106e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom100106e%26sid%3Dliteratum%253Aachs%26aulast%3DFulmer%26aufirst%3DG.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DSherden%26aufirst%3DN.%2BH.%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26aulast%3DBercaw%26aufirst%3DJ.%2BE.%26aulast%3DGoldberg%26aufirst%3DK.%2BI.%26atitle%3DNMR%2520Chemical%2520Shifts%2520of%2520Trace%2520Impurities%253A%2520Common%2520Laboratory%2520Solvents%252C%2520Organics%252C%2520and%2520Gases%2520in%2520Deuterated%2520Solvents%2520Relevant%2520to%2520the%2520Organometallic%2520Chemist%26jtitle%3DOrganometallics%26date%3D2010%26volume%3D29%26spage%3D2176%26epage%3D2179%26doi%3D10.1021%2Fom100106e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krachler, M.</span></span> <span> </span><span class="NLM_article-title">Environmental Applications of Single Collector High Resolution ICP-MS</span>. <i>J. Environ. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">790</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1039/b703823m</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb703823m" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17671659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVentbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=790-804&author=M.+Krachler&title=Environmental+Applications+of+Single+Collector+High+Resolution+ICP-MS&doi=10.1039%2Fb703823m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Environmental applications of single collector high resolution ICP-MS</span></div><div class="casAuthors">Krachler, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Environmental Monitoring</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">790-804</span>CODEN:
                <span class="NLM_cas:coden">JEMOFW</span>;
        ISSN:<span class="NLM_cas:issn">1464-0325</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The no. of environmental applications of single collector high resoln. ICP-MS (HR-ICP-MS) has increased rapidly in recent years.  There are many factors that contribute to make HR-ICP-MS a very powerful tool in environmental anal.  They include the extremely low detection limits achievable, tremendously high sensitivity, the ability to sep. ICP-MS signals of the analyte from spectral interferences, enabling the reliable detn. of many trace elements, and the reasonable precision of isotope ratio measurements.  These assets are improved even further using high efficiency sample introduction systems.  Therefore, external factors such as the stability of lab. blanks are frequently the limiting factor in HR-ICP-MS anal. rather than the detection power.  This review aims to highlight the most recent applications of HR-ICP-MS in this sector, focusing on matrixes and applications where the superior capabilities of the instrumental technique are most useful and often ultimately required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0fUSHSSSPrVg90H21EOLACvtfcHk0lgM5KKC0XiVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVentbs%253D&md5=31223d5635c9d203bfb70fc9750a5801</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1039%2Fb703823m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb703823m%26sid%3Dliteratum%253Aachs%26aulast%3DKrachler%26aufirst%3DM.%26atitle%3DEnvironmental%2520Applications%2520of%2520Single%2520Collector%2520High%2520Resolution%2520ICP-MS%26jtitle%3DJ.%2520Environ.%2520Monit.%26date%3D2007%26volume%3D9%26spage%3D790%26epage%3D804%26doi%3D10.1039%2Fb703823m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_publisher-name">Rigaku Oxford
Diffraction Ltd.</span>: <span class="NLM_publisher-loc">Yarnton, England</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rigaku+Oxford%0ADiffraction+Ltd.%3A+Yarnton%2C+England."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26pub%3DRigaku%2520Oxford%250ADiffraction%2520Ltd" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. S.</span></span> <span> </span><span class="NLM_article-title">The Analytical Calculation of Absorption in Multifaceted Crystals</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1107/S0108767395007367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS0108767395007367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK2MXpsFeju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1995&pages=887-897&author=R.+C.+Clarkauthor=J.+S.+Reid&title=The+Analytical+Calculation+of+Absorption+in+Multifaceted+Crystals&doi=10.1107%2FS0108767395007367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The analytical calculation of absorption in multifaceted crystals</span></div><div class="casAuthors">Clark, R. C.; Reid, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">A51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-97</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">The exact analytic method of evaluating the absorption during scattering in multifaceted convex crystals is developed in a way that permits efficient computation.  A fast and accurate algorithm is given for finding the Howells polyhedra whose detn. is fundamental to the analytic method.  The algorithm allows for the evaluation of cases when the sample is only partly illuminated, can be adapted to more general situations and can be used to generate an est. of the error in the computation.  In most cases this is to 1 part in 1014.  Results of std. tests are given to greater accuracy than previously available and results for multifaceted approxns. to a cylinder and a sphere are given to illustrate the power of the method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoifLKiRM8dHbVg90H21EOLACvtfcHk0lgM5KKC0XiVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsFeju7g%253D&md5=c01042b701ddc5898022cd373ff08092</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1107%2FS0108767395007367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767395007367%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BC.%26aulast%3DReid%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520Analytical%2520Calculation%2520of%2520Absorption%2520in%2520Multifaceted%2520Crystals%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1995%26volume%3D51%26spage%3D887%26epage%3D897%26doi%3D10.1107%2FS0108767395007367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Rigaku OD</span>.  <i>CrysAlis PRO</i>, version
1.171.39.9f; <span class="NLM_publisher-name">Rigaku Oxford Diffraction Ltd.</span>: <span class="NLM_publisher-loc">Yarnton, England</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Rigaku+OD&title=CrysAlis+PRO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DCrysAlis%2520PRO%26pub%3DRigaku%2520Oxford%2520Diffraction%2520Ltd%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolomanov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, J. A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschmann, H.</span></span> <span> </span><span class="NLM_article-title">OLEX2: A Complete Structure Solution, Refinement and Analysis Program</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1107/S0021889808042726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS0021889808042726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=339-341&author=O.+V.+Dolomanovauthor=L.+J.+Bourhisauthor=R.+J.+Gildeaauthor=J.+A.+K.+Howardauthor=H.+Puschmann&title=OLEX2%3A+A+Complete+Structure+Solution%2C+Refinement+and+Analysis+Program&doi=10.1107%2FS0021889808042726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">OLEX2: a complete structure solution, refinement and analysis program</span></div><div class="casAuthors">Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J.; Howard, Judith A. K.; Puschmann, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-341</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">New software, OLEX2, was developed for the detn., visualization and anal. of mol. crystal structures.  The software has a portable mouse-driven workflow-oriented and fully comprehensive graphical user interface for structure soln., refinement and report generation, as well as novel tools for structure anal.  OLEX2 seamlessly links all aspects of the structure soln., refinement and publication process and presents them in a single workflow-driven package, with the ultimate goal of producing an application which will be useful to both chemists and crystallographers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIYSUbyzIgxbVg90H21EOLACvtfcHk0lgM5KKC0XiVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D&md5=7a2f9697b13b8e76de0e7dc5074ab229</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1107%2FS0021889808042726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889808042726%26sid%3Dliteratum%253Aachs%26aulast%3DDolomanov%26aufirst%3DO.%2BV.%26aulast%3DBourhis%26aufirst%3DL.%2BJ.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DHoward%26aufirst%3DJ.%2BA.%2BK.%26aulast%3DPuschmann%26aufirst%3DH.%26atitle%3DOLEX2%253A%2520A%2520Complete%2520Structure%2520Solution%252C%2520Refinement%2520and%2520Analysis%2520Program%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2009%26volume%3D42%26spage%3D339%26epage%3D341%26doi%3D10.1107%2FS0021889808042726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">SHELXT - Integrated Space-Group and Crystal-Structure Determination</span>. <i>Acta Crystallogr., Sect. A: Found. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=SHELXT+-+Integrated+Space-Group+and+Crystal-Structure+Determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0ljHDYnnjtNhZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXT%2520-%2520Integrated%2520Space-Group%2520and%2520Crystal-Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure Refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+Structure+Refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0ljHDYnnjtNhZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520Structure%2520Refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">Single-Crystal Structure Validation with the Program PLATON</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1107/S0021889802022112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS0021889802022112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=7-13&author=A.+L.+Spek&title=Single-Crystal+Structure+Validation+with+the+Program+PLATON&doi=10.1107%2FS0021889802022112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Single-crystal structure validation with the program PLATON</span></div><div class="casAuthors">Spek, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The results of a single-crystal structure detn. when in CIF format can now be validated routinely by automatic procedures.  In this way, many errors in published papers can be avoided.  The validation software generates a set of ALERTS detailing issues to be addressed by the experimenter, author, referee and publication journal.  Validation was pioneered by the IUCr journal Acta Crystallographica Section C and is currently std. procedure for structures submitted for publication in all IUCr journals.  The implementation of validation procedures by other journals is in progress.  This paper describes the concepts of validation and the classes of checks that are carried out by the program PLATON as part of the IUCr check CIF facility.  PLATON validation can be run at any stage of the structure refinement, independent of the structure detn. package used, and is recommended for use as a routine tool during or at least at the completion of every structure detn.  Two examples are discussed where proper validation procedures could have avoided the publication of incorrect structures that had serious consequences for the chem. involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ6b1zRgqUqbVg90H21EOLACvtfcHk0ljHDYnnjtNhZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlChtw%253D%253D&md5=0a85de2407551632bb287508534904e2</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1107%2FS0021889802022112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889802022112%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DSingle-Crystal%2520Structure%2520Validation%2520with%2520the%2520Program%2520PLATON%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2003%26volume%3D36%26spage%3D7%26epage%3D13%26doi%3D10.1107%2FS0021889802022112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, A.</span></span> <span> </span><span class="NLM_article-title">EasySpin, a Comprehensive Software Package for Spectral Simulation and Analysis in EPR</span>. <i>J. Magn. Reson.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.jmr.2005.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jmr.2005.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=16188474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12it7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2006&pages=42-55&author=S.+Stollauthor=A.+Schweiger&title=EasySpin%2C+a+Comprehensive+Software+Package+for+Spectral+Simulation+and+Analysis+in+EPR&doi=10.1016%2Fj.jmr.2005.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">EasySpin, a comprehensive software package for spectral simulation and analysis in EPR</span></div><div class="casAuthors">Stoll, Stefan; Schweiger, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Magnetic Resonance</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-55</span>CODEN:
                <span class="NLM_cas:coden">JMARF3</span>;
        ISSN:<span class="NLM_cas:issn">1090-7807</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">EasySpin, a computational package for spectral simulation and anal. in EPR, is described.  It is based on Matlab, a com. tech. computation software.  EasySpin provides extensive EPR-related functionality, ranging from elementary spin physics to data anal.  It provides routines for the simulation of liq.- and solid-state EPR and ENDOR spectra.  These simulation functions are built on novel algorithms that enhance scope, speed and accuracy of spectral simulations.  Spin systems with an arbitrary no. of electron and nuclear spins are supported.  The structure of the toolbox as well as the theor. background underlying its simulation functionality are presented, and some illustrative examples are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg4IrreHx5d7Vg90H21EOLACvtfcHk0ljrTiVANKiumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12it7bE&md5=2fffe78f07a39f44fa3279a64e68b5d3</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.jmr.2005.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmr.2005.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DStoll%26aufirst%3DS.%26aulast%3DSchweiger%26aufirst%3DA.%26atitle%3DEasySpin%252C%2520a%2520Comprehensive%2520Software%2520Package%2520for%2520Spectral%2520Simulation%2520and%2520Analysis%2520in%2520EPR%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D2006%26volume%3D178%26spage%3D42%26epage%3D55%26doi%3D10.1016%2Fj.jmr.2005.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><a href="http://Https://rockland-inc.com/Nuclear-Extract-Protocol.aspx" class="extLink">Https://rockland-inc.com/Nuclear-Extract-Protocol.aspx</a> (accessed
Oct 3, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Https%3A%2F%2Frockland-inc.com%2FNuclear-Extract-Protocol.aspx+%28accessed%0AOct+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tharaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardoll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khelifi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivry, Y.</span></span> <span> </span><span class="NLM_article-title">UFREASI: User-FRiendly Elemental DAta ProcesSIng. A Free and Easy-to-Use Tool for Elemental Data Treatment</span>. <i>Microchem. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.microc.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.microc.2015.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVOnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2015&pages=32-40&author=M.+Tharaudauthor=S.+Gardollauthor=O.+Khelifiauthor=M.+F.+Benedettiauthor=Y.+Sivry&title=UFREASI%3A+User-FRiendly+Elemental+DAta+ProcesSIng.+A+Free+and+Easy-to-Use+Tool+for+Elemental+Data+Treatment&doi=10.1016%2Fj.microc.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">uFREASI: user-FRiendly Elemental dAta procesSIng. A free and easy-to-use tool for elemental data treatment</span></div><div class="casAuthors">Tharaud, M.; Gardoll, S.; Khelifi, O.; Benedetti, M. F.; Sivry, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Microchemical Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-40</span>CODEN:
                <span class="NLM_cas:coden">MICJAN</span>;
        ISSN:<span class="NLM_cas:issn">0026-265X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) allows the quantification of trace and ultra-trace elements (mg/kg to fg/kg) by sepg. elements as a function of their mass-to-charge ratios (m/z) after ionisation into an argon plasma.  In spite of being rigorous and accurate, the "Results" modules provided by many manufacturers are often uneasy to use and operators have little control on the calcn.  Moreover, the large amt. of raw data generated makes the manual treatment very long and not reliable using a "home-made" spreadsheet.  The user-FRiendly Elemental dAta procesSIng (uFREASI) software presented in this paper follows a configurable step-by-step procedure allowing a quick and reliable data treatment plus an automatic uncertainty propagation.  The concn. calcn. is performed using the ordinary least square method after an external calibration.  The software proposes many options to correct and to monitor the signal, to warrant both quality and understanding of data treatment. uFREASI is supported by Windows, Mac OS X and Linux operating systems, is open and extensible, and is freely downloadable at http://www.ipgp.fr/∼tharaud/uFREASI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUp-vn1yhxrrVg90H21EOLACvtfcHk0ljrTiVANKiumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVOnur8%253D&md5=a1868d65bddff731c07ac6c7ef62b19c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.microc.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.microc.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DTharaud%26aufirst%3DM.%26aulast%3DGardoll%26aufirst%3DS.%26aulast%3DKhelifi%26aufirst%3DO.%26aulast%3DBenedetti%26aufirst%3DM.%2BF.%26aulast%3DSivry%26aufirst%3DY.%26atitle%3DUFREASI%253A%2520User-FRiendly%2520Elemental%2520DAta%2520ProcesSIng.%2520A%2520Free%2520and%2520Easy-to-Use%2520Tool%2520for%2520Elemental%2520Data%2520Treatment%26jtitle%3DMicrochem.%2520J.%26date%3D2015%26volume%3D121%26spage%3D32%26epage%3D40%26doi%3D10.1016%2Fj.microc.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Małecka</span>, <span class="hlFld-ContribAuthor ">Anna  Skoczyńska</span>, <span class="hlFld-ContribAuthor ">David M.  Goodman</span>, <span class="hlFld-ContribAuthor ">Christian G.  Hartinger</span>, <span class="hlFld-ContribAuthor ">Elzbieta  Budzisz</span>. </span><span class="cited-content_cbyCitation_article-title">Biological properties of ruthenium(II)/(III) complexes with flavonoids as ligands. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>436 </em>, 213849. <a href="https://doi.org/10.1016/j.ccr.2021.213849" title="DOI URL">https://doi.org/10.1016/j.ccr.2021.213849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2021.213849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2021.213849%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DBiological%252Bproperties%252Bof%252Bruthenium%252528II%252529%25252F%252528III%252529%252Bcomplexes%252Bwith%252Bflavonoids%252Bas%252Bligands%26aulast%3DMa%25C5%2582ecka%26aufirst%3DMagdalena%26date%3D2021%26volume%3D436%26spage%3D213849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luna  Song</span>, <span class="hlFld-ContribAuthor ">Hehe  Bai</span>, <span class="hlFld-ContribAuthor ">Chenyang  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjun  Gong</span>, <span class="hlFld-ContribAuthor ">Ai  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongfei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biomacromolecular Interactions, Photodynamic NO Releasing and Cellular Imaging of Two [RuCl(qn)(Lbpy)(NO)]X Complexes. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2545. <a href="https://doi.org/10.3390/molecules26092545" title="DOI URL">https://doi.org/10.3390/molecules26092545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092545%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BBiomacromolecular%252BInteractions%25252C%252BPhotodynamic%252BNO%252BReleasing%252Band%252BCellular%252BImaging%252Bof%252BTwo%252B%25255BRuCl%252528qn%252529%252528Lbpy%252529%252528NO%252529%25255DX%252BComplexes%26aulast%3DSong%26aufirst%3DLuna%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebeca  Arevalo</span>, <span class="hlFld-ContribAuthor ">Ramón  López</span>, <span class="hlFld-ContribAuthor ">Larry R.  Falvello</span>, <span class="hlFld-ContribAuthor ">Lucía  Riera</span>, <span class="hlFld-ContribAuthor ">Julio  Perez</span>. </span><span class="cited-content_cbyCitation_article-title">Building C(sp
              3
              ) Molecular Complexity on 2,2′‐Bipyridine and 1,10‐Phenanthroline in Rhenium Tricarbonyl Complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (1)
                                     , 379-389. <a href="https://doi.org/10.1002/chem.202003814" title="DOI URL">https://doi.org/10.1002/chem.202003814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202003814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202003814%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DBuilding%252BC%252528sp%252B3%252B%252529%252BMolecular%252BComplexity%252Bon%252B2%25252C2%2525E2%252580%2525B2%2525E2%252580%252590Bipyridine%252Band%252B1%25252C10%2525E2%252580%252590Phenanthroline%252Bin%252BRhenium%252BTricarbonyl%252BComplexes%26aulast%3DArevalo%26aufirst%3DRebeca%26date%3D2021%26date%3D2020%26volume%3D27%26issue%3D1%26spage%3D379%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang Yeul  Lee</span>, <span class="hlFld-ContribAuthor ">Chul Young  Kim</span>, <span class="hlFld-ContribAuthor ">Tae-Gyu  Nam</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives</p>. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2020,</strong> <em>Volume 14 </em>, 5375-5392. <a href="https://doi.org/10.2147/DDDT.S275007" title="DOI URL">https://doi.org/10.2147/DDDT.S275007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S275007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S275007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3D%25253Cp%25253ERuthenium%252BComplexes%252Bas%252BAnticancer%252BAgents%25253A%252BA%252BBrief%252BHistory%252Band%252BPerspectives%25253C%25252Fp%25253E%26aulast%3DLee%26aufirst%3DSang%2BYeul%26date%3D2020%26date%3D2020%26volume%3DVolume%252014%26spage%3D5375%26epage%3D5392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) Synthesis of <b>[Ru(DIP)<sub>2</sub>(sq)](PF<sub>6</sub>)</b>;<sup>a</sup> (b) Catecholate (cat) and Its Oxidized Forms, Semiquinonate (sq) and Quinone (q)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(I) DIP, LiCl, dimethylformamide (DMF), reflux, 24 h, 78%; (II) (i) NaOH, catechol, 2-propanol, reflux, 24 h; (ii) air, 2 h; and (iii) NH<sub>4</sub>PF<sub>6</sub>, 2-propanol/H<sub>2</sub>O (1:8), 19%.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structure of [Ru(DIP)<sub>2</sub>(sq)](Cl). The asymmetric unit contains two crystallographically independent Ru cations, only one of which is presented. The Cl<sup>–</sup> counterions, H atoms, and solvent molecules are omitted for clarity. The thermal ellipsoids are shown at the 30% probability level.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Structures of <b>Ru-cat</b>, <b>Ru-sq</b>, and <b>Ru</b><sup><b>+</b></sup><b>-sq</b>, Carrying a Catecholate or a Semiquinonate Ligand and Ru in the Oxidation State +II (<b>Ru</b>) or +III (<b>Ru</b><sup><b>+</b></sup>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Growth kinetics of HeLa MCTS upon treatment with different concentrations of <b>Ru-sq</b> (1, 2.5, 5, 10, and 20 μM). (a) Images collected at day 0 (before treatment) and at day 3, 6, 9, and 13. (b) MCTS diameter calculated at different time points. The dotted blue line indicates the day of seeding, the dashed red line indicates the day of the treatment, and the dotted green lines indicate the days of washing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Induction of apoptosis/necrosis in HeLa cells upon treatment with <b>Ru-sq</b> (10 μM) and staurosporine (1 μM) at different time frames. The values are expressed as a mean ± standard deviation (SD) of three biological repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Cellular uptake, (b) cellular fractionation, and (c) DNA metalation of HeLa cells after treatment with tested compounds (5 μM, 2 h). Data are presented as the mean ± SD of at least three biological replicates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Fluorescence signal of the JC-1 dye detected in HeLa cells treated for 24 h with different concentrations of <b>Ru-sq</b> (from 0.2 to 0.6 μM). The bar marked in red indicates the IC<sub>50</sub> concentration (0.5 μM). FCCP is used as a positive control, and cisplatin and DMSO (1%) are used as negative controls. (b) Mito stress test profile in HeLa cells after 24 h treatment; the oxygen consumption rate (OCR) changes after treatment with specific electron transport chain inhibitors: oligomycin (inhibitor of ATP synthase (complex V)), FCCP (uncoupling agent), antimycin-A (complex III inhibitor), and rotenone (complex I inhibitor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Kaplan–Meier analysis of the survival of immunocompetent NMRI mice bearing Ehrlich carcinoma. Only the administration of complex <b>Ru-sq</b> 5 mg/kg intraperitoneally (i.p.) and that of cisplatin (5 mg/kg) significantly prolonged the survival of tumor-bearing mice when compared with the mixture of the co-solvent and water. The compounds were administered i.p. on days 1 and 7 after tumor inoculation (<i>n</i> = 7 in each group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Weight of the solid Ehrlich tumor (in grams) on day 10 of mice injected on days 1 and 7 i.p. with the pure vehicle, <b>Ru-sq</b>, or cisplatin. Values are the means ± standard error of the mean (SEM) (<i>n</i> = 7 in each group). Control: the tumor-bearing control treated with a mixture of the co-solvent and water; Pt: cisplatin 5 mg/kg i.p.; Ru 5: <b>Ru-sq</b> 5 mg/kg i.p.; Ru 10: <b>Ru-sq</b> 10 mg/kg i.p.; and Ru 15: <b>Ru-sq</b> 15 mg/kg i.p. Significantly different from the controls (**<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Kaplan–Meier analysis of the survival of immunodeficient nude mice bearing A2780 human ovarian cancer. The treatment of Ru 15 mg/kg led to a completely cancer free mouse. The compounds were administered i.p. on days 1 and 7 after the tumor reached 5–8 mm in size (<i>n</i> = 8 in each group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Tumor growth of the A2780 cancer cell line in nude mice in the first 15 days of therapy. The tumor size is shown as the volume in cm<sup>3</sup>. Control: the tumor-bearing control treated with a mixture of the co-solvent and water; Pt: cisplatin 5 mg/kg i.p.; Ru 5: <b>Ru-sq</b> 5 mg/kg i.p.; Ru 10: <b>Ru-sq</b> 10 mg/kg i.p.; and Ru 15: <b>Ru-sq</b> 15 mg/kg i.p. The most significant slowing down of tumor growth is observable in the group with <b>Ru-sq</b> 15 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/medium/jm0c00431_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Western blot analysis of Akt-1 protein levels in the HeLa cell line after 24 h treatment with different concentrations of <b>Ru-sq</b>. Cisplatin, doxorubicin, and untreated cells were used as controls. The positions of the nearest molecular weight markers are indicated. (b) Akt-1 protein levels normalized to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) signal. Data is presented as the mean ± SD of at least three independent experiments. The IC<sub>50</sub> concentration of the complex is marked in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00431/20200520/images/large/jm0c00431_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00431&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 112 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urruticoechea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemany, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viñals, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capellá, G.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Cancer Therapy: An Overview</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.2174/138161210789941847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2174%2F138161210789941847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=20214614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3-10&author=A.+Urruticoecheaauthor=R.+Alemanyauthor=J.+Balartauthor=A.+Villanuevaauthor=F.+Vi%C3%B1alsauthor=G.+Capell%C3%A1&title=Recent+Advances+in+Cancer+Therapy%3A+An+Overview&doi=10.2174%2F138161210789941847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in cancer therapy: an overview</span></div><div class="casAuthors">Urruticoechea, A.; Alemany, R.; Balart, J.; Villanueva, A.; Vinals, F.; Capella, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The landscape of cancer treatment has dramatically changed over the last four decades.  The age when surgery and radiotherapy were the only effective way to fight tumor growth has ended.  A complex scenario where the mol. features of tumors seem to be the cornerstone of any therapy is now emerging.  Here we provide an overview on the different approaches to cancer treatment.  This review will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanims underpinning their efficacy.  Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small mols., antiangiogenics and viral therapy.  We briefly elaborate, finally, on new biomarkers development and how it should rule and det. the future of therapeutic research in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFhYFS1gpWjrVg90H21EOLACvtfcHk0ljaoJ1XUdumqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKmu7c%253D&md5=b81c202cb6bc38fedaeaea1e139858f5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161210789941847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210789941847%26sid%3Dliteratum%253Aachs%26aulast%3DUrruticoechea%26aufirst%3DA.%26aulast%3DAlemany%26aufirst%3DR.%26aulast%3DBalart%26aufirst%3DJ.%26aulast%3DVillanueva%26aufirst%3DA.%26aulast%3DVi%25C3%25B1als%26aufirst%3DF.%26aulast%3DCapell%25C3%25A1%26aufirst%3DG.%26atitle%3DRecent%2520Advances%2520in%2520Cancer%2520Therapy%253A%2520An%2520Overview%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3%26epage%3D10%26doi%3D10.2174%2F138161210789941847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Camp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krigas, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cell Division in <i>Escherichia coli</i> by Electrolysis Products from a Platinum Electrode</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">699</span>, <span class="refDoi"> DOI: 10.1038/205698a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2F205698a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=14287410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaF2MXns1aruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1965&pages=698-699&author=B.+Rosenbergauthor=L.+Van+Campauthor=T.+Krigas&title=Inhibition+of+Cell+Division+in+Escherichia+coli+by+Electrolysis+Products+from+a+Platinum+Electrode&doi=10.1038%2F205698a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode</span></div><div class="casAuthors">Rosenberg, Barnett; Van Camp, Loretta; Krigas, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">4972</span>),
    <span class="NLM_cas:pages">698-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">E. coli cells grown in a continuous culture app. with an esp. designed chamber contg. 2 Pt electrodes were subjected to an elec. field in an O atm.  With an applied voltage of 500 to 6000 cycles/sec., cell division ceased and filamentous growth occurred.  A similar effect was shown with a soln. of 10 ppm. (NH4)2PtCl6.  Pt(IV) was found in the electrolyzed medium in concns. of 8 ppm.  Other transition metal ions, including Rh, in concns. of 1-10 ppm. inhibited cell division in E. coli while not interfering with growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDyKBEDeGaCrVg90H21EOLACvtfcHk0ljaoJ1XUdumqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXns1aruw%253D%253D&md5=2d2e79bfe93d202de21a43b131ea95b2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F205698a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F205698a0%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%26aulast%3DVan%2BCamp%26aufirst%3DL.%26aulast%3DKrigas%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Cell%2520Division%2520in%2520Escherichia%2520coli%2520by%2520Electrolysis%2520Products%2520from%2520a%2520Platinum%2520Electrode%26jtitle%3DNature%26date%3D1965%26volume%3D205%26spage%3D698%26epage%3D699%26doi%3D10.1038%2F205698a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Camp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimley, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, A. J.</span></span> <span> </span><span class="NLM_article-title">The Inhibition of Growth or Cell Division in <i>Escherichia coli</i> by Different Ionic Species of Platinum (IV) Complexes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>242</i></span>,  <span class="NLM_fpage">1347</span>– <span class="NLM_lpage">1352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=5337590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaF2sXntlGjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=1967&pages=1347-1352&author=B.+Rosenbergauthor=L.+van+Campauthor=E.+B.+Grimleyauthor=A.+J.+Thomson&title=The+Inhibition+of+Growth+or+Cell+Division+in+Escherichia+coli+by+Different+Ionic+Species+of+Platinum+%28IV%29+Complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes</span></div><div class="casAuthors">Rosenberg, Barnett; Van Camp, Loretta; Grimley, Eugene B.; Thomson, Andrew James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">242</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1347-52</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">When a soln. contg. the complex ion, [PtCl6]=, and NH4+ ions is irradiated, a photochem. change occurs in which the chloride ions of the ligand are sequentially replaced by 1, 2, or 3 ammonia mols.  The total charge on the complex ion decreases by 1 neg. charge for each replacement.  These changes can be followed by changes occurring in absorption spectra or in ionophoretic patterns.  Each charged species of the complex has a unique effect on the growth of E. coli.  The doubly neg. species is a bactericide.  The singly neg. species appears to have little effect on either growth or cell division processes.  The neutral species has little effect on growth, but markedly inhibits cell division processes, forcing filamentous growth.  The cis and trans forms of the diamino complex, [PtCl4(NH3)2]0, have been synthesized.  The absorption spectra of both have a λmax. at 207 mμ.  The electrophoretic patterns indicate predominantly neutral species in both cases.  The trans form is relatively inefficient in inhibiting cell division, whereas the cis form is fully as efficient as the neutral species in inhibiting cell division, identifying the neutral species as the cis form of the complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTlqzE2htyHbVg90H21EOLACvtfcHk0ljaoJ1XUdumqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXntlGjtA%253D%253D&md5=0dba955e8327fc9b31455fe342311640</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%26aulast%3Dvan%2BCamp%26aufirst%3DL.%26aulast%3DGrimley%26aufirst%3DE.%2BB.%26aulast%3DThomson%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520Inhibition%2520of%2520Growth%2520or%2520Cell%2520Division%2520in%2520Escherichia%2520coli%2520by%2520Different%2520Ionic%2520Species%2520of%2520Platinum%2520%2528IV%2529%2520Complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1967%26volume%3D242%26spage%3D1347%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Camp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trosko, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, V. H.</span></span> <span> </span><span class="NLM_article-title">Platinum Compounds: A New Class of Potent Antitumour Agents</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>222</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1038/222385a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2F222385a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=5782119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaF1MXktVWquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=1969&pages=385-386&author=B.+Rosenbergauthor=L.+Van+Campauthor=J.+E.+Troskoauthor=V.+H.+Mansour&title=Platinum+Compounds%3A+A+New+Class+of+Potent+Antitumour+Agents&doi=10.1038%2F222385a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum compounds:  a new class of potent antitumor agents</span></div><div class="casAuthors">Rosenberg, Barnett; VanCamp, Loretta; Trosko, James E.; Mansour, Virginia H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">5191</span>),
    <span class="NLM_cas:pages">385-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The platinum compds., cis-Pt(NH3)2Cl4, cis-Pt(NH3)2Cl2, Pt(en)Cl2, and Pt(en)Cl4, when injected i.p. at 0.5-10.0 mg./kg., daily, inhibited sarcoma 180 in mice.  cis-Pt(NH3)2Cl2 injected i.p. at 5-10 mg./kg. was a potent antileukemic agent against leukemia L-1210 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2aCa0V0sT0bVg90H21EOLACvtfcHk0lhSfAAQNBCftg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXktVWquro%253D&md5=dc39b2856a15013e111128b36ec22855</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F222385a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F222385a0%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%26aulast%3DVan%2BCamp%26aufirst%3DL.%26aulast%3DTrosko%26aufirst%3DJ.%2BE.%26aulast%3DMansour%26aufirst%3DV.%2BH.%26atitle%3DPlatinum%2520Compounds%253A%2520A%2520New%2520Class%2520of%2520Potent%2520Antitumour%2520Agents%26jtitle%3DNature%26date%3D1969%26volume%3D222%26spage%3D385%26epage%3D386%26doi%3D10.1038%2F222385a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, B. B.</span></span> <span> </span><span class="NLM_article-title">Some Biological Effects of Platinum Compounds</span>. <i>Platinum Met. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaE3MXksVOjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1971&pages=42-51&author=B.+B.+Rosenberg&title=Some+Biological+Effects+of+Platinum+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Biological effects of platinum compounds.  New agents for the control of tumors</span></div><div class="casAuthors">Rosenberg, Barnett</div><div class="citationInfo"><span class="NLM_cas:title">Platinum Metals Review</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">PTMRA3</span>;
        ISSN:<span class="NLM_cas:issn">0032-1400</span>.
    </div><div class="casAbstract">A review is given of the properties and effects of Pt compds.  Topics mentioned include antitumor activity, toxicol. effects of Pt complexes, mol. biol. of Pt complexes, and speculation on the mode of action of the antitumor effects.  Possible antitumor activity is mentioned for cis-dichlorodiamineplatinum and other inorg. compds.  20 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyyVK5yDzUubVg90H21EOLACvtfcHk0lhSfAAQNBCftg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXksVOjsb4%253D&md5=58c5434d36355c00ba6956e071f673c4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DB.%2BB.%26atitle%3DSome%2520Biological%2520Effects%2520of%2520Platinum%2520Compounds%26jtitle%3DPlatinum%2520Met.%2520Rev.%26date%3D1971%26volume%3D15%26spage%3D42%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pil, P.</span>; <span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Cisplatin and Related Drugs</span>. In  <i>Encyclopedia of Cancer</i>;<span class="NLM_contrib-group"><span class="NLM_string-name">Bertino, J. R.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">1</span>, p  <span class="NLM_fpage">392</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=392&author=P.+Pil&author=S.+J.+Lippardauthor=J.+R.+Bertino&title=Encyclopedia+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPil%26aufirst%3DP.%26atitle%3DCisplatin%2520and%2520Related%2520Drugs%26btitle%3DEncyclopedia%2520of%2520Cancer%26aulast%3DBertino%26aufirst%3DJ.%2BR.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D1%26spage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giandomenico, C. M.</span></span> <span> </span><span class="NLM_article-title">Current Status of Platinum-Based Antitumor Drugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">2451</span>– <span class="NLM_lpage">2466</span>, <span class="refDoi"> DOI: 10.1021/cr980420v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr980420v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK1MXltFSrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2451-2466&author=E.+Wongauthor=C.+M.+Giandomenico&title=Current+Status+of+Platinum-Based+Antitumor+Drugs&doi=10.1021%2Fcr980420v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Current Status of Platinum-Based Antitumor Drugs</span></div><div class="casAuthors">Wong, Ernest; Giandomenico, Christen M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2451-2466</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 239 refs.  The primary purpose of this review is to give an update of the Pt drugs currently in human clin. trials and to give an overview of the design of new compds. within the last 10 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4bnyP6NJWybVg90H21EOLACvtfcHk0lhSfAAQNBCftg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFSrsrc%253D&md5=85f7f4c185096f8b3bb1676629ccb3ae</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcr980420v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980420v%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26aulast%3DGiandomenico%26aufirst%3DC.%2BM.%26atitle%3DCurrent%2520Status%2520of%2520Platinum-Based%2520Antitumor%2520Drugs%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2451%26epage%3D2466%26doi%3D10.1021%2Fcr980420v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebwohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canetta, R.</span></span> <span> </span><span class="NLM_article-title">Clinical Development of Platinum Complexes in Cancer Therapy: An Historical Perspective and an Update</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1522</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(98)00224-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2FS0959-8049%2898%2900224-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=9893623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVSku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=1522-1534&author=D.+Lebwohlauthor=R.+Canetta&title=Clinical+Development+of+Platinum+Complexes+in+Cancer+Therapy%3A+An+Historical+Perspective+and+an+Update&doi=10.1016%2FS0959-8049%2898%2900224-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical development of platinum complexes in cancer therapy: an historical perspective and an update</span></div><div class="casAuthors">Lebwohl, D.; Canetta, R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1522-1534</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 132 refs.  The vast amt. of basic research on platinum coordination complexes has produced, over the past 25 yr, several thousand new mols. for preclin. screening and 28 compds. which have entered clin. development.  The goals of these research activities have been to identify compds. with superior efficacy, reduced toxicity, lack of cross-resistance or improved pharmacol. characteristics as compared with the parent compd., cisplatin.  After the remarkable therapeutic effects of cisplatin had been established, only a few other platinum compds. succeeded in reaching general availability.  Whereas carboplatin is an analog with an improved therapeutic index (mostly driven by reduced organ toxicity) over that of cisplatin, new compds. clearly more active than or non-cross-resistant with cisplatin have not yet been identified.  The platinum analogs that remain under investigation are focusing on expanding the utilisation of platinum therapy to tumor types not usually treated with, or responsive to, cisplatin or carboplatin.  In addn., novel routes of administration constitute another avenue of research.  The clin. development of platinum coordination complexes, with emphasis on those compds. still under active development, is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4jtprGEjGjbVg90H21EOLACvtfcHk0lhSfAAQNBCftg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVSku7Y%253D&md5=5c440a98eae520a9c5f61bdebb01b84e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2898%2900224-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252898%252900224-X%26sid%3Dliteratum%253Aachs%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DCanetta%26aufirst%3DR.%26atitle%3DClinical%2520Development%2520of%2520Platinum%2520Complexes%2520in%2520Cancer%2520Therapy%253A%2520An%2520Historical%2520Perspective%2520and%2520an%2520Update%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1998%26volume%3D34%26spage%3D1522%26epage%3D1534%26doi%3D10.1016%2FS0959-8049%2898%2900224-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fricker, S. P.</span></span> <span> </span><span class="NLM_article-title">Metal Based Drugs: From Serendipity to Design</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">4903</span>– <span class="NLM_lpage">4917</span>, <span class="refDoi"> DOI: 10.1039/b705551j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb705551j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17992275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=4903-4917&author=S.+P.+Fricker&title=Metal+Based+Drugs%3A+From+Serendipity+to+Design&doi=10.1039%2Fb705551j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Metal based drugs: from serendipity to design</span></div><div class="casAuthors">Fricker, Simon Paul</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4903-4917</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The platinum anticancer drug cisplatin has made a major contribution to the treatment of testicular and ovarian cancer.  This chance discovery has been the stimulus for research into other metal-based drugs.  Inorg. chem. offers many opportunities for medicinal chem., and the discovery of metal-based drugs has moved on from chance discovery to rational drug design.  There are however, many challenges assocd. with the drug discovery and development process.  The aim of this review is to provide case histories exemplifying the role of rational drug design in modern inorg. medicinal chem. in the context of these challenges.  The evolution of platinum drugs from cisplatin to third generation drugs is described.  The mol. target for the platinum agents is DNA.  Alternative mol. targets such as thiol-contg. proteins and redox processes are proposed.  The example of a simple, safe, efficacious metal-based drug, Fosrenol, is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnD2NhKPWN7Vg90H21EOLACvtfcHk0lh2GufZ2NhZng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eht7rJ&md5=6467524515fc593832760ea0dc511a81</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1039%2Fb705551j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705551j%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DMetal%2520Based%2520Drugs%253A%2520From%2520Serendipity%2520to%2520Design%26jtitle%3DDalton%2520Trans.%26date%3D2007%26spage%3D4903%26epage%3D4917%26doi%3D10.1039%2Fb705551j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azad, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomar, R. S.</span></span> <span> </span><span class="NLM_article-title">Anti-Cancer Drug KP1019 Induces Hog1 Phosphorylation and Protein Ubiquitylation in <i>Saccharomyces cerevisiae</i></span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>736</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.ejphar.2014.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24797784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=736&publication_year=2014&pages=77-85&author=V.+Singhauthor=G.+K.+Azadauthor=M.+A.+Reddyauthor=S.+Baranwalauthor=R.+S.+Tomar&title=Anti-Cancer+Drug+KP1019+Induces+Hog1+Phosphorylation+and+Protein+Ubiquitylation+in+Saccharomyces+cerevisiae&doi=10.1016%2Fj.ejphar.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer drug KP1019 induces Hog1 phosphorylation and protein ubiquitylation in Saccharomyces cerevisiae</span></div><div class="casAuthors">Singh, Vikash; Azad, Gajendra Kumar; Reddy M., Amarendar; Baranwal, Shivani; Tomar, Raghuvir S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">736</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-85</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ruthenium-based anti-cancer drugs have attracted increasing interest in the last 20 years.  KP1019 is one of the ruthenium-contg. compds. that has demonstrated anti-tumor activity against various cancers, and has been tested in several clin. trials.  Despite its success, the mode of action of KP1019 is not well described.  In the present study, we have used budding yeast Saccharomyces cerevisiae to elucidate the action of KP1019.  We have found that KP1019 causes dose-dependent cell arrest in the S-phase of cell cycle.  Furthermore, we have demonstrated for the first time that the yeast mitogen-activated protein (MAP) kinase Hog1 is essential for the cells in response to KP1019.  Hog1 is rapidly phosphorylated upon treatment with KP1019, and the deletion of the HOG1 gene potentiates the growth inhibition effect of KP1019.  Moreover, we also obsd. the up-regulation of glycerol-3-phosphate dehydrogenase 1 (GPD1) mRNA in response to KP1019 treatment, a factor that is essential for the hyperosmotic stress response.  Our results also reveal that membrane-bound sensor proteins of high osmolarity glycerol (HOG) pathway are crucial for Hog1 phosphorylation in response to KP1019-induced stress.  Furthermore, KP1019 has also been found to increase the accumulation of ubiquitinated proteins and deletion of several members of ubiquitination pathways conferred sensitivity for KP1019.  The findings presented here strongly suggest the ability of KP1019 to activate Hog1 MAP kinase and induce protein ubiquitination, which may underlie the therapeutic potential of this compd.  In summary, we have disclosed a novel mechanism of KP1019 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9WSyFcOp0rVg90H21EOLACvtfcHk0lh2GufZ2NhZng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFSqt7g%253D&md5=286539ac54e6845c498ce4331426c883</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DAzad%26aufirst%3DG.%2BK.%26aulast%3DReddy%26aufirst%3DM.%2BA.%26aulast%3DBaranwal%26aufirst%3DS.%26aulast%3DTomar%26aufirst%3DR.%2BS.%26atitle%3DAnti-Cancer%2520Drug%2520KP1019%2520Induces%2520Hog1%2520Phosphorylation%2520and%2520Protein%2520Ubiquitylation%2520in%2520Saccharomyces%2520cerevisiae%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D736%26spage%3D77%26epage%3D85%26doi%3D10.1016%2Fj.ejphar.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Classification of Metal-Based Drugs According to Their Mechanisms of Action</span>. <i>Chem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.chempr.2019.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.chempr.2019.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=32864503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslGmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=41-60&author=E.+Borosauthor=P.+J.+Dysonauthor=G.+Gasser&title=Classification+of+Metal-Based+Drugs+According+to+Their+Mechanisms+of+Action&doi=10.1016%2Fj.chempr.2019.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of Metal-Based Drugs according to Their Mechanisms of Action</span></div><div class="casAuthors">Boros, Eszter; Dyson, Paul J.; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-60</span>CODEN:
                <span class="NLM_cas:coden">CHEMVE</span>;
        ISSN:<span class="NLM_cas:issn">2451-9294</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metal-based drugs and imaging agents are extensively used in the clinic for the treatment and diagnosis of cancers and a wide range of other diseases.  The current clin. arsenal of compds. operate via a limited no. of mechanisms, whereas new putative compds. explore alternative mechanisms of action, which could potentially bring new chemotherapeutic approaches into the clinic.  In this review, metal-based drugs and imaging agents are characterized according to their primary mode of action, and the key properties and features of each class of compds. are defined wherever possible.  A better understanding of the roles played by metal compds. at a mechanistic level will help to deliver new metal-based therapies to the clinic by providing an alternative, targeted, and rational approach to supplement non-targeted screening of novel chem. entities for biol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wpw2si5_UrVg90H21EOLACvtfcHk0lh2GufZ2NhZng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslGmsrg%253D&md5=38ac3bc496a57accfa26907ad8f73412</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chempr.2019.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chempr.2019.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DClassification%2520of%2520Metal-Based%2520Drugs%2520According%2520to%2520Their%2520Mechanisms%2520of%2520Action%26jtitle%3DChem%26date%3D2020%26volume%3D6%26spage%3D41%26epage%3D60%26doi%3D10.1016%2Fj.chempr.2019.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S. W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B. Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, V. K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. H.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">13091</span>– <span class="NLM_lpage">13095</span>, <span class="refDoi"> DOI: 10.1002/anie.201807305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fanie.201807305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCls7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=13091-13095&author=G.+J.+Yangauthor=W.+Wangauthor=S.+W.+F.+Mokauthor=C.+Wuauthor=B.+Y.+K.+Lawauthor=X.+M.+Miaoauthor=K.+J.+Wuauthor=H.+J.+Zhongauthor=C.+Y.+Wongauthor=V.+K.+W.+Wongauthor=D.+L.+Maauthor=C.+H.+Leung&title=Selective+Inhibition+of+Lysine-Specific+Demethylase+5A+%28KDM5A%29+Using+a+Rhodium%28III%29+Complex+for+Triple-Negative+Breast+Cancer+Therapy&doi=10.1002%2Fanie.201807305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy</span></div><div class="casAuthors">Yang, Guan-Jun; Wang, Wanhe; Mok, Simon Wing Fai; Wu, Chun; Law, Betty Yuen Kwan; Miao, Xiang-Min; Wu, Ke-Jia; Zhong, Hai-Jing; Wong, Chun-Yuen; Wong, Vincent Kam Wai; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">13091-13095</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 5A (KDM5A) has recently become a promising target for epigenetic therapy.  In this study, the authors designed and synthesized metal complexes bearing ligands with reported demethylase and p27 modulating activities.  The Rh(III) complex 1 (I) was identified as a direct, selective and potent inhibitor of KDM5A that directly abrogate KDM5A demethylase activity via antagonizing the KDM5A-tri-/di-methylated histone 3 protein-protein interaction (PPI) in vitro and in cellulo.  Complex 1 induced accumulation of H3K4me3 and H3K4me2 levels in cells, causing growth arrest at G1 phase in the triple-neg. breast cancer (TNBC) cell lines, MDA-MB-231 and 4T1.  Finally, 1 exhibited potent anti-tumor activity against TNBC xenografts in an in vivo mouse model, presumably via targeting of KDM5A and hence upregulating p27.  Moreover, complex 1 was less toxic compared with two clin. drugs, cisplatin and doxorubicin.  To the authors' knowledge, complex 1 is the first metal-based KDM5A inhibitor reported in the literature.  The authors anticipate that complex 1 may be used as a novel scaffold for the further development of more potent epigenetic agents against cancers, including TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriUnhpINRuOrVg90H21EOLACvtfcHk0li0c0lxBYPkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCls7vM&md5=9a8f6097e7401592667690c255f1c9e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fanie.201807305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201807305%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMok%26aufirst%3DS.%2BW.%2BF.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DLaw%26aufirst%3DB.%2BY.%2BK.%26aulast%3DMiao%26aufirst%3DX.%2BM.%26aulast%3DWu%26aufirst%3DK.%2BJ.%26aulast%3DZhong%26aufirst%3DH.%2BJ.%26aulast%3DWong%26aufirst%3DC.%2BY.%26aulast%3DWong%26aufirst%3DV.%2BK.%2BW.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DSelective%2520Inhibition%2520of%2520Lysine-Specific%2520Demethylase%25205A%2520%2528KDM5A%2529%2520Using%2520a%2520Rhodium%2528III%2529%2520Complex%2520for%2520Triple-Negative%2520Breast%2520Cancer%2520Therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D13091%26epage%3D13095%26doi%3D10.1002%2Fanie.201807305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndagi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mhlongo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, M. E.</span></span> <span> </span><span class="NLM_article-title">Metal Complexes in Cancer Therapy – An Update from Drug Design Perspective</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S119488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2147%2FDDDT.S119488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28424538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOgs7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=599-616&author=U.+Ndagiauthor=N.+Mhlongoauthor=M.+E.+Soliman&title=Metal+Complexes+in+Cancer+Therapy+%E2%80%93+An+Update+from+Drug+Design+Perspective&doi=10.2147%2FDDDT.S119488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Metal complexes in cancer therapy - an update from drug design perspective</span></div><div class="casAuthors">Ndagi, Umar; Mhlongo, Ndumiso; Soliman, Mahmoud E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">599-616</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">In the past, metal-based compds. were widely used in the treatment of disease conditions, but the lack of clear distinction between the therapeutic and toxic doses was a major challenge.  With the discovery of cisplatin by Barnett Rosenberg in 1960, a milestone in the history of metal-based compds. used in the treatment of cancers was witnessed.  This forms the foundation for the modern era of the metal-based anticancer drugs.  Platinum drugs, such as cisplatin, carboplatin and oxaliplatin, are the mainstay of the metal-based compds. in the treatment of cancer, but the delay in the therapeutic accomplishment of other metal-based compds. hampered the progress of research in this field.  Recently, however, there has been an upsurge of activities relying on the structural information, aimed at improving and developing other forms of metal-based compds. and nonclassical platinum complexes whose mechanism of action is distinct from known drugs such as cisplatin.  In line with this, many more metal-based compds. have been synthesized by redesigning the existing chem. structure through ligand substitution or building the entire new compd. with enhanced safety and cytotoxic profile.  However, because of increased emphasis on the clin. relevance of metal-based complexes, a few of these drugs are currently on clin. trial and many more are awaiting ethical approval to join the trial.  In this review, we seek to give an overview of previous reviews on the cytotoxic effect of metal-based complexes while focusing more on newly designed metal-based complexes and their cytotoxic effect on the cancer cell lines, as well as on new approach to metal-based drug design and mol. target in cancer therapy.  We are optimistic that the concept of selective targeting remains the hope of the future in developing therapeutics that would selectively target cancer cells and leave healthy cells unharmed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltxUp021QdrVg90H21EOLACvtfcHk0li0c0lxBYPkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOgs7bI&md5=3ef5ff6ea1338c3c47fb10901a18c4c8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S119488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S119488%26sid%3Dliteratum%253Aachs%26aulast%3DNdagi%26aufirst%3DU.%26aulast%3DMhlongo%26aufirst%3DN.%26aulast%3DSoliman%26aufirst%3DM.%2BE.%26atitle%3DMetal%2520Complexes%2520in%2520Cancer%2520Therapy%2520%25E2%2580%2593%2520An%2520Update%2520from%2520Drug%2520Design%2520Perspective%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2017%26volume%3D11%26spage%3D599%26epage%3D616%26doi%3D10.2147%2FDDDT.S119488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vellaisamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span> <span> </span><span class="NLM_article-title">A Long-Lived Peptide-Conjugated Iridium(III) Complex as a Luminescent Probe and Inhibitor of the Cell Migration Mediator, Formyl Peptide Receptor 2</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">8171</span>– <span class="NLM_lpage">8177</span>, <span class="refDoi"> DOI: 10.1039/C8SC02733A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC8SC02733A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30568767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVamt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=8171-8177&author=K.+Vellaisamyauthor=G.+Liauthor=W.+Wangauthor=C.+H.+Leungauthor=D.+L.+Ma&title=A+Long-Lived+Peptide-Conjugated+Iridium%28III%29+Complex+as+a+Luminescent+Probe+and+Inhibitor+of+the+Cell+Migration+Mediator%2C+Formyl+Peptide+Receptor+2&doi=10.1039%2FC8SC02733A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A long-lived peptide-conjugated iridium(III) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2</span></div><div class="casAuthors">Vellaisamy, Kasipandi; Li, Guodong; Wang, Wanhe; Leung, Chung-Hang; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">8171-8177</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Formyl peptide receptors play important biol. and therapeutic roles in wound repair and inflammatory diseases.  In this work, we present a luminescent iridium(III) complex (6) conjugated with the peptide agonist WKYMVm as a luminescent formyl peptide receptor 2 (FPR2) imaging probe in living cells.  Complex 6 displayed ideal cell imaging characteristics, high photostability and low cytotoxicity.  Competition assays with a known FPR2 antagonist, WRW4, and siRNA knockdown expts. both revealed that complex 6 selectively targeted FPR2 in living HUVEC cells.  Moreover, complex 6 regulated FPR2 signalling in HUVEC cells as shown using a mech. scratch assay.  Finally, complex 6 reduced epithelial cell migration capacity and inhibited lipoxin A4 (LXA4)-triggered cell migration in HUVEC cells, demonstrating the ability of this complex to inhibit FPR2 in living cells.  To our knowledge, this is the first long-lived probe for imaging FPR2 in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZynoDN9lu7Vg90H21EOLACvtfcHk0li0c0lxBYPkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVamt7zN&md5=d8615d4bb3be18434b1ff5c22eeb8658</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC8SC02733A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC02733A%26sid%3Dliteratum%253Aachs%26aulast%3DVellaisamy%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26aulast%3DMa%26aufirst%3DD.%2BL.%26atitle%3DA%2520Long-Lived%2520Peptide-Conjugated%2520Iridium%2528III%2529%2520Complex%2520as%2520a%2520Luminescent%2520Probe%2520and%2520Inhibitor%2520of%2520the%2520Cell%2520Migration%2520Mediator%252C%2520Formyl%2520Peptide%2520Receptor%25202%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D8171%26epage%3D8177%26doi%3D10.1039%2FC8SC02733A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Rhodamine-Modified Fluorescent Half-Sandwich Iridium and Ruthenium Complexes: Potential Application as Bioimaging and Anticancer Agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4788</span>– <span class="NLM_lpage">4793</span>, <span class="refDoi"> DOI: 10.1039/C9DT00999J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC9DT00999J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30892340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks12mtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=4788-4793&author=W.+Maauthor=L.+Guoauthor=Z.+Tianauthor=S.+Zhangauthor=X.+Heauthor=J.+Liauthor=Y.+Yangauthor=Z.+Liu&title=Rhodamine-Modified+Fluorescent+Half-Sandwich+Iridium+and+Ruthenium+Complexes%3A+Potential+Application+as+Bioimaging+and+Anticancer+Agents&doi=10.1039%2FC9DT00999J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents</span></div><div class="casAuthors">Ma, Wenli; Guo, Lihua; Tian, Zhenzhen; Zhang, Shumiao; He, Xiangdong; Li, JuanJuan; Yang, Yuliang; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4788-4793</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Most half-sandwich metal anticancer complexes are non-fluorescent, which results in an uncertain mechanism of action (MoA).  The authors designed and synthesized eight fluorescent half-sandwich iridium(Ir) and ruthenium (Ru) complexes by introducing rhodamine derivs. into the N-N-chelating ligand.  These complexes have features of bio-imaging and anticancer agents and may merit future development as novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMUUWoGJtWLVg90H21EOLACvtfcHk0lgpUDhdgJ8SBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks12mtbk%253D&md5=615a128072c2c4170d08fc347d19a251</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2FC9DT00999J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9DT00999J%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DRhodamine-Modified%2520Fluorescent%2520Half-Sandwich%2520Iridium%2520and%2520Ruthenium%2520Complexes%253A%2520Potential%2520Application%2520as%2520Bioimaging%2520and%2520Anticancer%2520Agents%26jtitle%3DDalton%2520Trans.%26date%3D2019%26volume%3D48%26spage%3D4788%26epage%3D4793%26doi%3D10.1039%2FC9DT00999J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Bichromophoric Anticancer Drug: Targeting Lysosome with Rhodamine Modified Cyclometalated Iridium(III) Complexes</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2018.10.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.dyepig.2018.10.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyit7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=385-393&author=W.+Maauthor=X.+Geauthor=L.+Guoauthor=S.+Zhangauthor=J.+J.+Liauthor=X.+Heauthor=Z.+Liu&title=Bichromophoric+Anticancer+Drug%3A+Targeting+Lysosome+with+Rhodamine+Modified+Cyclometalated+Iridium%28III%29+Complexes&doi=10.1016%2Fj.dyepig.2018.10.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bichromophoric anticancer drug: Targeting lysosome with rhodamine modified cyclometalated Iridium(III) complexes</span></div><div class="casAuthors">Ma, Wenli; Ge, Xingxing; Guo, Lihua; Zhang, Shumiao; Li, JuanJuan; He, Xiangdong; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-393</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Four bichromophoric cyclometalated iridium complexes were synthesized and fully characterized.  Their antiproliferative capacity against A549, HepG2 cells and HeLa cells as well as two human normal cells was studied by MTT assay.  Rhodamine B modified complexes 2 and 4 were not cytotoxic to A549 cells while both rhodamine 6 g modified complexes 1 and 3 showed greater cytotoxicity than cisplatin.  In particular, the antiproliferative activity of complex 3 was about 4.6 times than that of cisplatin.  Thus, complex 3 was used for stability and pH sensitivity studies.  The results indicated that the complex not only had rich fluorescence properties under acidic conditions, but also showed good stability.  Further, interaction of complex with bovine serum albumin (BSA) has been investigated by UV-vis, fluorescence, synchronous fluorescence spectroscopy.  The complexes have a certain ability to bind the BSA.  Interestingly, these complexes can catalyze the reaction of the coenzyme NADH to NAD+, which is consistent with the apparent growth of ROS in cells.  In addn., complex 3 can cause S phase arrest in the cell cycle, induce apoptosis, and affect mitochondrial membrane potential changes.  Localization expts. of intracellular complexes by confocal microscopy suggested that these complexes enter cancer cells through energy dependence and specifically target the lysosomes, thus resulting in the damage of lysosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybDB7VJ5HS7Vg90H21EOLACvtfcHk0lgpUDhdgJ8SBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyit7%252FL&md5=0b4eb62fda5e25e8f39cac71e81e8dc3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2018.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2018.10.019%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DBichromophoric%2520Anticancer%2520Drug%253A%2520Targeting%2520Lysosome%2520with%2520Rhodamine%2520Modified%2520Cyclometalated%2520Iridium%2528III%2529%2520Complexes%26jtitle%3DDyes%2520Pigm.%26date%3D2019%26volume%3D162%26spage%3D385%26epage%3D393%26doi%3D10.1016%2Fj.dyepig.2018.10.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">13552</span>– <span class="NLM_lpage">13563</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b02161</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b02161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGju7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=13552-13563&author=J.+Liauthor=L.+Guoauthor=Z.+Tianauthor=S.+Zhangauthor=Z.+Xuauthor=Y.+Hanauthor=R.+Liauthor=Y.+Liauthor=Z.+Liu&title=Half-Sandwich+Iridium+and+Ruthenium+Complexes%3A+Effective+Tracking+in+Cells+and+Anticancer+Studies&doi=10.1021%2Facs.inorgchem.8b02161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies</span></div><div class="casAuthors">Li, JuanJuan; Guo, Lihua; Tian, Zhenzhen; Zhang, Shumiao; Xu, Zhishan; Han, Yali; Li, Ruixia; Li, Yan; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13552-13563</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Half-sandwich metal-based 2-pyridinecarbaldimine anticancer complexes [Cp'Ir(L2)Cl] and [(arene)Ru(L2)Cl] [1-6; Cp' = C5Me5, C5Me4, 4-PhC6H4; arene = C6H6, p-cymene, Ph(CH2)3OH, Ph(CH2)4OH; L2 = 2-pyCH:NCPh3] suffer from uncertain targets and mechanisms of action.  Herein we report the observation of the images of half-sandwich iridium and ruthenium complexes in cells detected by confocal microscopy.  The confocal microscopy images showed that the cyclopentadienyl iridium complex 1 mainly accumulated in nuclei in A549 lung cancer cells, whereas the arene ruthenium complex 3 is located in mitochondria and lysosomes, mostly in mitochondria, although both complexes entered A549 cells mainly through energy-dependent active transport.  The nuclear morphol. changes caused by Ir complex 1 were also detected by confocal microscopy.  Ir complex 1 is more potent than cisplatin toward A549 and HeLa cells.  DNA binding studies involved interaction with the nucleobases 9-ethylguanine, 9-methyladenine, ctDNA, and plasmid DNA.  The detn. of bovine serum albumin binding was also performed.  Hydrolysis, stability, nucleobase binding, and catalytic NAD+/NADH hydride transfer tests for complexes 1 and 3 were also carried out.  Both complexes activated depolarization of mitochondrial membrane potential and intracellular ROS overprodn. and induced cell apoptosis.  Complex 3 arrested the cell cycle at the G0/G1 phase by inactivation of CDK 4/cyclin D1.  This work paves the way to track and monitor half-sandwich metal complexes in cells, shines a light on understanding their mechanism of action, and indicates their potential application as theranostic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruWrOZczbNY7Vg90H21EOLACvtfcHk0lgpUDhdgJ8SBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGju7nI&md5=7afbfa5bef2a4aebdda9e16438ce30f6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b02161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b02161%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DHalf-Sandwich%2520Iridium%2520and%2520Ruthenium%2520Complexes%253A%2520Effective%2520Tracking%2520in%2520Cells%2520and%2520Anticancer%2520Studies%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26spage%3D13552%26epage%3D13563%26doi%3D10.1021%2Facs.inorgchem.8b02161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Theranostic Iridium(III) Complexes as One- and Two-Photon Phosphorescent Trackers to Monitor Autophagic Lysosomes</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">12137</span>– <span class="NLM_lpage">12141</span>, <span class="refDoi"> DOI: 10.1002/anie.201407468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fanie.201407468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVenu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=12137-12141&author=L.+Heauthor=C.+P.+Tanauthor=R.+R.+Yeauthor=Y.+Z.+Zhaoauthor=Y.+H.+Liuauthor=Q.+Zhaoauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Theranostic+Iridium%28III%29+Complexes+as+One-+and+Two-Photon+Phosphorescent+Trackers+to+Monitor+Autophagic+Lysosomes&doi=10.1002%2Fanie.201407468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Iridium(III) Complexes as One- and Two-Photon Phosphorescent Trackers to Monitor Autophagic Lysosomes</span></div><div class="casAuthors">He, Liang; Tan, Cai-Ping; Ye, Rui-Rong; Zhao, Yi-Zhi; Liu, Ya-Hong; Zhao, Qiang; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">12137-12141</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">During autophagy, the intracellular components are captured in autophagosomes and delivered to lysosomes for degrdn. and recycling.  Changes in lysosomal trafficking and contents are key events in the regulation of autophagy, which has been implicated in many physiol. and pathol. processes.  In this work, two iridium(III) complexes (LysoIr1 and LysoIr2) are developed as theranostic agents to monitor autophagic lysosomes.  These complexes display lysosome-activated phosphorescence and can specifically label lysosomes with high photostability.  Simultaneously, they can induce autophagy potently without initiating an apoptosis response.  We demonstrate that LysoIr2 can effectively implement two functions, namely autophagy induction and lysosomal tracking, in the visualization of autophagosomal-lysosomal fusion.  More importantly, they display strong two-photon excited fluorescence (TPEF), which is favorable for live cell imaging and in vivo applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUHVPaqhDpPrVg90H21EOLACvtfcHk0lhYESMJfP9ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVenu73M&md5=22f87ed3ce76f90623a68d7810d6040e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407468%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DYe%26aufirst%3DR.%2BR.%26aulast%3DZhao%26aufirst%3DY.%2BZ.%26aulast%3DLiu%26aufirst%3DY.%2BH.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DTheranostic%2520Iridium%2528III%2529%2520Complexes%2520as%2520One-%2520and%2520Two-Photon%2520Phosphorescent%2520Trackers%2520to%2520Monitor%2520Autophagic%2520Lysosomes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D12137%26epage%3D12141%26doi%3D10.1002%2Fanie.201407468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allardyce, B. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium in Medicine: Current Clinical Uses and Future Prospects</span>. <i>Platinum Met. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=62-69&author=B.+C.+S.+Allardyceauthor=P.+J.+Dyson&title=Ruthenium+in+Medicine%3A+Current+Clinical+Uses+and+Future+Prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium in medicine: Current clinical uses and future prospects</span></div><div class="casAuthors">Allardyce, Claire S.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Platinum Metals Review</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">62-69</span>CODEN:
                <span class="NLM_cas:coden">PTMRA3</span>;
        ISSN:<span class="NLM_cas:issn">0032-1400</span>.
    
            (<span class="NLM_cas:orgname">Johnson Matthey Public Ltd. Co.</span>)
        </div><div class="casAbstract">A review.  There is no doubt about the success of precious metals in the clinic, with, for example, platinum compds. being widely used in the treatment of cancer, silver compds. being useful antimicrobial agents and gold compds. used routinely in the treatment of rheumatoid arthritis.  The medicinal properties of the other platinum group metals are now being recognized and of these a ruthenium anticancer agent has recently entered the clinic, showing promising activity on otherwise resistant tumors.  Like all metal drugs, the activity of the ruthenium compds. depends on both the oxidn. state and the ligands.  By manipulating these features ruthenium-centered antimalarial, antibiotic and immunosuppressive drugs have been made.  In addn., ruthenium has unique properties which make it particularly useful in drug design.  In this review we discuss ruthenium from a clin. stance and outline the medicinal uses of ruthenium-based compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppc8V-Mj8EArVg90H21EOLACvtfcHk0lhYESMJfP9ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D&md5=778378be61f6e9a4629abe1c585cf87a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllardyce%26aufirst%3DB.%2BC.%2BS.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DRuthenium%2520in%2520Medicine%253A%2520Current%2520Clinical%2520Uses%2520and%2520Future%2520Prospects%26jtitle%3DPlatinum%2520Met.%2520Rev.%26date%3D2001%26volume%3D45%26spage%3D62%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonarakis, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emadi, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-Based Chemotherapeutics: Are They Ready for Prime Time?</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s00280-010-1293-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1007%2Fs00280-010-1293-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=20213076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1-9&author=E.+S.+Antonarakisauthor=A.+Emadi&title=Ruthenium-Based+Chemotherapeutics%3A+Are+They+Ready+for+Prime+Time%3F&doi=10.1007%2Fs00280-010-1293-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-based chemotherapeutics: are they ready for prime time?</span></div><div class="casAuthors">Antonarakis, Emmanuel S.; Emadi, Ashkan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Since the discovery of cis-platinum, many transition metal complexes have been synthesized and assayed for antineoplastic activity.  In recent years, ruthenium-based mols. have emerged as promising antitumor and antimetastatic agents with potential uses in platinum-resistant tumors or as alternatives to platinum.  Ruthenium compds. theor. possess unique biochem. features allowing them to accumulate preferentially in neoplastic tissues and to convert to their active state only after entering tumor cells.  Intriguingly, some ruthenium agents show significant activity against cancer metastases but have minimal effects on primary tumors.  Two ruthenium-based drugs, NAMI-A and KP1019, have reached human clin. testing.  This review will highlight the chem. properties, mechanism of action, preclin. data, and early phase clin. results of these two lead ruthenium compds.  Other promising ruthenium agents will also be reviewed with emphasis on the novel ruthenium compd. ONCO4417, and DW1/2 that has demonstrated Pim-1 kinase inhibition in preclin. systems.  Further development of these and other ruthenium agents may rely on novel approaches including rational combination strategies as well as identification of potential pharmacodynamic biomarkers of drug activity aiding early phase clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAaeL0zbqnFLVg90H21EOLACvtfcHk0lhYESMJfP9ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D&md5=cb705a7e874eeb25d755a8096e6b2a4e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1293-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1293-1%26sid%3Dliteratum%253Aachs%26aulast%3DAntonarakis%26aufirst%3DE.%2BS.%26aulast%3DEmadi%26aufirst%3DA.%26atitle%3DRuthenium-Based%2520Chemotherapeutics%253A%2520Are%2520They%2520Ready%2520for%2520Prime%2520Time%253F%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D1%26epage%3D9%26doi%3D10.1007%2Fs00280-010-1293-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pongratz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schluga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arion, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allmaier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">Transferrin Binding and Transferrin-Mediated Cellular Uptake of the Ruthenium Coordination Compound KP1019, Studied by Means of AAS, ESI-MS and CD Spectroscopy</span>. <i>J. Anal. At. Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1039/b309160k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb309160k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=46-51&author=M.+Pongratzauthor=P.+Schlugaauthor=M.+A.+Jakupecauthor=V.+B.+Arionauthor=C.+G.+Hartingerauthor=G.+Allmaierauthor=B.+K.+Keppler&title=Transferrin+Binding+and+Transferrin-Mediated+Cellular+Uptake+of+the+Ruthenium+Coordination+Compound+KP1019%2C+Studied+by+Means+of+AAS%2C+ESI-MS+and+CD+Spectroscopy&doi=10.1039%2Fb309160k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy</span></div><div class="casAuthors">Pongratz, Martina; Schluga, Petra; Jakupec, Michael A.; Arion, Vladimir B.; Hartinger, Christian G.; Allmaier, Guenter; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Analytical Atomic Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-51</span>CODEN:
                <span class="NLM_cas:coden">JASPE2</span>;
        ISSN:<span class="NLM_cas:issn">0267-9477</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(iii)] (KP1019) shows particular promise as an antitumor agent against colorectal cancer.  It is known that KP1019 reacts with human serum proteins, whereby the major amt. binds to albumin (present in large excess) and a smaller amt. to transferrin.  It has been hypothesised that transferrin-mediated uptake by transferrin receptor expressing tumor cells may in part explain the apparent tumor selectivity of this compd.  CD spectroscopy and electrospray ionization mass spectrometry studies demonstrate that two equiv.  Of KP1019 bind specifically to human apotransferrin, while addnl. amts. of the ruthenium complex bind unspecifically.  Uptake studies in the transferrin receptor-expressing human colon carcinoma cell line SW480 revealed a higher cellular accumulation of KP1019 in comparison to a KP1019-transferrin adduct (2:1), while the uptake of a KP1019-Fe(iii)-transferrin conjugate (1:0.3:1) significantly exceeded that of KP1019, suggesting that iron binding is necessary to obtain a protein conformation which favors recognition by the transferrin receptors on the cell surface.  Our study showed that KP1019 is transported into the cell by both transferrin-independent and transferrin-dependent mechanisms.  Transferrin-mediated uptake is more efficient when transferrin is satd. with iron to a physiol. degree (∼30%).  Cell fractionation expts. demonstrated that after a 2 h treatment of human colon cancer cells with 10 μM KP1019 on av. 55% of the intracellular ruthenium is located in the cellular nucleus, while 45% remain in the cytosol and other cellular components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Ias6Es1jfbVg90H21EOLACvtfcHk0lhYESMJfP9ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslehtA%253D%253D&md5=640227f005871cd1ca1d827389a18487</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2Fb309160k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb309160k%26sid%3Dliteratum%253Aachs%26aulast%3DPongratz%26aufirst%3DM.%26aulast%3DSchluga%26aufirst%3DP.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DArion%26aufirst%3DV.%2BB.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DAllmaier%26aufirst%3DG.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DTransferrin%2520Binding%2520and%2520Transferrin-Mediated%2520Cellular%2520Uptake%2520of%2520the%2520Ruthenium%2520Coordination%2520Compound%2520KP1019%252C%2520Studied%2520by%2520Means%2520of%2520AAS%252C%2520ESI-MS%2520and%2520CD%2520Spectroscopy%26jtitle%3DJ.%2520Anal.%2520At.%2520Spectrom.%26date%3D2004%26volume%3D19%26spage%3D46%26epage%3D51%26doi%3D10.1039%2Fb309160k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span> <span> </span><span class="NLM_article-title">Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1560</span>, <span class="refDoi"> DOI: 10.1002/ejic.201600986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fejic.201600986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1549-1560&author=E.+Alessio&title=Thirty+Years+of+the+Drug+Candidate+NAMI-A+and+the+Myths+in+the+Field+of+Ruthenium+Anticancer+Compounds%3A+A+Personal+Perspective&doi=10.1002%2Fejic.201600986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective</span></div><div class="casAuthors">Alessio, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1549-1560</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">As anticipated in the title, this contribution is basically divided into two, strictly connected, parts.  The first is a personal overview of the ruthenium drug candidate NAMI-A, almost 30 years after its synthesis and the discovery of its unprecedented antimetastatic properties in animal models at nontoxic dosages.  The sections relating to the chem. and biol. behavior of the complex, and the hypotheses on its mechanism(s) of action, are kept to a min., whereas more space is devoted to discussion of the results of the clin. investigations.  The second part deals in detail with a no. of undemonstrated misconceptions (or myths) that, over the years, have thrived around NAMI-A and other ruthenium drug candidates, thus neg. affecting the whole field of Ru anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjex9sRUkCbVg90H21EOLACvtfcHk0lidodYSvtASUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK&md5=ca48413b7dd02a63edf5049a9a5c7377</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fejic.201600986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201600986%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26atitle%3DThirty%2520Years%2520of%2520the%2520Drug%2520Candidate%2520NAMI-A%2520and%2520the%2520Myths%2520in%2520the%2520Field%2520of%2520Ruthenium%2520Anticancer%2520Compounds%253A%2520A%2520Personal%2520Perspective%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1549%26epage%3D1560%26doi%3D10.1002%2Fejic.201600986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E. J.</span></span> <span> </span><span class="NLM_article-title">Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5805</span>– <span class="NLM_lpage">5821</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01689</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5805-5821&author=S.+Thotaauthor=D.+A.+Rodriguesauthor=D.+C.+Cransauthor=E.+J.+Barreiro&title=Ru%28II%29+Compounds%3A+Next-Generation+Anticancer+Metallotherapeutics%3F&doi=10.1021%2Facs.jmedchem.7b01689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?</span></div><div class="casAuthors">Thota, Sreekanth; Rodrigues, Daniel A.; Crans, Debbie C.; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5805-5821</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metal based therapeutics are a precious class of drugs in oncol. research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics applications.  Ruthenium compds. have shown selective bioactivity and the ability to overcome the resistance that platinum-based therapeutics face, making them effective oncotherapeutic competitors in rational drug invention approaches.  The development of antineoplastic ruthenium therapeutics is of particular interest because ruthenium contg. complexes NAMI-A, KP1019, and KP1339 entered clin. trials and DW1/2 is in preclin. levels.  The very robust, conformationally rigid organometallic Ru(II) compd. DW1/2 is a protein kinase inhibitor and presents new Ru(II) compd. designs as anticancer agents.  Over the recent years, numerous strategies have been used to encapsulate Ru(II) derived compds. in a nanomaterial system, improving their targeting and delivery into neoplastic cells.  A new photodynamic therapy based Ru(II) therapeutic, TLD-1433, has also entered clin. trials.  Ru(II)-based compds. can also be photosensitizers for photodynamic therapy, which has proven to be an effective new, alternative, and noninvasive oncotherapy modality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpCNrozZw4y7Vg90H21EOLACvtfcHk0lidodYSvtASUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCgsbc%253D&md5=2b539999f1e68e2ea1369b8f8ff9c719</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01689%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DRu%2528II%2529%2520Compounds%253A%2520Next-Generation%2520Anticancer%2520Metallotherapeutics%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5805%26epage%3D5821%26doi%3D10.1021%2Facs.jmedchem.7b01689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Notaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Monomeric and Dimeric Coordinatively Saturated and Substitutionally Inert Ru(II) Polypyridyl Complexes as Anticancer Drug Candidates</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7317</span>– <span class="NLM_lpage">7337</span>, <span class="refDoi"> DOI: 10.1039/C7CS00356K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC7CS00356K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=29027562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7317-7337&author=A.+Notaroauthor=G.+Gasser&title=Monomeric+and+Dimeric+Coordinatively+Saturated+and+Substitutionally+Inert+Ru%28II%29+Polypyridyl+Complexes+as+Anticancer+Drug+Candidates&doi=10.1039%2FC7CS00356K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(II) polypyridyl complexes as anticancer drug candidates</span></div><div class="casAuthors">Notaro, Anna; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7317-7337</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Due to the increasing impact of cancer on worldwide mortality, more and more attention is being devoted to the investigation of novel anticancer strategies.  Among these, chemotherapy plays a key role in fighting cancer.  This explains the increasing engagement of both the pharmaceutical industry and academia towards the discovery of new chemotherapeutic agents.  In recent years, metal-based drugs have attracted much attention due to their atypical physico-chem. properties compared to org. mols.  After the approval of cisplatin as a chemotherapeutic agent in 1978, several types of metal-based drugs have been explored.  Among them, Ru-based anticancer drug candidates have become a central subject in this research field.  However, most of the Ru-based compds. investigated over the last two decades express their cytotoxicity with a mechanism of action involving, among others, a ligand-exchange mechanism.  In this Review, we give a complete overview of a specific class of antiproliferative ruthenium complexes, namely coordinatively satd. and substitutionally inert Ru(II) polypyridyl complexes.  This implies that the cytotoxicity obsd. comes from the entire complex and not from ligand-exchange.  In this Review, we present monomeric and dimeric Ru(II) polypyridyl complexes, which have been found to be toxic to cancer cells.  More specifically, monomeric Ru(II) polypyridyl complexes are analyzed considering their direct interaction or not with DNA as the cause of cell death, while dimeric Ru(II) polypyridyl complexes are classified according to their biol. targets.  Very importantly, the cellular targets of these complexes are discussed in detail.  Indeed, several targets were identified and different mechanisms of action were suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC29dn6JqWwLVg90H21EOLACvtfcHk0lidodYSvtASUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI&md5=7e75dd00ef156901717f18db3f67d304</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7CS00356K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00356K%26sid%3Dliteratum%253Aachs%26aulast%3DNotaro%26aufirst%3DA.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMonomeric%2520and%2520Dimeric%2520Coordinatively%2520Saturated%2520and%2520Substitutionally%2520Inert%2520Ru%2528II%2529%2520Polypyridyl%2520Complexes%2520as%2520Anticancer%2520Drug%2520Candidates%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D7317%26epage%3D7337%26doi%3D10.1039%2FC7CS00356K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">KP1019, a New Redox-Active Anticancer Agent--Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2155</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200890195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcbdv.200890195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=18972504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWktLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=2140-2155&author=C.+G.+Hartingerauthor=M.+A.+Jakupecauthor=S.+Zorbas-Seifriedauthor=M.+Groesslauthor=A.+Eggerauthor=W.+Bergerauthor=H.+Zorbasauthor=P.+J.+Dysonauthor=B.+K.+Keppler&title=KP1019%2C+a+New+Redox-Active+Anticancer+Agent%2D%2DPreclinical+Development+and+Results+of+a+Clinical+Phase+I+Study+in+Tumor+Patients&doi=10.1002%2Fcbdv.200890195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients</span></div><div class="casAuthors">Hartinger, Christian G.; Jakupec, Michael A.; Zorbas-Seifried, Stefanie; Groessl, Michael; Egger, Alexander; Berger, Walter; Zorbas, Haralabos; Dyson, Paul J.; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2140-2155</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">A review.  The promising drug candidate indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) is the second Ru-based anticancer agent to enter clin. trials.  In this review, which is an update of a paper from 2006, the exptl. evidence for the proposed mode of action of this coordination compd. is discussed, including transport into the cell via the transferrin cycle and activation by redn.  The results of the early clin. development of KP1019 are summarized in which 5 out of 6 evaluated patients experienced disease stabilization with no severe side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFbfjYPQ2wKrVg90H21EOLACvtfcHk0liCeFX0AtS7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWktLvO&md5=2d209d437e1c5fefb72827d3eade21d7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200890195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200890195%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DGroessl%26aufirst%3DM.%26aulast%3DEgger%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DKP1019%252C%2520a%2520New%2520Redox-Active%2520Anticancer%2520Agent--Preclinical%2520Development%2520and%2520Results%2520of%2520a%2520Clinical%2520Phase%2520I%2520Study%2520in%2520Tumor%2520Patients%26jtitle%3DChem.%2520Biodiversity%26date%3D2008%26volume%3D5%26spage%3D2140%26epage%3D2155%26doi%3D10.1002%2Fcbdv.200890195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, K. K.</span></span> <span> </span><span class="NLM_article-title">Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2231</span>– <span class="NLM_lpage">2247</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b02979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b02979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=2231-2247&author=J.+Shumauthor=P.+K.+Leungauthor=K.+K.+Lo&title=Luminescent+Ruthenium%28II%29+Polypyridine+Complexes+for+a+Wide+Variety+of+Biomolecular+and+Cellular+Applications&doi=10.1021%2Facs.inorgchem.8b02979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications</span></div><div class="casAuthors">Shum, Justin; Leung, Peter Kam-Keung; Lo, Kenneth Kam-Wing</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2231-2247</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with refs.  Ruthenium(II) polypyridine complexes are one of the most extensively studied and developed systems in the family of luminescent transition-metal complexes.  Notably, there has been a large amt. of interest in the biol. applications of these luminescent ruthenium(II) complexes because of their rich photophys. and photochem. properties.  In this Viewpoint, we explore past and recent works on the possible biol. and cellular applications of these promising complexes, with a focus on their use as bioimaging reagents, biomol. probes, and phototherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq19TDxfAlWLVg90H21EOLACvtfcHk0liCeFX0AtS7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWmt70%253D&md5=3c63870a2c07c7a0a8d9f44eb4cdb69c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b02979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b02979%26sid%3Dliteratum%253Aachs%26aulast%3DShum%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DP.%2BK.%26aulast%3DLo%26aufirst%3DK.%2BK.%26atitle%3DLuminescent%2520Ruthenium%2528II%2529%2520Polypyridine%2520Complexes%2520for%2520a%2520Wide%2520Variety%2520of%2520Biomolecular%2520and%2520Cellular%2520Applications%26jtitle%3DInorg.%2520Chem.%26date%3D2019%26volume%3D58%26spage%3D2231%26epage%3D2247%26doi%3D10.1021%2Facs.inorgchem.8b02979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Organometallic Compounds: An Opportunity for Chemical Biology?</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1252</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcbic.201200159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=22619182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1232-1252&author=M.+Patraauthor=G.+Gasser&title=Organometallic+Compounds%3A+An+Opportunity+for+Chemical+Biology%3F&doi=10.1002%2Fcbic.201200159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Compounds: An Opportunity for Chemical Biology?</span></div><div class="casAuthors">Patra, Malay; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1232-1252</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Organometallic compds. are renowned for their remarkable applications in the field of catalysis, but much less is known about their potential in chem. biol.  Indeed, such compds. have long been considered to be either unstable under physiol. conditions or cytotoxic.  As a consequence, little attention has been paid to their possible utilization for biol. purposes.  Because of their outstanding physicochem. properties, which include chem. stability, structural diversity and unique photo- and electrochem. properties, however, organometallic compds. have the ability to play a leading role in the field of chem. biol.  Indeed, remarkable examples of the use of such compds.-notably as enzyme inhibitors and as luminescent agents-have recently been reported.  Here we summarise recent advances in the use of organometallic compds. for chem. biol. purposes, an area that we define as "organometallic chem. biol.".  We also demonstrate that these recent discoveries are only a beginning and that many other organometallic complexes are likely to be found useful in this field of research in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNf0UB7MS87Vg90H21EOLACvtfcHk0liCeFX0AtS7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D&md5=45260dcd1168ae3b7311dad351669eda</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200159%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DOrganometallic%2520Compounds%253A%2520An%2520Opportunity%2520for%2520Chemical%2520Biology%253F%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26spage%3D1232%26epage%3D1252%26doi%3D10.1002%2Fcbic.201200159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dörr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Metal Complexes as Structural Templates for Targeting Proteins</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2014.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.cbpa.2014.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24561508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A280%3ADC%252BC2cvnt1ClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=76-81&author=M.+D%C3%B6rrauthor=E.+Meggers&title=Metal+Complexes+as+Structural+Templates+for+Targeting+Proteins&doi=10.1016%2Fj.cbpa.2014.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Metal complexes as structural templates for targeting proteins</span></div><div class="casAuthors">Dorr Markus; Meggers Eric</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in chemical biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article reviews recent advances in the design and discovery of inert metal complexes as protein binders.  In these metal-based probes or drug candidates, the metal is supposed to exert a purely structural role by organizing the coordinating ligands in the three dimensional space to achieve a shape and functional group complementarity with the targeted protein pockets.  Presented examples of sandwich, half-sandwich and octahedral d(6)-metal complexes reinforce previous perceptions that metal complexes are highly promising scaffolds for the design of small-molecule protein binders and complement the molecular diversity of organic chemistry by opening untapped chemical space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsX3lyk_77rjnyZkbE8yXfW6udTcc2eYqRTLEqMikrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvnt1ClsA%253D%253D&md5=b27797c33ed4ef96ee3185c8ed3fecda</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2014.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2014.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25B6rr%26aufirst%3DM.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DMetal%2520Complexes%2520as%2520Structural%2520Templates%2520for%2520Targeting%2520Proteins%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D19%26spage%3D76%26epage%3D81%26doi%3D10.1016%2Fj.cbpa.2014.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakubaszek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goud, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Action of Ru (II) Polypyridyl Complexes in Living Cells upon Light Irradiation</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">13040</span>– <span class="NLM_lpage">13059</span>, <span class="refDoi"> DOI: 10.1039/C8CC05928D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC8CC05928D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30398487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFynsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=13040-13059&author=M.+Jakubaszekauthor=B.+Goudauthor=S.+Ferrariauthor=G.+Gasser&title=Mechanisms+of+Action+of+Ru+%28II%29+Polypyridyl+Complexes+in+Living+Cells+upon+Light+Irradiation&doi=10.1039%2FC8CC05928D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of Ru(II) polypyridyl complexes in living cells upon light irradiation</span></div><div class="casAuthors">Jakubaszek, Marta; Goud, Bruno; Ferrari, Stefano; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">93</span>),
    <span class="NLM_cas:pages">13040-13059</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The unique photophys. properties of Ru(II) polypyridyl complexes make them very attractive candidates as photosensitizers in Photodynamic Therapy (PDT).  However, to date, there are not many studies exploring in detail the mechanism(s) of action of such compds. in living systems upon light irradn.  This feature article provides an overview of the most in-depth biol. studies on such compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru9cgu7gof7LVg90H21EOLACvtfcHk0ljBm5qXFqJ_fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFynsrfF&md5=5a2720aac8223eb35c5560865b88efef</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC8CC05928D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC05928D%26sid%3Dliteratum%253Aachs%26aulast%3DJakubaszek%26aufirst%3DM.%26aulast%3DGoud%26aufirst%3DB.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMechanisms%2520of%2520Action%2520of%2520Ru%2520%2528II%2529%2520Polypyridyl%2520Complexes%2520in%2520Living%2520Cells%2520upon%2520Light%2520Irradiation%26jtitle%3DChem.%2520Commun.%26date%3D2018%26volume%3D54%26spage%3D13040%26epage%3D13059%26doi%3D10.1039%2FC8CC05928D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capozzi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clerici, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Control of Lung Metastases of Solid Tumours by a Novel Ruthenium Complex</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1023/A:1006521715400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1023%2FA%3A1006521715400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=9626816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK1cXktVCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=371-379&author=G.+Savaauthor=I.+Capozziauthor=K.+Clericiauthor=G.+Gagliardiauthor=E.+Alessioauthor=G.+Mestroni&title=Pharmacological+Control+of+Lung+Metastases+of+Solid+Tumours+by+a+Novel+Ruthenium+Complex&doi=10.1023%2FA%3A1006521715400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological control of lung metastases of solid tumors by a novel ruthenium complex</span></div><div class="casAuthors">Sava, G.; Capozzi, I.; Clerici, K.; Gagliardi, G.; Alessio, E.; Mestroni, G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-379</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Imidazolium trans-imidazoledimethylsulfoxidetetrachlororuthenate ImH[trans-RuCl4(DMSO)Im] (NAMI-A), a ruthenium compd. that replaces Na+ with ImH+ in the mol. of Na[trans-RuCl4(DMSO)Im] (NAMI), was studied for the anti-metastasis effects in models of solid metastasizing tumors of the mouse.  NAMI-A, given i.p. at 35 mg/kg/day for six consecutive days, a dose equimolar to that of NAMI, to mice bearing Lewis lung carcinoma and MCa mammary carcinoma, markedly reduces lung metastasis wt. by 80-90%, with an effect equal or even superior to that of NAMI, depending on the exptl. system adopted.  Correspondingly, NAMI-A increases the content of connective tissue in the tumor matrix, around blood vessels, and in the tumor capsule, augments the percentage of tumor cells in G2/M phase and reduces the amt. of CD45+ cells infiltrating the tumor parenchyma.  The effects of the same doses on spleen lymphocytes correspond to an increase of CD8+ subset without any change of the distribution of cells in G0/G1, S and G2/M phases.  The study shows that NAMI-A behaves similarly to NAMI on the several parameters examd. in comparison expts. and therefore we suggest to credit NAMI-A with all the biol. actions already described for NAMI during the last 3 yr.  The replacement of Na+ with ImH+ therefore, besides the better chem. stability of the mol., confers to [trans-RuCl4(DMSO)Im]- a closer similarity with a true drug to be used in humans, and suggests this mol. for future studies of preclin. toxicol. and phase I and II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroao_W_m8lCbVg90H21EOLACvtfcHk0ljBm5qXFqJ_fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVCls74%253D&md5=90d2e969623e74ae0c788017193ce0b2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006521715400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006521715400%26sid%3Dliteratum%253Aachs%26aulast%3DSava%26aufirst%3DG.%26aulast%3DCapozzi%26aufirst%3DI.%26aulast%3DClerici%26aufirst%3DK.%26aulast%3DGagliardi%26aufirst%3DG.%26aulast%3DAlessio%26aufirst%3DE.%26aulast%3DMestroni%26aufirst%3DG.%26atitle%3DPharmacological%2520Control%2520of%2520Lung%2520Metastases%2520of%2520Solid%2520Tumours%2520by%2520a%2520Novel%2520Ruthenium%2520Complex%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D1998%26volume%3D16%26spage%3D371%26epage%3D379%26doi%3D10.1023%2FA%3A1006521715400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lentz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drescher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheulen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaehde, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of a Novel Anticancer Ruthenium Complex (KP1019, FFC14A) in a Phase I Dose-Escalation Study</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1097/CAD.0b013e328322fbc5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1097%2FCAD.0b013e328322fbc5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=19209025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVSitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=97-103&author=F.+Lentzauthor=A.+Drescherauthor=A.+Lindauerauthor=M.+Henkeauthor=R.+A.+Hilgerauthor=C.+G.+Hartingerauthor=M.+E.+Scheulenauthor=C.+Dittrichauthor=B.+K.+Kepplerauthor=U.+Jaehde&title=Pharmacokinetics+of+a+Novel+Anticancer+Ruthenium+Complex+%28KP1019%2C+FFC14A%29+in+a+Phase+I+Dose-Escalation+Study&doi=10.1097%2FCAD.0b013e328322fbc5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study</span></div><div class="casAuthors">Lentz, Frederike; Drescher, Anne; Lindauer, Andreas; Henke, Magdalena; Hilger, Ralf A.; Hartinger, Christian G.; Scheulen, Max E.; Dittrich, Christian; Keppler, Bernhard K.; Jaehde, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A phase I and pharmacokinetic study was carried out with the new ruthenium complex indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019, FFC14A).  Seven patients with various types of solid tumors refractory to std. therapy were treated with escalating doses of KP1019 (25-600 mg) twice weekly for 3 wk.  No dose-limiting toxicity occurred.  Ruthenium plasma concn.-time profiles after the first dose and under multiple-dose conditions were analyzed using a compartmental approach.  The pharmacokinetic disposition was characterized by a small vol. of distribution, low clearance and long half-life.  Only a small fraction of ruthenium was excreted renally.  The area under the curve values increased proportionally with dose indicating linear pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoISQUGWLMSRLVg90H21EOLACvtfcHk0ljBm5qXFqJ_fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVSitLk%253D&md5=d9932340c33d687d18de202db61cb853</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1097%2FCAD.0b013e328322fbc5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0b013e328322fbc5%26sid%3Dliteratum%253Aachs%26aulast%3DLentz%26aufirst%3DF.%26aulast%3DDrescher%26aufirst%3DA.%26aulast%3DLindauer%26aufirst%3DA.%26aulast%3DHenke%26aufirst%3DM.%26aulast%3DHilger%26aufirst%3DR.%2BA.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DScheulen%26aufirst%3DM.%2BE.%26aulast%3DDittrich%26aufirst%3DC.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DJaehde%26aufirst%3DU.%26atitle%3DPharmacokinetics%2520of%2520a%2520Novel%2520Anticancer%2520Ruthenium%2520Complex%2520%2528KP1019%252C%2520FFC14A%2529%2520in%2520a%2520Phase%2520I%2520Dose-Escalation%2520Study%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D97%26epage%3D103%26doi%3D10.1097%2FCAD.0b013e328322fbc5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trondl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">NKP-1339, the First Ruthenium-Based Anticancer Drug on the Edge to Clinical Application</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2925</span>– <span class="NLM_lpage">2932</span>, <span class="refDoi"> DOI: 10.1039/C3SC53243G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC3SC53243G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2925-2932&author=R.+Trondlauthor=P.+Heffeterauthor=C.+R.+Kowolauthor=M.+A.+Jakupecauthor=W.+Bergerauthor=B.+K.+Keppler&title=NKP-1339%2C+the+First+Ruthenium-Based+Anticancer+Drug+on+the+Edge+to+Clinical+Application&doi=10.1039%2FC3SC53243G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application</span></div><div class="casAuthors">Trondl, Robert; Heffeter, Petra; Kowol, Christian R.; Jakupec, Michael A.; Berger, Walter; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2925-2932</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">NKP-1339 is the first-in-class ruthenium-based anticancer drug in clin. development against solid cancer and has recently been studied successfully in a phase I clin. trial.  Ruthenium compds. such as KP1019 (indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) and NKP-1339 (the sodium salt analog of KP1019, sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) have a high tumor targeting potential based (1) on their strong binding to serum proteins such as albumin and transferrin as well as (2) on their activation in the reductive tumor milieu.  The redox activity of ruthenium compds. is believed to represent one major mode of action leading to disturbance of the cellular redox balance and, consequently, induction of G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway.  Moreover, potent synergistic activities of NKP-1339 with the clin. approved tyrosine kinase inhibitor sorafenib were recently reported in vitro and in vivo.  Taken together, KP1019 and NKP-1339 are promising drug candidates, and esp. the very limited side effects obsd. so far in clin. phase I trials seem to be a major advantage of this class of ruthenium drugs as compared to other chemotherapeutics and targeted anticancer compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEg6EqdpG67rVg90H21EOLACvtfcHk0lgh8Y1TXRmanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM&md5=6f64a036fee96d03f0f0803b80ff1da7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC3SC53243G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3SC53243G%26sid%3Dliteratum%253Aachs%26aulast%3DTrondl%26aufirst%3DR.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DKowol%26aufirst%3DC.%2BR.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DNKP-1339%252C%2520the%2520First%2520Ruthenium-Based%2520Anticancer%2520Drug%2520on%2520the%2520Edge%2520to%2520Clinical%2520Application%26jtitle%3DChem.%2520Sci.%26date%3D2014%26volume%3D5%26spage%3D2925%26epage%3D2932%26doi%3D10.1039%2FC3SC53243G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kynast, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">From Bench to Bedside - Preclinical and Early Clinical Development of the Anticancer Agent Indazolium Trans-[Tetrachlorobis(1H-Indazole)Ruthenate(III)] (KP1019 or FFC14A)</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2006.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jinorgbio.2006.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=16603249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=891-904&author=C.+G.+Hartingerauthor=S.+Zorbas-Seifriedauthor=M.+A.+Jakupecauthor=B.+Kynastauthor=H.+Zorbasauthor=B.+K.+Keppler&title=From+Bench+to+Bedside+-+Preclinical+and+Early+Clinical+Development+of+the+Anticancer+Agent+Indazolium+Trans-%5BTetrachlorobis%281H-Indazole%29Ruthenate%28III%29%5D+%28KP1019+or+FFC14A%29&doi=10.1016%2Fj.jinorgbio.2006.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)</span></div><div class="casAuthors">Hartinger, Christian G.; Zorbas-Seifried, Stefanie; Jakupec, Michael A.; Kynast, Bernd; Zorbas, Haralabos; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">891-904</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A) is just the second ruthenium-based anticancer agent after NAMI-A which was developed to the stage of clin. trials.  Important steps in the mode of action of KP1019 are thought to be the binding to the serum protein transferrin and the transport into the cell via the transferrin pathway.  Addnl., the selective activation by redn. in the tumor might contribute to the low side effects obsd. in in vivo studies.  Apoptosis is induced at non-toxic levels via the mitochondrial pathway.  These features distinguish it from the established platinum anticancer drugs and suggest that different types of cancer might be treatable with this drug.  Indeed, promising activity against certain types of tumors, which are not successfully treatable with cisplatin, and only a very low incidence of acquired resistance has been obsd. in in vitro and in vivo studies.  Recently, a clin. phase I trial was finished in which none of the treated patients experienced serious side effects, while disease stabilization in five of six evaluable patients was achieved.  In this review, the preclin. and early clin. development of KP1019 - from bench to bedside - is recapitulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQXGOcIpo0P7Vg90H21EOLACvtfcHk0lgh8Y1TXRmanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D&md5=8fe177baac72fa807e2eb96ecce7e07a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2006.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2006.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DKynast%26aufirst%3DB.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DFrom%2520Bench%2520to%2520Bedside%2520-%2520Preclinical%2520and%2520Early%2520Clinical%2520Development%2520of%2520the%2520Anticancer%2520Agent%2520Indazolium%2520Trans-%255BTetrachlorobis%25281H-Indazole%2529Ruthenate%2528III%2529%255D%2520%2528KP1019%2520or%2520FFC14A%2529%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2006%26volume%3D100%26spage%3D891%26epage%3D904%26doi%3D10.1016%2Fj.jinorgbio.2006.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakewell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigel, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D.</span></span> <span> </span><span class="NLM_article-title">Safety and Activity of IT-139, a Ruthenium-Based Compound, in Patients with Advanced Solid Tumours: A First- Phase I Study with Expansion Cohort</span>. <i>ESMO Open</i> <span class="NLM_year" style="font-weight: bold;">2016</span>, <span class="NLM_elocation-id">e000154</span> <span class="refDoi"> DOI: 10.1136/esmoopen-2016-000154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1136%2Fesmoopen-2016-000154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28848672" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+A.+Burrisauthor=S.+Bakewellauthor=J.+C.+Bendellauthor=J.+Infanteauthor=S.+F.+Jonesauthor=D.+R.+Spigelauthor=G.+J.+Weissauthor=R.+K.+Ramanathanauthor=A.+Ogdenauthor=D.+Von+Hoff&title=Safety+and+Activity+of+IT-139%2C+a+Ruthenium-Based+Compound%2C+in+Patients+with+Advanced+Solid+Tumours%3A+A+First-+Phase+I+Study+with+Expansion+Cohort&doi=10.1136%2Fesmoopen-2016-000154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1136%2Fesmoopen-2016-000154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fesmoopen-2016-000154%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DBakewell%26aufirst%3DS.%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DOgden%26aufirst%3DA.%26aulast%3DVon%2BHoff%26aufirst%3DD.%26atitle%3DSafety%2520and%2520Activity%2520of%2520IT-139%252C%2520a%2520Ruthenium-Based%2520Compound%252C%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumours%253A%2520A%2520First-%2520Phase%2520I%2520Study%2520with%2520Expansion%2520Cohort%26jtitle%3DESMO%2520Open%26date%3D2016%26doi%3D10.1136%2Fesmoopen-2016-000154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumoulin-White, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Metal-Based Photosensitizers for Photodynamic Therapy: The Future of Multimodal Oncology?</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2019.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.cbpa.2019.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=31759225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1arsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2020&pages=23-27&author=S.+A.+McFarlandauthor=A.+Mandelauthor=R.+Dumoulin-Whiteauthor=G.+Gasser&title=Metal-Based+Photosensitizers+for+Photodynamic+Therapy%3A+The+Future+of+Multimodal+Oncology%3F&doi=10.1016%2Fj.cbpa.2019.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?</span></div><div class="casAuthors">McFarland, Sherri A.; Mandel, Arkady; Dumoulin-White, Roger; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an approved medical technique to treat certain forms of cancer.  It has been used to complement traditional anticancer modalities such as surgery, chemotherapy or radiotherapy, and in certain cases, to replace these treatments.  One crit. parameter of PDT is the photosensitizer (PS); historically, a purely org. macrocyclic tetrapyrrole-based structure.  This short review surveys two recent clin. examples of metal complexes, namely TOOKAD-Sol. and TLD-1433, which have ideal photophys. properties to act as PDT PSs.  We highlight the important role played by the metal ions in the PS for PDT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1FSY6muUTurVg90H21EOLACvtfcHk0lgh8Y1TXRmanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1arsrzE&md5=2d29a57575c5fd9d67a210683fbcab0d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26aulast%3DMandel%26aufirst%3DA.%26aulast%3DDumoulin-White%26aufirst%3DR.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMetal-Based%2520Photosensitizers%2520for%2520Photodynamic%2520Therapy%253A%2520The%2520Future%2520of%2520Multimodal%2520Oncology%253F%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2020%26volume%3D56%26spage%3D23%26epage%3D27%26doi%3D10.1016%2Fj.cbpa.2019.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colo, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcfarland, S. A.</span></span> <span> </span><span class="NLM_article-title">Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=797-828&author=H.+Yinauthor=J.+Roqueauthor=P.+Kondaauthor=S.+Monroauthor=K.+L.+Coloauthor=S.+Gujarauthor=R.+P.+Thummelauthor=L.+Lilgeauthor=C.+G.+Cameronauthor=S.+A.+Mcfarland&title=Transition+Metal+Complexes+and+Photodynamic+Therapy+from+a+Tumor-Centered+Approach%3A+Challenges%2C+Opportunities%2C+and+Highlights+from+the+Development+of+TLD1433&doi=10.1021%2Facs.chemrev.8b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433</span></div><div class="casAuthors">Monro, Susan; Colon, Katsuya L.; Yin, Huimin; Roque, John; Konda, Prathyusha; Gujar, Shashi; Thummel, Randolph P.; Lilge, Lothar; Cameron, Colin G.; McFarland, Sherri A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-828</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition metal complexes are of increasing interest as photosensitizers in photodynamic therapy (PDT) and, more recently, for photochemotherapy (PCT).  In recent years, Ru(II) polypyridyl complexes have emerged as promising systems for both PDT and PCT.  Their rich photochem. and photophys. properties derive from a variety of excited-state electronic configurations accessible with visible and near-IR light, and these properties can be exploited for both energy- and electron-transfer processes that can yield highly potent oxygen-dependent and/or oxygen-independent photobiol. activity.  Selected examples highlight the use of rational design in coordination chem. to control the lowest-energy triplet excited-state configurations for eliciting a particular type of photoreactivity for PDT and/or PCT effects.  These principles are also discussed in the context of the development of TLD1433, the first Ru(II)-based photosensitizer for PDT to enter a human clin. trial.  The design of TLD1433 arose from a tumor-centered approach, as part of a complete PDT package that includes the light component and the protocol for treating non-muscle invasive bladder cancer.  Briefly, this review summarizes the challenges to bringing PDT into mainstream cancer therapy.  It considers the chem. and photophys. solns. that transition metal complexes offer, and it puts into context the multidisciplinary effort needed to bring a new drug to clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvMiOuSE20lbVg90H21EOLACvtfcHk0ljvxZ9S28_j2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK&md5=73b333b327b1f83a6146b321dfe80ba9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00211%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DRoque%26aufirst%3DJ.%26aulast%3DKonda%26aufirst%3DP.%26aulast%3DMonro%26aufirst%3DS.%26aulast%3DColo%26aufirst%3DK.%2BL.%26aulast%3DGujar%26aufirst%3DS.%26aulast%3DThummel%26aufirst%3DR.%2BP.%26aulast%3DLilge%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DC.%2BG.%26aulast%3DMcfarland%26aufirst%3DS.%2BA.%26atitle%3DTransition%2520Metal%2520Complexes%2520and%2520Photodynamic%2520Therapy%2520from%2520a%2520Tumor-Centered%2520Approach%253A%2520Challenges%252C%2520Opportunities%252C%2520and%2520Highlights%2520from%2520the%2520Development%2520of%2520TLD1433%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D797%26epage%3D828%26doi%3D10.1021%2Facs.chemrev.8b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><a href="http://Https://clinicaltrials.gov/ct2/show/NCT03945162?term=TLD-1433&amp;rank=1" class="extLink">Https://clinicaltrials.gov/ct2/show/NCT03945162?term=TLD-1433&rank=1</a> (accessed Sept 27, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03945162%3Fterm%3DTLD-1433%26rank%3D1+%28accessed+Sept+27%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smythe, C. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) Metallo-Intercalators: DNA Imaging and Cytotoxicity</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1002/cbic.201000782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcbic.201000782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=21433240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12huro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=877-880&author=M.+R.+Gillauthor=H.+Derratauthor=C.+G.+W.+Smytheauthor=G.+Battagliaauthor=J.+A.+Thomas&title=Ruthenium%28II%29+Metallo-Intercalators%3A+DNA+Imaging+and+Cytotoxicity&doi=10.1002%2Fcbic.201000782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) Metallo-intercalators: DNA Imaging and Cytotoxicity</span></div><div class="casAuthors">Gill, Martin R.; Derrat, Hanan; Smythe, Carl G. W.; Battaglia, Giuseppe; Thomas, Jim A.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">877-880</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ruthenium(II) metallo-intercalator imaging of tumors and cytotoxicity were studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0UAUiJit37LVg90H21EOLACvtfcHk0ljvxZ9S28_j2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12huro%253D&md5=8211ef3f1e015e9061a3f1b7f8679b91</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201000782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201000782%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DM.%2BR.%26aulast%3DDerrat%26aufirst%3DH.%26aulast%3DSmythe%26aufirst%3DC.%2BG.%2BW.%26aulast%3DBattaglia%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26atitle%3DRuthenium%2528II%2529%2520Metallo-Intercalators%253A%2520DNA%2520Imaging%2520and%2520Cytotoxicity%26jtitle%3DChemBioChem%26date%3D2011%26volume%3D12%26spage%3D877%26epage%3D880%26doi%3D10.1002%2Fcbic.201000782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deepika, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shobha Devi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praveen Kumar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laxma Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkat Reddy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anil Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satyanarayana, S.</span></span> <span> </span><span class="NLM_article-title">DNA-Binding, Cytotoxicity, Cellular Uptake, Apoptosis and Photocleavage Studies of Ru(II) Complexes</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2016.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jphotobiol.2016.03.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=27107334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVGmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=142-153&author=N.+Deepikaauthor=C.+Shobha+Deviauthor=Y.+Praveen+Kumarauthor=K.+Laxma+Reddyauthor=P.+Venkat+Reddyauthor=D.+Anil+Kumarauthor=S.+S.+Singhauthor=S.+Satyanarayana&title=DNA-Binding%2C+Cytotoxicity%2C+Cellular+Uptake%2C+Apoptosis+and+Photocleavage+Studies+of+Ru%28II%29+Complexes&doi=10.1016%2Fj.jphotobiol.2016.03.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-binding, cytotoxicity, cellular uptake, apoptosis and photocleavage studies of Ru(II) complexes</span></div><div class="casAuthors">Deepika, N.; Shobha Devi, C.; Praveen Kumar, Y.; Laxma Reddy, K.; Venkat Reddy, P.; Anil Kumar, D.; Singh, Surya S.; Satyanarayana, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">142-153</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two Ru(II) complexes [Ru(phen)2bppp](ClO4)2 (1) and [Ru(phen)27-Br-dppz](ClO4)2 (2) [phen = 1,10 phenanthroline, 7-Br-dppz = 7-fluorodipyrido[3,2-a:2',3'-c]phenazine, bppp = 11-bromo-pyrido[2',3':5,6]pyrazino[2,3-f] [1,10]phenanthroline] have been synthesized and characterized by elemental anal., ES-MS, 1H-NMR, 13C-NMR and IR.  The in vitro cytotoxicity of the complexes examd. against a panel of cancer cell lines (HeLa, Du145 and A549) by MTT method, both complexes show prominent anticancer activity against various cancer cells.  Live cell imaging study and flow cytometric anal. demonstrate that both the complexes 1 and 2 could cross the cell membrane accumulating in the nucleus.  Further, flow cytometry expts. showed that the cytotoxic Ru(II) complexes 1 and 2 induced apoptosis of HeLa tumor cell lines.  Photo induced DNA cleavage studies have been performed and results indicate that both the complexes efficiently photo cleave pBR322 DNA.  The binding properties of two complexes toward CT-DNA were investigated by various optical methods and viscosity measurements.  The exptl. results suggested that both Ru(II) complexes can intercalate into DNA base pairs.  The complexes were docked into DNA-base pairs using the GOLD docking program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMQmCqtnGu87Vg90H21EOLACvtfcHk0ljPYsc6tLmGfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVGmt7o%253D&md5=1069e390ce8531b90bc6bfa39faa8d6b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2016.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2016.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DDeepika%26aufirst%3DN.%26aulast%3DShobha%2BDevi%26aufirst%3DC.%26aulast%3DPraveen%2BKumar%26aufirst%3DY.%26aulast%3DLaxma%2BReddy%26aufirst%3DK.%26aulast%3DVenkat%2BReddy%26aufirst%3DP.%26aulast%3DAnil%2BKumar%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DS.%2BS.%26aulast%3DSatyanarayana%26aufirst%3DS.%26atitle%3DDNA-Binding%252C%2520Cytotoxicity%252C%2520Cellular%2520Uptake%252C%2520Apoptosis%2520and%2520Photocleavage%2520Studies%2520of%2520Ru%2528II%2529%2520Complexes%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2016%26volume%3D160%26spage%3D142%26epage%3D153%26doi%3D10.1016%2Fj.jphotobiol.2016.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.-N.</span></span> <span> </span><span class="NLM_article-title">Targeting Telomeric G-Quadruplexes with the Ruthenium(II) Complexes [Ru(Bpy)<sub>2</sub>(Ptpn)]<sup>2+</sup> and [Ru(Phen)<sub>2</sub>(Ptpn)]<sup>2+</sup></span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4397</span>, <span class="refDoi"> DOI: 10.1039/c3dt32921f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fc3dt32921f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23400220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFegtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=4386-4397&author=X.+Chenauthor=J.-H.+Wuauthor=Y.-W.+Laiauthor=R.+Zhaoauthor=H.+Chaoauthor=L.-N.+Ji&title=Targeting+Telomeric+G-Quadruplexes+with+the+Ruthenium%28II%29+Complexes+%5BRu%28Bpy%292%28Ptpn%29%5D2%2B+and+%5BRu%28Phen%292%28Ptpn%29%5D2%2B&doi=10.1039%2Fc3dt32921f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting telomeric G-quadruplexes with the ruthenium(II) complexes [Ru(bpy)2(ptpn)]2+ and [Ru(phen)2(ptpn)]2+</span></div><div class="casAuthors">Chen, Xiang; Wu, Jing-Heng; Lai, Ying-Wei; Zhao, Rong; Chao, Hui; Ji, Liang-Nian</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4386-4397</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two ruthenium(II) polypyridyl complexes, [Ru(bpy)2(ptpn)]2+ (1) (bpy = 2,2'-bipyridine, ptpn = 3-(1,10-phenanthroline-2-yl)-as-triazino[5,6-f]1,10-phenanthroline) and [Ru(phen)2(ptpn)]2+ (2) (phen = 1,10-phenanthroline), were synthesized and characterized.  Crystal structure anal. shows that complex 1 has a large planar arom. area and possesses the potential to fit the geometric structure of G-quadruplex.  The interaction of the G-quadruplex DNA with Ru(II) complexes was explored by means of CD (CD), fluorescence resonance energy transfer (FRET) melting assay, competitive FRET assay and polymerase chain reaction (PCR) stop assay.  The results indicated that complexes 1 and 2 both have the ability to promote the formation and stabilization of the human telomeric d[(TTAGGG)n] (HTG22) quadruplex and exhibit high G-quadruplex DNA selectivity over duplex DNA.  The telomere repeat amplification protocol (TRAP) assay and long-term proliferation expts. further demonstrate that the Ru(II) complexes are potent telomerase inhibitors and HeLa cell proliferation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquU8BlqaHxPbVg90H21EOLACvtfcHk0ljPYsc6tLmGfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFegtLw%253D&md5=decbc4138712e57318eaf2d7a138063b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2Fc3dt32921f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3dt32921f%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DLai%26aufirst%3DY.-W.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DL.-N.%26atitle%3DTargeting%2520Telomeric%2520G-Quadruplexes%2520with%2520the%2520Ruthenium%2528II%2529%2520Complexes%2520%255BRu%2528Bpy%25292%2528Ptpn%2529%255D2%252B%2520and%2520%255BRu%2528Phen%25292%2528Ptpn%2529%255D2%252B%26jtitle%3DDalton%2520Trans.%26date%3D2013%26volume%3D42%26spage%3D4386%26epage%3D4397%26doi%3D10.1039%2Fc3dt32921f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srishailam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkat Reddy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambigari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuruputuri, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satyanarayana, S.</span></span> <span> </span><span class="NLM_article-title">Cellular Uptake, Cytotoxicity, Apoptosis, DNA-Binding, Photocleavage and Molecular Docking Studies of Ruthenium(II) Polypyridyl Complexes</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jphotobiol.2014.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24607611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2014&pages=111-123&author=A.+Srishailamauthor=Y.+P.+Kumarauthor=P.+Venkat+Reddyauthor=N.+Nambigariauthor=U.+Vuruputuriauthor=S.+S.+Singhauthor=S.+Satyanarayana&title=Cellular+Uptake%2C+Cytotoxicity%2C+Apoptosis%2C+DNA-Binding%2C+Photocleavage+and+Molecular+Docking+Studies+of+Ruthenium%28II%29+Polypyridyl+Complexes&doi=10.1016%2Fj.jphotobiol.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium(II) polypyridyl complexes</span></div><div class="casAuthors">Srishailam, A.; Kumar, Yata Praveen; Venkat Reddy, P.; Nambigari, Navaneetha; Vuruputuri, Uma; Singh, Surya S.; Satyanarayana, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111-123</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three new mononuclear [Ru (phen)2 ptip]2+ (1), [Ru (bpy)2 ptip]2+ (2) and [Ru (dmb)2 ptip]2+ (3) [ptip = (2-(5-phenylthiophen-2-yl)-1H-imidazo[4, 5-f][1,10 phenanthroline, phen = 1, 10 phenanthroline, bpy = 2, 2' bipyridine, dmb = 4, 4'-dimethyl 2, 2' bipyridine] complexes were synthesized and characterized by elemental anal., IR, NMR and Mass spectra.  The DNA-binding behaviors were investigated by electronic absorption titrn., luminescence spectra, viscosity measurements and photo-activated cleavage.  The DNA-binding consts. Kb of complexes 1, 2 and 3 were detd. to be 7.0 (±0.06) × 105, 3.87 (±0.04) × 105, 2.79 (±0.07) × 105 resp.  The results showed that these complexes interact with CT-DNA by intercalative mode.  Cell viability expts. indicated that the Ru(II) complex showed significant dose-dependent cytotoxicity to HeLa tumor cell lines.  Further flow cytometry expts. showed that the cytotoxic Ru(II) complex induced apoptosis of HeLa tumor cell lines.  Our data demonstrated that the Ru(II) polypyridyl complex binds to DNA and thereby induces apoptosis in tumor cells, suggesting that anti-tumor activity of the Ru(II) complex could be related to its interaction with DNA.  The mol. dynamic simulations and docking methods were used to predict the DNA binding affinity of ruthenium complexes and with good visualisation images supporting with exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNyXMTBkNDp7Vg90H21EOLACvtfcHk0ljPYsc6tLmGfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGnsbw%253D&md5=45a212bc41a9b9f8ad4e7c055d5ce9bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DSrishailam%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DY.%2BP.%26aulast%3DVenkat%2BReddy%26aufirst%3DP.%26aulast%3DNambigari%26aufirst%3DN.%26aulast%3DVuruputuri%26aufirst%3DU.%26aulast%3DSingh%26aufirst%3DS.%2BS.%26aulast%3DSatyanarayana%26aufirst%3DS.%26atitle%3DCellular%2520Uptake%252C%2520Cytotoxicity%252C%2520Apoptosis%252C%2520DNA-Binding%252C%2520Photocleavage%2520and%2520Molecular%2520Docking%2520Studies%2520of%2520Ruthenium%2528II%2529%2520Polypyridyl%2520Complexes%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2014%26volume%3D132%26spage%3D111%26epage%3D123%26doi%3D10.1016%2Fj.jphotobiol.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear Permeable Ruthenium(II) β-Carboline Complexes Induce Autophagy to Antagonize Mitochondrial-Mediated Apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7613</span>– <span class="NLM_lpage">7624</span>, <span class="refDoi"> DOI: 10.1021/jm1009296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7613-7624&author=C.+Tanauthor=S.+Laiauthor=S.+Wuauthor=S.+Huauthor=L.+Zhouauthor=Y.+Chenauthor=M.+Wangauthor=Y.+Zhuauthor=W.+Lianauthor=W.+Pengauthor=L.+Jiauthor=A.+Xu&title=Nuclear+Permeable+Ruthenium%28II%29+%CE%B2-Carboline+Complexes+Induce+Autophagy+to+Antagonize+Mitochondrial-Mediated+Apoptosis&doi=10.1021%2Fjm1009296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Permeable Ruthenium(II) β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis</span></div><div class="casAuthors">Tan, Caiping; Lai, Sensen; Wu, Shouhai; Hu, Sheng; Zhou, Lingjun; Chen, Yu; Wang, Minxu; Zhu, Yiping; Lian, Wu; Peng, Wenlie; Ji, Liangnian; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7613-7624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The role of autophagy in cancer development and response to cancer therapy has been a subject of debate.  Here we demonstrate that a series of ruthenium(II) complexes contg. a β-carboline alkaloid as ligand can simultaneously induce autophagy and apoptosis in tumor cells.  These Ru(II) complexes are nuclear permeable and highly active against a panel of human cancer cell lines, with complex 3 displaying activities greater than those of cisplatin.  The antiproliferative potentialities of 1-3 are in accordance with their relative lipophilicities, cell membrane penetration abilities, and in vitro DNA binding affinities.  Complexes 1-3 trigger release of reactive oxygen species (ROS) and attenuation of ROS by scavengers reduced the sub-G1 population, suggesting ROS-dependent apoptosis.  Inhibition of ROS generation also reduces autophagy, indicating that ROS triggers autophagy.  Further studies show that suppression of autophagy using pharmacol. inhibitors (3-methyladenine and chloroquine) enhances apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfI94bSBZCQLVg90H21EOLACvtfcHk0lhzXEnJ0-LATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN&md5=8c2e1e1037d4a28e485e4776ddef930c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm1009296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009296%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DNuclear%2520Permeable%2520Ruthenium%2528II%2529%2520%25CE%25B2-Carboline%2520Complexes%2520Induce%2520Autophagy%2520to%2520Antagonize%2520Mitochondrial-Mediated%2520Apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7613%26epage%3D7624%26doi%3D10.1021%2Fjm1009296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonidova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiccia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-Pyrimidine-4-Carboxylic Acid</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">20376</span>– <span class="NLM_lpage">20387</span>, <span class="refDoi"> DOI: 10.1021/ja307288s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja307288s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=20376-20387&author=V.+Pierrozauthor=T.+Joshiauthor=A.+Leonidovaauthor=C.+Mariauthor=J.+Schurauthor=I.+Ottauthor=L.+Spicciaauthor=S.+Ferrariauthor=G.+Gasser&title=Molecular+and+Cellular+Characterization+of+the+Biological+Effects+of+Ruthenium%28II%29+Complexes+Incorporating+2-Pyridyl-2-Pyrimidine-4-Carboxylic+Acid&doi=10.1021%2Fja307288s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid</span></div><div class="casAuthors">Pierroz, Vanessa; Joshi, Tanmaya; Leonidova, Anna; Mari, Cristina; Schur, Julia; Ott, Ingo; Spiccia, Leone; Ferrari, Stefano; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20376-20387</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A great majority of the Ru complexes currently studied in anticancer research exert their antiproliferative activity, at least partially, through ligand exchange.  In recent years, however, coordinatively satd. and substitutionally inert polypyridyl Ru(II) compds. have emerged as potential anticancer drug candidates.  In this work, we present the synthesis and detailed characterization of two novel inert Ru(II) complexes, namely, [Ru(bipy)2(Cpp-NH-Hex-COOH)]2+ (2) and [Ru(dppz)2(CppH)]2+ (3) (bipy = 2,2'-bipyridine; CppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid; Cpp-NH-Hex-COOH = 6-(2-(pyridin-2-yl)pyrimidine-4-carboxamido)hexanoic acid; dppz = dipyrido[3,2-a:2',3'-c]phenazine).  3 Is of particular interest as it was found to have IC50 values comparable to cisplatin, a benchmark std. in the field, on three cancer cell lines and a better activity on one cisplatin-resistant cell line than cisplatin itself.  The mechanism of action of 3 was then investigated in detail and it could be demonstrated that, although 3 binds to calf-thymus DNA by intercalation, the biol. effects that it induces did not involve a nuclear DNA related mode of action.  On the contrary, confocal microscopy colocalization studies in HeLa cells showed that 3 specifically targeted mitochondria.  This was further correlated by ruthenium quantification using High-resoln. at. absorption spectrometry.  Furthermore, as detd. by two independent assays, 3 induced apoptosis at a relatively late stage of treatment.  The generation of reactive oxygen species could be excluded as the cause of the obsd. cytotoxicity.  It was demonstrated that the mitochondrial membrane potential in HeLa was impaired by 3 as early as 2 h after its introduction and even more with increasing time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJRlZwbuToLVg90H21EOLACvtfcHk0lhzXEnJ0-LATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgsLjJ&md5=d83dbd762eca12ef0daf75aa060d3853</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja307288s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja307288s%26sid%3Dliteratum%253Aachs%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DJoshi%26aufirst%3DT.%26aulast%3DLeonidova%26aufirst%3DA.%26aulast%3DMari%26aufirst%3DC.%26aulast%3DSchur%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DI.%26aulast%3DSpiccia%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMolecular%2520and%2520Cellular%2520Characterization%2520of%2520the%2520Biological%2520Effects%2520of%2520Ruthenium%2528II%2529%2520Complexes%2520Incorporating%25202-Pyridyl-2-Pyrimidine-4-Carboxylic%2520Acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D20376%26epage%3D20387%26doi%3D10.1021%2Fja307288s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) Polypyridyl Complexes Induce BEL-7402 Cell Apoptosis by ROS-Mediated Mitochondrial Pathway</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2014.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jinorgbio.2014.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25268891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOqsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=170-179&author=G.-B.+Jiangauthor=X.+Zhengauthor=J.-H.+Yaoauthor=B.-J.+Hanauthor=W.+Liauthor=J.+Wangauthor=H.-L.+Huangauthor=Y.-J.+Liu&title=Ruthenium%28II%29+Polypyridyl+Complexes+Induce+BEL-7402+Cell+Apoptosis+by+ROS-Mediated+Mitochondrial+Pathway&doi=10.1016%2Fj.jinorgbio.2014.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway</span></div><div class="casAuthors">Jiang, Guang-Bin; Zheng, Xiang; Yao, Jun-Hua; Han, Bing-Jie; Li, Wei; Wang, Ji; Huang, Hong-Liang; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">170-179</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A new ligand dmdppz and its four ruthenium(II) polypyridyl complexes [Ru(dmb)2(dmdppz)](ClO4)2 (1), [Ru(bpy)2(dmdppz)](ClO4)2 (2), [Ru(phen)2(dmdppz)](ClO4)2 (3) and [Ru(dmp)2(dmdppz)](ClO4)2 (4) (where dmb, bpy, phen, dmp and dmdppz stand for 4,4'-dimethyl-2,2'-bipyridine, 2,2'-bipyridine, 1,10-phenanthroline, 2,9-dimethyl-1,10-phenanthroline and 5,8-dimethoxylpyrido[3,2-a:2',3'-c]phenazine, resp.) have been synthesized and characterized.  Their DNA binding behaviors show that the complexes bind to calf thymus DNA by intercalation.  The complexes exhibit efficient photocleavage of pBR322 DNA on irradn.  The cytotoxicity of the ligand and the complexes toward HepG-2, HeLa, MG-63, A549 and BEL-7402 were assayed by MTT ((3-(4,5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide)) method.  The IC50 values of the complexes 1, 2, 3 and 4 toward BEL-7402 cells are 14.6, 16.8, 18.0 and 16.7 μM, resp.  Dmdppz shows no cytotoxic activity against selected cell lines.  The cellular uptake, apoptosis, comet assay, reactive oxygen species (ROS), mitochondrial membrane potential and western blot anal. were investigated.  These results indicate that complexes 1-4 exert their toxicity through the intrinsic ROS-mediated mitochondrial pathway, which is accompanied by the regulation of Bcl-2 family proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOidPqyTc7eLVg90H21EOLACvtfcHk0lhzXEnJ0-LATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOqsL3N&md5=cf025ba89250d70c28809f92dd04d0c3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DG.-B.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DJ.-H.%26aulast%3DHan%26aufirst%3DB.-J.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.-L.%26aulast%3DLiu%26aufirst%3DY.-J.%26atitle%3DRuthenium%2528II%2529%2520Polypyridyl%2520Complexes%2520Induce%2520BEL-7402%2520Cell%2520Apoptosis%2520by%2520ROS-Mediated%2520Mitochondrial%2520Pathway%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D141%26spage%3D170%26epage%3D179%26doi%3D10.1016%2Fj.jinorgbio.2014.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span> <span> </span><span class="NLM_article-title">Dual Topoisomerase i and II Poisoning by Chiral Ru(II) Complexes Containing 2-Thiophenylimidazo[4,5-f][1,10]Phenanthroline Derivatives</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2013.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jinorgbio.2013.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24145066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=15-27&author=Y.+C.+Wangauthor=C.+Qianauthor=Z.+L.+Pengauthor=X.+J.+Houauthor=L.+L.+Wangauthor=H.+Chaoauthor=L.+N.+Ji&title=Dual+Topoisomerase+i+and+II+Poisoning+by+Chiral+Ru%28II%29+Complexes+Containing+2-Thiophenylimidazo%5B4%2C5-f%5D%5B1%2C10%5DPhenanthroline+Derivatives&doi=10.1016%2Fj.jinorgbio.2013.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f|[1,10|phenanthroline derivatives</span></div><div class="casAuthors">Wang, Yu-Chuan; Qian, Chen; Peng, Zai-Li; Hou, Xiao-Juan; Wang, Li-Li; Chao, Hui; Ji, Liang-Nian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A series of chiral RuII complexes bearing thiophene ligands were synthesized and characterized.  Both RuII complexes Δ/Λ-Rubpy2pscl|2+ Δ/Λ-1 and Δ/Λ-Rubpy2psbr|2+ Δ/Λ-2 bpy = 2,2'-bipyridine, pscl = 2-5-chlorothiophen-2-ylimidazo4,5-f|1,10|phenanthroline, psbr = 2-5-bromothiophen-2-ylimidazo4,5-f|1,10|phenanthroline showed antitumor activities against A549, HepG2 and BEL-7402 tumor cell lines, esp. HeLa tumor cell line.  Moreover, Δ enantiomers were more active than Λ enantiomers, accounting for the different cellular uptake.  In addn., with the extension of time, these enantiomers could finally accumulate in the nucleus, suggesting that nucleic acids were the cellular target of these enantiomers.  The DNA-binding behaviors of complexes were studied using spectroscopic and viscosity measurements.  Results suggested that four complexes could bind to DNA in an intercalative mode but no obvious DNA-binding selectivity between the enantiomers was obsd.  Topoisomerase inhibition and DNA religation assay confirmed that four complexes acted as efficient dual topoisomerase I and II poisons, DNA strand breaks had also been obsd. from alk. single cell gel electrophoresis comet assay. Δ-1 and Δ-2 inhibited the growth of HeLa cells through the induction of apoptotic cell death, as evidenced by the Alexa Fluor 488 annexin V staining assays and flow cytometry anal.  The results demonstrated that Δ/Λ-1 and Δ/Λ-2 acted as dual topoisomerase I and II poisons and caused DNA damage that could lead to cell cycle arrest by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JeacrSJiWrVg90H21EOLACvtfcHk0lhHYPTrJzBH_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vN&md5=6401d758e09548ffdb3ed7aebb6889e8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2013.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2013.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DZ.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BL.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DL.%2BN.%26atitle%3DDual%2520Topoisomerase%2520i%2520and%2520II%2520Poisoning%2520by%2520Chiral%2520Ru%2528II%2529%2520Complexes%2520Containing%25202-Thiophenylimidazo%255B4%252C5-f%255D%255B1%252C10%255DPhenanthroline%2520Derivatives%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D130%26spage%3D15%26epage%3D27%26doi%3D10.1016%2Fj.jinorgbio.2013.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span> <span> </span><span class="NLM_article-title">Chiral Ruthenium(II) Anthraquinone Complexes as Dual Inhibitors of Topoisomerases I and II</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1007/s00775-011-0831-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1007%2Fs00775-011-0831-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=21858685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVCqt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=81-96&author=J.+F.+Kouauthor=C.+Qianauthor=J.+Q.+Wangauthor=X.+Chenauthor=L.+L.+Wangauthor=H.+Chaoauthor=L.+N.+Ji&title=Chiral+Ruthenium%28II%29+Anthraquinone+Complexes+as+Dual+Inhibitors+of+Topoisomerases+I+and+II&doi=10.1007%2Fs00775-011-0831-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II</span></div><div class="casAuthors">Kou, Jun-Feng; Qian, Chen; Wang, Jin-Quan; Chen, Xiang; Wang, Li-Li; Chao, Hui; Ji, Liang-Nian</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-96</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: DNA topoisomerases (I and II) have been one of the excellent targets in anticancer drug development.  Here two chiral ruthenium(II) anthraquinone complexes, Δ- and Λ-[Ru(bpy)2(ipad)]2+, where bpy is 2,2'-bipyridine and ipad is 2-(anthracene-9,10-dione-2-yl)imidazo[4,5-f][1,10]phenanthroline, were synthesized and characterized.  As expected, both of the Ru(II) complexes intercalate into DNA base pairs and possess an obviously greater affinity with DNA.  Topoisomerase inhibition and DNA strand passage assay confirmed that the two complexes are efficient dual inhibitors of topoisomerases I and II by interference with the DNA religation.  In MTT cytotoxicity studies, two Ru(II) complexes exhibited antitumor activity against HeLa, MCF-7, HepG2 and BEL-7402 tumor cell lines.  Flow cytometry anal. shows an increase in the percentage of cells with apoptotic morphol. features in the sub-G1 phase for Ru(II) complexes.  Nuclear chromatin cleavage has also been obsd. from AO/EB staining assay and alk. single-cell gel electrophoresis (comet assay).  The results demonstrated that Δ- and Λ-[Ru(bpy)2(ipad)]2+ act as dual inhibitors of topoisomerases I and II, and cause DNA damage that can lead to cell cycle arrest and/or cell death by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJQ1mIWegYO7Vg90H21EOLACvtfcHk0lhHYPTrJzBH_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVCqt7vF&md5=de4b490f9df023d8502d371855ab5ba9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00775-011-0831-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-011-0831-6%26sid%3Dliteratum%253Aachs%26aulast%3DKou%26aufirst%3DJ.%2BF.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%2BQ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%2BL.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DL.%2BN.%26atitle%3DChiral%2520Ruthenium%2528II%2529%2520Anthraquinone%2520Complexes%2520as%2520Dual%2520Inhibitors%2520of%2520Topoisomerases%2520I%2520and%2520II%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2012%26volume%3D17%26spage%3D81%26epage%3D96%26doi%3D10.1007%2Fs00775-011-0831-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schatzschneider, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niesel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alborzinia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wölfl, S.</span></span> <span> </span><span class="NLM_article-title">Cellular Uptake, Cytotoxicity, and Metabolic Profiling of Human Cancer Cells Treated with Ruthenium(II) Polypyridyl Complexes [Ru(Bpy) 2(N-N)]Cl2 with N-N = bpy, Phen, Dpq, Dppz, and Dppn</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1104</span>– <span class="NLM_lpage">1109</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fcmdc.200800039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=18425738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1104-1109&author=U.+Schatzschneiderauthor=J.+Nieselauthor=I.+Ottauthor=R.+Gustauthor=H.+Alborziniaauthor=S.+W%C3%B6lfl&title=Cellular+Uptake%2C+Cytotoxicity%2C+and+Metabolic+Profiling+of+Human+Cancer+Cells+Treated+with+Ruthenium%28II%29+Polypyridyl+Complexes+%5BRu%28Bpy%29+2%28N-N%29%5DCl2+with+N-N+%3D+bpy%2C+Phen%2C+Dpq%2C+Dppz%2C+and+Dppn&doi=10.1002%2Fcmdc.200800039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N-N)]Cl2 with N-N = bpy, phen, dpq, dppz, and dppn</span></div><div class="casAuthors">Schatzschneider, Ulrich; Niesel, Johanna; Ott, Ingo; Gust, Ronald; Alborzinia, Hamed; Woelfl, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1104-1109</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of five ruthenium(II) polypyridyl complexes [Ru(bpy)2(N-N)]Cl2 was tested against human HT-29 and MCF-7 cancer cell lines.  Cellular uptake efficiency and cytotoxicity were found to increase with the size of the arom. surface area of the N-N ligand.  The most active compd. carrying the dppn ligand exhibits a low micromolar IC50 value against both cell lines comparable to that of cisplatin under similar conditions.  Continuous measurement of oxygen consumption, extracellular acidification rate, and impedance of the cell layer with a chip-based sensor system upon exposure to the complexes showed only small changes for the first two parameters throughout the series.  A significant and irreversible decrease in impedance was, however, found for the dppn compd.  This suggests that its biol. activity is related to modifications in cell morphol. or cell-cell and cell-matrix contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ5JwIvtSnN7Vg90H21EOLACvtfcHk0lhHYPTrJzBH_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWgsbY%253D&md5=2cb0f9be5c2808d478dbd7f9efd08cde</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800039%26sid%3Dliteratum%253Aachs%26aulast%3DSchatzschneider%26aufirst%3DU.%26aulast%3DNiesel%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DI.%26aulast%3DGust%26aufirst%3DR.%26aulast%3DAlborzinia%26aufirst%3DH.%26aulast%3DW%25C3%25B6lfl%26aufirst%3DS.%26atitle%3DCellular%2520Uptake%252C%2520Cytotoxicity%252C%2520and%2520Metabolic%2520Profiling%2520of%2520Human%2520Cancer%2520Cells%2520Treated%2520with%2520Ruthenium%2528II%2529%2520Polypyridyl%2520Complexes%2520%255BRu%2528Bpy%2529%25202%2528N-N%2529%255DCl2%2520with%2520N-N%2520%253D%2520bpy%252C%2520Phen%252C%2520Dpq%252C%2520Dppz%252C%2520and%2520Dppn%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1104%26epage%3D1109%26doi%3D10.1002%2Fcmdc.200800039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mccleverty, J. A.</span></span> <span> </span><span class="NLM_article-title">Non-Innocent Behaviour in Mononuclear and Polynuclear Complexes: Consequences for Redox and Electronic Spectroscopic Properties</span>. <i>J. Chem. Soc., Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1039/b110131p</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb110131p" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=275-288&author=M.+D.+Wardauthor=J.+A.+Mccleverty&title=Non-Innocent+Behaviour+in+Mononuclear+and+Polynuclear+Complexes%3A+Consequences+for+Redox+and+Electronic+Spectroscopic+Properties&doi=10.1039%2Fb110131p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Non-innocent behavior in mononuclear and polynuclear complexes: consequences for redox and electronic spectroscopic properties</span></div><div class="casAuthors">Ward, Michael D.; McCleverty, Jon A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Dalton Transactions</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-288</span>CODEN:
                <span class="NLM_cas:coden">JCSDAA</span>;
        ISSN:<span class="NLM_cas:issn">1472-7773</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This article reviews recent work in the area of non-innocent behavior in polynuclear metal complexes.  Non-innocence, which occurs when metal-based and ligand-based redox orbitals are similar in energy, was known since the 1st dithiolene complexes of the Ni triad.  The authors' recent work in this field is with complexes of two distinct types: polynuclear complexes of Ru(ii) with dioxolene-type bridging ligands; and dinuclear complexes based on tris(pyrazolyl)borato-Mo(v) or -Mo(i) units linked by bis-phenolate or bis-pyridyl bridging ligands.  Detailed redox and UV/visible/NIR spectroelectrochem. studies on these complexes were carried out.  An important point which emerges is that non-innocent behavior in dinuclear complexes is an essential prerequisite for strong metal-metal electronic coupling across extended bridging ligands.  Many of the complexes studied show intense charge-transfer transitions in the near-IR region of the spectrum, and the use of these in prototypical optical devices is briefly discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhY5G4HCnmW7Vg90H21EOLACvtfcHk0lguoEcGzcGMzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gnt7k%253D&md5=0c24a8f5e1b178e09200c695127a4083</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2Fb110131p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb110131p%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DM.%2BD.%26aulast%3DMccleverty%26aufirst%3DJ.%2BA.%26atitle%3DNon-Innocent%2520Behaviour%2520in%2520Mononuclear%2520and%2520Polynuclear%2520Complexes%253A%2520Consequences%2520for%2520Redox%2520and%2520Electronic%2520Spectroscopic%2520Properties%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Dalton%2520Trans.%26date%3D2002%26spage%3D275%26epage%3D288%26doi%3D10.1039%2Fb110131p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlček, A.</span></span> <span> </span><span class="NLM_article-title">Metal and Ligand Oxidation States in Dioxolene Complexes: Meaning, Assignment and Control</span>. <i>Comments Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1080/02603599408035860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1080%2F02603599408035860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK28Xms1ahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1994&pages=207-228&author=A.+Vl%C4%8Dek&title=Metal+and+Ligand+Oxidation+States+in+Dioxolene+Complexes%3A+Meaning%2C+Assignment+and+Control&doi=10.1080%2F02603599408035860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Metal and ligand oxidation states in dioxolene complexes: meaning, assignment and control</span></div><div class="casAuthors">Vlcek, Antonin, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Comments on Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-228</span>CODEN:
                <span class="NLM_cas:coden">COICDZ</span>;
        ISSN:<span class="NLM_cas:issn">0260-3594</span>.
    
            (<span class="NLM_cas:orgname">Gordon & Breach</span>)
        </div><div class="casAbstract">A review, with ∼72 refs.  Many features of the structural, magnetochem., spectral, electrochem., and chem. behavior of transition metal complexes with redox-active dioxolene ligands indicate that most of them are valence-localized species with well defined and exptl. distinguishable metal- and dioxolene-oxidn. states.  The valence localization results mainly from large structural differences between individual oxidn. states of the dioxolene ligands.  Dioxolene complexes may be treated like weakly coupled mixed-valence compds., and a qual. localized-valence model is developed to interpret phys. and chem. properties of dioxolene complexes, including their bistability, in a unifying way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmheOlkp4b47Vg90H21EOLACvtfcHk0lguoEcGzcGMzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xms1ahu7g%253D&md5=581773247f4867f47674fd33b237ba86</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F02603599408035860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02603599408035860%26sid%3Dliteratum%253Aachs%26aulast%3DVl%25C4%258Dek%26aufirst%3DA.%26atitle%3DMetal%2520and%2520Ligand%2520Oxidation%2520States%2520in%2520Dioxolene%2520Complexes%253A%2520Meaning%252C%2520Assignment%2520and%2520Control%26jtitle%3DComments%2520Inorg.%2520Chem.%26date%3D1994%26volume%3D16%26spage%3D207%26epage%3D228%26doi%3D10.1080%2F02603599408035860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierpont, C. G.</span></span> <span> </span><span class="NLM_article-title">Studies on Charge Distribution and Valence Tautomerism in Transition Metal Complexes of Catecholate and Semiquinonate Ligands</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>216–217</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/S0010-8545(01)00309-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2FS0010-8545%2801%2900309-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlCgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216%E2%80%93217&publication_year=2001&pages=99-125&author=C.+G.+Pierpont&title=Studies+on+Charge+Distribution+and+Valence+Tautomerism+in+Transition+Metal+Complexes+of+Catecholate+and+Semiquinonate+Ligands&doi=10.1016%2FS0010-8545%2801%2900309-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on charge distribution and valence tautomerism in transition metal complexes of catecholate and semiquinonate ligands</span></div><div class="casAuthors">Pierpont, C. G.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">216-217</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99-125</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review with 42 refs. presents an overview of recent research on complexes of quinone ligands that exhibit reversible shifts in charge distribution under equil. conditions.  Transition metal complexes contg. 1st row metal ions chelated by catecholate (Cat) and semiquinonate (SQ) ligands have localized electronic structures with quinone ligands bonded in both SQ and Cat electronic forms.  In exceptional cases the balance of metal and quinone orbital energies is sufficiently close as to permit magnetic and spectroscopic observations on isomers differing in charge distribution together under equil. conditions.  Equil. occurring between Mn(SQ√-) and Mn+1(Cat2-) redox isomers were obsd. in soln. and in the solid state for complexes of Co, Mn, and Cu.  The temp. range over which equil. may be obsd., is defined by enthalpy and entropy changes assocd., mainly, with changes in charge and spin-state of the metal ion.  This effect was considered as an example of valence tautomerism (VT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9Amu8_u6GsrVg90H21EOLACvtfcHk0lguoEcGzcGMzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlCgu7w%253D&md5=0d14cffeda2095ca24ab8f1c063627d3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2801%2900309-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252801%252900309-5%26sid%3Dliteratum%253Aachs%26aulast%3DPierpont%26aufirst%3DC.%2BG.%26atitle%3DStudies%2520on%2520Charge%2520Distribution%2520and%2520Valence%2520Tautomerism%2520in%2520Transition%2520Metal%2520Complexes%2520of%2520Catecholate%2520and%2520Semiquinonate%2520Ligands%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2001%26volume%3D216%25E2%2580%2593217%26spage%3D99%26epage%3D125%26doi%3D10.1016%2FS0010-8545%2801%2900309-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creutz, C.</span></span> In  <i>Progress in Inorganic Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, K. D.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>, <span class="NLM_year">1994</span>; Vol.  <span class="NLM_volume">41</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=C.+Creutzauthor=K.+D.+Karlin&title=Progress+in+Inorganic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCreutz%26aufirst%3DC.%26btitle%3DProgress%2520in%2520Inorganic%2520Chemistry%26aulast%3DKarlin%26aufirst%3DK.%2BD.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D1994%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodsworth, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, A. B. P.</span></span> <span> </span><span class="NLM_article-title">Catechol-Quinone Redox Series Involving Bis (Bipyridine) Ruthenium (II) and Tetrakis (Pyridine) Ruthenium (II)</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1021/ic00224a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00224a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL28Xht1Wrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=447-453&author=M.+Hagaauthor=E.+S.+Dodsworthauthor=A.+B.+P.+Lever&title=Catechol-Quinone+Redox+Series+Involving+Bis+%28Bipyridine%29+Ruthenium+%28II%29+and+Tetrakis+%28Pyridine%29+Ruthenium+%28II%29&doi=10.1021%2Fic00224a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-quinone redox series involving bis(bipyridine)ruthenium(II) and tetrakis(pyridine)ruthenium(II)</span></div><div class="casAuthors">Haga, Masaaki; Dodsworth, Elaine S.; Lever, A. B. P.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-53</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">A series of species belonging to the redox chain RuL4(cat), [RuL4(sq)]+, and [RuL4(q)]2+ were prepd. and characterized by electronic, IR, and ESR spectroscopy and electrochem. (L2 = 2,2'-bipyridine, L = py; H2cat = catechol, 3,5-di-tert-butylcatechol, and tetrachlorocatechol and their 1- and 2-electron-oxidn. products sq and q, resp.).  Evidence is presented that oxidn. of the dioxolene ligand to quinone occurs before oxidn. of Ru(II) to Ru(III).  Rich electronic spectra and electrochem. are reported and assigned.  The positions of the charge-transfer bands (metal to ligand, and ligand to ligand) are discussed in terms of the electrochem. potentials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowncrPLO4IwLVg90H21EOLACvtfcHk0lgN2ClLp2qodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1Wrtbc%253D&md5=bee22ecd5b3b446db1004fc4811b6e08</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fic00224a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00224a013%26sid%3Dliteratum%253Aachs%26aulast%3DHaga%26aufirst%3DM.%26aulast%3DDodsworth%26aufirst%3DE.%2BS.%26aulast%3DLever%26aufirst%3DA.%2BB.%2BP.%26atitle%3DCatechol-Quinone%2520Redox%2520Series%2520Involving%2520Bis%2520%2528Bipyridine%2529%2520Ruthenium%2520%2528II%2529%2520and%2520Tetrakis%2520%2528Pyridine%2529%2520Ruthenium%2520%2528II%2529%26jtitle%3DInorg.%2520Chem.%26date%3D1986%26volume%3D25%26spage%3D447%26epage%3D453%26doi%3D10.1021%2Fic00224a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Experimental and Theoretical Evaluation of the Charge Distribution over the Ruthenium and Dioxolene Framework of [Ru(OAc)(Dioxolene)(Terpy)] (Terpy = 2,2′:6′,2″-Terpyridine) Depending on the Substituents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">8887</span>– <span class="NLM_lpage">8894</span>, <span class="refDoi"> DOI: 10.1021/ic060696i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic060696i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVChtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=8887-8894&author=T.+Wadaauthor=M.+Yamanakaauthor=T.+Fujiharaauthor=Y.+Miyazatoauthor=K.+Tanaka&title=Experimental+and+Theoretical+Evaluation+of+the+Charge+Distribution+over+the+Ruthenium+and+Dioxolene+Framework+of+%5BRu%28OAc%29%28Dioxolene%29%28Terpy%29%5D+%28Terpy+%3D+2%2C2%E2%80%B2%3A6%E2%80%B2%2C2%E2%80%B3-Terpyridine%29+Depending+on+the+Substituents&doi=10.1021%2Fic060696i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Theoretical Evaluation of the Charge Distribution over the Ruthenium and Dioxolene Framework of [Ru(OAc)(dioxolene)(terpy)] (terpy = 2,2':6',2''-terpyridine) Depending on the Substituents</span></div><div class="casAuthors">Wada, Tohru; Yamanaka, Masahiro; Fujihara, Tetsuaki; Miyazato, Yuji; Tanaka, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8887-8894</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ru complexes [Ru(OAc)(dioxolene)(terpy)] having various substituents on the dioxolene ligand (dioxolene = 3,5-t-Bu2C6H2O2 (1), 4-t-BuC6H3O2 (2), 4-ClC6H3O2 (3), 3,5-Cl2C6H2O2 (4), Cl4C6O2 (5); terpy = 2,2':6'2''-terpyridine) were prepd.  EPR spectra of these complexes in glassy frozen solns. (CH2Cl2:MeOH = 95:5, vol./vol.) at 20 K showed anisotropic signals with g tensor components 2.242 > g1 > 2.104, 2.097 > g2 > 2.042, and 1.951 > g3 > 1.846.  An anisotropic value, Δg = g1-g3, and an isotropic g value, 〈g〉 = [(g12 + g22 + g32)/3]1/2, increase in the order 1 < 2 < 3 < 4 < 5.  The resonance between the RuII(sq) (sq = semiquinone) and RuIII(cat) (cat = catecholato) frameworks shifts to the latter with an increase of the no. of electron-withdrawing substituents on the dioxolene ligand.  DFT calcns. of 1, 2, 3, and 5 also support the increase of the Ru spin d. (RuIII character) with an increase of the no. of Cl atoms on the dioxolene ligand.  The singly occupied MOs (SOMOs) of 1 and 5 are very similar to each other and stretch out the Ru-dioxolene frameworks, whereas the LUMO of 5 is localized on Ru and two O atoms of dioxolene in comparison with that of 1.  Electron-withdrawing groups decrease the energy levels of both the SOMO and LUMO.  An increase in the no. of Cl atoms in the dioxolene ligand results in an increase of the pos. charge on Ru.  Successive shifts in the electronic structure between the RuII(sq) and RuIII(cat) frameworks caused by the variation of the substituents are compatible with the exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzusMh4cRpWrVg90H21EOLACvtfcHk0lgN2ClLp2qodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVChtrjK&md5=623adeaedd6f88429c27c757cc7b3edc</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fic060696i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic060696i%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DM.%26aulast%3DFujihara%26aufirst%3DT.%26aulast%3DMiyazato%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DExperimental%2520and%2520Theoretical%2520Evaluation%2520of%2520the%2520Charge%2520Distribution%2520over%2520the%2520Ruthenium%2520and%2520Dioxolene%2520Framework%2520of%2520%255BRu%2528OAc%2529%2528Dioxolene%2529%2528Terpy%2529%255D%2520%2528Terpy%2520%253D%25202%252C2%25E2%2580%25B2%253A6%25E2%2580%25B2%252C2%25E2%2580%25B3-Terpyridine%2529%2520Depending%2520on%2520the%2520Substituents%26jtitle%3DInorg.%2520Chem.%26date%3D2006%26volume%3D45%26spage%3D8887%26epage%3D8894%26doi%3D10.1021%2Fic060696i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muckerman, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyansky, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, E.</span></span> <span> </span><span class="NLM_article-title">Water Oxidation by a Ruthenium Complex with Noninnocent Quinone Ligands: Possible Formation of an O-O Bond at a Low Oxidation State of the Metal</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1021/ic701892v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic701892v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFChsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1787-1802&author=J.+T.+Muckermanauthor=D.+E.+Polyanskyauthor=T.+Wadaauthor=K.+Tanakaauthor=E.+Fujita&title=Water+Oxidation+by+a+Ruthenium+Complex+with+Noninnocent+Quinone+Ligands%3A+Possible+Formation+of+an+O-O+Bond+at+a+Low+Oxidation+State+of+the+Metal&doi=10.1021%2Fic701892v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Water Oxidation by a Ruthenium Complex with Noninnocent Quinone Ligands: Possible Formation of an O-O Bond at a Low Oxidation State of the Metal</span></div><div class="casAuthors">Muckerman, James T.; Polyansky, Dmitry E.; Wada, Tohru; Tanaka, Koji; Fujita, Etsuko</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1787-1802</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tanaka and co-workers reported a novel dinuclear Ru complex, [Ru2(OH)2(3,6-Bu2Q)2(btpyan)](SbF6)2 (3,6-Bu2Q = 3,6-ditert-butyl-1,2-benzoquinone, btpyan = 1,8-bis(2,2':6',2''-terpyrid-4'-yl)anthracene), that contains redox active quinone ligands and has an excellent electrocatalytic activity for H2O oxidn. when immobilized on an In-Sn-oxide electrode (Inorg. Chem., 2001, 40, 329-337).  The novel features of the dinuclear and related mononuclear Ru species with quinone ligands, and comparison of their properties to those of the Ru analogs with the bpy ligand (bpy = 2,2'-bipyridine) replacing quinone, are summarized here together with new theor. and exptl. results that show striking features for both the dinuclear and mononuclear species.  The identity and oxidn. state of key mononuclear species, including the previously reported oxyl radical, were reassigned.  The gas-phase theor. calcns. indicate that the Tanaka Ru-dinuclear catalyst seems to maintain predominantly Ru(II) centers while the quinone ligands and H2O moiety are involved in redox reactions throughout the entire catalytic cycle for H2O oxidn.  The theor. study identifies [Ru2(O2-)(Q-1.5)2(btpyan)] as a key intermediate and the most reduced catalyst species that is formed by removal of all 4 protons before 4-electron oxidn. takes place.  While the study toward understanding the complicated electronic and geometric structures of possible intermediates in the catalytic cycle is still in progress, the current status and new directions for kinetic and mechanistic studies, and key issues and challenges in H2O oxidn. with the Tanaka catalyst (and its analogs with Cl- or NO2-substituted quinones and a species with a xanthene bridge instead an anthracene) are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBjjw_tm4NCbVg90H21EOLACvtfcHk0lgN2ClLp2qodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFChsr0%253D&md5=4d0e0f2f5ba0dfd8cd5f4bf1dedbc199</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fic701892v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic701892v%26sid%3Dliteratum%253Aachs%26aulast%3DMuckerman%26aufirst%3DJ.%2BT.%26aulast%3DPolyansky%26aufirst%3DD.%2BE.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DE.%26atitle%3DWater%2520Oxidation%2520by%2520a%2520Ruthenium%2520Complex%2520with%2520Noninnocent%2520Quinone%2520Ligands%253A%2520Possible%2520Formation%2520of%2520an%2520O-O%2520Bond%2520at%2520a%2520Low%2520Oxidation%2520State%2520of%2520the%2520Metal%26jtitle%3DInorg.%2520Chem.%26date%3D2008%26volume%3D47%26spage%3D1787%26epage%3D1802%26doi%3D10.1021%2Fic701892v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, D. T.</span></span> <span> </span><span class="NLM_article-title">Redox Chemistry of Metal-Catechol Complexes in Aprotic Media. 2. 3,5-Di-Fert-Butylcatecholato Complexes of Manganese(IV) and Manganese(III)</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4257</span>– <span class="NLM_lpage">4262</span>, <span class="refDoi"> DOI: 10.1021/ic50226a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic50226a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL3MXmtFWrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1981&pages=4257-4262&author=S.+E.+Jonesauthor=D.+Chinauthor=D.+T.+Sawyer&title=Redox+Chemistry+of+Metal-Catechol+Complexes+in+Aprotic+Media.+2.+3%2C5-Di-Fert-Butylcatecholato+Complexes+of+Manganese%28IV%29+and+Manganese%28III%29&doi=10.1021%2Fic50226a045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Redox chemistry of metal-catechol complexes in aprotic media.  2.  3,5-Di-tert-butylcatecholato complexes of manganese(IV) and manganese(III)</span></div><div class="casAuthors">Jones, Stephen E.; Chin, Der Hang; Sawyer, Donald T.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4257-62</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">When mixts. of Mn(II) and 3,5-di-tert-butyl-o-quinone (DTBQ) with 1:3 and 1:2 molar ratios are reduced in aprotic solvents, stable [Mn(DTBC)3]2- and [Mn(DTBC)2]- (where H2DTBC is di-tert-butylcatechol) complexes are formed, resp.  These complexes and their oxidn.-redn. products were characterized by cyclic voltammetry, controlled-potential electrolysis, optical spectroscopy, ESR spectroscopy, and magnetic susceptibility measurements in DMF, Me2SO and MeCN.  Based on these results, a self-consistent redox mechanism is presented for the interconversion of the various species of Mn(II)-DTBQ system with 1:1, 1:2, and 1:3 molar ratios.  The catechol complexes of Mn(II), -(III), and -(IV) are versatile electron-transfer agents and should be effective redox catalysts and O activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldIs4DM2ItLVg90H21EOLACvtfcHk0ljslFy4qd0SVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmtFWrurk%253D&md5=0d8e021b6fc3078236aa44789d944d47</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fic50226a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic50226a045%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BE.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DSawyer%26aufirst%3DD.%2BT.%26atitle%3DRedox%2520Chemistry%2520of%2520Metal-Catechol%2520Complexes%2520in%2520Aprotic%2520Media.%25202.%25203%252C5-Di-Fert-Butylcatecholato%2520Complexes%2520of%2520Manganese%2528IV%2529%2520and%2520Manganese%2528III%2529%26jtitle%3DInorg.%2520Chem.%26date%3D1981%26volume%3D20%26spage%3D4257%26epage%3D4262%26doi%3D10.1021%2Fic50226a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+Nature%E2%80%99s+PAINS%3A+Natural+Products%2C+Natural+Product+Drugs%2C+and+Pan+Assay+Interference+Compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0ljslFy4qd0SVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520Nature%25E2%2580%2599s%2520PAINS%253A%2520Natural%2520Products%252C%2520Natural%2520Product%2520Drugs%252C%2520and%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lima, R. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, L. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarêncio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bachá, R. S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic Effects of Catechol to Neuroblastoma N2a Cells</span>. <i>Gen. Physiol. Biophys</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=19202205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=306-314&author=R.+M.+F.+Limaauthor=L.+D.+G.+Alvarezauthor=M.+F.+D.+Costaauthor=S.+Costaauthor=J.+Clar%C3%AAncioauthor=R.+S.+El-Bach%C3%A1&title=Cytotoxic+Effects+of+Catechol+to+Neuroblastoma+N2a+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of catechol to neuroblastoma N2a cells</span></div><div class="casAuthors">Lima, Rute M. F.; Alvarez, Lisandro D. G.; Costa, Maria F. D.; Costa, Silvia L.; Clarencio, Jorge; El-Bacha, Ramon S.</div><div class="citationInfo"><span class="NLM_cas:title">General Physiology and Biophysics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">306-314</span>CODEN:
                <span class="NLM_cas:coden">GPBIE2</span>;
        ISSN:<span class="NLM_cas:issn">0231-5882</span>.
    
            (<span class="NLM_cas:orgname">Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences</span>)
        </div><div class="casAbstract">The mechanisms of catechol-induced cytotoxicity were studied in cultures of neuroblastoma N2a cells.  The minimal cytotoxic concn. after 72 h was 20 μmol/l-1.  The EC50 after 72 h was 38 μmol/l-1.  There was not a correlation between the cytotoxicity and the formation of quinones in the medium.  Catechol-induced cytotoxicity was increased significantly when superoxide dismutase (SOD) was added.  The addn. of catalase did not protect cells, but this enzyme reverted the deleterious effect of SOD.  The exptl. studies showed a detrimental effect of deferoxamine on catechol-induced cytotoxicity suggesting that cells need iron to maintain its metab.  NF-κB inhibitors increased the cytotoxicity, suggesting that this factor is also important for cell viability.  L-cysteine and N-acetyl-L-cysteine protected cells significantly in a dose-dependent manner.  The use of monochlorobimane showed that catechol induced reduced glutathione (GSH) depletion after 24 h, prior to cell death.  The mode of cell death was studied by flow cytometry after double staining with annexin V and propidium iodide.  Catechol induced apoptosis after 72 h.  Furthermore, catechol also induced nuclear fragmentation.  These data showed that catechol-induced cytotoxicity to N2a cell was not directly a consequence of reactive oxygen species prodn.  Rather, it was due to GSH depletion followed by the induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqm4qQxCC7X7Vg90H21EOLACvtfcHk0ljslFy4qd0SVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCit78%253D&md5=27a9a156fab210c77f5c2054c0bdcb8c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DR.%2BM.%2BF.%26aulast%3DAlvarez%26aufirst%3DL.%2BD.%2BG.%26aulast%3DCosta%26aufirst%3DM.%2BF.%2BD.%26aulast%3DCosta%26aufirst%3DS.%26aulast%3DClar%25C3%25AAncio%26aufirst%3DJ.%26aulast%3DEl-Bach%25C3%25A1%26aufirst%3DR.%2BS.%26atitle%3DCytotoxic%2520Effects%2520of%2520Catechol%2520to%2520Neuroblastoma%2520N2a%2520Cells%26jtitle%3DGen.%2520Physiol.%2520Biophys%26date%3D2008%26volume%3D27%26spage%3D306%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, W. L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vítor, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, M. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desá, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, L. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Rocha, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bachá, R. S.</span></span> <span> </span><span class="NLM_article-title">Redox Properties of Ruthenium Complex with Catechol Are Involved in Toxicity to Glial Cells</span>. <i>J. Chil. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1240</span>– <span class="NLM_lpage">1243</span>, <span class="refDoi"> DOI: 10.4067/S0717-97072007000300010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.4067%2FS0717-97072007000300010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSqtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1240-1243&author=W.+L.+C.+Almeidaauthor=D.+N.+V%C3%ADtorauthor=M.+R.+G.+Pereiraauthor=D.+S.+Des%C3%A1author=L.+D.+G.+Alvarezauthor=A.+M.+Pinheiroauthor=S.+L.+Costaauthor=M.+F.+D.+Costaauthor=Z.+N.+Da+Rochaauthor=R.+S.+El-Bach%C3%A1&title=Redox+Properties+of+Ruthenium+Complex+with+Catechol+Are+Involved+in+Toxicity+to+Glial+Cells&doi=10.4067%2FS0717-97072007000300010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Redox properties of ruthenium complex with catechol are involved in toxicity to glial cells</span></div><div class="casAuthors">Almeida, Wagner L. C.; Vitor, Daniela N.; Pereira, Marco R. G.; De Sa, Denise S.; Alvarez, Lisandro D. G.; Pinheiro, Alexandre M.; Costa, Silvia L.; Costa, Maria F. D.; Da Rocha, Zenis N.; El-Bacha, Ramon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chilean Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1240-1243</span>CODEN:
                <span class="NLM_cas:coden">JCCSCB</span>;
        ISSN:<span class="NLM_cas:issn">0717-9324</span>.
    
            (<span class="NLM_cas:orgname">Journal of the Chilean Chemical Society</span>)
        </div><div class="casAbstract">Since the biol. activity of [RuIII(NH3)4(catechol)]+ has never been tested, its cytotoxicity to glial cells was assayed and correlated with its redox properties.  Coordinated catechol oxidizes faster than catechol in the presence of oxygen, but controlled potential electrolysis showed that its oxidn. involves only one-electron.  However, the oxidn. of the free ligand by oxygen involves two electrons, which could generate more reactive oxygen species.  Indeed, catechol was more cytotoxic than [RuIII(NH3)4(catechol)]+ complex to human glioblastoma GL-15 cells and also to rat astrocytes.  [RuIII(NH3)4(catechol)]+-induced cytotoxicity was related to the generation of reactive oxygen species and [RuII(NH3)4(quinone)]2+.  However, other mechanisms should be involved since antioxidant enzymes and deferoxamine only partially protected GL-15 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_76dkR2goQrVg90H21EOLACvtfcHk0ljlTm-x1gfDew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSqtLbN&md5=eb0487a4a1a59941ca85f33b681a3164</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4067%2FS0717-97072007000300010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4067%252FS0717-97072007000300010%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DW.%2BL.%2BC.%26aulast%3DV%25C3%25ADtor%26aufirst%3DD.%2BN.%26aulast%3DPereira%26aufirst%3DM.%2BR.%2BG.%26aulast%3DDes%25C3%25A1%26aufirst%3DD.%2BS.%26aulast%3DAlvarez%26aufirst%3DL.%2BD.%2BG.%26aulast%3DPinheiro%26aufirst%3DA.%2BM.%26aulast%3DCosta%26aufirst%3DS.%2BL.%26aulast%3DCosta%26aufirst%3DM.%2BF.%2BD.%26aulast%3DDa%2BRocha%26aufirst%3DZ.%2BN.%26aulast%3DEl-Bach%25C3%25A1%26aufirst%3DR.%2BS.%26atitle%3DRedox%2520Properties%2520of%2520Ruthenium%2520Complex%2520with%2520Catechol%2520Are%2520Involved%2520in%2520Toxicity%2520to%2520Glial%2520Cells%26jtitle%3DJ.%2520Chil.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D52%26spage%3D1240%26epage%3D1243%26doi%3D10.4067%2FS0717-97072007000300010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span> <span> </span><span class="NLM_article-title">Toward an Understanding of the Role of a Catechol Moiety in Cancer Chemoprevention: The Case of Copper- and o-Quinone-Dependent Nrf2 Activation by a Catechol-Type Resveratrol Analog</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2395</span>– <span class="NLM_lpage">2406</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201500297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fmnfr.201500297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=26314862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=2395-2406&author=D.+Linauthor=F.+Daiauthor=L.-D.+Sunauthor=B.+Zhou&title=Toward+an+Understanding+of+the+Role+of+a+Catechol+Moiety+in+Cancer+Chemoprevention%3A+The+Case+of+Copper-+and+o-Quinone-Dependent+Nrf2+Activation+by+a+Catechol-Type+Resveratrol+Analog&doi=10.1002%2Fmnfr.201500297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog</span></div><div class="casAuthors">Lin, Dong; Dai, Fang; Sun, Lan-Di; Zhou, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2395-2406</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Scope : Catechol moieties are commonly present in dietary natural products that exert cancer chemopreventive activity.  While the oxidative conversion of catechols into their corresponding o-quinones is generally considered to contribute to their cancer chemopreventive effects, the mechanism of the intracellular conversion has not been fully elucidated.  Methods and results : Among resveratrol and its hydroxylated analogs examd., only 3,4-dihydroxy-trans-stilbene exerted cytoprotective effects against t-butylhydroperoxide-induced death of HepG2 cells.  This resveratrol analog activated the nuclear factor erythroid-2-related factor 2 (Nrf2) pathway through stimulating phosphorylation of Akt and inducing keap1 modification, thereby resulting in its nuclear translocation and subsequent transcriptional induction of phase II detoxifying enzymes.  Its cytoprotective effect through Nrf2 activation was largely abrogated by pretreatment of cells with DTT, a sulfhydryl-contg. nucleophile, and neocuproine, a specific chelating agent for copper ions.  Conclusion : We identified 3,4-dihydroxy-trans-stilbene as a novel Nrf2 activator that is converted intracellularly into its corresponding o-quinone electrophile by copper ions.  The copper-mediated oxidn. was required for the Nrf2 activation, subsequent transcriptional induction of phase II detoxifying enzymes and ultimately for cytoprotection.  The findings demonstrate a previously underrecognized role for intracellular copper ions in the cancer chemopreventive effects of catechol-contg. dietary natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD5oMLcomlnbVg90H21EOLACvtfcHk0ljlTm-x1gfDew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb%252FL&md5=f95d11ec79e6f4c3bb883bd1503e3b3b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201500297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201500297%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DD.%26aulast%3DDai%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DL.-D.%26aulast%3DZhou%26aufirst%3DB.%26atitle%3DToward%2520an%2520Understanding%2520of%2520the%2520Role%2520of%2520a%2520Catechol%2520Moiety%2520in%2520Cancer%2520Chemoprevention%253A%2520The%2520Case%2520of%2520Copper-%2520and%2520o-Quinone-Dependent%2520Nrf2%2520Activation%2520by%2520a%2520Catechol-Type%2520Resveratrol%2520Analog%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2015%26volume%3D59%26spage%3D2395%26epage%3D2406%26doi%3D10.1002%2Fmnfr.201500297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lima, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, A. B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana
da Silva, R.</span></span> <span> </span><span class="NLM_article-title">Antifungal Activity of Novel Catecholamine Ruthenium (III) Complexes</span>. <i>Transition Met. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1023/A:1022967403627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1023%2FA%3A1022967403627" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=272-275&author=R.+G.+de%0ALimaauthor=A.+B.+P.+Leverauthor=I.+Y.+Itoauthor=R.+Santana%0Ada+Silva&title=Antifungal+Activity+of+Novel+Catecholamine+Ruthenium+%28III%29+Complexes&doi=10.1023%2FA%3A1022967403627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022967403627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022967403627%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLima%26aufirst%3DR.%2BG.%26aulast%3DLever%26aufirst%3DA.%2BB.%2BP.%26aulast%3DIto%26aufirst%3DI.%2BY.%26aulast%3DSantana%2Bda%2BSilva%26aufirst%3DR.%26atitle%3DAntifungal%2520Activity%2520of%2520Novel%2520Catecholamine%2520Ruthenium%2520%2528III%2529%2520Complexes%26jtitle%3DTransition%2520Met.%2520Chem.%26date%3D2003%26volume%3D28%26spage%3D272%26epage%3D275%26doi%3D10.1023%2FA%3A1022967403627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huong, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanouchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimauchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umakoshi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuboi, R.</span></span> <span> </span><span class="NLM_article-title">Catechol Derivatives Inhibit the Fibril Formation of Amyloid-β Peptides</span>. <i>J. Biosci. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/j.jbiosc.2009.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jbiosc.2009.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=20471605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCktbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2010&pages=629-634&author=V.+T.+Huongauthor=T.+Shimanouchiauthor=N.+Shimauchiauthor=H.+Yagiauthor=H.+Umakoshiauthor=Y.+Gotoauthor=R.+Kuboi&title=Catechol+Derivatives+Inhibit+the+Fibril+Formation+of+Amyloid-%CE%B2+Peptides&doi=10.1016%2Fj.jbiosc.2009.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol derivatives inhibit the fibril formation of amyloid-β peptides</span></div><div class="casAuthors">Huong, Vu Thi; Shimanouchi, Toshinori; Shimauchi, Naoya; Yagi, Hisashi; Umakoshi, Hiroshi; Goto, Yuji; Kuboi, Ryoichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioscience and Bioengineering</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">629-634</span>CODEN:
                <span class="NLM_cas:coden">JBBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1389-1723</span>.
    
            (<span class="NLM_cas:orgname">Society for Biotechnology, Japan</span>)
        </div><div class="casAbstract">The inhibition of fibril formation of amyloid β proteins (Aβ) would be attractive therapeutic targets for the treatment of Alzheimer's disease (AD).  Dopamine (DA) and other catechol derivs. were used as inhibitory factors for Aβ fibril formation.  The fibril formation of Aβ was monitored by Thioflavin T fluorescence, a transmission electron microscopy (TEM) and a total internal reflection fluorescence microscopy (TIRFM).  Catechol and its derivs. showed the dose-dependent inhibitory effects on the spontaneous Aβ fibril formation.  The inhibitory activity depended on the chem. structure of catechol derivs. both in the presence and absence of the liposome a model of biomembrane.  Formation of catechol quinone-conjugated-Aβ adduct by a Schiff-base is a key step for the inhibition effect of Aβ fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu1GULN78jEbVg90H21EOLACvtfcHk0ljlTm-x1gfDew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCktbrO&md5=9a7ca59c2a561d580c6bef63316fb0aa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiosc.2009.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiosc.2009.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DHuong%26aufirst%3DV.%2BT.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DShimauchi%26aufirst%3DN.%26aulast%3DYagi%26aufirst%3DH.%26aulast%3DUmakoshi%26aufirst%3DH.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DKuboi%26aufirst%3DR.%26atitle%3DCatechol%2520Derivatives%2520Inhibit%2520the%2520Fibril%2520Formation%2520of%2520Amyloid-%25CE%25B2%2520Peptides%26jtitle%3DJ.%2520Biosci.%2520Bioeng.%26date%3D2010%26volume%3D109%26spage%3D629%26epage%3D634%26doi%3D10.1016%2Fj.jbiosc.2009.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehn, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petry, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glover, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijetunga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lay, P. A.</span></span> <span> </span><span class="NLM_article-title">Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(v) catecholate complexes</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6383</span>– <span class="NLM_lpage">6395</span>, <span class="refDoi"> DOI: 10.1039/C9DT00601J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC9DT00601J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30941380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvV2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=6383-6395&author=D.+C.+Cransauthor=J.+T.+Koehnauthor=S.+M.+Petryauthor=C.+M.+Gloverauthor=A.+Wijetungaauthor=R.+Kaurauthor=A.+Levinaauthor=P.+A.+Lay&title=Hydrophobicity+may+enhance+membrane+affinity+and+anti-cancer+effects+of+Schiff+base+vanadium%28v%29+catecholate+complexes&doi=10.1039%2FC9DT00601J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(V) catecholate complexes</span></div><div class="casAuthors">Crans, Debbie C.; Koehn, Jordan T.; Petry, Stephanie M.; Glover, Caleb M.; Wijetunga, Asanka; Kaur, Ravinder; Levina, Aviva; Lay, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6383-6395</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Anti-cancer activities of vanadium compds. have generated recent interest because of a combination of desirable properties for chemotherapy, i.e., strong cytotoxicities, anti-metastatic activities and relatively low systemic toxicities.  Certain hydrophobic vanadium(V) Schiff base/catecholate compds., which as shown herein, have increased stability in aq. media and affinity for membrane interfaces.  Depending on their hydrophobicity, they may be able to enter cells intact.  In this manuscript, two hydrophobic V(V) catecholate substituted analogs, [VO(Hshed)(cat)] and [VO(Hshed)(dtb)], (Hshed = N-(salicylideneaminato)-N'-(2-hydroxyethyl)-1,2-ethanediamine, cat = pyrocatechol, and dtb = 3,5-di(tert-butyl)catechol and the vanadium(V) precursor [V(O)2(Hshed)]) were synthesized for their ability to interact with membranes and their anti-cancer effects.  Using 51V and 1H NMR spectroscopy, the presence and location of the free ligand, H2shed, and the three V(V) complexes were examd. in a model membrane microemulsion system.  The stability of the three complexes was measured in aq. soln., cell media and an inhomogeneous microemulsion system.  The results demonstrated here that free ligand H2shed and the intact V(V) complexes assocd. with the interface but that the V-complexes hydrolyzed to some extent because oxovanadates were obsd. by 51V NMR spectroscopy and decreasing complex by absorption spectroscopy in cell media.  When detg. the effects of V(V) catecholate complexes on bone cancer cells, the strongest effects were obsd. with the more stable hydrophobic complex [VO(Hshed)(dtb)] that was able to best assoc. and penetrate the model membrane system intact.  These studies are consistent with the membrane permeability studies being a good predictor for in vitro cytotoxicity assays because [VO(Hshed)(dtb)] can pass through the cellular membrane intact, which may enhance its anti-cancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZU4YFJIVhBrVg90H21EOLACvtfcHk0lj9kxMd5QWTAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvV2ht7g%253D&md5=3e8cd564f35ccbc769fcabae7c5d0a2c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1039%2FC9DT00601J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9DT00601J%26sid%3Dliteratum%253Aachs%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DKoehn%26aufirst%3DJ.%2BT.%26aulast%3DPetry%26aufirst%3DS.%2BM.%26aulast%3DGlover%26aufirst%3DC.%2BM.%26aulast%3DWijetunga%26aufirst%3DA.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DLevina%26aufirst%3DA.%26aulast%3DLay%26aufirst%3DP.%2BA.%26atitle%3DHydrophobicity%2520may%2520enhance%2520membrane%2520affinity%2520and%2520anti-cancer%2520effects%2520of%2520Schiff%2520base%2520vanadium%2528v%2529%2520catecholate%2520complexes%26jtitle%3DDalton%2520Trans.%26date%3D2019%26volume%3D48%26spage%3D6383%26epage%3D6395%26doi%3D10.1039%2FC9DT00601J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemons, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richens, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedgwick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. D.</span></span> <span> </span><span class="NLM_article-title">Stabilization of a Vanadium(V)–Catechol Complex by Compartmentalization and Reduced Solvation inside Reverse Micelles</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1039/C2NJ40524E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC2NJ40524E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVertL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2013&pages=75-91&author=B.+G.+Lemonsauthor=D.+T.+Richensauthor=A.+Andersonauthor=M.+Sedgwickauthor=D.+C.+Cransauthor=M.+D.+Johnson&title=Stabilization+of+a+Vanadium%28V%29%E2%80%93Catechol+Complex+by+Compartmentalization+and+Reduced+Solvation+inside+Reverse+Micelles&doi=10.1039%2FC2NJ40524E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of a vanadium(V)-catechol complex by compartmentalization and reduced solvation inside reverse micelles</span></div><div class="casAuthors">Lemons, Brant G.; Richens, David T.; Anderson, Ashley; Sedgwick, Myles; Crans, Debbie C.; Johnson, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">New Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">NJCHE5</span>;
        ISSN:<span class="NLM_cas:issn">1144-0546</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The kinetics of 1 : 1 complex formation and hydrolysis between catechol and 3-substituted catechols with aq. vanadium(V) at pH ∼ 1 have been investigated in NaAOT (sodium bis(2-ethylhexyl)sulfosuccinate) derived aq. reverse micelle microemulsions in isooctane.  Compared with the reaction in bulk water, the forward rate const. of catechol complexation was modestly accelerated (2 fold) in the reverse micelle microemulsions for even the smallest nanosized water pools (wo = 2).  In contrast, the first order reverse (aquation) reaction was significantly suppressed in the water pools below wo = 10.  The modest rate acceleration of complex formation within the microemulsions is attributed to changes in water solvation, reaction properties and compartmentalization of the reactants.  The dramatic fall off in the rate of catechol dissocn. from [VO2(cat)(OH2)2]- is attributed to the redn. in water content as the size of the nanopools is decreased below 200 water mols.  The result is a 10 fold increase in the kinetic formation const. for [VO2(cat)(OH2)2]- under confinement in the RM microemulsion environment.  This increase predicts that vanadium catechol complexes will be more stable in vivo and may suggest a general principle for fine-tuning efficacy of metal-based drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0fLj9WvafCrVg90H21EOLACvtfcHk0lj9kxMd5QWTAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVertL7J&md5=652aaba8e042c4e76269c93e063c5b0a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1039%2FC2NJ40524E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2NJ40524E%26sid%3Dliteratum%253Aachs%26aulast%3DLemons%26aufirst%3DB.%2BG.%26aulast%3DRichens%26aufirst%3DD.%2BT.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DSedgwick%26aufirst%3DM.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26atitle%3DStabilization%2520of%2520a%2520Vanadium%2528V%2529%25E2%2580%2593Catechol%2520Complex%2520by%2520Compartmentalization%2520and%2520Reduced%2520Solvation%2520inside%2520Reverse%2520Micelles%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2013%26volume%3D37%26spage%3D75%26epage%3D91%26doi%3D10.1039%2FC2NJ40524E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brastos, I.</span>; <span class="NLM_string-name">Alessio, E.</span>; <span class="NLM_string-name">Ringenberg, M. E.</span>; <span class="NLM_string-name">Rauchfuss, T. B.</span></span> <span> </span><span class="NLM_article-title">Ruthenium Complexes</span>. In  <i>Inorganic Syntheses</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauchfuss, T. B.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Chichester</span>, <span class="NLM_year">2010</span>; Vol.  <span class="NLM_volume">35</span>, pp  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">163</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=148-163&author=I.+Brastos&author=E.+Alessio&author=M.+E.+Ringenberg&author=T.+B.+Rauchfussauthor=T.+B.+Rauchfuss&title=Inorganic+Syntheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrastos%26aufirst%3DI.%26atitle%3DRuthenium%2520Complexes%26btitle%3DInorganic%2520Syntheses%26aulast%3DRauchfuss%26aufirst%3DT.%2BB.%26pub%3DWiley%26date%3D2010%26volume%3D35%26spage%3D148%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caspar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waern, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyard-Duhayon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruselle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Floch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amouri, H.</span></span> <span> </span><span class="NLM_article-title">A New Family of Mono- and Dicarboxylic Ruthenium Complexes [Ru(DIP)<sub>2</sub>(L2)]<sup>2+</sup> (DIP = 4,7-Diphenyl-1,10-Phenanthroline): Synthesis, Solution Behavior, and X-Ray Molecular Structure of Trans -[Ru(DIP)<sub>2</sub>(MeOH)<sub>2</sub>][OTf]<sub>2</sub></span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4071</span>– <span class="NLM_lpage">4078</span>, <span class="refDoi"> DOI: 10.1021/ic0601236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic0601236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFWnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=4071-4078&author=R.+Casparauthor=C.+Cordierauthor=J.+B.+Waernauthor=C.+Guyard-Duhayonauthor=M.+Gruselleauthor=P.+Le+Flochauthor=H.+Amouri&title=A+New+Family+of+Mono-+and+Dicarboxylic+Ruthenium+Complexes+%5BRu%28DIP%292%28L2%29%5D2%2B+%28DIP+%3D+4%2C7-Diphenyl-1%2C10-Phenanthroline%29%3A+Synthesis%2C+Solution+Behavior%2C+and+X-Ray+Molecular+Structure+of+Trans+-%5BRu%28DIP%292%28MeOH%292%5D%5BOTf%5D2&doi=10.1021%2Fic0601236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A New Family of Mono- and Dicarboxylic Ruthenium Complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): Synthesis, Solution Behavior, and X-ray Molecular Structure of trans-[Ru(DIP)2(MeOH)2][OTf]2</span></div><div class="casAuthors">Caspar, Regis; Cordier, Christine; Waern, Jenny B.; Guyard-Duhayon, Carine; Gruselle, Michel; Le Floch, Pascal; Amouri, Hani</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4071-4078</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new family of Ru complexes [Ru(DIP)2(L2)]2+, where DIP = 4,7-diphenyl-1,10-phenanthroline, a bidentate ligand with an extended arom. system, was prepd. and fully characterized.  When L is a monodentate ligand, the following complexes were obtained: L = CF3SO3-1 (2), MeCN (3), and MeOH (4).  When L2 is a bidentate ligand, [Ru(DIP)2(Hcmbpy)][Cl]2 (5) and [Ru(DIP)2(H2dcbpy)][Cl]2 (6) were prepd. (Hcmbpy = 4-carboxy-4'-methyl-2,2-bipyridine, H2dcbpy = 4,4'-dicarboxy-2,2'-bipyridine).  [Ru(DIP)2(MeOH)2][OTf]2 (4) displayed a trans configuration of the DIP ligands, which is rare for octahedral complexes featuring DIP bidentate ligands.  DFT calcns. carried out on 4 showed that the cis isomer is more stable by 12.2 kcal/mol relative to the trans species.  The soln. behaviors of monocarboxylic complex [Ru(DIP)2(Hcmbpy)][Cl]2 (5) and dicarboxylic complex [Ru(DIP)2(H2dcbpy)][Cl]2 (6) were studied by 1H NMR spectroscopy.  VT-NMR, concn. dependence, and reaction with NaOD allowed the authors to suggest that aggregation of the cationic species in soln., esp. for 6, originates mainly from H bonding interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5q49bOX8ksrVg90H21EOLACvtfcHk0lj9kxMd5QWTAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFWnt7c%253D&md5=cf9491f29e38d68d94e259f988488216</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fic0601236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic0601236%26sid%3Dliteratum%253Aachs%26aulast%3DCaspar%26aufirst%3DR.%26aulast%3DCordier%26aufirst%3DC.%26aulast%3DWaern%26aufirst%3DJ.%2BB.%26aulast%3DGuyard-Duhayon%26aufirst%3DC.%26aulast%3DGruselle%26aufirst%3DM.%26aulast%3DLe%2BFloch%26aufirst%3DP.%26aulast%3DAmouri%26aufirst%3DH.%26atitle%3DA%2520New%2520Family%2520of%2520Mono-%2520and%2520Dicarboxylic%2520Ruthenium%2520Complexes%2520%255BRu%2528DIP%25292%2528L2%2529%255D2%252B%2520%2528DIP%2520%253D%25204%252C7-Diphenyl-1%252C10-Phenanthroline%2529%253A%2520Synthesis%252C%2520Solution%2520Behavior%252C%2520and%2520X-Ray%2520Molecular%2520Structure%2520of%2520Trans%2520-%255BRu%2528DIP%25292%2528MeOH%25292%255D%255BOTf%255D2%26jtitle%3DInorg.%2520Chem.%26date%3D2006%26volume%3D45%26spage%3D4071%26epage%3D4078%26doi%3D10.1021%2Fic0601236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carugo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellani, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djinovicb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span> <span> </span><span class="NLM_article-title">Ligands Derived from O-Benzoquinone: Statistical Correlation between Oxidation State and Structural Features</span>. <i>J. Chem. Soc., Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">837</span>, <span class="refDoi"> DOI: 10.1039/dt9920000837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fdt9920000837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1992&pages=837&author=O.+Carugoauthor=C.+B.+Castellaniauthor=K.+Djinovicbauthor=M.+Rizzi&title=Ligands+Derived+from+O-Benzoquinone%3A+Statistical+Correlation+between+Oxidation+State+and+Structural+Features&doi=10.1039%2Fdt9920000837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2Fdt9920000837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fdt9920000837%26sid%3Dliteratum%253Aachs%26aulast%3DCarugo%26aufirst%3DO.%26aulast%3DCastellani%26aufirst%3DC.%2BB.%26aulast%3DDjinovicb%26aufirst%3DK.%26aulast%3DRizzi%26aufirst%3DM.%26atitle%3DLigands%2520Derived%2520from%2520O-Benzoquinone%253A%2520Statistical%2520Correlation%2520between%2520Oxidation%2520State%2520and%2520Structural%2520Features%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Dalton%2520Trans.%26date%3D1992%26volume%3D10%26spage%3D837%26doi%3D10.1039%2Fdt9920000837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, S. L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. J.</span></span> <span> </span><span class="NLM_article-title">Redox, Spectroscopic, and Photophysical Properties of Ru-Pt Mixed-Metal Complexes Incorporating 4,7-Diphenyl-1,10-Phenanthroline as Efficient DNA Binding and Photocleaving Agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1021/ic100958r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic100958r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=463-470&author=S.+L.+H.+Higginsauthor=T.+A.+Whiteauthor=B.+S.+J.+Winkelauthor=K.+J.+Brewer&title=Redox%2C+Spectroscopic%2C+and+Photophysical+Properties+of+Ru-Pt+Mixed-Metal+Complexes+Incorporating+4%2C7-Diphenyl-1%2C10-Phenanthroline+as+Efficient+DNA+Binding+and+Photocleaving+Agents&doi=10.1021%2Fic100958r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Redox, Spectroscopic, and Photophysical Properties of Ru-Pt Mixed-Metal Complexes Incorporating 4,7-Diphenyl-1,10-phenanthroline as Efficient DNA Binding and Photocleaving Agents</span></div><div class="casAuthors">Higgins, Samantha L. H.; White, Travis A.; Winkel, Brenda S. J.; Brewer, Karen J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The redox, spectroscopic, and photophys. properties as well as DNA interactions of the new bimetallic complexes [(Ph2phen)2Ru(BL)PtCl2]2+ (Ph2phen = 4,7-diphenyl-1,10-phenanthroline, and BL (bridging ligand) dpp = 2,3-bis(2-pyridyl)pyrazine, or dpq = 2,3-bis(2-pyridyl)quinoxaline) were investigated.  These Ru-polyazine chromophores with Ph2phen TLs (terminal ligands) and polyazine BLs are efficient light absorbers.  The [(Ph2phen)2Ru(BL)PtCl2]2+ complexes display reversible RuII/III oxidns. at 1.57 (dpp) and 1.58 (dpq) V vs. SCE with an irreversible PtII/IV oxidn. occurring prior at 1.47 V vs. SCE.  Four, reversible ligand redns. occur at -0.50 dpp0/-, -1.06 dpp-/2-, -1.37 Ph2phen0/-, and -1.56 V vs. SCE Ph2phen0/-.  For the [(Ph2phen)2Ru(dpq)PtCl2]2+ complex, the first two redns. shift to more pos. potentials at -0.23 and -0.96 V vs. SCE.  The electronic absorption spectroscopy is dominated in the UV region by π→π* ligand transitions and in the visible region by metal-to-ligand charge transfer (MLCT) transitions at 517 nm for [(Ph2phen)2Ru(dpp)PtCl2]2+ and 600 nm for [(Ph2phen)2Ru(dpq)PtCl2]2+.  Emission spectroscopy shows that upon attaching Pt to the Ru monometallic precursor the λmaxem shifts from 664 nm for [(Ph2phen)2Ru(dpp)]2+ to 740 nm for [(Ph2phen)2Ru(dpp)PtCl2]2+.  The cis-PtIICl2 bioactive site offers the potential of targeting DNA by covalently binding the mixed-metal complex to DNA bases.  The multifunctional interactions with DNA were assayed using both linear and circular plasmid pUC18 DNA gel shift assays.  Both title complexes can bind to and photocleave DNA with dramatically enhanced efficiency relative to previously reported systems.  The impact of the Ph2phen TL on photophysics and bioreactivity is somewhat surprising given the Ru→BL charge transfer (CT) nature of the photoreactive state in the complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3qKniILId7Vg90H21EOLACvtfcHk0lhfa_eZiQFvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt77F&md5=5a2cd38d01d9df412faf06eb2568bd36</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fic100958r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic100958r%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DS.%2BL.%2BH.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DWinkel%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DBrewer%26aufirst%3DK.%2BJ.%26atitle%3DRedox%252C%2520Spectroscopic%252C%2520and%2520Photophysical%2520Properties%2520of%2520Ru-Pt%2520Mixed-Metal%2520Complexes%2520Incorporating%25204%252C7-Diphenyl-1%252C10-Phenanthroline%2520as%2520Efficient%2520DNA%2520Binding%2520and%2520Photocleaving%2520Agents%26jtitle%3DInorg.%2520Chem.%26date%3D2011%26volume%3D50%26spage%3D463%26epage%3D470%26doi%3D10.1021%2Fic100958r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mongelli, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, K. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Study of the Light Absorbing, Redox and Photophysical Properties of Ru(II) and Os(II) Complexes of 4,7-Diphenyl-1,10-Phenanthroline Containing the Polyazine Bridging Ligand 2,3-Bis(2-Pyridyl)Pyrazine</span>. <i>Inorg. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1016/j.inoche.2006.04.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.inoche.2006.04.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=877-881&author=M.+T.+Mongelliauthor=K.+J.+Brewer&title=Synthesis+and+Study+of+the+Light+Absorbing%2C+Redox+and+Photophysical+Properties+of+Ru%28II%29+and+Os%28II%29+Complexes+of+4%2C7-Diphenyl-1%2C10-Phenanthroline+Containing+the+Polyazine+Bridging+Ligand+2%2C3-Bis%282-Pyridyl%29Pyrazine&doi=10.1016%2Fj.inoche.2006.04.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and study of the light absorbing, redox and photophysical properties of Ru(II) and Os(II) complexes of 4,7-diphenyl-1,10-phenanthroline containing the polyazine bridging ligand 2,3-bis(2-pyridyl)pyrazine</span></div><div class="casAuthors">Mongelli, Matthew T.; Brewer, Karen J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">877-881</span>CODEN:
                <span class="NLM_cas:coden">ICCOFP</span>;
        ISSN:<span class="NLM_cas:issn">1387-7003</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monometallic light absorbing complexes [(Ph2phen)2M(dpp)]2+ (M = Os(II) or Ru(II), Ph2phen = 4,7-diphenyl-1,10-phenanthroline, dpp = 2,3-bis(2-pyridyl)pyrazine) were synthesized.  The coupling of Ph2phen to Ru and Os complexes with polyazine bridging ligands will allow for the incorporation of these chromophores into supramol. assemblies.  The spectroscopic, redox and photochem. properties were studied.  The complexes exhibit overlapping 1MLCT (metal-to-ligand charge transfer) transitions in their electronic absorbance spectroscopy with lowest energy peaks at 444 nm and 494 nm for [(Ph2phen)2Ru(dpp)]2+ and [(Ph2phen)2Os(dpp)]2+, resp.  An intense 3MLCT absorption for the Os complex centered at ∼650 nm is also obsd.  The redox properties show significantly different reversible one electron metal oxidns., E0x1/2 = 1.39 V and 1.02 V vs. Ag/AgCl for the Ru and Os complexes, resp.  Each complex displays three reversible redns. based on each polyazine ligand.  The photophys. properties show strong 3MLCT emissions centered at 697 and 800 nm for the Ru and Os complexes, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonJl_DVCrPBbVg90H21EOLACvtfcHk0lhfa_eZiQFvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrtrc%253D&md5=1f58312ff9178e73260b2459bd9ce6c7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.inoche.2006.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.inoche.2006.04.022%26sid%3Dliteratum%253Aachs%26aulast%3DMongelli%26aufirst%3DM.%2BT.%26aulast%3DBrewer%26aufirst%3DK.%2BJ.%26atitle%3DSynthesis%2520and%2520Study%2520of%2520the%2520Light%2520Absorbing%252C%2520Redox%2520and%2520Photophysical%2520Properties%2520of%2520Ru%2528II%2529%2520and%2520Os%2528II%2529%2520Complexes%2520of%25204%252C7-Diphenyl-1%252C10-Phenanthroline%2520Containing%2520the%2520Polyazine%2520Bridging%2520Ligand%25202%252C3-Bis%25282-Pyridyl%2529Pyrazine%26jtitle%3DInorg.%2520Chem.%2520Commun.%26date%3D2006%26volume%3D9%26spage%3D877%26epage%3D881%26doi%3D10.1016%2Fj.inoche.2006.04.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medhi, O. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwala, U.</span></span> <span> </span><span class="NLM_article-title">Electron Spin Resonance Studies of Some Ruthenium(III) Complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1384</span>, <span class="refDoi"> DOI: 10.1021/ic50207a055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic50207a055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL3cXitVKmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=1381-1384&author=O.+K.+Medhiauthor=U.+Agarwala&title=Electron+Spin+Resonance+Studies+of+Some+Ruthenium%28III%29+Complexes&doi=10.1021%2Fic50207a055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Electron spin resonance studies of some ruthenium(III) complexes</span></div><div class="casAuthors">Medhi, O. K.; Agarwala, U.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1381-4</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">An ESR study was carried out on a no. of low-spin Ru(III) complexes contg. Ph3As, Ph3P, and β-diketonate ligands.  Their geometries, ground states, and other spectral parameters were obtained by using the ligand field theory for low-spin d5 systems.  The results show a large axial distortion and a 2B(or 2A) ground term for these complexes.  The low-symmetry ligand field component is larger than the spin-orbit coupling const.  There may be 2 contributing factors for the large axial distortion: (1) a geometric factor; and (2) anisotropy in the covalent bonding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9FVHFvxZBr7Vg90H21EOLACvtfcHk0lhXA-3zs-9xdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXitVKmtbg%253D&md5=c8c5b53623a8ffc8a3e657017439a8fe</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fic50207a055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic50207a055%26sid%3Dliteratum%253Aachs%26aulast%3DMedhi%26aufirst%3DO.%2BK.%26aulast%3DAgarwala%26aufirst%3DU.%26atitle%3DElectron%2520Spin%2520Resonance%2520Studies%2520of%2520Some%2520Ruthenium%2528III%2529%2520Complexes%26jtitle%3DInorg.%2520Chem.%26date%3D1980%26volume%3D19%26spage%3D1381%26epage%3D1384%26doi%3D10.1021%2Fic50207a055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, W. E.</span></span> <span> </span><span class="NLM_article-title">Chemical Redox Agents for Organometallic Chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">910</span>, <span class="refDoi"> DOI: 10.1021/cr940053x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr940053x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK28XhsVGhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=877-910&author=N.+G.+Connellyauthor=W.+E.+Geiger&title=Chemical+Redox+Agents+for+Organometallic+Chemistry&doi=10.1021%2Fcr940053x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Redox Agents for Organometallic Chemistry</span></div><div class="casAuthors">Connelly, Neil G.; Geiger, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-910</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with >461 refs., showing how one-electron oxidants and reductants have been used in preparative chem. (incorporating both synthetic applications and generation of species for in situ characterization) in nonaq. solns., the usual media for organometallic ET reactions.  The authors do not treat photochem.-generated reducing agents which, although generally transient species, may have advantages in some applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgEDXkQMqzxLVg90H21EOLACvtfcHk0lhXA-3zs-9xdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVGhu7Y%253D&md5=205b204d99818aded3c41067d4bf85e3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcr940053x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr940053x%26sid%3Dliteratum%253Aachs%26aulast%3DConnelly%26aufirst%3DN.%2BG.%26aulast%3DGeiger%26aufirst%3DW.%2BE.%26atitle%3DChemical%2520Redox%2520Agents%2520for%2520Organometallic%2520Chemistry%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D877%26epage%3D910%26doi%3D10.1021%2Fcr940053x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyer, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerasimenko, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullev, V. I.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Oxidation of Ferrocene: A Strong Dependence on the Concentration of the Supporting Electrolyte for Nonpolar Solvents</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1021/jp809105f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp809105f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1259-1267&author=D.+Baoauthor=B.+Millareauthor=W.+Xiaauthor=B.+G.+Steyerauthor=A.+A.+Gerasimenkoauthor=A.+Ferreiraauthor=A.+Contrerasauthor=V.+I.+Vullev&title=Electrochemical+Oxidation+of+Ferrocene%3A+A+Strong+Dependence+on+the+Concentration+of+the+Supporting+Electrolyte+for+Nonpolar+Solvents&doi=10.1021%2Fjp809105f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical Oxidation of Ferrocene: A Strong Dependence on the Concentration of the Supporting Electrolyte for Nonpolar Solvents</span></div><div class="casAuthors">Bao, Duoduo; Millare, Brent; Xia, Wei; Steyer, Benjamin G.; Gerasimenko, Alexander A.; Ferreira, Amy; Contreras, Antonio; Vullev, Valentine I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1259-1267</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The estn. of the driving force for photoinduced charge-transfer processes, using the Rehm-Weller equation, requires the employment of redox and spectroscopic quantities describing the participating electron donor and acceptor.  Although the spectroscopic data are usually obtained from dild. solns., the redox potentials are most frequently obtained from electrochem. measurements conducted in concd. electrolyte solns.  To correct for the differences in the media, in which the various types of measurements are conducted, a term, based on the Born equation for solvation energy of ions, is introduced in the Rehm-Weller equation.  The Born correction term, however, requires a prior knowledge of the dielec. consts. of the electrolyte solns. used for the redox measurements.  Because of limited information for such dielecs., the values for the dielec. consts. of electrolyte solns. are approximated to the values of the dielec. consts. of the corresponding neat solvents.  The authors examd. the validity of this approxn.  Using cyclic voltammetry, the authors recorded the 1st 1-electron oxidn. potential of ferrocene for 3 different solvents in the presence of 1-500 mM supporting electrolyte.  The dielec. consts. for some of the electrolyte solns. were extd. from fluorescence measurements of a dimethylaminonaphthalimide chromophore that exhibits pronounced solvatochromism.  The dielec. consts. of the concd. electrolyte solns. correlated well with the corresponding oxidn. potentials.  The dependence of the oxidn. potential of ferrocene on the electrolyte concn. for different solvents revealed that the abovementioned approxn. in the Born correction term indeed introduces a significant error in the estn. of the charge-transfer driving force from redox data collected using relatively nonpolar solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTEUH9F5-rs7Vg90H21EOLACvtfcHk0lhvkT9VIMt2zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlOgtw%253D%253D&md5=45127d9df45b0419f247fa541f9ab6b4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjp809105f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp809105f%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DD.%26aulast%3DMillare%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DSteyer%26aufirst%3DB.%2BG.%26aulast%3DGerasimenko%26aufirst%3DA.%2BA.%26aulast%3DFerreira%26aufirst%3DA.%26aulast%3DContreras%26aufirst%3DA.%26aulast%3DVullev%26aufirst%3DV.%2BI.%26atitle%3DElectrochemical%2520Oxidation%2520of%2520Ferrocene%253A%2520A%2520Strong%2520Dependence%2520on%2520the%2520Concentration%2520of%2520the%2520Supporting%2520Electrolyte%2520for%2520Nonpolar%2520Solvents%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2009%26volume%3D113%26spage%3D1259%26epage%3D1267%26doi%3D10.1021%2Fjp809105f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbiani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubafard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstaett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felgenträger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiccia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Characterization, and Biological Evaluation of New Ru(II) Polypyridyl Photosensitizers for Photodynamic Therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7280</span>– <span class="NLM_lpage">7292</span>, <span class="refDoi"> DOI: 10.1021/jm500566f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500566f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7280-7292&author=A.+Freiauthor=R.+Rubbianiauthor=S.+Tubafardauthor=O.+Blacqueauthor=P.+Anstaettauthor=A.+Felgentr%C3%A4gerauthor=T.+Maischauthor=L.+Spicciaauthor=G.+Gasser&title=Synthesis%2C+Characterization%2C+and+Biological+Evaluation+of+New+Ru%28II%29+Polypyridyl+Photosensitizers+for+Photodynamic+Therapy&doi=10.1021%2Fjm500566f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Biological Evaluation of New Ru(II) Polypyridyl Photosensitizers for Photodynamic Therapy</span></div><div class="casAuthors">Frei, Angelo; Rubbiani, Riccardo; Tubafard, Solmaz; Blacque, Olivier; Anstaett, Philipp; Felgentrager, Ariane; Maisch, Tim; Spiccia, Leone; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7280-7292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two Ru(II) polypyridyl complexes, Ru(DIP)2(bdt) (1) and [Ru(dqpCO2Me)(ptpy)]2+ (2) (DIP = 4,7-diphenyl-1,10-phenanthroline, bdt = 1,2-benzenedithiolate, dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2''-terpyridine) have been investigated as photosensitizers (PSs) for photodynamic therapy (PDT).  In our exptl. settings, the phototoxicity and phototoxic index (PI) of 2 (IC50(light): 25.3 μM, 420 nm, 6.95 J/cm2; PI >4) and particularly of 1 (IC50(light): 0.62 μM, 420 nm, 6.95 J/cm2; PI: 80) are considerably superior compared to the two clin. approved PSs porfimer sodium and 5-aminolevulinic acid.  Cellular uptake and distribution of these complexes was investigated by confocal microscopy (1) and by inductively coupled plasma mass spectrometry (1 and 2).  Their phototoxicity was also detd. against the Gram-(+) Staphylococcus aureus and Gram-(-) Escherichia coli for potential antimicrobial PDT (aPDT) applications.  Both complexes showed significant aPDT activity (420 nm, 8 J/cm2) against Gram-(+) (S. aureus; >6 log10 CFU redn.) and, for 2, also against Gram-(-) E. coli (>4 log10 CFU redn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QENinj0EILVg90H21EOLACvtfcHk0ljcPjeLtrF1bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M&md5=95f232e052cf5ad756557e861e9086e5</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm500566f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500566f%26sid%3Dliteratum%253Aachs%26aulast%3DFrei%26aufirst%3DA.%26aulast%3DRubbiani%26aufirst%3DR.%26aulast%3DTubafard%26aufirst%3DS.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DAnstaett%26aufirst%3DP.%26aulast%3DFelgentr%25C3%25A4ger%26aufirst%3DA.%26aulast%3DMaisch%26aufirst%3DT.%26aulast%3DSpiccia%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520Characterization%252C%2520and%2520Biological%2520Evaluation%2520of%2520New%2520Ru%2528II%2529%2520Polypyridyl%2520Photosensitizers%2520for%2520Photodynamic%2520Therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7280%26epage%3D7292%26doi%3D10.1021%2Fjm500566f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cepeda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuertes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castilla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J.</span></span> <span> </span><span class="NLM_article-title">Biochemical Mechanisms of Cisplatin Cytotoxicity</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.2174/187152007779314044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2174%2F187152007779314044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17266502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlyktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=3-18&author=V.+Cepedaauthor=M.+Fuertesauthor=J.+Castillaauthor=C.+Alonsoauthor=C.+Quevedoauthor=J.+Perez&title=Biochemical+Mechanisms+of+Cisplatin+Cytotoxicity&doi=10.2174%2F187152007779314044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical mechanisms of cisplatin cytotoxicity</span></div><div class="casAuthors">Cepeda, Victoria; Fuertes, Miguel A.; Castilla, Josefina; Alonso, Carlos; Quevedo, Celia; Perez, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-18</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery by Rosenberg and collaborators of the antitumor activity of cisplatin 35 years ago, 3 platinum antitumor drugs (cisplatin, carboplatin, and oxaliplatin) have enjoyed a huge clin. and com. hit.  Ever since the initial discovery of the anticancer activity of cisplatin, major efforts were devoted to elucidate the biochem. mechanisms of antitumor activity of cisplatin to be able to rationally design novel Pt based drugs with superior pharmacol. profiles.  In this report we attempt to provide a current picture of the known facts pertaining to the mechanism of action of the drug, including those involved in drug uptake, DNA damage signals transduction, and cell death through apoptosis or necrosis.  A deep knowledge of the biochem. mechanisms, which are triggered in the tumor cell in response to cisplatin injury not only may lead to the design of more efficient Pt antitumor drugs but also may provide new therapeutic strategies based on the biochem. modulation of cisplatin activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP_AAU2HTQbbVg90H21EOLACvtfcHk0ljcPjeLtrF1bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlyktL8%253D&md5=af25f14b9970e88e255c14b03028f294</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2174%2F187152007779314044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152007779314044%26sid%3Dliteratum%253Aachs%26aulast%3DCepeda%26aufirst%3DV.%26aulast%3DFuertes%26aufirst%3DM.%26aulast%3DCastilla%26aufirst%3DJ.%26aulast%3DAlonso%26aufirst%3DC.%26aulast%3DQuevedo%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DJ.%26atitle%3DBiochemical%2520Mechanisms%2520of%2520Cisplatin%2520Cytotoxicity%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D3%26epage%3D18%26doi%3D10.2174%2F187152007779314044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keizer, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinedo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuurhuis, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joenje, H.</span></span> <span> </span><span class="NLM_article-title">Doxorubicin (Adriamycin): A Critical Review of Free Radical-Dependent Mechanisms of Cyototoxicity</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(90)90088-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2F0163-7258%2890%2990088-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=2203071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=219-231&author=H.+G.+Keizerauthor=H.+M.+Pinedoauthor=G.+J.+Schuurhuisauthor=H.+Joenje&title=Doxorubicin+%28Adriamycin%29%3A+A+Critical+Review+of+Free+Radical-Dependent+Mechanisms+of+Cyototoxicity&doi=10.1016%2F0163-7258%2890%2990088-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin (adriamycin):  a critical review of free radical-dependent mechanisms of cytotoxicity</span></div><div class="casAuthors">Keizer, H. G.; Pinedo, H. M.; Schuurhuis, G. J.; Joenje, H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-31</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼130 refs.  The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered crit. for its antitumor action.  However, for most tumor cell lines, this mechanism of cytotoxicity does not appear to play a major role.  Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh7SgS1hAtL7Vg90H21EOLACvtfcHk0ljcPjeLtrF1bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D&md5=4dd568ea3172c73030b58b6822f9477f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2890%2990088-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252890%252990088-J%26sid%3Dliteratum%253Aachs%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DSchuurhuis%26aufirst%3DG.%2BJ.%26aulast%3DJoenje%26aufirst%3DH.%26atitle%3DDoxorubicin%2520%2528Adriamycin%2529%253A%2520A%2520Critical%2520Review%2520of%2520Free%2520Radical-Dependent%2520Mechanisms%2520of%2520Cyototoxicity%26jtitle%3DPharmacol.%2520Ther.%26date%3D1990%26volume%3D47%26spage%3D219%26epage%3D231%26doi%3D10.1016%2F0163-7258%2890%2990088-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelm, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fussenegger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L. K.</span></span> <span> </span><span class="NLM_article-title">Multicellular Tumor Spheroids Applicable to a Wide Variety of Cell Types</span>. <i>Biotechnol. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1002/bit.10655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fbit.10655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=12768623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslaitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2003&pages=173-180&author=J.+M.+Kelmauthor=N.+E.+Timminsauthor=C.+J.+Brownauthor=M.+Fusseneggerauthor=L.+K.+Nielsen&title=Multicellular+Tumor+Spheroids+Applicable+to+a+Wide+Variety+of+Cell+Types&doi=10.1002%2Fbit.10655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types</span></div><div class="casAuthors">Kelm, Jens M.; Timmins, Nicholas E.; Brown, Catherine J.; Fussenegger, Martin; Nielsen, Lars K.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology and Bioengineering</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-180</span>CODEN:
                <span class="NLM_cas:coden">BIBIAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3592</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Multicellular tumor spheroids (MCTS) are used as organotypic models of normal and solid tumor tissue.  Traditional techniques for generating MCTS, such as growth on nonadherent surfaces, in suspension, or on scaffolds, have a no. of drawbacks, including the need for manual selection to achieve a homogeneous population and the use of nonphysiol. matrix compds.  In this study the authors describe a mild method for the generation of MCTS, in which individual spheroids form in hanging drops suspended from a microtiter plate.  The method was successfully applied to a broad range of cell lines and shows nearly 100% efficiency (i.e., one spheroid per drop).  Using the hepatoma cell line, HepG2, the hanging drop method generated well-rounded MCTS with a narrow size distribution (coeff. of variation [CV] 10% to 15%, compared with 40% to 60% for growth on nonadherent surfaces).  Structural anal. of HepG2 and a mammary gland adenocarcinoma cell line, MCF-7, composed spheroids, revealed highly organized, 3-dimensional, tissue-like structures with an extensive extracellular matrix.  The hanging drop method represents an attractive for MCTS prodn., because it is mild, can be applied to a wide variety of cell lines, and can produce spheroids of a homogeneous size without the need for sieving or manual selection.  The method has applications for basic studies of physiol. and metab., tumor biol., toxicol., cellular organization, and the development of bioartificial tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfiddBoeMx_bVg90H21EOLACvtfcHk0li1C5zryBc3Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslaitbk%253D&md5=1277f55c4fcec36c0fe94ee1f8245cac</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fbit.10655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbit.10655%26sid%3Dliteratum%253Aachs%26aulast%3DKelm%26aufirst%3DJ.%2BM.%26aulast%3DTimmins%26aufirst%3DN.%2BE.%26aulast%3DBrown%26aufirst%3DC.%2BJ.%26aulast%3DFussenegger%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DL.%2BK.%26atitle%3DMulticellular%2520Tumor%2520Spheroids%2520Applicable%2520to%2520a%2520Wide%2520Variety%2520of%2520Cell%2520Types%26jtitle%3DBiotechnol.%2520Bioeng.%26date%3D2003%26volume%3D83%26spage%3D173%26epage%3D180%26doi%3D10.1002%2Fbit.10655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomshine, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.-J.</span></span> <span> </span><span class="NLM_article-title">Multicellular Tumor Spheroids as an In Vivo-Like Tumor Model for Three-Dimensional Imaging of Chemotherapeutic and Nano Material Cellular Penetration</span>. <i>Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.2310/7290.2012.00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2310%2F7290.2012.00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23084249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVel" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=487-498&author=H.-l.+Maauthor=Q.+Jiangauthor=S.+Hanauthor=Y.+Wuauthor=J.+C.+Tomshineauthor=D.+Wangauthor=Y.+Ganauthor=G.+Zouauthor=X.-J.+Liang&title=Multicellular+Tumor+Spheroids+as+an+In+Vivo-Like+Tumor+Model+for+Three-Dimensional+Imaging+of+Chemotherapeutic+and+Nano+Material+Cellular+Penetration&doi=10.2310%2F7290.2012.00012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration</span></div><div class="casAuthors">Ma, Hui-li; Jiang, Qiao; Han, Siyuan; Wu, Yan; Tomshine, Jin Cui; Wang, Dongliang; Gan, Yaling; Zou, Guozhang; Liang, Xing-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">487-498</span>CODEN:
                <span class="NLM_cas:coden">MIOMBP</span>;
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    
            (<span class="NLM_cas:orgname">Decker Publishing</span>)
        </div><div class="casAbstract">A flexible and highly reproducible method was developed using three-dimensional (3D) multicellular tumor spheroids to quantify chemotherapeutic and nanoparticle penetration properties in vitro.  Generated was HeLa cell-derived spheroids using the liq. overlay method.  To properly characterize HeLa spheroids, SEM, transmission electron microscopy, and multiphoton microscopy were used to obtain high-resoln. 3D images of HeLa spheroids.  Next, pairing high-resoln. optical characterization techniques with flow cytometry, we quant. compared the penetration of doxorubicin, quantum dots, and synthetic micelles into 3D HeLa spheroid vs. HeLa cells grown in a traditional two-dimensional culturing system.  The 3D cultured HeLa cells acquired several clin. relevant morpol. and cellular characteristics (such as resistance to chemotherapeutics) often found in human solid tumors.  These characteristic, however, could not be captured using conventional two-dimensional cell culture techniques.  This study demonstrated the remarkable versatility of HeLa spheroid 3D imaging.  In addn., the results revealed the capability of HeLa spheroids to function as a screening tool for nanoparticles or synthetic micelles that, due to their inherent size, charge, and hydrophobicity, can penetrate into solid tumors and act as delivery vehicles for chemotherapeutics.  The development of this image-based, reproducible, and quantifiable in vitro HeLa spheroid screening tool will greatly aid future exploration of chemotherapeutics and nanoparticle delivery into solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8UaDBbDeBLVg90H21EOLACvtfcHk0li1C5zryBc3Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVel&md5=fca14f9809f9f403cad39c1440e0afee</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.2310%2F7290.2012.00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2310%252F7290.2012.00012%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.-l.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DTomshine%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DGan%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DX.-J.%26atitle%3DMulticellular%2520Tumor%2520Spheroids%2520as%2520an%2520In%2520Vivo-Like%2520Tumor%2520Model%2520for%2520Three-Dimensional%2520Imaging%2520of%2520Chemotherapeutic%2520and%2520Nano%2520Material%2520Cellular%2520Penetration%26jtitle%3DMol.%2520Imaging%26date%3D2012%26volume%3D11%26spage%3D487%26epage%3D498%26doi%3D10.2310%2F7290.2012.00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapałczyńska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolenda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybyła, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zajączkowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teresiak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliźniak, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">State of the Art Paper 2D and 3D Cell Cultures – a Comparison of Different Types of Cancer Cell Cultures</span>. <i>Arch. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">910</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.5114/aoms.2016.63743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.5114%2Faoms.2016.63743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30002710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fns1GnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=910-919&author=M.+Kapa%C5%82czy%C5%84skaauthor=T.+Kolendaauthor=W.+Przyby%C5%82aauthor=M.+Zaj%C4%85czkowskaauthor=A.+Teresiakauthor=V.+Filasauthor=M.+Ibbsauthor=R.+Bli%C5%BAniak&title=State+of+the+Art+Paper+2D+and+3D+Cell+Cultures+%E2%80%93+a+Comparison+of+Different+Types+of+Cancer+Cell+Cultures&doi=10.5114%2Faoms.2016.63743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">2D and 3D cell cultures - a comparison of different types of cancer cell cultures</span></div><div class="casAuthors">Kapalczynska Marta; Kolenda Tomasz; Przybyla Weronika; ZajAczkowska Maria; Teresiak Anna; Blizniak Renata; Lamperska Katarzyna; Kolenda Tomasz; Filas Violetta; Ibbs Matthew; Luczewski Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Archives of medical science : AMS</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">910-919</span>
        ISSN:<span class="NLM_cas:issn">1734-1922</span>.
    </div><div class="casAbstract">Cell culture is a widely used in vitro tool for improving our understanding of cell biology, tissue morphology, and mechanisms of diseases, drug action, protein production and the development of tissue engineering.  Most research regarding cancer biology is based on experiments using two-dimensional (2D) cell cultures in vitro.  However, 2D cultures have many limitations, such as the disturbance of interactions between the cellular and extracellular environments, changes in cell morphology, polarity, and method of division.  These disadvantages led to the creation of models which are more closely able to mimic conditions in vivo.  One such method is three-dimensional culture (3D).  Optimisation of the culture conditions may allow for a better understanding of cancer biology and facilitate the study of biomarkers and targeting therapies.  In this review, we compare 2D and 3D cultures in vitro as well as different versions of 3D cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgPZJo90OQZ9bHMBt0mMIXfW6udTcc2eYkNkXCjrBwPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fns1GnsQ%253D%253D&md5=b8314bcbb043ebe5b611bb12107584ed</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.5114%2Faoms.2016.63743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5114%252Faoms.2016.63743%26sid%3Dliteratum%253Aachs%26aulast%3DKapa%25C5%2582czy%25C5%2584ska%26aufirst%3DM.%26aulast%3DKolenda%26aufirst%3DT.%26aulast%3DPrzyby%25C5%2582a%26aufirst%3DW.%26aulast%3DZaj%25C4%2585czkowska%26aufirst%3DM.%26aulast%3DTeresiak%26aufirst%3DA.%26aulast%3DFilas%26aufirst%3DV.%26aulast%3DIbbs%26aufirst%3DM.%26aulast%3DBli%25C5%25BAniak%26aufirst%3DR.%26atitle%3DState%2520of%2520the%2520Art%2520Paper%25202D%2520and%25203D%2520Cell%2520Cultures%2520%25E2%2580%2593%2520a%2520Comparison%2520of%2520Different%2520Types%2520of%2520Cancer%2520Cell%2520Cultures%26jtitle%3DArch.%2520Med.%2520Sci.%26date%3D2018%26volume%3D14%26spage%3D910%26epage%3D919%26doi%3D10.5114%2Faoms.2016.63743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz-Schughart, L. A.</span></span> <span> </span><span class="NLM_article-title">Spheroid-Based Drug Screen: Considerations and Practical Approach</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2Fnprot.2008.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=19214182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslymtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=309-324&author=J.+Friedrichauthor=C.+Seidelauthor=R.+Ebnerauthor=L.+A.+Kunz-Schughart&title=Spheroid-Based+Drug+Screen%3A+Considerations+and+Practical+Approach&doi=10.1038%2Fnprot.2008.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Spheroid-based drug screen: considerations and practical approach</span></div><div class="casAuthors">Friedrich, Juergen; Seidel, Claudia; Ebner, Reinhard; Kunz-Schughart, Leoni A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-324</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although used in academic research for several decades, 3D culture models have long been regarded expensive, cumbersome and unnecessary in drug development processes.  Tech. advances, coupled with recent observations showing that gene expression in 3D is much closer to clin. expression profiles than those seen in 2D, have renewed attention and generated hope in the feasibility of maturing organotypic 3D systems to therapy test platforms with greater power to predict clin. efficacies.  Here we describe a standardized setup for reproducible, easy-handling culture, treatment and routine anal. of multicellular spheroids, the classical 3D culture system resembling many aspects of the pathophysiol. situation in human tumor tissue.  We discuss essential conceptual and practical considerations for an adequate establishment and use of spheroid-based drug screening platforms and also provide a list of human carcinoma cell lines, partly on the basis of the NCI-DTP 60-cell line screen, that produce treatable spheroids under identical culture conditions.  In contrast to many other settings with which to achieve similar results, the protocol is particularly useful to be integrated into standardized large-scale drug test routines as it requires a min. no. of defined spheroids and a limited amt. of drug.  The estd. time to run the complete screening protocol described herein, including spheroid initiation, drug treatment and detn. of the anal. end points (spheroid integrity, and cell survival through the acid phosphatase assay), is about 170 h.  Monitoring of spheroid growth kinetics to det. growth delay and regrowth, resp., after drug treatment requires long-term culturing (≥ 14 d).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvr2BggrU09LVg90H21EOLACvtfcHk0li1C5zryBc3Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslymtL8%253D&md5=9da11d166be494083e674206cbb4ee05</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.226%26sid%3Dliteratum%253Aachs%26aulast%3DFriedrich%26aufirst%3DJ.%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DEbner%26aufirst%3DR.%26aulast%3DKunz-Schughart%26aufirst%3DL.%2BA.%26atitle%3DSpheroid-Based%2520Drug%2520Screen%253A%2520Considerations%2520and%2520Practical%2520Approach%26jtitle%3DNat.%2520Protoc.%26date%3D2009%26volume%3D4%26spage%3D309%26epage%3D324%26doi%3D10.1038%2Fnprot.2008.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Evaluation of the Medicinal Potential of Two Ruthenium (II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">9888</span>– <span class="NLM_lpage">9896</span>, <span class="refDoi"> DOI: 10.1002/chem.201701392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fchem.201701392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28509422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=9888-9896&author=J.+Hessauthor=H.+Huangauthor=A.+Kaiserauthor=V.+Pierrozauthor=O.+Blacque&title=Evaluation+of+the+Medicinal+Potential+of+Two+Ruthenium+%28II%29+Polypyridine+Complexes+as+One-+and+Two-Photon+Photodynamic+Therapy+Photosensitizers&doi=10.1002%2Fchem.201701392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers</span></div><div class="casAuthors">Hess, Jeannine; Huang, Huaiyi; Kaiser, Adrian; Pierroz, Vanessa; Blacque, Olivier; Chao, Hui; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">9888-9896</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two [Ru(phen)2dppz]2+ derivs. (phen=1,10-phenantroline, dppz=dipyrido[3,2-a:2',3'-c]phenazine) with different functional groups on the dppz ligand [dppz-7,8-(OMe)2 (1), dppz-7,8-(OH)2 (2)] have been synthesized, characterized and investigated as photosensitizers (PSs) for photodynamic therapy (PDT) against cancer.  Both complexes showed intense red phosphorescence and promising singlet oxygen (1O2) quantum yields of 75 % (1) and 54 % (2) in acetonitrile.  Complex 1 (logPo/w=-0.52, 2.4 nmol Ru per mg protein) was found to be more lipophilic, having also a higher cellular uptake efficiency compared to 2 (logPo/w=-0.20, 0.9 nmol Ru per mg protein).  Complex 1 localized evenly in HeLa cells whereas 2, was mainly visualized in the cell membrane by confocal microscopy.  In the dark, complex 1 (IC50=36.5 μm) was found to be more toxic than complex 2 (IC50 >100 μm) on a HeLa cells monolayer.  Importantly, in view of PDT applications, both complexes were found to be non-toxic in the dark towards multicellular HeLa spheroids (IC50>100 μM).  Upon one-photon irradn. (420 nm, 9.27 J cm-2), 1 exhibited higher phototoxicity (IC50=3.1 μm) than 2 (IC50=16.7 μm) on HeLa cell monolayers.  When two-photon irradn. (800 nm, 9.90 J cm-2) was applied, only 1 (IC50=9.5 μm) was found to be active toward HeLa spheroids.  This study demonstrates that the functional group on the intercalative ligand has a strong influence on the cellular localization and anticancer activity of RuII polypyridyl complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALsMHxl67W7Vg90H21EOLACvtfcHk0liDPu0ulORAbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K&md5=5f4b0fb8ecd4d2cd980344015aaec947</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701392%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DBlacque%26aufirst%3DO.%26atitle%3DEvaluation%2520of%2520the%2520Medicinal%2520Potential%2520of%2520Two%2520Ruthenium%2520%2528II%2529%2520Polypyridine%2520Complexes%2520as%2520One-%2520and%2520Two-Photon%2520Photodynamic%2520Therapy%2520Photosensitizers%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D9888%26epage%3D9896%26doi%3D10.1002%2Fchem.201701392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seo, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S. S. A.</span></span> <span> </span><span class="NLM_article-title">Monitoring the Effects of Doxorubicin on 3D-Spheroid Tumor Cells in Real-Time</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">7207</span>– <span class="NLM_lpage">7218</span>, <span class="refDoi"> DOI: 10.2147/OTT.S112566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2147%2FOTT.S112566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=27920558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFais73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=7207-7218&author=O.+W.+Seoauthor=M.+Kimauthor=J.+Hulmeauthor=S.+S.+A.+An&title=Monitoring+the+Effects+of+Doxorubicin+on+3D-Spheroid+Tumor+Cells+in+Real-Time&doi=10.2147%2FOTT.S112566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time</span></div><div class="casAuthors">Baek, NamHuk; Seo, Ok Won; Kim, MinSung; Hulme, John; An, Seong Soo A.</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7207-7218</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Recently, increasing nos. of cell culture expts. with 3D spheroids presented better correlating results in vivo than traditional 2D cell culture systems. 3D spheroids could offer a simple and highly reproducible model that would exhibit many characteristics of natural tissue, such as the prodn. of extracellular matrix.  In this paper numerous cell lines were screened and selected depending on their ability to form and maintain a spherical shape.  The effects of increasing concns. of doxorubicin (DXR) on the integrity and viability of the selected spheroids were then measured at regular intervals and in real-time.  In total 12 cell lines, adenocarcinomic alveolar basal epithelial (A549), muscle (C2C12), prostate (DU145), testis (F9), pituitary epithelial-like (GH3), cervical cancer (HeLa), HeLa contaminant (HEp2), embryo (NIH3T3), embryo (PA317), neuroblastoma (SH-SY5Y), osteosarcoma U2OS, and embryonic kidney cells (293T), were screened.  Out of the 12, 8 cell lines, NIH3T3, C2C12, 293T, SH-SY5Y, A549, HeLa, PA317, and U2OS formed regular spheroids and the effects of DXR on these structures were measured at regular intervals.  Finally, 5 cell lines, A549, HeLa, SH-SY5Y, U2OS, and 293T, were selected for real-time monitoring and the effects of DXR treatment on their behavior were continuously recorded for 5 days.  A potential correlation regarding the effects of DXR on spheroid viability and ATP prodn. was measured on days 1, 3, and 5.  Cytotoxicity of DXR seemed to occur after endocytosis, since the cellular activities and ATP productions were still viable after 1 day of the treatment in all spheroids, except SH-SY5Y.  Both cellular activity and ATP prodn. were halted 3 and 5 days from the start of the treatment in all spheroids.  All cell lines maintained their spheroid shape, except SHSY-5, which behaved in an unpredictable manner when exposed to toxic concns. of DXR.  Cytotoxic effects of DXR towards SH-SY5Y seemed to cause degrdn. of the extracellular matrix, since all cells were dismantled from the spheroid upon cell death.  On the other hand, 293T spheroids revealed retarded cellular activity and ATP productions upon DXR treatment throughout the expt.  Since 293T was the embryonic kidney cells, the fast clearance or neutralizations could have made them resistant towards DXR.  In conclusion, the same degree of sensitivity from the 2D system did not translate to a 3D culture system, resulting in higher IC50 values than the 2D system.  The varying sensitivities and tolerances to drugs could be better understood with a 3D cell culture system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRUzfRKssbd7Vg90H21EOLACvtfcHk0liDPu0ulORAbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFais73P&md5=478cb185cc57506c530a5035f802e441</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.2147%2FOTT.S112566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S112566%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DO.%2BW.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHulme%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DS.%2BS.%2BA.%26atitle%3DMonitoring%2520the%2520Effects%2520of%2520Doxorubicin%2520on%25203D-Spheroid%2520Tumor%2520Cells%2520in%2520Real-Time%26jtitle%3DOncoTargets%2520Ther.%26date%3D2016%26volume%3D9%26spage%3D7207%26epage%3D7218%26doi%3D10.2147%2FOTT.S112566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konowalchuk, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreda, D. R.</span></span> <span> </span><span class="NLM_article-title">Modified Annexin V/Propidium Iodide Apoptosis Assay For Accurate Assessment of Cell Death</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.3791/2597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.3791%2F2597" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=2-5&author=A.+M.+Riegerauthor=K.+L.+Nelsonauthor=J.+D.+Konowalchukauthor=D.+R.+Barreda&title=Modified+Annexin+V%2FPropidium+Iodide+Apoptosis+Assay+For+Accurate+Assessment+of+Cell+Death&doi=10.3791%2F2597"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3791%2F2597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F2597%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DA.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DKonowalchuk%26aufirst%3DJ.%2BD.%26aulast%3DBarreda%26aufirst%3DD.%2BR.%26atitle%3DModified%2520Annexin%2520V%252FPropidium%2520Iodide%2520Apoptosis%2520Assay%2520For%2520Accurate%2520Assessment%2520of%2520Cell%2520Death%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2011%26volume%3D50%26spage%3D2%26epage%3D5%26doi%3D10.3791%2F2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belmokhtar, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillion, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ségal-Bendirdjian, E.</span></span> <span> </span><span class="NLM_article-title">Staurosporine Induces Apoptosis through Both Caspase-Dependent and Caspase-Independent Mechanisms</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3354</span>– <span class="NLM_lpage">3362</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1204436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2Fsj.onc.1204436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=11423986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=3354-3362&author=A.+C.+Belmokhtarauthor=J.+Hillionauthor=E.+S%C3%A9gal-Bendirdjian&title=Staurosporine+Induces+Apoptosis+through+Both+Caspase-Dependent+and+Caspase-Independent+Mechanisms&doi=10.1038%2Fsj.onc.1204436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms</span></div><div class="casAuthors">Belmokhtar, Chafke Ahmed; Hillion, Josette; Segal-Bendirdjian, Evelyne</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3354-3362</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sensitivity of tumor cells to anticancer therapy depends on the ability of the drug to induce apoptosis.  However, multiple signaling pathways control this induction and thus det. this sensitivity.  We report here that staurosporine, a well known inducer of apoptosis in a wide range of cell lines, displays distinct ability to trigger apoptosis in two different L1210 sublines (termed L1210/S and L1210/0).  Staurosporine treatment resulted in an early cell death (within 3 h) in L1210/S cells, while in L1210/0 cells, death occurred only after 12 h.  In both instances, death occurred by apoptosis.  A broad spectrum caspase inhibitor, z-VAD-fmk, blocked early apoptosis in L1210/S cells but did not confer any protection on late apoptosis in L1210/0 cells.  Protection by z-VAD-fmk obsd. in L1210/S cells was not lasting and unmasked a secondary process of cell death that also exhibited characteristics of apoptosis.  Thus, staurosporine induces apoptotic cell death through at least two redundant parallel pathways.  These two pathways normally coexist in L1210/S cells.  However, the early cell death mechanism depending on caspase activation disguises the late caspase-independent apoptotic process.  Staurosporine-induced apoptosis in L1210/0 cells develops only by the caspase-independent mechanism due to a general defect in caspase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9z7y7ORZWrVg90H21EOLACvtfcHk0lgUragoaU94Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVSqsbc%253D&md5=370eb9557924e10b1167c304f91dde05</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1204436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1204436%26sid%3Dliteratum%253Aachs%26aulast%3DBelmokhtar%26aufirst%3DA.%2BC.%26aulast%3DHillion%26aufirst%3DJ.%26aulast%3DS%25C3%25A9gal-Bendirdjian%26aufirst%3DE.%26atitle%3DStaurosporine%2520Induces%2520Apoptosis%2520through%2520Both%2520Caspase-Dependent%2520and%2520Caspase-Independent%2520Mechanisms%26jtitle%3DOncogene%26date%3D2001%26volume%3D20%26spage%3D3354%26epage%3D3362%26doi%3D10.1038%2Fsj.onc.1204436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">15308</span>– <span class="NLM_lpage">15319</span>, <span class="refDoi"> DOI: 10.1002/chem.201502154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1002%2Fchem.201502154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=26338207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOms73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=15308-15319&author=L.+Zengauthor=Y.+Chenauthor=H.+Huangauthor=J.+Wangauthor=D.+Zhaoauthor=L.+Jiauthor=H.+Chao&title=Cyclometalated+Ruthenium%28II%29+Anthraquinone+Complexes+Exhibit+Strong+Anticancer+Activity+in+Hypoxic+Tumor+Cells&doi=10.1002%2Fchem.201502154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells</span></div><div class="casAuthors">Zeng, Leli; Chen, Yu; Huang, Huaiyi; Wang, Jinquan; Zhao, Donglei; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15308-15319</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Hypoxia is the crit. feature of the tumor microenvironment that is known to lead to resistance to many chemotherapeutic drugs.  Six novel ruthenium(II) anthraquinone complexes were designed and synthesized; they exhibit similar or superior cytotoxicity compared to cisplatin in hypoxic HeLa, A549, and multidrug-resistant (A549R) tumor cell lines.  Their anticancer activities are related to their lipophilicity and cellular uptake; therefore, these physicochem. properties of the complexes can be changed by modifying the ligands to obtain better anticancer candidates.  Complex 1, the most potent member of the series, is highly active against hypoxic HeLa cancer cells (IC50=0.53 μΜ).  This complex likely has 46-fold better activity than cisplatin (IC50=24.62 μΜ) in HeLa cells.  This complex tends to accumulate in the mitochondria and the nucleus of hypoxic HeLa cells.  Further mechanistic studies show that complex 1 induced cell apoptosis during hypoxia through multiple pathways, including those of DNA damage, mitochondrial dysfunction, and the inhibition of DNA replication and HIF-1α expression, making it an outstanding candidate for further in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHe1ooDZtJLVg90H21EOLACvtfcHk0lgUragoaU94Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOms73L&md5=26bba75899e5c715072ae71df1d82b6c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502154%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DCyclometalated%2520Ruthenium%2528II%2529%2520Anthraquinone%2520Complexes%2520Exhibit%2520Strong%2520Anticancer%2520Activity%2520in%2520Hypoxic%2520Tumor%2520Cells%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D15308%26epage%3D15319%26doi%3D10.1002%2Fchem.201502154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zisowsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarakonda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaehde, U.</span></span> <span> </span><span class="NLM_article-title">Relevance of Drug Uptake and Efflux for Cisplatin Sensitivity of Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2006.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.bcp.2006.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17097621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12rsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=298-307&author=J.+Zisowskyauthor=S.+Koegelauthor=S.+Leyersauthor=K.+Devarakondaauthor=M.+U.+Kassackauthor=M.+Osmakauthor=U.+Jaehde&title=Relevance+of+Drug+Uptake+and+Efflux+for+Cisplatin+Sensitivity+of+Tumor+Cells&doi=10.1016%2Fj.bcp.2006.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells</span></div><div class="casAuthors">Zisowsky, Jochen; Koegel, Susanne; Leyers, Stefan; Devarakonda, Krishna; Kassack, Matthias U.; Osmak, Maja; Jaehde, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-307</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Platinum sensitivity and platinum resistance may involve altered activity of transport proteins.  In order to assess the role of drug uptake and efflux in this phenomenon, we compared the expression of three copper transporters, intracellular platinum accumulation, DNA platination and cytotoxicity of cisplatin in two cisplatin-sensitive and -resistant tumor cell line pairs (ovarian A2780/A2780cis and cervical HeLa/HeLaCK cells).  Gene expression of importer CTR1, and ATP7A and ATP7B efflux transporters (with and without cisplatin treatment) was investigated using quant. real-time PCR and platinum concns. were detd. by flameless at. absorption spectrometry.  After incubation with cisplatin, DNA platination was significantly lower in the resistant variants compared to the resp. sensitive cell lines, whereas no obvious difference in DNA repair was found.  Accordingly, the resistant variants exhibited lower intracellular platinum concns. than their resp. parental cells (2.5- and 2.9-fold lower in A2780cis and HeLaCK cells, resp.).  No differences in efflux were obsd.  Resistant cells expressed lower levels of CTR1 (1.5-1.8-fold) than their sensitive counterparts.  Expression differences of ATP7A and ATP7B between resistant and sensitive cells were cell type-specific.  The results highlight the relevance of CTR1 for cisplatin sensitivity as there is a clear relationship between lower CTR1 expression, intracellular concn., DNA platination and cytotoxicity of cisplatin in both resistant cell lines.  Our data provide the basis for a quant. understanding of alterations in uptake and efflux processes leading to cisplatin resistance and might hence facilitate the development of ex vivo assays that can predict cisplatin sensitivity in tumor specimens of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqh6hqnZBhrrVg90H21EOLACvtfcHk0lgUragoaU94Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12rsbbM&md5=41a415da97aa804a1bbd91f76ff2682d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DZisowsky%26aufirst%3DJ.%26aulast%3DKoegel%26aufirst%3DS.%26aulast%3DLeyers%26aufirst%3DS.%26aulast%3DDevarakonda%26aufirst%3DK.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DOsmak%26aufirst%3DM.%26aulast%3DJaehde%26aufirst%3DU.%26atitle%3DRelevance%2520of%2520Drug%2520Uptake%2520and%2520Efflux%2520for%2520Cisplatin%2520Sensitivity%2520of%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D298%26epage%3D307%26doi%3D10.1016%2Fj.bcp.2006.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Fluorescein Redirects a Ruthenium - Octaarginine Conjugate to the Nucleus</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">8738</span>– <span class="NLM_lpage">8739</span>, <span class="refDoi"> DOI: 10.1021/ja9025165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9025165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFCks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=8738-8739&author=C.+A.+Puckettauthor=J.+K.+Barton&title=Fluorescein+Redirects+a+Ruthenium+-+Octaarginine+Conjugate+to+the+Nucleus&doi=10.1021%2Fja9025165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescein Redirects a Ruthenium-Octaarginine Conjugate to the Nucleus</span></div><div class="casAuthors">Puckett, Cindy A.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8738-8739</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cellular uptake and localization of a Ru-octaarginine conjugate with and without an appended fluorescein are compared.  The inherent luminescence of the Ru(II) dipyridophenazine complex allows observation of its uptake without the addn. of a fluorophore.  Ru-octaarginine-fluorescein stains the cytosol, nuclei, and nucleoli of HeLa cells under conditions where the Ru-octaarginine conjugate without fluorescein shows only punctate cytoplasmic labeling.  At higher concns., however, Ru-octaarginine without the fluorescein tag does exhibit cytoplasmic, nuclear, and nucleolar staining.  Attaching fluorescein to Ru-octaarginine lowers the threshold concn. required for diffuse cytoplasmic labeling and nuclear entry.  Hence, the localization of the fluorophore-bound peptide cannot serve as a proxy for that of the free peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1rpVDe7aJHrVg90H21EOLACvtfcHk0lgUragoaU94Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFCks7g%253D&md5=3ddba2b8aaed5063679feb966145ae0a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fja9025165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9025165%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DFluorescein%2520Redirects%2520a%2520Ruthenium%2520-%2520Octaarginine%2520Conjugate%2520to%2520the%2520Nucleus%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D8738%26epage%3D8739%26doi%3D10.1021%2Fja9025165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, H. M.</span></span> <span> </span><span class="NLM_article-title">Crystal and Molecular Structure of a Chiral-Specific DNA-Binding Agent: Tris(4,7-Diphenyl-1,10-Phenanthroline)Ruthenium(II)</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1021/ic00226a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00226a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaL28Xht1SgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=842-847&author=B.+M.+Goldsteinauthor=J.+K.+Bartonauthor=H.+M.+Berman&title=Crystal+and+Molecular+Structure+of+a+Chiral-Specific+DNA-Binding+Agent%3A+Tris%284%2C7-Diphenyl-1%2C10-Phenanthroline%29Ruthenium%28II%29&doi=10.1021%2Fic00226a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal and molecular structure of a chiral-specific DNA-binding agent:  tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II)</span></div><div class="casAuthors">Goldstein, Barry M.; Barton, Jacqueline K.; Berman, Helen M.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">842-7</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">The title complex is monoclinic, space group P21/c, with a 13.085(2), b 24.173(1), c 22.773(4) Å, and β = 110.91 (1)°; Z = 4.  The final R value is 0.082.  At. coordinates, bond lengths, and bond angles are given.  All the Ph groups are skew to the phenanthroline ligands.  There are no stacking interactions in the crystal.  A plausible model for the Δ enantiomer binding to right-handed DNA is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7GkBAbTTtDLVg90H21EOLACvtfcHk0li0Z-Fw25fGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1SgtbY%253D&md5=6d066dd27cea34298b9c46d3dc5c3f60</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fic00226a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00226a024%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DB.%2BM.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26aulast%3DBerman%26aufirst%3DH.%2BM.%26atitle%3DCrystal%2520and%2520Molecular%2520Structure%2520of%2520a%2520Chiral-Specific%2520DNA-Binding%2520Agent%253A%2520Tris%25284%252C7-Diphenyl-1%252C10-Phenanthroline%2529Ruthenium%2528II%2529%26jtitle%3DInorg.%2520Chem.%26date%3D1986%26volume%3D25%26spage%3D842%26epage%3D847%26doi%3D10.1021%2Fic00226a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Mitochondria and Cell Death</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4400645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1038%2Fsj.cdd.4400645" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=134-135&author=Y.+Tsujimoto&title=Mitochondria+and+Cell+Death&doi=10.1038%2Fsj.cdd.4400645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4400645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4400645%26sid%3Dliteratum%253Aachs%26aulast%3DTsujimoto%26aufirst%3DY.%26atitle%3DMitochondria%2520and%2520Cell%2520Death%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2000%26volume%3D7%26spage%3D134%26epage%3D135%26doi%3D10.1038%2Fsj.cdd.4400645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dedov, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roufogalis, B. D.</span></span> <span> </span><span class="NLM_article-title">Visualisation of Mitochondria in Living Neurons with Single- and Two-Photon Fluorescence Laser Microscopy</span>. <i>Micron</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1016/S0968-4328(00)00065-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2FS0968-4328%2800%2900065-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=11334734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1Gnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=653-660&author=V.+N.+Dedovauthor=G.+C.+Coxauthor=B.+D.+Roufogalis&title=Visualisation+of+Mitochondria+in+Living+Neurons+with+Single-+and+Two-Photon+Fluorescence+Laser+Microscopy&doi=10.1016%2FS0968-4328%2800%2900065-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Visualization of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy</span></div><div class="casAuthors">Dedov, V. N.; Cox, G. C.; Roufogalis, B. D.</div><div class="citationInfo"><span class="NLM_cas:title">Micron</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">MCONEN</span>;
        ISSN:<span class="NLM_cas:issn">0968-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In this work we investigated the relative merits of conventional single-photon confocal laser scanning fluorescence microscopy (CLSM) and two-photon laser scanning fluorescence microscopy (2p-LSM) for the study of mitochondria in living neurons.  Dorsal root ganglion neurons were loaded with the mitochondrion-specific fluorescent dye JC-1, the ratio between red (J-aggregates) and green (monomer) fluorescence of which reflects mitochondrial membrane potential.  Cells were illuminated at 488 nm for single-photon excitation or at 870 nm for two-photon excitation.  In both modalities we found that mitochondria showed: (i) similar appearance; (ii) similar fluorescence ratio values over both whole cell bodies and individual mitochondria; and (iii) similar responses to mitochondrial uncoupler, which dropped the ratio values by 50%.  However, 2p-LSM exhibited several advantages over CLSM: (i) better signal/noise ratio in the green emission channel; (ii) less phototoxicity upon repetitive scanning in the focal plane; and (iii) no significant loss of image quality upon repetitive scans in the z direction.  We conclude that, while both techniques enable visualization of individual mitochondria in living cells, 2p-LSM has significant advantages for physiol. work requiring time-lapse expts. or four-dimensional reconstructs of mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtIC5q_a96bVg90H21EOLACvtfcHk0li0Z-Fw25fGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1Gnt70%253D&md5=b9c840959373ab79c7cbd9e7e9f8049b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0968-4328%2800%2900065-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-4328%252800%252900065-2%26sid%3Dliteratum%253Aachs%26aulast%3DDedov%26aufirst%3DV.%2BN.%26aulast%3DCox%26aufirst%3DG.%2BC.%26aulast%3DRoufogalis%26aufirst%3DB.%2BD.%26atitle%3DVisualisation%2520of%2520Mitochondria%2520in%2520Living%2520Neurons%2520with%2520Single-%2520and%2520Two-Photon%2520Fluorescence%2520Laser%2520Microscopy%26jtitle%3DMicron%26date%3D2001%26volume%3D32%26spage%3D653%26epage%3D660%26doi%3D10.1016%2FS0968-4328%2800%2900065-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">Achieving Efficient Photodynamic Therapy under Both Normoxia and Hypoxia Using Cyclometalated Ru(II) Photosensitizer through Type</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1039/C7SC03765A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2FC7SC03765A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=29619206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslChtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=502-512&author=Z.+Lvauthor=H.+Weiauthor=Q.+Liauthor=X.+Suauthor=S.+Liuauthor=K.+Y.+Zhangauthor=W.+Lvauthor=Q.+Zhaoauthor=X.+Liauthor=W.+Huang&title=Achieving+Efficient+Photodynamic+Therapy+under+Both+Normoxia+and+Hypoxia+Using+Cyclometalated+Ru%28II%29+Photosensitizer+through+Type&doi=10.1039%2FC7SC03765A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(II) photosensitizer through type I photochemical process</span></div><div class="casAuthors">Lv, Zhuang; Wei, Huanjie; Li, Qing; Su, Xianlong; Liu, Shujuan; Zhang, Kenneth Yin; Lv, Wen; Zhao, Qiang; Li, Xianghong; Huang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">502-512</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) through the generation of singlet oxygen utilizing photosensitizers (PSs) is significantly limited under hypoxic conditions in solid tumors.  So it is meaningful to develop effective PSs which can maintain excellent therapeutic effects under hypoxia.  Here we reported a coumarin-modified cyclometalated Ru(II) photosensitizer (Ru2), which exhibits lower oxidn. potential and stronger absorption in the visible region than the coumarin-free counterpart.  The evaluation of the PDT effect was performed under both normoxia and hypoxia.  The results showed that Ru2 has a better therapeutic effect than the coumarin-free counterpart in in vitro expts.  Esp. under hypoxia, Ru2 still retained an excellent PDT effect, which can be attributed to the direct charge transfer between the excited PS and an adjacent substrate through a type I photochem. process, forming highly-oxidative hydroxyl radicals to damage tumor cells.  The anti-tumor activity of Ru2 was further proven to be effective in tumor-bearing mice, and tumor growth was inhibited remarkably under PDT treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHsNotT-Qq7Vg90H21EOLACvtfcHk0li0Z-Fw25fGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslChtrbM&md5=0513e9691b155940e6321180e118e238</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1039%2FC7SC03765A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC03765A%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DAchieving%2520Efficient%2520Photodynamic%2520Therapy%2520under%2520Both%2520Normoxia%2520and%2520Hypoxia%2520Using%2520Cyclometalated%2520Ru%2528II%2529%2520Photosensitizer%2520through%2520Type%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D502%26epage%3D512%26doi%3D10.1039%2FC7SC03765A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorova, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popkov, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikov, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silachev, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pevzner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankauskas, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babenko, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorov, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakireva, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhaszova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollott, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorov, D. B.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Membrane Potential</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.ab.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28711444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1entbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2018&pages=50-59&author=L.+D.+Zorovaauthor=V.+A.+Popkovauthor=E.+Y.+Plotnikovauthor=D.+N.+Silachevauthor=B.+Pevznerauthor=S.+S.+Jankauskasauthor=V.+A.+Babenkoauthor=S.+D.+Zorovauthor=A.+V.+Balakirevaauthor=M.+Juhaszovaauthor=S.+J.+Sollottauthor=D.+B.+Zorov&title=Mitochondrial+Membrane+Potential&doi=10.1016%2Fj.ab.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial membrane potential</span></div><div class="casAuthors">Zorova, Ljubava D.; Popkov, Vasily A.; Plotnikov, Egor Y.; Silachev, Denis N.; Pevzner, Irina B.; Jankauskas, Stanislovas S.; Babenko, Valentina A.; Zorov, Savva D.; Balakireva, Anastasia V.; Juhaszova, Magdalena; Sollott, Steven J.; Zorov, Dmitry B.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-59</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mitochondrial membrane potential (ΔΨm) generated by proton pumps (Complexes I, III and IV) is an essential component in the process of energy storage during oxidative phosphorylation.  Together with the proton gradient (ΔpH), ΔΨm forms the transmembrane potential of hydrogen ions which is harnessed to make ATP.  The levels of ΔΨm and ATP in the cell are kept relatively stable although there are limited fluctuations of both these factors that can occur reflecting normal physiol. activity.  However, sustained changes in both factors may be deleterious.  A long-lasting drop or rise of ΔΨm vs. normal levels may induce unwanted loss of cell viability and be a cause of various pathologies.  Among other factors, ΔΨm plays a key role in mitochondrial homeostasis through selective elimination of dysfunctional mitochondria.  It is also a driving force for transport of ions (other than H+) and proteins which are necessary for healthy mitochondrial functioning.  The authors propose addnl. potential mechanisms for which ΔΨm is essential for maintenance of cellular health and viability and provide recommendations how to accurately measure ΔΨm in a cell and discuss potential sources of artifacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr64t9rQy__dLVg90H21EOLACvtfcHk0ljfas1e3VuJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1entbnE&md5=93008a20d59f326e9e5ce21fc859708b</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DZorova%26aufirst%3DL.%2BD.%26aulast%3DPopkov%26aufirst%3DV.%2BA.%26aulast%3DPlotnikov%26aufirst%3DE.%2BY.%26aulast%3DSilachev%26aufirst%3DD.%2BN.%26aulast%3DPevzner%26aufirst%3DB.%26aulast%3DJankauskas%26aufirst%3DS.%2BS.%26aulast%3DBabenko%26aufirst%3DV.%2BA.%26aulast%3DZorov%26aufirst%3DS.%2BD.%26aulast%3DBalakireva%26aufirst%3DA.%2BV.%26aulast%3DJuhaszova%26aufirst%3DM.%26aulast%3DSollott%26aufirst%3DS.%2BJ.%26aulast%3DZorov%26aufirst%3DD.%2BB.%26atitle%3DMitochondrial%2520Membrane%2520Potential%26jtitle%3DAnal.%2520Biochem.%26date%3D2018%26volume%3D552%26spage%3D50%26epage%3D59%26doi%3D10.1016%2Fj.ab.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">The Mitochondrial Membrane Potential (Δ ψ m) in Apoptosis; an Update</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1023/A:1022945107762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1023%2FA%3A1022945107762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=12766472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=115-128&author=J.+D.+Lyauthor=D.+R.+Grubbauthor=A.+Lawen&title=The+Mitochondrial+Membrane+Potential+%28%CE%94+%CF%88+m%29+in+Apoptosis%3B+an+Update&doi=10.1023%2FA%3A1022945107762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The mitochondrial membrane potential (Δψm) in apoptosis; an update</span></div><div class="casAuthors">Ly, J. D.; Grubb, D. R.; Lawen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-128</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Mitochondrial dysfunction has been shown to participate in the induction of apoptosis and has even been suggested to be central to the apoptotic pathway.  Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to induce depolarization of the transmembrane potential (Δψm), release of apoptogenic factors, and loss of oxidative phosphorylation.  In some apoptotic systems, loss of Δψm may be an early event in the apoptotic process.  However, there are emerging data suggesting that, depending on the model of apoptosis, the loss of Δψm may not be an early requirement for apoptosis, but on the contrary may be a consequence of the apoptotic-signaling pathway.  Furthermore, to add to these conflicting data, loss of Δψm has been demonstrated to not be required for cytochrome c release, whereas release of apoptosis-inducing factor AIF is dependent upon disruption of Δψm early in the apoptotic pathway.  Together, the existing literature suggests that depending on the cell system under investigation and the apoptotic stimuli used, dissipation of Δψm may or may not be an early event in the apoptotic pathway.  Discrepancies in this area of apoptosis research may be attributed to the fluorochromes used to detect Δψm.  Differential degrees of sensitivity of these fluorochromes exist, and there are also important factors that contribute to their ability to accurately discriminate changes in Δψm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOzp4dhnT9xLVg90H21EOLACvtfcHk0ljfas1e3VuJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D&md5=f1369780028cb13a045faf2a3db73c87</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022945107762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022945107762%26sid%3Dliteratum%253Aachs%26aulast%3DLy%26aufirst%3DJ.%2BD.%26aulast%3DGrubb%26aufirst%3DD.%2BR.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3DThe%2520Mitochondrial%2520Membrane%2520Potential%2520%2528%25CE%2594%2520%25CF%2588%2520m%2529%2520in%2520Apoptosis%253B%2520an%2520Update%26jtitle%3DApoptosis%26date%3D2003%26volume%3D8%26spage%3D115%26epage%3D128%26doi%3D10.1023%2FA%3A1022945107762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamuru, S.</span>; <span class="NLM_string-name">Attene-Ramos, M. S.</span>; <span class="NLM_string-name">Xia, M.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Membrane Potential Assay</span>. In  <i>High-Throughput Screening Assays in Toxicology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span>; <span class="NLM_string-name">Xia, M.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>, <span class="NLM_year">2016</span>; Vol.  <span class="NLM_volume">1473</span>, pp  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">22</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1007%2F978-1-4939-6346-1_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=17-22&author=S.+Sakamuru&author=M.+S.+Attene-Ramos&author=M.+Xiaauthor=H.+Zhu&author=M.+Xia&title=High-Throughput+Screening+Assays+in+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-6346-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4939-6346-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DSakamuru%26aufirst%3DS.%26atitle%3DMitochondrial%2520Membrane%2520Potential%2520Assay%26btitle%3DHigh-Throughput%2520Screening%2520Assays%2520in%2520Toxicology%26aulast%3DZhu%26aufirst%3DH.%26pub%3DHumana%2520Press%26date%3D2016%26volume%3D1473%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Z.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.-l.</span></span> <span> </span><span class="NLM_article-title">Immunocompromised and Immunocompetent Mouse Models for Head and Neck Squamous Cell Carcinoma</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.2147/OTT.S95633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2147%2FOTT.S95633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=26869799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvFyrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=545-555&author=Z.-g.+Leiauthor=X.-h.+Renauthor=S.-s.+Wangauthor=X.-h.+Liangauthor=Y.-l.+Tang&title=Immunocompromised+and+Immunocompetent+Mouse+Models+for+Head+and+Neck+Squamous+Cell+Carcinoma&doi=10.2147%2FOTT.S95633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma</span></div><div class="casAuthors">Lei, Zhen-ge; Ren, Xiao-hua; Wang, Sha-sha; Liang, Xin-hua; Tang, Ya-ling</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Mouse models can closely mimic human oral squamous epithelial carcinogenesis, greatly expand the in vivo research possibilities, and play a crit. role in the development of diagnosis, monitoring, and treatment of head and neck squamous cell carcinoma.  With the development of the recent research on the contribution of immunity/inflammation to cancer initiation and progression, mouse models have been divided into two categories, namely, immunocompromised and immunocompetent mouse models.  And thus, this paper will review these two kinds of models applied in head and neck squamous cell carcinoma to provide a platform to understand the complicated histol., mol., and genetic changes of oral squamous epithelial tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgqfKwIwFr_LVg90H21EOLACvtfcHk0ljfas1e3VuJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvFyrtbY%253D&md5=3631ac8c1e8f305f4fc54835debf815b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.2147%2FOTT.S95633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S95633%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DZ.-g.%26aulast%3DRen%26aufirst%3DX.-h.%26aulast%3DWang%26aufirst%3DS.-s.%26aulast%3DLiang%26aufirst%3DX.-h.%26aulast%3DTang%26aufirst%3DY.-l.%26atitle%3DImmunocompromised%2520and%2520Immunocompetent%2520Mouse%2520Models%2520for%2520Head%2520and%2520Neck%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DOncoTargets%2520Ther.%26date%3D2016%26volume%3D9%26spage%3D545%26epage%3D555%26doi%3D10.2147%2FOTT.S95633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span> <span> </span><span class="NLM_article-title">Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development</span>. <i>Toxicol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.5487/TR.2014.30.1.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.5487%2FTR.2014.30.1.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=24795792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A280%3ADC%252BC2cnps12ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=1-5&author=J.+Jung&title=Human+Tumor+Xenograft+Models+for+Preclinical+Assessment+of+Anticancer+Drug+Development&doi=10.5487%2FTR.2014.30.1.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Human tumor xenograft models for preclinical assessment of anticancer drug development</span></div><div class="casAuthors">Jung Joohee</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-5</span>
        ISSN:<span class="NLM_cas:issn">1976-8257</span>.
    </div><div class="casAbstract">Xenograft models of human cancer play an important role in the screening and evaluation of candidates for new anticancer agents.  The models, which are derived from human tumor cell lines and are classified according to the transplant site, such as ectopic xenograft and orthotopic xenograft, are still utilized to evaluate therapeutic efficacy and toxicity.  The metastasis model is modified for the evaluation and prediction of cancer progression.  Recently, animal models are made from patient-derived tumor tissue.  The patient-derived tumor xenograft models with physiological characters similar to those of patients have been established for personalized medicine.  In the discovery of anticancer drugs, standard animal models save time and money and provide evidence to support clinical trials.  The current strategy for using xenograft models as an informative tool is introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpIORyaoe3FJ6KlWarZTAzfW6udTcc2ealFGk7aUSKGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnps12ktQ%253D%253D&md5=d674c1a53649f8b9c78837908af34731</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.5487%2FTR.2014.30.1.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5487%252FTR.2014.30.1.001%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.%26atitle%3DHuman%2520Tumor%2520Xenograft%2520Models%2520for%2520Preclinical%2520Assessment%2520of%2520Anticancer%2520Drug%2520Development%26jtitle%3DToxicol.%2520Res.%26date%3D2014%26volume%3D30%26spage%3D1%26epage%3D5%26doi%3D10.5487%2FTR.2014.30.1.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span> <span> </span><span class="NLM_article-title">Patient - Derived Xenograft Mouse Models: A High Fidelity Tool for Individualized Medicine (Review)</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.9583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.3892%2Fol.2018.9583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=30655732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFejtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=3-10&author=C.+Xuauthor=X.+Liauthor=P.+Liuauthor=M.+A.+N.+Liauthor=F.+Luo&title=Patient+-+Derived+Xenograft+Mouse+Models%3A+A+High+Fidelity+Tool+for+Individualized+Medicine+%28Review%29&doi=10.3892%2Fol.2018.9583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Patient-derived xenograft mouse models: a high fidelity tool for individualized medicine (Review)</span></div><div class="casAuthors">Xu, Cong; Li, Xuelu; Liu, Pixu; Li, Man; Luo, Fuwen</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1082</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Patient-derived xenograft (PDX) mouse models involve the direct transfer of fresh human tumor samples into immunodeficient mice following surgical resection or other medical operations.  Gene expression in tumors may be maintained by serial passages of tumors from mouse to mouse.  These models aid research into tumor biol. and pharmacol. without manual manipulation of cell cultures in vitro. and are widely used in individualized cancer therapy/translational medicine, drug development and coclin. trials.  PDX models exhibit higher predictive values for clin. outcomes than cell line-derived xenograft models and genetically engineered mouse models.  However, PDX models are assocd. with certain challenges in clin. application.  The present study reviewed current collections of PDX models and assessed the challenges and future directions of this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3qg1QBflNO7Vg90H21EOLACvtfcHk0lgMCuK5z0NwHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFejtbbE&md5=a1ecbd184fc1cbd8b90a5aef7c23a6a1</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.9583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.9583%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DM.%2BA.%2BN.%26aulast%3DLuo%26aufirst%3DF.%26atitle%3DPatient%2520-%2520Derived%2520Xenograft%2520Mouse%2520Models%253A%2520A%2520High%2520Fidelity%2520Tool%2520for%2520Individualized%2520Medicine%2520%2528Review%2529%26jtitle%3DOncol.%2520Lett.%26date%3D2019%26volume%3D17%26spage%3D3%26epage%3D10%26doi%3D10.3892%2Fol.2018.9583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, P. A.</span></span> <span> </span><span class="NLM_article-title">Constitutive and Inducible Akt Activity Promotes Resistance to Chemotherapy, Trastuzumab, or Tamoxifen in Breast Cancer Cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=12479367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=707-717&author=A.+S.+Clarkauthor=K.+Westauthor=S.+Streicherauthor=P.+A.+Dennis&title=Constitutive+and+Inducible+Akt+Activity+Promotes+Resistance+to+Chemotherapy%2C+Trastuzumab%2C+or+Tamoxifen+in+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells</span></div><div class="casAuthors">Clark, Amy S.; West, Kip; Streicher, Samantha; Dennis, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">707-717</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To evaluate the role of the phosphatidylinositol 3-kinase (Pl3K)/Akt pathway in breast cancer cell survival and therapeutic resistance, we analyzed a panel of six breast cancer cell lines that varied in erbB2 and estrogen receptor status.  Akt activity was constitutive in four cell lines and was assocd. with either PTEN mutations or erbB2 overexpression.  Akt promoted breast cancer cell survival because a Pl3K inhibitor, LY294002, or transient transfection of a dominant-neg. Akt mutant inhibited Akt activity and increased apoptosis.  When combined with therapies commonly used in breast cancer treatment, LY294002 potentiated apoptosis caused by doxorubicin, trastuzumab, paclitaxel, or etoposide.  Potentiation of apoptosis by LY294002 correlated with induction of Akt by doxorubicin or trastuzumab alone that occurred before the onset of apoptosis.  Similar results were obsd. with tamoxifen.  Combining LY294002 with tamoxifen in estrogen receptor-pos. cells greatly potentiated apoptosis, which was correlated with tamoxifen-induced Akt phosphorylation that preceded apoptosis.  To confirm that the effects of LY294002 on chemotherapy-induced apoptosis were attributable to inhibition of Akt, we transiently transfected breast cancer cells with dominant-neg. Akt and obsd. increased doxorubicin-induced apoptosis.  Conversely, stably transfecting cells with constitutively active Akt increased Akt activity and attenuated doxorubicin-induced apoptosis.  These studies show that endogenous Akt activity promotes breast cancer cell survival and therapeutic resistance, and that induction of Akt by chemotherapy, trastuzumab, or tamoxifen might be an early compensatory mechanism that could be exploited to increase the efficacy of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFulbrsRhrLVg90H21EOLACvtfcHk0lgMCuK5z0NwHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D&md5=8524c66f332d0596592e72f57275a14b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BS.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DStreicher%26aufirst%3DS.%26aulast%3DDennis%26aufirst%3DP.%2BA.%26atitle%3DConstitutive%2520and%2520Inducible%2520Akt%2520Activity%2520Promotes%2520Resistance%2520to%2520Chemotherapy%252C%2520Trastuzumab%252C%2520or%2520Tamoxifen%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D707%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.-G.</span></span> <span> </span><span class="NLM_article-title">Regulation of AKT Gene Expression by Cisplatin</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.3892/ol.2013.1132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.3892%2Fol.2013.1132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23426872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1WnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=756-760&author=J.+Zhangauthor=L.-L.+Zhangauthor=L.+Shenauthor=X.-M.+Xuauthor=H.-G.+Yu&title=Regulation+of+AKT+Gene+Expression+by+Cisplatin&doi=10.3892%2Fol.2013.1132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of AKT gene expression by cisplatin</span></div><div class="casAuthors">Zhang, Jun; Zhang, Ling-Li; Shen, Lei; Xu, Xi-Ming; Yu, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">756-760</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The use of chemotherapy drugs for the treatment of cancer is an effective therapeutic measure.  However, chemoresistance affects the effectiveness of the treatment.  AKT overexpression has been obsd. in chemoresistance.  AKT expression in colon cells induced cisplatin resistance.  The present study demonstrated the role of reactive oxygen species (ROS) in the induction of AKT regulation by cisplatin through the activation of JAK2/STAT3 at the transcriptional level in colon cancer cells.  HCT-116 cells treated with cisplatin exhibited increased JAK2 and STAT3 activities.  Reducing the expression of JAK2 in colon cancer cells using small interfering RNA (siRNA) decreased AKT expression.  The present study demonstrated that AKT activation is closely assocd. with chemoresistance in human tumors.  The inhibition of ROS decreased the levels of AKT in colon cancer cell lines.  The JAK2/STAT3 pathway was also shown to mediate AKT expression and represents a potential target for overcoming cisplatin resistance in human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTNRVdDRrv7Vg90H21EOLACvtfcHk0liOts3u0h1DiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1WnsLg%253D&md5=bdb145cb87de53647848562079e61fc4</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.3892%2Fol.2013.1132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2013.1132%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.-M.%26aulast%3DYu%26aufirst%3DH.-G.%26atitle%3DRegulation%2520of%2520AKT%2520Gene%2520Expression%2520by%2520Cisplatin%26jtitle%3DOncol.%2520Lett.%26date%3D2013%26volume%3D5%26spage%3D756%26epage%3D760%26doi%3D10.3892%2Fol.2013.1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, A. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee</span></span> <span> </span><span class="NLM_article-title">The Akt Isoforms, Their Unique Functions and Potential as Anticancer Therapeutic Targets</span>. <i>BioMol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1515/bmc.2010.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1515%2Fbmc.2010.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25962012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=389-401&author=S.+A.+Santiauthor=A.+C.+H.+Douglasauthor=+Lee&title=The+Akt+Isoforms%2C+Their+Unique+Functions+and+Potential+as+Anticancer+Therapeutic+Targets&doi=10.1515%2Fbmc.2010.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt isoforms, their unique functions and potential as anticancer therapeutic targets</span></div><div class="casAuthors">Santi, Stacey A.; Douglas, Alison C.; Lee, Hoyun</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">389-401</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Akt (also known as protein kinase B or PKB) is the major downstream nodal point of the PI3K signaling pathway.  This pathway is a promising anticancer therapeutic target, because constitutive activation of the PI3K-Akt pathway is correlated with tumor development, progression, poor prognosis, and resistance to cancer therapies.  The Akt serine/threonine kinase regulates diverse cellular functions including cell growth, proliferation, glucose metab., and survival.  Although all three known Akt isoforms (Akt1-3) are encoded by sep. genes, their amino acid sequences show a high degree of similarity.  For this and other reasons, it has long been assumed that all three Akt isoforms are activated in the same way, and their functions largely overlap.  However, accumulating lines of evidence now suggest that the three Akt isoforms might have unique modes of activation and many distinct functions.  In particular, it has recently been found that the Akt isoforms are localized at different subcellular compartments in both adipocytes and cancer cells.  In this review, we highlight the unique roles of each Akt isoform by introducing published data obtained from both in vitro and in vivo studies.  We also discuss the significant potential of the Akt isoforms as effective anticancer therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBb0klElcohLVg90H21EOLACvtfcHk0liOts3u0h1DiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejtrvP&md5=246869bd1e0c0f60c2d4a4873a12d5f9</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1515%2Fbmc.2010.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc.2010.035%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DS.%2BA.%26aulast%3DDouglas%26aufirst%3DA.%2BC.%2BH.%26aulast%3DLee%26atitle%3DThe%2520Akt%2520Isoforms%252C%2520Their%2520Unique%2520Functions%2520and%2520Potential%2520as%2520Anticancer%2520Therapeutic%2520Targets%26jtitle%3DBioMol.%2520Concepts%26date%3D2010%26volume%3D1%26spage%3D389%26epage%3D401%26doi%3D10.1515%2Fbmc.2010.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, A.</span></span> <span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating the Network</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.cell.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=28431241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=381-405&author=B.+D.+Manningauthor=A.+Toker&title=AKT%2FPKB+Signaling%3A+Navigating+the+Network&doi=10.1016%2Fj.cell.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">AKT/PKB signaling: Navigating the network</span></div><div class="casAuthors">Manning, Brendan D.; Toker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-405</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The Ser and Thr kinase AKT, also known as protein kinase B (PKB), was discovered 25 years ago and has been the focus of tens of thousands of studies in diverse fields of biol. and medicine.  There have been many advances in our knowledge of the upstream regulatory inputs into AKT, key multifunctional downstream signaling nodes (GSK3, FoxO, mTORC1), which greatly expand the functional repertoire of AKT, and the complex circuitry of this dynamically branching and looping signaling network that is ubiquitous to nearly every cell in our body.  Mouse and human genetic studies have also revealed physiol. roles for the AKT network in nearly every organ system.  Our comprehension of AKT regulation and functions is particularly important given the consequences of AKT dysfunction in diverse pathol. settings, including developmental and overgrowth syndromes, cancer, cardiovascular disease, insulin resistance and type 2 diabetes, inflammatory and autoimmune disorders, and neurol. disorders.  There has also been much progress in developing AKT-selective small mol. inhibitors.  Improved understanding of the mol. wiring of the AKT signaling network continues to make an impact that cuts across most disciplines of the biomedical sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kLW6vEG_DrVg90H21EOLACvtfcHk0liOts3u0h1DiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D&md5=46302014c33b00c447f187eeaf0162c4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DToker%26aufirst%3DA.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520the%2520Network%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D381%26epage%3D405%26doi%3D10.1016%2Fj.cell.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, J. R.</span></span> <span> </span><span class="NLM_article-title">Diverse Mechanisms of AKT Pathway Activation in Human Malignancy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.2174/1568009611313030002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.2174%2F1568009611313030002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=23297823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVOjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=234-244&author=M.+Cheungauthor=J.+R.+Testa&title=Diverse+Mechanisms+of+AKT+Pathway+Activation+in+Human+Malignancy&doi=10.2174%2F1568009611313030002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse mechanisms of AKT pathway activation in human malignancy</span></div><div class="casAuthors">Cheung, Mitchell; Testa, Joseph R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  AKT/PKB (Protein Kinase B) are central proteins mediating signals from receptor tyrosine kinases and phosphatidylinositol 3-kinase.  AKT kinases are involved in a no. of important cellular processes including cell proliferation and survival, cell size in response to nutrient availability, tumor invasion/metastasis, and angiogenesis.  Various components of the AKT signaling pathway are encoded by tumor suppressor genes and oncogenes whose loss or activation, resp., plays an important role in tumorigenesis.  The growing body of evidence connecting deregulated AKT signaling with sporadic human cancers and inherited cancer predisposition syndromes is discussed.  The authors also highlight new findings regarding the involvement of activating mutations of AKT1, AKT2, and AKT3 in somatic overgrowth disorders: Proteus syndrome, hypoglycemia with hypertrophy, and hemimegalencephaly, resp.  In addn., the authors review recent literature documenting the various ways the AKT signaling pathway is activated in human cancers and consequences for molecularly targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEi7WX9g3ssLVg90H21EOLACvtfcHk0liOts3u0h1DiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVOjsb4%253D&md5=d4367e31345ebe32edfe9da2e1367611</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.2174%2F1568009611313030002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009611313030002%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DDiverse%2520Mechanisms%2520of%2520AKT%2520Pathway%2520Activation%2520in%2520Human%2520Malignancy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2013%26volume%3D13%26spage%3D234%26epage%3D244%26doi%3D10.2174%2F1568009611313030002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulmer, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherden, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercaw, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K. I.</span></span> <span> </span><span class="NLM_article-title">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2176</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1021/om100106e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om100106e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=2176-2179&author=G.+R.+Fulmerauthor=A.+J.+M.+Millerauthor=N.+H.+Sherdenauthor=H.+E.+Gottliebauthor=A.+Nudelmanauthor=B.+M.+Stoltzauthor=J.+E.+Bercawauthor=K.+I.+Goldberg&title=NMR+Chemical+Shifts+of+Trace+Impurities%3A+Common+Laboratory+Solvents%2C+Organics%2C+and+Gases+in+Deuterated+Solvents+Relevant+to+the+Organometallic+Chemist&doi=10.1021%2Fom100106e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span></div><div class="casAuthors">Fulmer, Gregory R.; Miller, Alexander J. M.; Sherden, Nathaniel H.; Gottlieb, Hugo E.; Nudelman, Abraham; Stoltz, Brian M.; Bercaw, John E.; Goldberg, Karen I.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2176-2179</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tables of 1H and 13C NMR chem. shifts have been compiled for common org. compds. often used as reagents or found as products or contaminants in deuterated org. solvents.  Building upon the work of Gottlieb, Kotlyar, and Nudelman in the Journal of Org. Chem., signals for common impurities are now reported in addnl. NMR solvents (tetrahydrofuran-d8, toluene-d8, dichloromethane-d2, chlorobenzene-d5, and 2,2,2-trifluoroethanol-d3) which are frequently used in organometallic labs.  Chem. shifts for other orgs. which are often used as reagents or internal stds. or are found as products in organometallic chem. are also reported for all the listed solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3GGHumCq_P7Vg90H21EOLACvtfcHk0lh1BCP9wEPFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D&md5=53317e05fe3be77fe7de48d8fe1fb8b7</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fom100106e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom100106e%26sid%3Dliteratum%253Aachs%26aulast%3DFulmer%26aufirst%3DG.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DSherden%26aufirst%3DN.%2BH.%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26aulast%3DBercaw%26aufirst%3DJ.%2BE.%26aulast%3DGoldberg%26aufirst%3DK.%2BI.%26atitle%3DNMR%2520Chemical%2520Shifts%2520of%2520Trace%2520Impurities%253A%2520Common%2520Laboratory%2520Solvents%252C%2520Organics%252C%2520and%2520Gases%2520in%2520Deuterated%2520Solvents%2520Relevant%2520to%2520the%2520Organometallic%2520Chemist%26jtitle%3DOrganometallics%26date%3D2010%26volume%3D29%26spage%3D2176%26epage%3D2179%26doi%3D10.1021%2Fom100106e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krachler, M.</span></span> <span> </span><span class="NLM_article-title">Environmental Applications of Single Collector High Resolution ICP-MS</span>. <i>J. Environ. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">790</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1039/b703823m</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1039%2Fb703823m" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=17671659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVentbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=790-804&author=M.+Krachler&title=Environmental+Applications+of+Single+Collector+High+Resolution+ICP-MS&doi=10.1039%2Fb703823m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Environmental applications of single collector high resolution ICP-MS</span></div><div class="casAuthors">Krachler, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Environmental Monitoring</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">790-804</span>CODEN:
                <span class="NLM_cas:coden">JEMOFW</span>;
        ISSN:<span class="NLM_cas:issn">1464-0325</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The no. of environmental applications of single collector high resoln. ICP-MS (HR-ICP-MS) has increased rapidly in recent years.  There are many factors that contribute to make HR-ICP-MS a very powerful tool in environmental anal.  They include the extremely low detection limits achievable, tremendously high sensitivity, the ability to sep. ICP-MS signals of the analyte from spectral interferences, enabling the reliable detn. of many trace elements, and the reasonable precision of isotope ratio measurements.  These assets are improved even further using high efficiency sample introduction systems.  Therefore, external factors such as the stability of lab. blanks are frequently the limiting factor in HR-ICP-MS anal. rather than the detection power.  This review aims to highlight the most recent applications of HR-ICP-MS in this sector, focusing on matrixes and applications where the superior capabilities of the instrumental technique are most useful and often ultimately required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0fUSHSSSPrVg90H21EOLACvtfcHk0lh1BCP9wEPFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVentbs%253D&md5=31223d5635c9d203bfb70fc9750a5801</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1039%2Fb703823m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb703823m%26sid%3Dliteratum%253Aachs%26aulast%3DKrachler%26aufirst%3DM.%26atitle%3DEnvironmental%2520Applications%2520of%2520Single%2520Collector%2520High%2520Resolution%2520ICP-MS%26jtitle%3DJ.%2520Environ.%2520Monit.%26date%3D2007%26volume%3D9%26spage%3D790%26epage%3D804%26doi%3D10.1039%2Fb703823m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_publisher-name">Rigaku Oxford
Diffraction Ltd.</span>: <span class="NLM_publisher-loc">Yarnton, England</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rigaku+Oxford%0ADiffraction+Ltd.%3A+Yarnton%2C+England."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26pub%3DRigaku%2520Oxford%250ADiffraction%2520Ltd" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. S.</span></span> <span> </span><span class="NLM_article-title">The Analytical Calculation of Absorption in Multifaceted Crystals</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1107/S0108767395007367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS0108767395007367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADyaK2MXpsFeju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1995&pages=887-897&author=R.+C.+Clarkauthor=J.+S.+Reid&title=The+Analytical+Calculation+of+Absorption+in+Multifaceted+Crystals&doi=10.1107%2FS0108767395007367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The analytical calculation of absorption in multifaceted crystals</span></div><div class="casAuthors">Clark, R. C.; Reid, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">A51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-97</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">The exact analytic method of evaluating the absorption during scattering in multifaceted convex crystals is developed in a way that permits efficient computation.  A fast and accurate algorithm is given for finding the Howells polyhedra whose detn. is fundamental to the analytic method.  The algorithm allows for the evaluation of cases when the sample is only partly illuminated, can be adapted to more general situations and can be used to generate an est. of the error in the computation.  In most cases this is to 1 part in 1014.  Results of std. tests are given to greater accuracy than previously available and results for multifaceted approxns. to a cylinder and a sphere are given to illustrate the power of the method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoifLKiRM8dHbVg90H21EOLACvtfcHk0lh1BCP9wEPFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsFeju7g%253D&md5=c01042b701ddc5898022cd373ff08092</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1107%2FS0108767395007367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767395007367%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BC.%26aulast%3DReid%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520Analytical%2520Calculation%2520of%2520Absorption%2520in%2520Multifaceted%2520Crystals%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1995%26volume%3D51%26spage%3D887%26epage%3D897%26doi%3D10.1107%2FS0108767395007367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Rigaku OD</span>.  <i>CrysAlis PRO</i>, version
1.171.39.9f; <span class="NLM_publisher-name">Rigaku Oxford Diffraction Ltd.</span>: <span class="NLM_publisher-loc">Yarnton, England</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Rigaku+OD&title=CrysAlis+PRO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DCrysAlis%2520PRO%26pub%3DRigaku%2520Oxford%2520Diffraction%2520Ltd%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolomanov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, J. A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschmann, H.</span></span> <span> </span><span class="NLM_article-title">OLEX2: A Complete Structure Solution, Refinement and Analysis Program</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1107/S0021889808042726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS0021889808042726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=339-341&author=O.+V.+Dolomanovauthor=L.+J.+Bourhisauthor=R.+J.+Gildeaauthor=J.+A.+K.+Howardauthor=H.+Puschmann&title=OLEX2%3A+A+Complete+Structure+Solution%2C+Refinement+and+Analysis+Program&doi=10.1107%2FS0021889808042726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">OLEX2: a complete structure solution, refinement and analysis program</span></div><div class="casAuthors">Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J.; Howard, Judith A. K.; Puschmann, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-341</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">New software, OLEX2, was developed for the detn., visualization and anal. of mol. crystal structures.  The software has a portable mouse-driven workflow-oriented and fully comprehensive graphical user interface for structure soln., refinement and report generation, as well as novel tools for structure anal.  OLEX2 seamlessly links all aspects of the structure soln., refinement and publication process and presents them in a single workflow-driven package, with the ultimate goal of producing an application which will be useful to both chemists and crystallographers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIYSUbyzIgxbVg90H21EOLACvtfcHk0lgG02FBs-6zsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFSnsbg%253D&md5=7a2f9697b13b8e76de0e7dc5074ab229</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1107%2FS0021889808042726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889808042726%26sid%3Dliteratum%253Aachs%26aulast%3DDolomanov%26aufirst%3DO.%2BV.%26aulast%3DBourhis%26aufirst%3DL.%2BJ.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DHoward%26aufirst%3DJ.%2BA.%2BK.%26aulast%3DPuschmann%26aufirst%3DH.%26atitle%3DOLEX2%253A%2520A%2520Complete%2520Structure%2520Solution%252C%2520Refinement%2520and%2520Analysis%2520Program%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2009%26volume%3D42%26spage%3D339%26epage%3D341%26doi%3D10.1107%2FS0021889808042726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">SHELXT - Integrated Space-Group and Crystal-Structure Determination</span>. <i>Acta Crystallogr., Sect. A: Found. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=SHELXT+-+Integrated+Space-Group+and+Crystal-Structure+Determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0lgG02FBs-6zsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXT%2520-%2520Integrated%2520Space-Group%2520and%2520Crystal-Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure Refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+Structure+Refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lgG02FBs-6zsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520Structure%2520Refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">Single-Crystal Structure Validation with the Program PLATON</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1107/S0021889802022112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1107%2FS0021889802022112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=7-13&author=A.+L.+Spek&title=Single-Crystal+Structure+Validation+with+the+Program+PLATON&doi=10.1107%2FS0021889802022112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Single-crystal structure validation with the program PLATON</span></div><div class="casAuthors">Spek, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The results of a single-crystal structure detn. when in CIF format can now be validated routinely by automatic procedures.  In this way, many errors in published papers can be avoided.  The validation software generates a set of ALERTS detailing issues to be addressed by the experimenter, author, referee and publication journal.  Validation was pioneered by the IUCr journal Acta Crystallographica Section C and is currently std. procedure for structures submitted for publication in all IUCr journals.  The implementation of validation procedures by other journals is in progress.  This paper describes the concepts of validation and the classes of checks that are carried out by the program PLATON as part of the IUCr check CIF facility.  PLATON validation can be run at any stage of the structure refinement, independent of the structure detn. package used, and is recommended for use as a routine tool during or at least at the completion of every structure detn.  Two examples are discussed where proper validation procedures could have avoided the publication of incorrect structures that had serious consequences for the chem. involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ6b1zRgqUqbVg90H21EOLACvtfcHk0lgG02FBs-6zsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlChtw%253D%253D&md5=0a85de2407551632bb287508534904e2</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1107%2FS0021889802022112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889802022112%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DSingle-Crystal%2520Structure%2520Validation%2520with%2520the%2520Program%2520PLATON%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2003%26volume%3D36%26spage%3D7%26epage%3D13%26doi%3D10.1107%2FS0021889802022112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, A.</span></span> <span> </span><span class="NLM_article-title">EasySpin, a Comprehensive Software Package for Spectral Simulation and Analysis in EPR</span>. <i>J. Magn. Reson.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.jmr.2005.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.jmr.2005.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=16188474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12it7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2006&pages=42-55&author=S.+Stollauthor=A.+Schweiger&title=EasySpin%2C+a+Comprehensive+Software+Package+for+Spectral+Simulation+and+Analysis+in+EPR&doi=10.1016%2Fj.jmr.2005.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">EasySpin, a comprehensive software package for spectral simulation and analysis in EPR</span></div><div class="casAuthors">Stoll, Stefan; Schweiger, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Magnetic Resonance</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-55</span>CODEN:
                <span class="NLM_cas:coden">JMARF3</span>;
        ISSN:<span class="NLM_cas:issn">1090-7807</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">EasySpin, a computational package for spectral simulation and anal. in EPR, is described.  It is based on Matlab, a com. tech. computation software.  EasySpin provides extensive EPR-related functionality, ranging from elementary spin physics to data anal.  It provides routines for the simulation of liq.- and solid-state EPR and ENDOR spectra.  These simulation functions are built on novel algorithms that enhance scope, speed and accuracy of spectral simulations.  Spin systems with an arbitrary no. of electron and nuclear spins are supported.  The structure of the toolbox as well as the theor. background underlying its simulation functionality are presented, and some illustrative examples are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg4IrreHx5d7Vg90H21EOLACvtfcHk0lidzBGZ3kUN4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12it7bE&md5=2fffe78f07a39f44fa3279a64e68b5d3</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.jmr.2005.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmr.2005.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DStoll%26aufirst%3DS.%26aulast%3DSchweiger%26aufirst%3DA.%26atitle%3DEasySpin%252C%2520a%2520Comprehensive%2520Software%2520Package%2520for%2520Spectral%2520Simulation%2520and%2520Analysis%2520in%2520EPR%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D2006%26volume%3D178%26spage%3D42%26epage%3D55%26doi%3D10.1016%2Fj.jmr.2005.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><a href="http://Https://rockland-inc.com/Nuclear-Extract-Protocol.aspx" class="extLink">Https://rockland-inc.com/Nuclear-Extract-Protocol.aspx</a> (accessed
Oct 3, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Https%3A%2F%2Frockland-inc.com%2FNuclear-Extract-Protocol.aspx+%28accessed%0AOct+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tharaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardoll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khelifi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivry, Y.</span></span> <span> </span><span class="NLM_article-title">UFREASI: User-FRiendly Elemental DAta ProcesSIng. A Free and Easy-to-Use Tool for Elemental Data Treatment</span>. <i>Microchem. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.microc.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=10.1016%2Fj.microc.2015.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVOnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2015&pages=32-40&author=M.+Tharaudauthor=S.+Gardollauthor=O.+Khelifiauthor=M.+F.+Benedettiauthor=Y.+Sivry&title=UFREASI%3A+User-FRiendly+Elemental+DAta+ProcesSIng.+A+Free+and+Easy-to-Use+Tool+for+Elemental+Data+Treatment&doi=10.1016%2Fj.microc.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">uFREASI: user-FRiendly Elemental dAta procesSIng. A free and easy-to-use tool for elemental data treatment</span></div><div class="casAuthors">Tharaud, M.; Gardoll, S.; Khelifi, O.; Benedetti, M. F.; Sivry, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Microchemical Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-40</span>CODEN:
                <span class="NLM_cas:coden">MICJAN</span>;
        ISSN:<span class="NLM_cas:issn">0026-265X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) allows the quantification of trace and ultra-trace elements (mg/kg to fg/kg) by sepg. elements as a function of their mass-to-charge ratios (m/z) after ionisation into an argon plasma.  In spite of being rigorous and accurate, the "Results" modules provided by many manufacturers are often uneasy to use and operators have little control on the calcn.  Moreover, the large amt. of raw data generated makes the manual treatment very long and not reliable using a "home-made" spreadsheet.  The user-FRiendly Elemental dAta procesSIng (uFREASI) software presented in this paper follows a configurable step-by-step procedure allowing a quick and reliable data treatment plus an automatic uncertainty propagation.  The concn. calcn. is performed using the ordinary least square method after an external calibration.  The software proposes many options to correct and to monitor the signal, to warrant both quality and understanding of data treatment. uFREASI is supported by Windows, Mac OS X and Linux operating systems, is open and extensible, and is freely downloadable at http://www.ipgp.fr/∼tharaud/uFREASI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUp-vn1yhxrrVg90H21EOLACvtfcHk0lidzBGZ3kUN4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVOnur8%253D&md5=a1868d65bddff731c07ac6c7ef62b19c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.microc.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.microc.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DTharaud%26aufirst%3DM.%26aulast%3DGardoll%26aufirst%3DS.%26aulast%3DKhelifi%26aufirst%3DO.%26aulast%3DBenedetti%26aufirst%3DM.%2BF.%26aulast%3DSivry%26aufirst%3DY.%26atitle%3DUFREASI%253A%2520User-FRiendly%2520Elemental%2520DAta%2520ProcesSIng.%2520A%2520Free%2520and%2520Easy-to-Use%2520Tool%2520for%2520Elemental%2520Data%2520Treatment%26jtitle%3DMicrochem.%2520J.%26date%3D2015%26volume%3D121%26spage%3D32%26epage%3D40%26doi%3D10.1016%2Fj.microc.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00431">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33316"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00431?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00431</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">NMR spectra and HPLC chromatogram, CV and RDE spectra, and electrochemical data of <b>Ru-sq</b>; crystallographic data of <b>[Ru(DIP)2(sq)](Cl)</b>; selected bond lengths and angles of <b>Ru-1</b> and <b>Ru-2</b> molecules; EPR spectra of <b>Ru-sq</b>, its reduced form <b>Ru-sq<sup>–</sup></b>, and its oxidized form <b>Ru-sq<sup>+</sup></b>; overlap of <sup>1</sup>H spectra of <b>Ru-sq</b> in DMSO over 8 days; UV traces of UPLC analysis of <b>Ru-sq</b> and percentage concentration of <b>Ru-sq</b> over time; fluorometric cell viability assay; CellTiter-Glo viability test; dot plots of cell death mechanism; cellular uptake mechanism; oxygen consumption rates and different respiration parameters in HeLa cells; extracellular acidification rate and different parameters of glycolytic respiration in HeLa cells; fuel flex assay in HeLa cells; and Akt-1 protein levels in HeLa cells treated with different concentrations of <b>Ru-sq</b>, doxorubicin, and cisplatin (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_001.pdf">jm0c00431_si_001.pdf (2.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00431/suppl_file/jm0c00431_si_002.csv">jm0c00431_si_002.csv (0.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00431&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00431%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00431" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a3365fe57d1a7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
